##ANALYSISTYPE=GERMLINE_TRIO
##PIPELINE=megSAP 0.1-1218-gf50c11d
##SAMPLE=<ID=GS140127_01,Gender=male,ExternalSampleName=131787,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
##SAMPLE=<ID=GS140550_01,Gender=male,ExternalSampleName=131751,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##SAMPLE=<ID=GS140549_01,Gender=female,ExternalSampleName=131752,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##DESCRIPTION=GS140127_01=genotype of sample GS140127_01
##DESCRIPTION=GS140550_01=genotype of sample GS140550_01
##DESCRIPTION=GS140549_01=genotype of sample GS140549_01
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=fathmm-MKL=fathmm-MKL score (for coding/non-coding regions). Deleterious threshold > 0.5.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=GeneSplicer=GeneSplicer splicing prediction (state/type/coordinates/confidence/score).
##DESCRIPTION=dbscSNV=dbscSNV splicing prediction (ADA/RF score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group (empty because group is n/a).
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=gene_blacklist=The gene(s) are contained on the blacklist of unreliable genes.
##FILTER=off-target=Variant marked as 'off-target'.
#chr	start	end	ref	obs	GS140127_01	GS140550_01	GS140549_01	filter	quality	gene	variant_type	coding_and_splicing	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	phyloP	Sift	PolyPhen	fathmm-MKL	CADD	REVEL	MaxEntScan	GeneSplicer	dbscSNV	COSMIC	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	957898	957898	G	T	hom	het	hom	off-target	QUAL=3682;DP=62,55,45;AF=0.98,0.64,1.00;MQM=60	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:exon2/35:c.463+56G>T::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs2799064	0.3285	0.3627	2084,.		-2.0720			0.00,0.12	3.31						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	977330	977330	T	C	hom	hom	hom		QUAL=1743;DP=13,26,20;AF=1.00,1.00,1.00;MQM=60	AGRN	splice_region&intron	AGRN:ENST00000379370:splice_region_variant&intron_variant:LOW:exon6/35:c.1178-6T>C::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128292 [benign DISEASE=not specified];			rs2799066	0.8852	0.9233	12149,.	0.7112,0.9515,0.9998,0.9180,0.9530	-0.8450			0.01,0.17	4.36		6.81>6.95		0.000/0.002		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	977570	977570	G	A	hom	hom	hom	off-target	QUAL=1516;DP=18,21,15;AF=1.00,1.00,1.00;MQM=59	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:exon7/35:c.1384+28G>A::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263159 [benign DISEASE=not specified];			rs2710876	0.7941	0.8973	10585,.	0.4355,0.9316,0.9726,0.9149,0.9451	-1.5510			0.03,0.18	3.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	978604	978605	CT	-	wt	het	wt	off-target	QUAL=1656;DP=59,192,167;AF=0.00,0.49,0.00;MQM=60	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:exon7/35:c.1385-15_1385-14del::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263160 [benign DISEASE=not specified];			rs35881187	0.4792	0.5514	3578,.	0.0943,0.6972,0.7858,0.5385,0.5463	0.0350				4.90						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	981087	981087	A	G	hom	hom	hom	off-target	QUAL=5690;DP=66,64,51;AF=1.00,1.00,1.00;MQM=59	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:exon14/35:c.2537-26A>G::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263172 [benign DISEASE=not specified];			rs3128098	0.8694	0.9206	11837,.	0.6365,0.9462,0.9999,0.9247,0.9552	-0.5730			0.04,0.15	1.32						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	981931	981931	A	G	hom	hom	hom		QUAL=6180;DP=51,93,69;AF=1.00,1.00,1.00;MQM=59	AGRN	synonymous	AGRN:ENST00000379370:synonymous_variant:LOW:exon18/36:c.3066A>G:p.Ser1022=:		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128297 [benign DISEASE=not specified];			rs2465128		0.8865	10697,.	0.4974,0.9296,0.9677,0.9059,0.8885	-1.7540			0.02,0.07	0.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	982941	982941	T	C	hom	hom	hom	off-target	QUAL=9200;DP=48,149,105;AF=1.00,1.00,1.00;MQM=59	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:exon20/35:c.3517-12T>C::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263181 [benign DISEASE=not specified];			rs3128102		0.8963	10707,.	0.4469,0.9319,0.9726,0.9133,0.9443	0.1090			0.03,0.17	2.83		6.84>6.29		0.000/0.014		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	982994	982994	T	C	hom	hom	hom		QUAL=15323;DP=134,208,142;AF=0.99,1.00,1.00;MQM=59	AGRN	synonymous	AGRN:ENST00000379370:synonymous_variant:LOW:exon21/36:c.3558T>C:p.Phe1186=:PF01390		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128302 [benign DISEASE=not specified];			rs10267	0.8359	0.9083	11210,.	0.5251,0.9388,0.9995,0.9167,0.9527	0.5010			0.09,0.93	4.81						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	984302	984302	T	C	het	hom	wt		QUAL=587;DP=9,19,17;AF=0.67,1.00,0.00;MQM=60	AGRN	synonymous	AGRN:ENST00000379370:synonymous_variant:LOW:exon24/36:c.4161T>C:p.Thr1387=:	regulatory_region_variant:open_chromatin_region	103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128307 [benign DISEASE=not specified];			rs9442391	0.5457	0.5883	4023,.	0.2729,0.7050,0.8196,0.5652,0.5594	-1.1240			0.01,0.16	0.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	985266	985266	C	T	het	hom	wt	off-target	QUAL=583;DP=8,20,11;AF=0.50,1.00,0.00;MQM=60	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:exon26/35:c.4745-17C>T::	regulatory_region_variant:open_chromatin_region	103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263188 [benign DISEASE=not specified];			rs2275813	0.4952	0.5575	3542,.	0.1480,0.7111,0.8103,0.5353,0.5454	1.9730			0.19,0.18	1.02		11.49>11.28				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	985444	985444	G	-	hom	wt	hom	off-target	QUAL=311;DP=4,6,9;AF=0.75,1.00,1.00;MQM=60	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:exon27/35:c.4879+41del::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs774490460		0.5598	3743,.	0.7422,0.5306,0.6485,0.4549,0.4871	0.1170				5.71						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	985446	985446	G	T	wt	het	wt	off-target	QUAL=311;DP=4,6,9;AF=0.75,1.00,1.00;MQM=60	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:exon27/35:c.4879+29G>T::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263191 [benign DISEASE=not specified];			rs2275812	0.3355	0.4151	1553,.	0.1015,0.4381,0.1553,0.4588,0.4611	-0.8900			0.08,0.12	1.10			gain/donor/985445-985446/Medium/5.794882			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	985449	985449	G	A	wt	hom	wt	off-target	QUAL=311;DP=4,6,9;AF=0.75,1.00,1.00;MQM=60	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:exon27/35:c.4879+32G>A::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263192 [benign DISEASE=not specified];			rs2799067	0.5256	0.5832	2268,.	0.2618,0.5481,0.5050,0.6172,0.6162	0.1530			0.03,0.07	0.10						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	985450	985450	G	A	hom	wt	hom	off-target	QUAL=311;DP=4,6,9;AF=0.75,1.00,1.00;MQM=60	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:exon27/35:c.4879+33G>A::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs397834473	0.4465	0.5096	3832,.	0.6971,0.4836,0.6056,0.4288,0.4499	-0.4470			0.15,0.26	7.75						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	987200	987200	C	T	hom	hom	hom		QUAL=10521;DP=63,150,134;AF=0.97,0.99,1.00;MQM=60	AGRN	splice_region&intron	AGRN:ENST00000379370:splice_region_variant&intron_variant:LOW:exon33/35:c.5651+5C>T::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128317 [benign DISEASE=not specified];			rs9803031		0.8871	10698,.	0.4387,0.9320,0.9957,0.9082,0.8828	-0.9360			0.02,0.14	0.29		9.65>8.73		0.000/0.016		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990280	990280	C	T	wt	het	het		QUAL=4765;DP=100,207,174;AF=0.00,0.59,0.51;MQM=60	AGRN	synonymous	AGRN:ENST00000379370:synonymous_variant:LOW:exon36/36:c.6057C>T:p.Asp2019=:PF00054	regulatory_region_variant:CTCF_binding_site	103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128319 [benign DISEASE=not specified];			rs4275402		0.6764	5782,.	0.3114,0.7722,0.8138,0.6980,0.6133	-0.7110			0.35,0.88	12.22						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990380	990380	C	T	hom	het	het		QUAL=12356;DP=159,428,329;AF=0.98,0.49,0.44;MQM=60	AGRN	3'UTR	AGRN:ENST00000379370:3_prime_UTR_variant:MODIFIER:exon36/36:c.*19C>T::	regulatory_region_variant:CTCF_binding_site	103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263157 [benign DISEASE=not specified];			rs3121561	0.3434	0.3621	2197,.	0.5233,0.2137,0.1794,0.2920,0.3087	-0.1240			0.05,0.09	0.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990417	990417	T	C	hom	het	het		QUAL=16537;DP=186,502,389;AF=0.99,0.49,0.46;MQM=59	AGRN,RP11-54O7.14	3'UTR,non_coding_transcript_exon	AGRN:ENST00000379370:3_prime_UTR_variant:MODIFIER:exon36/36:c.*56T>C::,RP11-54O7.14:ENST00000418300:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.5T>C::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs2465136	0.3840	0.3941	2699,.		0.3020			0.78,0.96	12.68						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32), RP11-54O7.14 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	990517	990517	C	T	hom	hom	het		QUAL=18344;DP=119,371,285;AF=0.99,1.00,0.48;MQM=60	AGRN,RP11-54O7.14	3'UTR,non_coding_transcript_exon	AGRN:ENST00000379370:3_prime_UTR_variant:MODIFIER:exon36/36:c.*156C>T::,RP11-54O7.14:ENST00000418300:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.105C>T::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs2710872	0.9179	0.8773	12103,.		-0.4100			0.04,0.14	3.67						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32), RP11-54O7.14 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	990773	990773	C	T	hom	hom	het		QUAL=22307;DP=178,404,296;AF=1.00,1.00,0.54;MQM=60	AGRN,RP11-54O7.14	3'UTR,intron&non_coding_transcript	AGRN:ENST00000379370:3_prime_UTR_variant:MODIFIER:exon36/36:c.*412C>T::,RP11-54O7.14:ENST00000418300:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.183+178C>T::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs2799072	0.8460	0.8187	10690,.		-0.5960			0.05,0.13	1.94						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32), RP11-54O7.14 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	990806	990806	G	A	hom	hom	het		QUAL=24451;DP=209,448,311;AF=1.00,1.00,0.54;MQM=60	AGRN,RP11-54O7.14	3'UTR,intron&non_coding_transcript	AGRN:ENST00000379370:3_prime_UTR_variant:MODIFIER:exon36/36:c.*445G>A::,RP11-54O7.14:ENST00000418300:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.183+211G>A::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs2799073		0.8188	10688,.		-0.1840			0.06,0.14	6.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32), RP11-54O7.14 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	990984	990984	G	A	hom	hom	het		QUAL=15848;DP=145,272,190;AF=1.00,1.00,0.59;MQM=59	AGRN,RP11-54O7.14	3'UTR,intron&non_coding_transcript	AGRN:ENST00000379370:3_prime_UTR_variant:MODIFIER:exon36/36:c.*623G>A::,RP11-54O7.14:ENST00000418300:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.184-294G>A::		103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs8014		0.8811	12210,.		-2.5600			0.00,0.06	0.79						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32), RP11-54O7.14 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	1956362	1956362	G	A	hom	het	het	off-target	QUAL=6554;DP=80,170,172;AF=1.00,0.48,0.49;MQM=60	GABRD	intron	GABRD:ENST00000378585:intron_variant:MODIFIER:exon1/8:c.69-19G>A::		137163 [GENE=GABRD PHENOS=Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant];	256824 [benign DISEASE=not specified];			rs2376805	0.7756	0.8119	10356,.	0.7935,0.7394,0.7174,0.8311,0.7722	-0.2280			0.00,0.15	0.89		7.68>6.22				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	1957037	1957037	T	C	het	het	wt		QUAL=6718;DP=155,399,340;AF=0.53,0.49,0.00;MQM=59	GABRD	synonymous	GABRD:ENST00000378585:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:PF02931		137163 [GENE=GABRD PHENOS=Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant];	256823 [benign DISEASE=not specified,not provided];			rs2229110	0.5613	0.6469	6668,.	0.7305,0.4736,0.3137,0.6572,0.4740	-1.3800			0.07,0.88	16.31						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	1957220	1957220	G	-	het	het	wt	off-target	QUAL=1331;DP=53,76,54;AF=0.47,0.51,0.00;MQM=60	GABRD	intron	GABRD:ENST00000378585:intron_variant:MODIFIER:exon4/8:c.470+45del::		137163 [GENE=GABRD PHENOS=Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant];				rs3831907	0.1080	0.1196	281,.	0.2114,0.0549,0.0248,0.1141,0.0777	-4.7340				0.18						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	1960674	1960674	C	T	het	wt	het		QUAL=4894;DP=115,385,265;AF=0.49,0.01,0.56;MQM=59	GABRD	synonymous	GABRD:ENST00000378585:synonymous_variant:LOW:exon7/9:c.816C>T:p.Ser272=:PF02932		137163 [GENE=GABRD PHENOS=Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant];	256825 [benign DISEASE=not specified];			rs28408173	0.1983	0.1918	416,.	0.0319,0.2378,0.4717,0.1428,0.2543	-0.7780			0.10,0.96	5.65						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	1961408	1961408	C	T	het	wt	het	off-target	QUAL=1598;DP=68,73,64;AF=0.56,0.01,0.50;MQM=59	GABRD	intron	GABRD:ENST00000378585:intron_variant:MODIFIER:exon8/8:c.1060-14C>T::		137163 [GENE=GABRD PHENOS=Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant];	256822 [benign DISEASE=not specified];			rs28431879	0.1999	0.1856	434,.	0.0295,0.2369,0.4852,0.1366,0.2428	-1.4010			0.00,0.11	0.13		7.61>6.94				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2337277	2337277	C	T	het	n/a	n/a		QUAL=107;DP=20,1,1;AF=0.40,0.00,0.00;MQM=60	PEX10	splice_region&intron,intron	PEX10:ENST00000288774:splice_region_variant&intron_variant:LOW:exon5/5:c.973-4G>A::,PEX10:ENST00000447513:splice_region_variant&intron_variant:LOW:exon5/5:c.913-4G>A::,PEX10:ENST00000507596:intron_variant:MODIFIER:exon5/5:c.913-10G>A::	regulatory_region_variant:promoter_flanking_region	602859 [GENE=PEX10 PHENOS=Peroxisome biogenesis disorder 6A (Zellweger),614870,Autosomal recessive/Peroxisome biogenesis disorder 6B,614871,Autosomal recessive];	262791 [benign/likely benign DISEASE=Zellweger syndrome,not specified,not provided];			rs11586985	0.0809	0.1050	168,.	0.0217,0.0584,0.1222,0.1219,0.1099	-1.9740			0.08,0.13	0.61		13.68>13.46,-18.79>-18.77		0.000/0.002		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2338126	2338126	C	A	wt	het	het	off-target	QUAL=1036;DP=46,55,44;AF=0.00,0.49,0.48;MQM=60	PEX10	intron	PEX10:ENST00000288774:intron_variant:MODIFIER:exon4/5:c.836+33G>T::,PEX10:ENST00000447513:intron_variant:MODIFIER:exon4/5:c.776+33G>T::,PEX10:ENST00000507596:intron_variant:MODIFIER:exon4/5:c.776+33G>T::	regulatory_region_variant:CTCF_binding_site	602859 [GENE=PEX10 PHENOS=Peroxisome biogenesis disorder 6A (Zellweger),614870,Autosomal recessive/Peroxisome biogenesis disorder 6B,614871,Autosomal recessive];				rs3795269	0.3391	0.4016	2574,.	0.2892,0.4078,0.2649,0.4329,0.3642	0.5730			0.20,0.15	5.25						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2340200	2340200	T	C	wt	het	het		QUAL=985;DP=41,48,39;AF=0.02,0.54,0.44;MQM=60	PEX10	synonymous	PEX10:ENST00000288774:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757,PEX10:ENST00000447513:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757,PEX10:ENST00000507596:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757		602859 [GENE=PEX10 PHENOS=Peroxisome biogenesis disorder 6A (Zellweger),614870,Autosomal recessive/Peroxisome biogenesis disorder 6B,614871,Autosomal recessive];	129884 [benign DISEASE=Zellweger syndrome,not specified,not provided];			rs2494598		0.7735	8639,.	0.5917,0.7710,0.7184,0.8112,0.7245	-6.5230			0.03,0.05	0.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	5922834	5922834	C	A	het	hom	wt	off-target	QUAL=1543;DP=54,42,26;AF=0.37,1.00,0.00;MQM=60	NPHP4,MIR4689	downstream_gene,upstream_gene	NPHP4:ENST00000378156:downstream_gene_variant:MODIFIER::::,MIR4689:ENST00000582517:upstream_gene_variant:MODIFIER::::						rs12133533	0.0966	0.1249	305,.	0.0152,0.0833,0.0529,0.1640,0.1101	-0.3700			0.06,0.16	0.97						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78), MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	5926507	5926507	T	C	het	hom	wt		QUAL=8883;DP=271,183,153;AF=0.50,0.99,0.00;MQM=60	NPHP4	synonymous	NPHP4:ENST00000378156:synonymous_variant:LOW:exon26/30:c.3570A>G:p.Glu1190=:	regulatory_region_variant:open_chromatin_region	607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	95683 [benign DISEASE=Nephronophthisis,Renal dysplasia and retinal aplasia,not specified];			rs555164	0.3197	0.3926	2149,.	0.2002,0.3706,0.2558,0.4222,0.4302	0.2880			0.02,0.92	13.85						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5927031	5927031	A	G	het	hom	wt	off-target	QUAL=3719;DP=80,96,65;AF=0.48,1.00,0.00;MQM=60	NPHP4	intron	NPHP4:ENST00000378156:intron_variant:MODIFIER:exon25/29:c.3558+59T>C::		607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];				rs12122135	0.1028	0.1260	296,.		-0.2430			0.02,0.10	0.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5927943	5927943	G	A	wt	het	wt		QUAL=3623;DP=131,358,269;AF=0.00,0.48,0.00;MQM=60	NPHP4	missense	NPHP4:ENST00000378156:missense_variant:MODERATE:exon24/30:c.3329C>T:p.Ala1110Val:		607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	95682 [likely benign(replaced by megSAP based on classifications:1x1,1x2,3x3) DISEASE=Nephronophthisis,Renal dysplasia and retinal aplasia,not specified];	CM125782 [CLASS=DM MUT=ALT PHEN="Cardiovascular malformations" GENE=NPHP4];		rs139767853	0.0014	0.0037	0,.	0.0012,0.0030,0.0000,0.0060,0.0008	0.0280	T(0.55)	B(0.01)	0.08,0.26	6.43	0.32		gain/donor/5927942-5927943/Medium/6.530789			1	69						NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5934490	5934490	A	G	hom	hom	het	off-target	QUAL=5970;DP=74,112,68;AF=0.99,1.00,0.49;MQM=60	NPHP4	intron	NPHP4:ENST00000378156:intron_variant:MODIFIER:exon22/29:c.3231+41T>C::		607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	260554 [benign DISEASE=not specified];			rs868163	0.5693	0.6453	6624,.	0.7125,0.4989,0.2688,0.6436,0.6148	-3.6260			0.01,0.09	0.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5935162	5935162	A	T	het	het	hom		QUAL=4958;DP=86,128,87;AF=0.38,0.52,1.00;MQM=60	NPHP4	splice_acceptor	NPHP4:ENST00000378156:splice_acceptor_variant:HIGH:exon20/29:c.2818-2T>A::		607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	167375 [benign DISEASE=not specified];			rs1287637		0.8606	11601,.	0.8938,0.7936,0.8101,0.8244,0.8282	0.4530			0.00,0.85	22.60		0.90>9.27	gain/acceptor/5935162-5935163/High/14.274034			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5937391	5937391	C	T	n/a	hom	n/a	off-target	QUAL=157;DP=1,4,0;AF=1.00,1.00,;MQM=60	NPHP4	intron	NPHP4:ENST00000378156:intron_variant:MODIFIER:exon19/29:c.2612-33G>A::		607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	260547 [benign DISEASE=not specified];			rs3747989		0.8299	10876,.	0.9382,0.7305,0.8517,0.8010,0.7363	-2.2310			0.00,0.05	0.24						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5947308	5947308	G	A	wt	het	wt	off-target	QUAL=1780;DP=128,187,146;AF=0.00,0.42,0.01;MQM=60	NPHP4	intron	NPHP4:ENST00000378156:intron_variant:MODIFIER:exon18/29:c.2485+38C>T::		607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	260546 [benign DISEASE=not specified];			rs41280814	0.0863	0.1342	259,.	0.0275,0.0789,0.0795,0.1716,0.1155	-1.8090			0.05,0.17	1.63						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5965381	5965381	C	T	wt	het	wt		QUAL=2692;DP=207,262,206;AF=0.00,0.43,0.00;MQM=60	NPHP4	synonymous	NPHP4:ENST00000378156:synonymous_variant:LOW:exon15/30:c.1926G>A:p.Glu642=:		607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	95673 [benign/likely benign DISEASE=Nephronophthisis,Renal dysplasia and retinal aplasia,not specified];			rs12120967	0.0841	0.1317	259,.	0.0271,0.0767,0.0768,0.1672,0.1125	-0.7650			0.03,0.33	1.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5987696	5987696	T	C	wt	het	wt	off-target	QUAL=2420;DP=133,184,150;AF=0.00,0.54,0.02;MQM=60	NPHP4	intron	NPHP4:ENST00000378156:intron_variant:MODIFIER:exon11/29:c.1441+13A>G::		607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	95671 [benign/likely benign DISEASE=Nephronophthisis,Renal dysplasia and retinal aplasia,not specified];			rs7520105	0.1412	0.1688	428,.	0.2101,0.0876,0.0770,0.1681,0.1150	0.8260			0.31,0.17	8.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	6046432	6046432	C	G	wt	het	wt	off-target	QUAL=788;DP=52,52,46;AF=0.00,0.63,0.02;MQM=60	NPHP4	intron	NPHP4:ENST00000378156:intron_variant:MODIFIER:exon1/29:c.-38-45G>C::		607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];				rs1295111	0.3878	0.4104	2658,.		-0.1940			0.09,0.19	1.88						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	6052571	6052571	G	A	wt	het	wt	off-target	QUAL=398;DP=3,39,29;AF=0.00,0.51,0.00;MQM=60	KCNAB2	5'UTR,intron	KCNAB2:ENST00000378097:5_prime_UTR_variant:MODIFIER:exon1/16:c.-330G>A::,KCNAB2:ENST00000378111:intron_variant:MODIFIER:exon1/7:c.-53+955G>A::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site					rs61760765	0.0218	0.0351	27,.		-0.2790			0.16,0.33	10.39						1	25						KCNAB2 (inh=AD oe_syn=0.95 oe_mis=0.55 oe_lof=0.18)
chr1	6052581	6052581	G	A	n/a	hom	het	off-target	QUAL=1335;DP=1,33,28;AF=1.00,1.00,0.68;MQM=60	KCNAB2	5'UTR,intron	KCNAB2:ENST00000378097:5_prime_UTR_variant:MODIFIER:exon1/16:c.-320G>A::,KCNAB2:ENST00000378111:intron_variant:MODIFIER:exon1/7:c.-53+965G>A::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site					rs806109		0.8310	10906,.		0.0500			0.10,0.21	9.08						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNAB2 (inh=AD oe_syn=0.95 oe_mis=0.55 oe_lof=0.18)
chr1	6526183	6526183	G	A	het	het	wt		QUAL=379;DP=12,20,5;AF=0.50,0.70,0.00;MQM=59	PLEKHG5,TNFRSF25	3'UTR,5'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,TNFRSF25:ENST00000351959:5_prime_UTR_variant:MODIFIER:exon1/9:c.-16C>T::,TNFRSF25:ENST00000356876:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1440C>T::,TNFRSF25:ENST00000377782:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::	regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297904 [benign DISEASE=Distal spinal muscular atrophy];			rs3007417	0.2023	0.1843	1065,.	0.5020,0.0510,0.0004,0.0703,0.0791	-0.6580			0.06,0.14	8.54			gain/donor/6526182-6526183/Medium/3.418541			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33)
chr1	6526203	6526210	CGTGCTCT	-	het	het	wt		QUAL=374;DP=11,21,6;AF=0.55,0.67,0.00;MQM=59	PLEKHG5,TNFRSF25	3'UTR,5'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1413_*1420del::,TNFRSF25:ENST00000351959:5_prime_UTR_variant:MODIFIER:exon1/9:c.-43_-36del::,TNFRSF25:ENST00000356876:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1413_*1420del::,TNFRSF25:ENST00000377782:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1413_*1420del::	regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297905 [benign DISEASE=Distal spinal muscular atrophy];			rs45616733	0.2027	0.1839	1053,.	0.4251,0.0464,0.0006,0.0579,0.0691	0.8620				10.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33)
chr1	6526241	6526244	CGCC	-	hom	het	wt		QUAL=317;DP=4,15,3;AF=1.00,0.73,0.00;MQM=60	PLEKHG5,TNFRSF25	3'UTR,5'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1379_*1382del::,TNFRSF25:ENST00000356876:5_prime_UTR_variant:MODIFIER:exon1/10:c.-77_-74del::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1379_*1382del::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1379_*1382del::	regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297906 [benign DISEASE=Distal spinal muscular atrophy];			rs45542640	0.2025	0.1838	1069,.		1.0930				6.53						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33)
chr1	6526319	6526319	C	T	het	het	wt		QUAL=296;DP=30,32,30;AF=0.37,0.38,0.00;MQM=60	PLEKHG5	3'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1304G>A::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1304G>A::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1304G>A::	regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297910 [likely benign DISEASE=Distal spinal muscular atrophy];			rs45604837	0.0863	0.0841	157,.		-0.5600			0.05,0.16	4.90						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6526465	6526465	C	G	het	het	wt		QUAL=3432;DP=81,199,150;AF=0.48,0.54,0.00;MQM=60	PLEKHG5	3'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1158G>C::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1158G>C::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1158G>C::	regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297912 [benign DISEASE=Distal spinal muscular atrophy];		MIR3 (SINE/MIR)	rs2986754	0.2043	0.1816	1155,.		-0.5720			0.01,0.10	1.23						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6526858	6526858	A	-	het	het	het		QUAL=253;DP=44,6,6;AF=0.25,0.17,0.50;MQM=60	PLEKHG5	3'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*765del::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*765del::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*765del::		611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297922 [uncertain significance DISEASE=Distal spinal muscular atrophy];		AluSz (SINE/Alu)	rs372197062		0.0962	182,.		-2.9090				0.12						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6527333	6527333	A	G	het	het	wt		QUAL=1589;DP=75,59,53;AF=0.51,0.47,0.00;MQM=60	PLEKHG5	3'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377725:3_prime_UTR_variant:MODIFIER:exon22/22:c.*318T>C::,PLEKHG5:ENST00000377728:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377732:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377737:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000377740:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000400915:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000535355:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::	regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297928 [benign DISEASE=Distal spinal muscular atrophy];			rs14708	0.2670	0.2632	1682,.		2.0370			0.00,0.11	11.50						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6529183	6529185	TCC	-	het	het	wt		QUAL=1156;DP=39,101,58;AF=0.38,0.45,0.05;MQM=60	PLEKHG5	inframe_deletion	PLEKHG5:ENST00000340850:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377725:inframe_deletion:MODERATE:exon19/22:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377728:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377732:inframe_deletion:MODERATE:exon19/21:c.2277_2279del:p.Glu760del:,PLEKHG5:ENST00000377737:inframe_deletion:MODERATE:exon20/22:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377740:inframe_deletion:MODERATE:exon20/22:c.2397_2399del:p.Glu800del:,PLEKHG5:ENST00000377748:inframe_deletion:MODERATE:exon20/22:c.2397_2399del:p.Glu800del:,PLEKHG5:ENST00000400913:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000400915:inframe_deletion:MODERATE:exon20/22:c.2334_2336del:p.Glu779del:,PLEKHG5:ENST00000535355:inframe_deletion:MODERATE:exon19/21:c.2373_2375del:p.Glu792del:,PLEKHG5:ENST00000537245:inframe_deletion:MODERATE:exon20/22:c.2403_2405del:p.Glu802del:,PLEKHG5:ENST00000544978:inframe_deletion:MODERATE:exon20/22:c.2166_2168del:p.Glu723del:	regulatory_region_variant:promoter_flanking_region	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	194979 [benign/likely benign DISEASE=Distal spinal muscular atrophy,not specified];		(TCC)n (Simple_repeat)	rs113541584	0.0972	0.0848	125,.	0.1890,0.0573,0.0085,0.0753,0.0956	0.1060				12.29					COSM4590012,COSM4590013,COSM911543	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6529443	6529443	A	G	het	het	wt		QUAL=9645;DP=314,486,391;AF=0.48,0.48,0.00;MQM=60	PLEKHG5	synonymous	PLEKHG5:ENST00000340850:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377725:synonymous_variant:LOW:exon18/22:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377728:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377732:synonymous_variant:LOW:exon18/21:c.2112T>C:p.Ser704=:,PLEKHG5:ENST00000377737:synonymous_variant:LOW:exon19/22:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377740:synonymous_variant:LOW:exon19/22:c.2232T>C:p.Ser744=:,PLEKHG5:ENST00000377748:synonymous_variant:LOW:exon19/22:c.2232T>C:p.Ser744=:,PLEKHG5:ENST00000400913:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000400915:synonymous_variant:LOW:exon19/22:c.2169T>C:p.Ser723=:,PLEKHG5:ENST00000535355:synonymous_variant:LOW:exon18/21:c.2208T>C:p.Ser736=:,PLEKHG5:ENST00000537245:synonymous_variant:LOW:exon19/22:c.2238T>C:p.Ser746=:,PLEKHG5:ENST00000544978:synonymous_variant:LOW:exon19/22:c.2001T>C:p.Ser667=:		611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	194881 [benign DISEASE=Distal spinal muscular atrophy,not specified];			rs730600	0.2696	0.2647	1701,.	0.5922,0.0937,0.0041,0.1423,0.1761	-0.2200			0.08,0.79	15.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6530435	6530435	A	G	het	het	wt	off-target	QUAL=1088;DP=39,55,49;AF=0.46,0.53,0.00;MQM=60	PLEKHG5	intron	PLEKHG5:ENST00000340850:intron_variant:MODIFIER:exon15/20:c.1681-20T>C::,PLEKHG5:ENST00000377725:intron_variant:MODIFIER:exon15/21:c.1681-20T>C::,PLEKHG5:ENST00000377728:intron_variant:MODIFIER:exon15/20:c.1681-20T>C::,PLEKHG5:ENST00000377732:intron_variant:MODIFIER:exon15/20:c.1792-20T>C::,PLEKHG5:ENST00000377737:intron_variant:MODIFIER:exon16/21:c.1681-20T>C::,PLEKHG5:ENST00000377740:intron_variant:MODIFIER:exon16/21:c.1912-20T>C::,PLEKHG5:ENST00000377748:intron_variant:MODIFIER:exon16/21:c.1912-20T>C::,PLEKHG5:ENST00000400913:intron_variant:MODIFIER:exon15/20:c.1681-20T>C::,PLEKHG5:ENST00000400915:intron_variant:MODIFIER:exon16/21:c.1849-20T>C::,PLEKHG5:ENST00000535355:intron_variant:MODIFIER:exon15/20:c.1888-20T>C::,PLEKHG5:ENST00000537245:intron_variant:MODIFIER:exon16/21:c.1918-20T>C::,PLEKHG5:ENST00000544978:intron_variant:MODIFIER:exon16/21:c.1681-20T>C::		611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];				rs2986753	0.1717	0.1803	622,.	0.3429,0.0779,0.0039,0.1301,0.1509	-0.4640			0.01,0.12	6.16		7.80>7.76				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6530965	6530965	-	G	hom	hom	hom	off-target	QUAL=5824;DP=37,115,83;AF=0.97,1.00,0.98;MQM=60	PLEKHG5	intron	PLEKHG5:ENST00000340850:intron_variant:MODIFIER:exon13/20:c.1393-22dup::,PLEKHG5:ENST00000377725:intron_variant:MODIFIER:exon13/21:c.1393-22dup::,PLEKHG5:ENST00000377728:intron_variant:MODIFIER:exon13/20:c.1393-22dup::,PLEKHG5:ENST00000377732:intron_variant:MODIFIER:exon13/20:c.1504-22dup::,PLEKHG5:ENST00000377737:intron_variant:MODIFIER:exon14/21:c.1393-22dup::,PLEKHG5:ENST00000377740:intron_variant:MODIFIER:exon14/21:c.1624-22dup::,PLEKHG5:ENST00000377748:intron_variant:MODIFIER:exon14/21:c.1624-22dup::,PLEKHG5:ENST00000400913:intron_variant:MODIFIER:exon13/20:c.1393-22dup::,PLEKHG5:ENST00000400915:intron_variant:MODIFIER:exon14/21:c.1561-22dup::,PLEKHG5:ENST00000535355:intron_variant:MODIFIER:exon13/20:c.1600-22dup::,PLEKHG5:ENST00000537245:intron_variant:MODIFIER:exon14/21:c.1630-22dup::,PLEKHG5:ENST00000544978:intron_variant:MODIFIER:exon14/21:c.1393-22dup::		611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];				rs111312565	1.0000	1.0000	15524,.	1.0000,1.0000,0.9999,1.0000,1.0000					3.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6531589	6531589	C	T	het	het	wt		QUAL=1641;DP=35,114,115;AF=0.66,0.45,0.00;MQM=60	PLEKHG5	missense	PLEKHG5:ENST00000340850:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621,PLEKHG5:ENST00000377725:missense_variant:MODERATE:exon12/22:c.1240G>A:p.Ala414Thr:PF00621,PLEKHG5:ENST00000377728:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621,PLEKHG5:ENST00000377732:missense_variant:MODERATE:exon12/21:c.1351G>A:p.Ala451Thr:PF00621,PLEKHG5:ENST00000377737:missense_variant:MODERATE:exon13/22:c.1240G>A:p.Ala414Thr:PF00621,PLEKHG5:ENST00000377740:missense_variant:MODERATE:exon13/22:c.1471G>A:p.Ala491Thr:PF00621,PLEKHG5:ENST00000377748:missense_variant:MODERATE:exon13/22:c.1471G>A:p.Ala491Thr:PF00621,PLEKHG5:ENST00000400913:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621,PLEKHG5:ENST00000400915:missense_variant:MODERATE:exon13/22:c.1408G>A:p.Ala470Thr:PF00621,PLEKHG5:ENST00000535355:missense_variant:MODERATE:exon12/21:c.1447G>A:p.Ala483Thr:PF00621,PLEKHG5:ENST00000537245:missense_variant:MODERATE:exon13/22:c.1477G>A:p.Ala493Thr:PF00621,PLEKHG5:ENST00000544978:missense_variant:MODERATE:exon13/22:c.1240G>A:p.Ala414Thr:PF00621	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297959 [likely benign DISEASE=Distal spinal muscular atrophy];			rs74809741	0.0553	0.0579	62,.	0.0889,0.0369,0.0002,0.0593,0.0518	0.6400	T(0.45),T(0.44),T(0.45),T(0.43),T(0.45),T(0.44),T(0.43),T(0.45),T(0.43),T(0.41),T(0.42),T(0.44)	B(0.01),B(0.00),B(0.01),B(0.01),B(0.01),B(0.00),B(0.01),B(0.01),B(0.01),B(0.01),B(0.01),B(0.00)	0.73,0.93	15.74	0.04					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6533393	6533393	G	C	het	het	wt		QUAL=479;DP=25,25,19;AF=0.44,0.56,0.00;MQM=60	PLEKHG5	missense	PLEKHG5:ENST00000340850:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377725:missense_variant:MODERATE:exon8/22:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377728:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377732:missense_variant:MODERATE:exon8/21:c.824C>G:p.Thr275Ser:,PLEKHG5:ENST00000377737:missense_variant:MODERATE:exon9/22:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377740:missense_variant:MODERATE:exon9/22:c.944C>G:p.Thr315Ser:,PLEKHG5:ENST00000377748:missense_variant:MODERATE:exon9/22:c.944C>G:p.Thr315Ser:,PLEKHG5:ENST00000400913:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000400915:missense_variant:MODERATE:exon9/22:c.881C>G:p.Thr294Ser:,PLEKHG5:ENST00000535355:missense_variant:MODERATE:exon8/21:c.920C>G:p.Thr307Ser:,PLEKHG5:ENST00000537245:missense_variant:MODERATE:exon9/22:c.950C>G:p.Thr317Ser:,PLEKHG5:ENST00000544978:missense_variant:MODERATE:exon9/22:c.713C>G:p.Thr238Ser:		611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	198895 [benign DISEASE=Distal spinal muscular atrophy,not specified];			rs61741379	0.2857	0.2786	1993,.	0.6445,0.0990,0.0072,0.1406,0.1621	0.8480	T(0.68),T(0.69),T(0.68),T(0.70),T(0.68),T(0.71),T(0.73),T(0.68),T(0.65),T(0.78),T(0.72),T(0.69)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.00,0.17	0.62	0.07					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6579521	6579521	G	C	het	het	het		QUAL=3405;DP=120,91,76;AF=0.53,0.52,0.46;MQM=60	PLEKHG5	5'UTR,missense	PLEKHG5:ENST00000377737:5_prime_UTR_variant:MODIFIER:exon1/22:c.-181C>G::,PLEKHG5:ENST00000377740:missense_variant:MODERATE:exon1/22:c.51C>G:p.Ser17Arg:,PLEKHG5:ENST00000377748:missense_variant:MODERATE:exon1/22:c.51C>G:p.Ser17Arg:	regulatory_region_variant:promoter_flanking_region	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];				rs17438786	0.0136	0.0242	10,.	0.0050,0.0165,0.0000,0.0326,0.0176	0.0870	 ,T(0.13),T(0.17)	 ,B(0.01),B(0.07)	0.13,0.49	9.74	0.09					10	394						PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6579607	6579607	C	T	hom	hom	hom		QUAL=19978;DP=175,269,204;AF=1.00,1.00,1.00;MQM=60	PLEKHG5	5'UTR	PLEKHG5:ENST00000377737:5_prime_UTR_variant:MODIFIER:exon1/22:c.-267G>A::,PLEKHG5:ENST00000377740:5_prime_UTR_variant:MODIFIER:exon1/22:c.-36G>A::,PLEKHG5:ENST00000377748:5_prime_UTR_variant:MODIFIER:exon1/22:c.-36G>A::	regulatory_region_variant:promoter_flanking_region	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	380860 [benign DISEASE=not specified];			rs1556035	0.7460	0.8595	9987,.	0.5189,0.9267,0.7933,0.8816,0.8645	0.2500			0.07,0.20	6.26						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6579843	6579843	C	T	hom	hom	hom		QUAL=41849;DP=290,585,454;AF=0.99,1.00,1.00;MQM=59	PLEKHG5	5'UTR	PLEKHG5:ENST00000377737:5_prime_UTR_variant:MODIFIER:exon1/22:c.-503G>A::,PLEKHG5:ENST00000377740:5_prime_UTR_variant:MODIFIER:exon1/22:c.-272G>A::,PLEKHG5:ENST00000377748:5_prime_UTR_variant:MODIFIER:exon1/22:c.-272G>A::	regulatory_region_variant:promoter_flanking_region	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];				rs1010584	0.7354	0.7734	9752,.		-0.5650			0.03,0.20	5.49						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	10318652	10318652	C	G	wt	wt	het		QUAL=2875;DP=314,250,229;AF=0.00,0.00,0.50;MQM=60	KIF1B	synonymous	KIF1B:ENST00000263934:synonymous_variant:LOW:exon4/47:c.285C>G:p.Ala95=:PF00225,KIF1B:ENST00000377081:synonymous_variant:LOW:exon3/48:c.285C>G:p.Ala95=:PF00225,KIF1B:ENST00000377083:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:PF00225,KIF1B:ENST00000377086:synonymous_variant:LOW:exon4/49:c.285C>G:p.Ala95=:PF00225,KIF1B:ENST00000377093:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:PF00225		605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	129399 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2,not specified];			rs12402052	0.2300	0.2766	1045,.	0.0864,0.3446,0.2917,0.2914,0.2293	0.0540			0.81,0.97	11.78						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10322054	10322054	G	A	wt	wt	het	off-target	QUAL=2023;DP=314,272,179;AF=0.00,0.00,0.46;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon5/46:c.429+26G>A::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon4/47:c.429+26G>A::,KIF1B:ENST00000377083:intron_variant:MODIFIER:exon5/20:c.429+26G>A::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon5/48:c.429+26G>A::,KIF1B:ENST00000377093:intron_variant:MODIFIER:exon5/20:c.429+26G>A::		605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs4846209	0.3399	0.3512	1943,.	0.3418,0.3938,0.3671,0.3431,0.2578	0.0780			0.00,0.08	3.30						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10327407	10327407	A	T	wt	wt	het	off-target	QUAL=1116;DP=256,130,100;AF=0.00,0.00,0.50;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon5/46:c.430-31A>T::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon4/47:c.430-31A>T::,KIF1B:ENST00000377083:intron_variant:MODIFIER:exon5/20:c.430-31A>T::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon5/48:c.430-31A>T::,KIF1B:ENST00000377093:intron_variant:MODIFIER:exon5/20:c.430-31A>T::		605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs12141246	0.3806	0.3770	2249,.	0.4133,0.3974,0.4087,0.3425,0.2575	-1.8450			0.00,0.07	2.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10328338	10328338	C	T	wt	wt	het	off-target	QUAL=2383;DP=239,187,186;AF=0.00,0.00,0.52;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon7/46:c.720+17C>T::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon6/47:c.720+17C>T::,KIF1B:ENST00000377083:intron_variant:MODIFIER:exon7/20:c.720+17C>T::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon7/48:c.720+17C>T::,KIF1B:ENST00000377093:intron_variant:MODIFIER:exon7/20:c.720+17C>T::		605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	260542 [benign DISEASE=not specified];			rs1339458	0.2540	0.2817	1113,.	0.1535,0.3485,0.2906,0.2919,0.2301	-1.1960			0.06,0.15	5.55						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10342629	10342629	G	A	wt	het	het	off-target	QUAL=5605;DP=180,224,219;AF=0.01,0.50,0.49;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon13/46:c.1296+38G>A::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon14/47:c.1434+38G>A::,KIF1B:ENST00000377083:intron_variant:MODIFIER:exon13/20:c.1296+38G>A::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon15/48:c.1434+38G>A::,KIF1B:ENST00000377093:intron_variant:MODIFIER:exon13/20:c.1296+38G>A::		605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];			L3 (LINE/CR1)	rs3748576	0.7127	0.7067	8153,.	0.9335,0.7352,0.5293,0.5971,0.6222	-0.7550			0.01,0.13	2.75						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10355834	10355834	C	T	wt	wt	het		QUAL=1539;DP=134,157,128;AF=0.01,0.00,0.48;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon17/46:c.1639+10C>T::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon18/47:c.1777+10C>T::,KIF1B:ENST00000377083:intron_variant:MODIFIER:exon17/20:c.1639+10C>T::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon19/48:c.1777+10C>T::,KIF1B:ENST00000377093:intron_variant:MODIFIER:exon17/20:c.1639+10C>T::	regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	177960 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2,not specified];			rs3753037	0.2640	0.2844	1165,.	0.1871,0.3503,0.2912,0.2920,0.2295	1.0480			0.09,0.20	4.17						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10357207	10357207	T	-	het	het	het	off-target	QUAL=3030;DP=138,219,155;AF=0.35,0.31,0.29;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon19/46:c.1905-9del::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon20/47:c.2043-9del::,KIF1B:ENST00000377083:intron_variant:MODIFIER:exon19/20:c.1905-9del::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon21/48:c.2043-9del::,KIF1B:ENST00000377093:intron_variant:MODIFIER:exon19/20:c.1905-9del::		605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];			(T)n (Simple_repeat)	rs199617049		0.4250	0,.	0.4308,0.4320,0.4215,0.4277,0.4367	-0.0240				0.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10366487	10366487	T	G	wt	wt	het		QUAL=2585;DP=247,227,230;AF=0.00,0.00,0.45;MQM=60	KIF1B	intron,3'UTR	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon20/46:c.1977+9183T>G::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon21/47:c.2115+9183T>G::,KIF1B:ENST00000377083:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon22/48:c.2115+9183T>G::,KIF1B:ENST00000377093:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::		605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs8019	0.3838	0.3972	2475,.		0.6540			0.00,0.09	2.21			gain/acceptor/10366486-10366487/Medium/2.203688			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10366692	10366692	C	G	wt	wt	het		QUAL=2901;DP=286,279,253;AF=0.00,0.00,0.47;MQM=60	KIF1B,RN7SL731P	intron,3'UTR,non_coding_transcript_exon	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon20/46:c.1977+9388C>G::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon21/47:c.2115+9388C>G::,KIF1B:ENST00000377083:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon22/48:c.2115+9388C>G::,KIF1B:ENST00000377093:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::,RN7SL731P:ENST00000584329:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.170C>G::	regulatory_region_variant:enhancer	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];			7SLRNA (srpRNA)	rs4623	0.3343	0.3429	1850,.		-0.5090			0.00,0.03	4.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10367424	10367424	G	A	wt	wt	het		QUAL=343;DP=114,46,43;AF=0.01,0.00,0.42;MQM=60	KIF1B	intron,3'UTR	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon20/46:c.1977+10120G>A::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon21/47:c.2115+10120G>A::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon22/48:c.2115+10120G>A::,KIF1B:ENST00000377093:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2719G>A::		605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];			AluSx (SINE/Alu)	rs2004034	0.2316	0.2406	1052,.		-0.1060			0.00,0.11	3.52						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10367591	10367591	T	C	wt	wt	het		QUAL=1131;DP=189,99,86;AF=0.00,0.01,0.58;MQM=60	KIF1B	intron,3'UTR	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon20/46:c.1977+10287T>C::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon21/47:c.2115+10287T>C::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon22/48:c.2115+10287T>C::,KIF1B:ENST00000377093:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2886T>C::		605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];			AluSx (SINE/Alu)	rs1065828	0.3341	0.3429	1865,.		-0.8920			0.00,0.03	3.81						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10384176	10384176	-	TTGAAA	het	het	het	off-target	QUAL=5222;DP=222,183,140;AF=0.44,0.43,0.46;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon23/46:c.2399+57_2399+58insTGAAAT::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon24/47:c.2537+57_2537+58insTGAAAT::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon25/48:c.2537+57_2537+58insTGAAAT::		605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs3831405	0.2326	0.2390	973,.						6.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10394536	10394536	C	G	het	het	het	off-target	QUAL=8196;DP=247,219,151;AF=0.53,0.53,0.48;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon25/46:c.2787-42C>G::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon26/47:c.2925-42C>G::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon27/48:c.2925-42C>G::		605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs2276100	0.3339	0.3308	1727,.	0.3230,0.3842,0.3667,0.3197,0.2621	-0.0570			0.09,0.23	6.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10397080	10397080	A	G	wt	het	wt	off-target	QUAL=1131;DP=202,101,79;AF=0.00,0.47,0.00;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon27/46:c.2992-52A>G::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon28/47:c.3130-52A>G::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon29/48:c.3130-52A>G::		605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs71643087	0.0112	0.0281	17,.		0.0100			0.01,0.20	3.94						6	373						KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10408838	10408838	T	-	het	wt	het	off-target	QUAL=121;DP=130,143,134;AF=0.16,0.10,0.17;MQM=59	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon35/46:c.3811+60del::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon36/47:c.3949+60del::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon37/48:c.3949+60del::		605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];			FRAM (SINE/Alu)	rs757373471		0.2842	3,.	0.2232,0.3608,0.4320,0.2693,0.2557	1.6680				0.94						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10420937	10420937	C	T	het	het	het	off-target	QUAL=11886;DP=258,372,298;AF=0.52,0.49,0.51;MQM=59	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon36/46:c.3918-50C>T::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon37/47:c.4056-50C>T::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon38/48:c.4056-50C>T::		605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs3748579	0.3341	0.3302	1713,.	0.3225,0.3839,0.3664,0.3196,0.2625	-0.4610			0.01,0.18	2.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10425118	10425118	T	-	het	het	het	off-target	QUAL=3230;DP=98,111,87;AF=0.47,0.52,0.46;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon39/46:c.4229-33del::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon40/47:c.4367-33del::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon41/48:c.4367-33del::		605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs34161257	0.5240	0.5252	4371,.	0.6622,0.4695,0.3722,0.4743,0.4639	0.5110				4.23						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10431158	10431158	T	C	het	het	het	off-target	QUAL=7041;DP=217,224,156;AF=0.45,0.53,0.47;MQM=60	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:exon42/46:c.4687-41T>C::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon43/47:c.4825-41T>C::,KIF1B:ENST00000377086:intron_variant:MODIFIER:exon44/48:c.4825-41T>C::		605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs17411502	0.2490	0.2841	1126,.	0.1495,0.3490,0.2841,0.2958,0.2375	-0.7390			0.03,0.17	11.51						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10435324	10435324	C	A	het	het	het		QUAL=7217;DP=295,148,115;AF=0.45,0.52,0.57;MQM=60	KIF1B	synonymous	KIF1B:ENST00000263934:synonymous_variant:LOW:exon46/47:c.5163C>A:p.Thr1721=:PF00169,KIF1B:ENST00000377081:synonymous_variant:LOW:exon47/48:c.5301C>A:p.Thr1767=:PF00169,KIF1B:ENST00000377086:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:PF00169		605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	129401 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2,not specified];			rs11121552	0.2316	0.2795	1058,.	0.0874,0.3464,0.2848,0.2956,0.2374	-0.4200			0.27,0.97	8.35						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10436892	10436892	-	AC	het	wt	het		QUAL=4075;DP=121,126,108;AF=0.81,0.52,0.31;MQM=59	KIF1B	3'UTR,intron	KIF1B:ENST00000263934:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279_*280dup::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon47/47:c.5409-1473_5409-1472dup::,KIF1B:ENST00000377086:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::	regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	291586 [uncertain significance DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];		(AC)n (Simple_repeat)	rs146112447		0.0594	37,.						2.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10436924	10436924	C	T	het	het	wt		QUAL=4075;DP=121,126,108;AF=0.81,0.52,0.31;MQM=59	KIF1B	3'UTR,intron	KIF1B:ENST00000263934:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279C>T::,KIF1B:ENST00000377081:intron_variant:MODIFIER:exon47/47:c.5409-1473C>T::,KIF1B:ENST00000377086:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::	regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	291594 [likely benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];		(AC)n (Simple_repeat)	rs78490707	0.0403	0.0080	11,.		-3.5950			0.04,0.22	1.90						0	5						KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10438006	10438006	A	T	het	wt	het		QUAL=1323;DP=82,72,54;AF=0.45,0.00,0.48;MQM=59	KIF1B	intron,3'UTR	KIF1B:ENST00000377081:intron_variant:MODIFIER:exon47/47:c.5409-391A>T::,KIF1B:ENST00000377086:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	291610 [likely benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];		AluSg (SINE/Alu)	rs2847347	0.0182	0.0370	20,.		0.2110			0.16,0.23	2.79						1	26						KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10438687	10438687	C	T	het	het	het		QUAL=12129;DP=252,354,281;AF=0.56,0.51,0.51;MQM=60	KIF1B	3'UTR	KIF1B:ENST00000377081:3_prime_UTR_variant:MODIFIER:exon48/48:c.*227C>T::,KIF1B:ENST00000377086:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::	regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	291618 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];			rs1536262	0.5465	0.5500	4954,.		-1.2450			0.03,0.16	0.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10438892	10438892	G	A	het	het	het		QUAL=8826;DP=281,190,160;AF=0.53,0.52,0.57;MQM=60	KIF1B	3'UTR	KIF1B:ENST00000377081:3_prime_UTR_variant:MODIFIER:exon48/48:c.*432G>A::,KIF1B:ENST00000377086:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::	regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	291619 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];			rs1002076	0.3337	0.3304	1723,.		0.4730			0.09,0.20	1.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10440556	10440556	A	G	het	het	het		QUAL=8917;DP=322,224,182;AF=0.50,0.48,0.49;MQM=51	KIF1B	3'UTR	KIF1B:ENST00000377081:3_prime_UTR_variant:MODIFIER:exon48/48:c.*2096A>G::,KIF1B:ENST00000377086:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::	regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	291652 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];		AluSx (SINE/Alu)	rs1138791	0.3488	0.3605	2039,.		-1.5600			0.00,0.08	9.18						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10441664	10441664	T	C	het	het	het		QUAL=13598;DP=454,349,272;AF=0.53,0.50,0.44;MQM=60	KIF1B	downstream_gene	KIF1B:ENST00000263934:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000377081:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000377086:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	368794 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];			rs3748581		0.5293	4497,.		0.2790			0.31,0.74	13.63						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	11085004	11085004	-	TGTTT	het	hom	het		QUAL=16528;DP=374,267,256;AF=0.49,1.00,0.50;MQM=60	TARDBP,MASP2,RP4-635E18.8	downstream_gene,upstream_gene	TARDBP:ENST00000240185:downstream_gene_variant:MODIFIER::::,TARDBP:ENST00000315091:downstream_gene_variant:MODIFIER::::,MASP2:ENST00000400897:downstream_gene_variant:MODIFIER::::,TARDBP:ENST00000439080:downstream_gene_variant:MODIFIER::::,RP4-635E18.8:ENST00000607145:upstream_gene_variant:MODIFIER::::			291763 [benign DISEASE=Frontotemporal dementia,MASP2 deficiency,Amyotrophic Lateral Sclerosis, Dominant];			rs5772439		0.8767	12057,.						10.55						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR+AD oe_syn=1.07 oe_mis=0.99 oe_lof=0.81), RP4-635E18.8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	11846092	11846092	-	T	het	hom	hom		QUAL=3884;DP=94,47,36;AF=0.77,0.89,0.89;MQM=59	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4644dup::,C1orf167:ENST00000433342:intron_variant:MODIFIER:exon16/20:c.3639+757dup::		607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292153 [benign DISEASE=Neural tube defects, folate-sensitive];			rs55740775		0.9797	13625,.						0.73						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63), C1orf167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84)
chr1	11846252	11846252	G	A	hom	het	het		QUAL=14962;DP=328,181,159;AF=1.00,0.54,0.50;MQM=60	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4485C>T::,C1orf167:ENST00000433342:intron_variant:MODIFIER:exon16/20:c.3639+906G>A::	regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292158 [likely benign DISEASE=Neural tube defects, folate-sensitive];		Tigger15a (DNA/TcMar-Tigger)	rs4846048	0.7065	0.6858	7531,.		0.4870			0.00,0.12	5.80						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63), C1orf167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84)
chr1	11846447	11846447	G	A	hom	hom	hom		QUAL=25214;DP=379,214,181;AF=1.00,1.00,1.00;MQM=60	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4290C>T::,C1orf167:ENST00000433342:intron_variant:MODIFIER:exon16/20:c.3640-998G>A::	regulatory_region_variant:CTCF_binding_site	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292160 [benign DISEASE=Neural tube defects, folate-sensitive];			rs4845884		0.9393	13972,.		-0.7990			0.00,0.10	3.88						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63), C1orf167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84)
chr1	11846660	11846663	TTTT	-	het	hom	het		QUAL=1662;DP=64,28,22;AF=0.63,0.57,0.45;MQM=57	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4074_*4077del::,C1orf167:ENST00000433342:intron_variant:MODIFIER:exon16/20:c.3640-770_3640-767del::		607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292164 [likely benign DISEASE=Neural tube defects, folate-sensitive];		AluJr (SINE/Alu)	rs55780505	0.7772	0.5146	3151,.		0.3100				1.71						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63), C1orf167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84)
chr1	11846660	11846664	TTTTT	-	het	wt	het		QUAL=1662;DP=64,28,22;AF=0.25,0.11,0.32;MQM=57	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4073_*4077del::,C1orf167:ENST00000433342:intron_variant:MODIFIER:exon16/20:c.3640-771_3640-767del::		607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];			AluJr (SINE/Alu)	rs1439949918		0.0078	0,.		0.3100				1.67						1	4						MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63), C1orf167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84)
chr1	11847334	11847334	-	GAA	hom	het	het		QUAL=9487;DP=224,220,132;AF=0.96,0.40,0.58;MQM=59	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*3400_*3402dup::,C1orf167:ENST00000433342:intron_variant:MODIFIER:exon16/20:c.3640-108_3640-106dup::	regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292171 [likely benign DISEASE=Neural tube defects, folate-sensitive];			rs35134728	0.5701	0.5694	5257,.						3.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63), C1orf167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84)
chr1	11847759	11847759	C	T	hom	het	het		QUAL=11910;DP=188,289,242;AF=0.99,0.52,0.50;MQM=59	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*2978G>A::,C1orf167:ENST00000433342:intron_variant:MODIFIER:exon17/20:c.3746-171C>T::	TF_binding_site_variant	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292181 [likely benign DISEASE=Neural tube defects, folate-sensitive];			rs3737966	0.5585	0.5604	5155,.		0.6900			0.30,0.29	7.48						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63), C1orf167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84)
chr1	11848139	11848139	G	A	wt	het	het		QUAL=2663;DP=120,122,84;AF=0.01,0.48,0.55;MQM=60	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*2598C>T::,C1orf167:ENST00000433342:intron_variant:MODIFIER:exon18/20:c.3920+35G>A::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292191 [likely benign DISEASE=Neural tube defects, folate-sensitive];			rs11559040	0.1268	0.1685	357,.	0.0352,0.0850,0.1026,0.1856,0.2669	-0.6770			0.09,0.19	4.97						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63), C1orf167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84)
chr1	11848879	11848879	A	G	hom	hom	hom		QUAL=18950;DP=240,217,151;AF=1.00,1.00,1.00;MQM=60	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376585:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1858T>C::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1858T>C::,C1orf167:ENST00000433342:intron_variant:MODIFIER:exon20/20:c.4245+76A>G::	regulatory_region_variant:promoter	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292203 [benign DISEASE=Neural tube defects, folate-sensitive];			rs2077360	0.9305	0.9366	13907,.		-0.5590			0.01,0.11	2.91						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63), C1orf167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84)
chr1	11849447	11849447	A	G	hom	hom	hom		QUAL=17679;DP=147,226,188;AF=1.00,1.00,1.00;MQM=59	MTHFR,C1orf167	3'UTR,missense	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376585:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1290T>C::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1290T>C::,C1orf167:ENST00000433342:missense_variant:MODERATE:exon21/21:c.4366A>G:p.Arg1456Gly:		607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292209 [benign DISEASE=Neural tube defects, folate-sensitive];			rs868014	0.9329	0.9874	13971,.	0.7812,0.9875,1.0000,0.9990,0.9997	-4.9500	 , , , ,T(0.24)	 , , , ,B(0.00)	0.02,0.21	4.70	0.03					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63), C1orf167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84)
chr1	11850365	11850365	T	G	hom	het	het		QUAL=18953;DP=313,383,346;AF=1.00,0.49,0.49;MQM=59	MTHFR	3'UTR	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376585:3_prime_UTR_variant:MODIFIER:exon13/13:c.*372A>C::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*372A>C::		607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292223 [likely benign DISEASE=Neural tube defects, folate-sensitive];			rs4846049		0.6369	6490,.		-0.6840			0.05,0.19	1.67						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11851003	11851003	G	C	wt	het	het	off-target	QUAL=3885;DP=207,179,167;AF=0.00,0.43,0.49;MQM=60	MTHFR	intron	MTHFR:ENST00000376583:intron_variant:MODIFIER:exon11/11:c.1876-48C>G::,MTHFR:ENST00000376585:intron_variant:MODIFIER:exon12/12:c.1876-48C>G::,MTHFR:ENST00000376590:intron_variant:MODIFIER:exon11/11:c.1753-48C>G::,MTHFR:ENST00000376592:intron_variant:MODIFIER:exon10/10:c.1753-48C>G::	TF_binding_site_variant	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];				rs3818762	0.2475	0.2600	880,.	0.1340,0.1420,0.2153,0.2748,0.4137	-1.1340			0.00,0.02	1.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11852300	11852300	C	T	wt	het	het	off-target	QUAL=4639;DP=170,207,197;AF=0.01,0.48,0.47;MQM=60	MTHFR	intron	MTHFR:ENST00000376583:intron_variant:MODIFIER:exon10/11:c.1755+35G>A::,MTHFR:ENST00000376585:intron_variant:MODIFIER:exon11/12:c.1755+35G>A::,MTHFR:ENST00000376590:intron_variant:MODIFIER:exon10/11:c.1632+35G>A::,MTHFR:ENST00000376592:intron_variant:MODIFIER:exon9/10:c.1632+35G>A::		607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];				rs1476413	0.2512	0.2614	890,.	0.1509,0.1389,0.2267,0.2731,0.4203	-1.1060			0.07,0.25	8.68						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11854457	11854457	G	A	hom	hom	hom		QUAL=18474;DP=119,264,202;AF=1.00,1.00,1.00;MQM=60	MTHFR	synonymous	MTHFR:ENST00000376583:synonymous_variant:LOW:exon8/12:c.1428C>T:p.Phe476=:,MTHFR:ENST00000376585:synonymous_variant:LOW:exon9/13:c.1428C>T:p.Phe476=:,MTHFR:ENST00000376590:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:ENST00000376592:synonymous_variant:LOW:exon7/11:c.1305C>T:p.Phe435=:		607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	167306 [benign DISEASE=Neural tube defects, folate-sensitive,not specified];			rs4846051	0.9030	0.9748	13266,.	0.6780,0.9819,0.9991,0.9983,0.9993	0.6310			0.47,0.83	11.08						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11854476	11854476	T	G	wt	het	het		QUAL=7153;DP=165,287,227;AF=0.01,0.54,0.54;MQM=60	MTHFR	missense	MTHFR:ENST00000376583:missense_variant:MODERATE:exon8/12:c.1409A>C:p.Glu470Ala:,MTHFR:ENST00000376585:missense_variant:MODERATE:exon9/13:c.1409A>C:p.Glu470Ala:,MTHFR:ENST00000376590:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:ENST00000376592:missense_variant:MODERATE:exon7/11:c.1286A>C:p.Glu429Ala:	regulatory_region_variant:promoter_flanking_region	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	3521 [likely benign(replaced by megSAP based on classifications:3x1,1x2,1x3) DISEASE=Schizophrenia, susceptibility to,Gastrointestinal stroma tumor,MTHFR deficiency, thermolabile type,Neural tube defects, folate-sensitive,not specified,not provided];	CM981315 [CLASS=DFP MUT=ALT PHEN="Neural tube defect increased risk association with" GENE=MTHFR];		rs1801131	0.2494	0.2890	1116,.	0.1582,0.1594,0.2198,0.3186,0.4116	3.7910	T(0.15),T(0.15),T(0.14),T(0.14)	B(0.07),B(0.07),B(0.01),B(0.01)	0.96,0.96	22.10	0.20					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11854755	11854755	G	A	hom	het	het	off-target	QUAL=3026;DP=70,54,57;AF=1.00,0.39,0.46;MQM=59	MTHFR	intron	MTHFR:ENST00000376583:intron_variant:MODIFIER:exon7/11:c.1289+31C>T::,MTHFR:ENST00000376585:intron_variant:MODIFIER:exon8/12:c.1289+31C>T::,MTHFR:ENST00000376590:intron_variant:MODIFIER:exon7/11:c.1166+31C>T::,MTHFR:ENST00000376592:intron_variant:MODIFIER:exon6/10:c.1166+31C>T::	regulatory_region_variant:promoter_flanking_region	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];				rs1994798	0.5793	0.6074	5239,.	0.4333,0.7727,0.7596,0.5879,0.4685	-3.8760			0.03,0.15	0.26						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	12009955	12009955	C	T	het	het	het		QUAL=6843;DP=122,248,190;AF=0.46,0.49,0.53;MQM=60	PLOD1	synonymous	PLOD1:ENST00000196061:synonymous_variant:LOW:exon3/19:c.294C>T:p.Phe98=:,PLOD1:ENST00000376369:synonymous_variant:LOW:exon4/20:c.435C>T:p.Phe145=:		153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];	255803 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified,Cardiovascular phenotype,not provided];			rs7529452	0.2678	0.3295	1533,.	0.0589,0.3522,0.3748,0.3160,0.4236	0.9490			0.69,0.83	11.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12009956	12009956	G	A	wt	wt	het		QUAL=1997;DP=145,243,186;AF=0.00,0.00,0.47;MQM=60	PLOD1	missense	PLOD1:ENST00000196061:missense_variant:MODERATE:exon3/19:c.295G>A:p.Ala99Thr:,PLOD1:ENST00000376369:missense_variant:MODERATE:exon4/20:c.436G>A:p.Ala146Thr:		153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];	196247 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified,Cardiovascular phenotype,not provided];	CM068658 [CLASS=DP MUT=ALT PHEN="Bone mineral density association with" GENE=PLOD1];		rs7551175	0.2995	0.2590	1527,.	0.5503,0.0894,0.2527,0.1526,0.2126	1.4500	T(1.00),T(1.00)	B(0.00),B(0.00)	0.03,0.33	14.54	0.15					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12016957	12016957	T	G	wt	wt	het	off-target	QUAL=3761;DP=107,391,311;AF=0.00,0.00,0.50;MQM=60	PLOD1	intron	PLOD1:ENST00000196061:intron_variant:MODIFIER:exon6/18:c.644-17T>G::,PLOD1:ENST00000376369:intron_variant:MODIFIER:exon7/19:c.785-17T>G::		153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];	384719 [benign DISEASE=not specified];			rs41307745	0.0769	0.0679	50,.	0.0104,0.0250,0.1423,0.0613,0.1356	3.2240			0.64,0.22	8.37		10.55>8.84				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12024235	12024235	C	T	het	het	het		QUAL=1166;DP=17,53,35;AF=0.59,0.53,0.40;MQM=60	PLOD1	synonymous	PLOD1:ENST00000196061:synonymous_variant:LOW:exon12/19:c.1206C>T:p.Asn402=:,PLOD1:ENST00000376369:synonymous_variant:LOW:exon13/20:c.1347C>T:p.Asn449=:		153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];	255799 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified,Cardiovascular phenotype,not provided];			rs1130529	0.3484	0.3609	2053,.	0.2929,0.3668,0.3896,0.3275,0.4443	-1.0670			0.12,0.58	7.93						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12027204	12027204	C	T	het	het	hom	off-target	QUAL=9494;DP=39,211,205;AF=0.44,0.52,1.00;MQM=60	PLOD1	intron	PLOD1:ENST00000196061:intron_variant:MODIFIER:exon16/18:c.1755+56C>T::,PLOD1:ENST00000376369:intron_variant:MODIFIER:exon17/19:c.1896+56C>T::	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];				rs2273293	0.5639	0.5222	4329,.		-3.7710			0.01,0.05	0.78						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12033113	12033113	A	G	het	het	hom	off-target	QUAL=11224;DP=132,263,209;AF=0.51,0.48,1.00;MQM=60	PLOD1	intron	PLOD1:ENST00000196061:intron_variant:MODIFIER:exon18/18:c.2028+59A>G::,PLOD1:ENST00000376369:intron_variant:MODIFIER:exon19/19:c.2169+59A>G::	regulatory_region_variant:promoter_flanking_region	153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];				rs3737961	0.6498	0.5826	5517,.		-0.4870			0.00,0.07	6.84						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12040203	12040203	A	G	het	het	hom	off-target	QUAL=904;DP=24,24,20;AF=0.46,0.46,1.00;MQM=60	PLOD1,MFN2	downstream_gene,upstream_gene	PLOD1:ENST00000196061:downstream_gene_variant:MODIFIER::::,MFN2:ENST00000235329:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000444836:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter					rs2236053		0.5216	4305,.		-0.9190			0.00,0.13	3.36			loss/acceptor/12040203-12040204/Medium/10.214891			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12040324	12040324	A	G	het	het	hom		QUAL=4120;DP=30,123,101;AF=0.47,0.36,1.00;MQM=60	MFN2	5'UTR	MFN2:ENST00000444836:5_prime_UTR_variant:MODIFIER:exon1/18:c.-222A>G::	regulatory_region_variant:promoter	608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];	292362 [benign DISEASE=Hereditary motor and sensory neuropathy,Ehlers-Danlos syndrome, hydroxylysine-deficient,Charcot-Marie-Tooth disease, type 2];			rs2236054		0.5264	4410,.		-0.9110			0.00,0.09	9.97						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12040479	12040479	T	C	het	het	hom		QUAL=5102;DP=51,128,113;AF=0.45,0.43,1.00;MQM=60	MFN2	5'UTR	MFN2:ENST00000235329:5_prime_UTR_variant:MODIFIER:exon1/19:c.-212T>C::,MFN2:ENST00000444836:5_prime_UTR_variant:MODIFIER:exon1/18:c.-67T>C::	regulatory_region_variant:promoter	608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];	292368 [benign DISEASE=Hereditary motor and sensory neuropathy,Ehlers-Danlos syndrome, hydroxylysine-deficient,Charcot-Marie-Tooth disease, type 2];			rs2180183		0.5520	4937,.		-0.2970			0.00,0.05	9.91						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12041977	12041977	-	TTTTTT	wt	wt	het	off-target	QUAL=253;DP=97,134,36;AF=0.08,0.12,0.28;MQM=59	MFN2	intron	MFN2:ENST00000235329:intron_variant:MODIFIER:exon1/18:c.-149-43_-149-38dup::,MFN2:ENST00000444836:intron_variant:MODIFIER:exon1/17:c.-5+1443_-5+1448dup::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];				rs763918741		0.0308	54,.						6.21						16	0						MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12041977	12041977	-	TTTTTTT	wt	het	het	off-target	QUAL=253;DP=97,134,36;AF=0.08,0.08,0.22;MQM=57	MFN2	intron	MFN2:ENST00000235329:intron_variant:MODIFIER:exon1/18:c.-149-44_-149-38dup::,MFN2:ENST00000444836:intron_variant:MODIFIER:exon1/17:c.-5+1442_-5+1448dup::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];				rs763918741		0.3083	1474,.						6.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12062205	12062205	A	G	hom	hom	hom	off-target	QUAL=14555;DP=177,190,138;AF=0.99,0.99,0.99;MQM=59	MFN2	intron	MFN2:ENST00000235329:intron_variant:MODIFIER:exon11/18:c.1160+45A>G::,MFN2:ENST00000444836:intron_variant:MODIFIER:exon10/17:c.1160+45A>G::	regulatory_region_variant:CTCF_binding_site	608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];				rs2236057	0.6579	0.6615	6882,.	0.6479,0.5317,0.6765,0.6679,0.7034	-2.0590			0.01,0.11	3.17						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12071680	12071680	A	G	hom	hom	hom		QUAL=29253;DP=253,417,322;AF=0.99,1.00,0.99;MQM=60	MFN2	3'UTR	MFN2:ENST00000235329:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000444836:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::		608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];	292381 [benign DISEASE=Hereditary motor and sensory neuropathy,Charcot-Marie-Tooth disease, type 2];			rs1042842	0.7324	0.7195	8238,.		-0.8580			0.04,0.13	0.64						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12072518	12072518	G	C	hom	hom	hom		QUAL=12729;DP=105,172,142;AF=0.99,1.00,1.00;MQM=60	MFN2	3'UTR	MFN2:ENST00000235329:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000444836:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::		608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];	292393 [benign DISEASE=Hereditary motor and sensory neuropathy,Charcot-Marie-Tooth disease, type 2];			rs3088064	0.5441	0.5709	5189,.		0.4850			0.22,0.22	2.93						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12072534	12072534	C	T	wt	wt	het		QUAL=1661;DP=101,189,143;AF=0.00,0.00,0.50;MQM=60	MFN2	3'UTR	MFN2:ENST00000235329:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000444836:3_prime_UTR_variant:MODIFIER:exon18/18:c.*912C>T::		608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];	292394 [likely benign DISEASE=Hereditary motor and sensory neuropathy,Charcot-Marie-Tooth disease, type 2];			rs14305	0.0843	0.0541	51,.		0.1270			0.12,0.31	8.69						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	16370428	16370432	GGGGG	-	n/a	hom	n/a	off-target	QUAL=50;DP=0,3,0;AF=,1.00,;MQM=60	CLCNKB	intron	CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon1/19:c.-8+61_-8+65del::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs140434107	0.9447	0.5123	2076,.		1.3540				4.15						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16371067	16371067	G	T	het	hom	n/a		QUAL=234;DP=4,5,1;AF=0.75,1.00,1.00;MQM=60	CLCNKB	missense	CLCNKB:ENST00000375679:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:	regulatory_region_variant:TF_binding_site	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447107 [benign DISEASE=not specified,not provided];			rs2015352		0.6267	4826,.	0.2881,0.7293,0.6328,0.6333,0.6878	-0.4670	D(0.01)	B(0.16)	0.14,0.92	23.00	0.30					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16372003	16372003	G	C	het	hom	het	off-target	QUAL=6432;DP=55,148,128;AF=0.42,1.00,0.48;MQM=60	CLCNKB	intron	CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon2/19:c.101-50G>C::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs6604910	0.5665	0.6357	4863,.	0.2698,0.7354,0.6801,0.6380,0.7118	0.6820			0.01,0.14	5.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16372971	16372971	G	A	hom	hom	hom	off-target	QUAL=12409;DP=79,182,142;AF=1.00,1.00,1.00;MQM=59	CLCNKB	intron	CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon3/19:c.230-59G>A::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs2014841		0.6933	8183,.		-0.2720			0.02,0.13	2.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16373124	16373124	A	G	hom	hom	hom		QUAL=23071;DP=177,312,247;AF=0.99,1.00,1.00;MQM=59	CLCNKB	synonymous	CLCNKB:ENST00000375679:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:PF00654		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447104 [benign DISEASE=not specified,not provided];			rs5257	0.7404	0.8121	8159,.	0.3791,0.8994,0.9891,0.8093,0.8739	-4.7220			0.03,0.24	0.31			loss/acceptor/16373124-16373125/Medium/12.831041			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16373200	16373202	CTT	-	hom	hom	het	off-target	QUAL=10067;DP=109,221,147;AF=1.00,1.00,0.50;MQM=59	CLCNKB	intron	CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon4/19:c.358+44_358+46del::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs35820664	0.7234	0.7861	7533,.	0.3540,0.8883,0.9891,0.7803,0.8442	0.5420				12.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16374533	16374533	G	C	hom	hom	hom		QUAL=383;DP=5,3,5;AF=1.00,1.00,1.00;MQM=60	CLCNKB	synonymous	CLCNKB:ENST00000375679:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:PF00654	regulatory_region_variant:promoter	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447105 [benign DISEASE=not specified,not provided];			rs2014562		0.9317	12637,.	0.7589,0.9575,0.9997,0.9439,0.9278	-0.3820			0.06,0.95	6.84						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16374994	16374994	C	T	hom	hom	hom		QUAL=17796;DP=152,244,202;AF=0.99,1.00,1.00;MQM=46	CLCNKB	splice_region&intron	CLCNKB:ENST00000375679:splice_region_variant&intron_variant:LOW:exon6/19:c.577-5C>T::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	381050 [benign/likely benign DISEASE=not specified,not provided];			rs34666902,rs1889788	0.7386	0.8104	8128,.	0.3760,0.8986,0.9890,0.8075,0.8732	-0.3170			0.02,0.22	1.17		4.28>4.16		0.000/0.000		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16375063	16375063	C	G	hom	hom	hom		QUAL=17412;DP=185,215,174;AF=0.99,1.00,1.00;MQM=52	CLCNKB	missense	CLCNKB:ENST00000375679:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:PF00654	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	504916 [benign DISEASE=not specified];			rs45612832,rs1889789		0.9069	11137,.	0.5589,0.9388,0.9997,0.9259,0.9256	-0.0390	T(0.79)	B(0.00)	0.06,0.42	11.39	0.22					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16375064	16375064	A	C	hom	hom	hom		QUAL=17412;DP=185,215,174;AF=0.99,1.00,1.00;MQM=52	CLCNKB	synonymous	CLCNKB:ENST00000375679:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:PF00654	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	504915 [benign DISEASE=not specified];			rs45575235,rs1889790		0.9069	11137,.	0.5589,0.9388,0.9997,0.9258,0.9256	-2.2040			0.07,0.28	9.84						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16375210	16375210	G	A	het	hom	wt	off-target	QUAL=4181;DP=96,100,103;AF=0.48,0.99,0.00;MQM=60	CLCNKB	intron	CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon7/19:c.655+133G>A::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs9633514	0.3570	0.2951	1647,.		-0.2940			0.09,0.19	7.94						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16375354	16375354	C	T	hom	hom	hom		QUAL=18576;DP=164,234,202;AF=1.00,1.00,1.00;MQM=60	CLCNKB	5'UTR,intron	CLCNKB:ENST00000375667:5_prime_UTR_variant:MODIFIER:exon1/13:c.-113C>T::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon7/19:c.656-261C>T::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];			MIR (SINE/MIR)	rs9442227	0.7274	0.6835	7971,.		-0.1220			0.08,0.21	9.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376191	16376191	C	T	hom	hom	hom		QUAL=25441;DP=179,402,312;AF=1.00,1.00,1.00;MQM=44	CLCNKB	missense	CLCNKB:ENST00000375667:missense_variant:MODERATE:exon2/13:c.353C>T:p.Ala118Val:PF00654,CLCNKB:ENST00000375679:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:PF00654		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447108 [benign DISEASE=not specified,not provided];			rs34188929,rs7367494	0.8299	0.9249	11278,.	0.5573,0.9597,0.9988,0.9484,0.9335	-0.3350	T(1.00),T(1.00)	B(0.00),B(0.01)	0.02,0.12	0.06	0.22					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376230	16376230	-	T	hom	hom	hom	off-target	QUAL=24384;DP=72,440,338;AF=1.00,0.95,0.96;MQM=51	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:exon2/12:c.359+33_359+34insT::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon9/19:c.866+33_866+34insT::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs59006537		0.9242	10761,.	0.4294,0.9451,0.9983,0.9544,0.9487					1.59						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376232	16376232	A	T	hom	hom	hom	off-target	QUAL=24384;DP=72,440,338;AF=1.00,0.95,0.96;MQM=51	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:exon2/12:c.359+35A>T::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon9/19:c.866+35A>T::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs59924562		0.9253	10777,.	0.4491,0.9459,0.9984,0.9547,0.9477	-2.8490			0.01,0.08	0.82						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376239	16376239	C	-	hom	hom	hom	off-target	QUAL=24207;DP=78,438,335;AF=0.99,0.99,0.99;MQM=52	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:exon2/12:c.359+47del::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon9/19:c.866+47del::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs34589727	0.8301	0.9148	10750,.	0.4231,0.9419,0.9988,0.9470,0.9354	-0.1430				1.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376278	16376278	G	A	hom	hom	hom	off-target	QUAL=30469;DP=135,499,364;AF=1.00,1.00,1.00;MQM=57	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:exon2/12:c.360-32G>A::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon9/19:c.867-32G>A::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs7365182	0.8279	0.9209	11342,.	0.5528,0.9546,0.9999,0.9463,0.9313	1.2090			0.08,0.18	1.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376319	16376319	T	C	hom	hom	hom		QUAL=32778;DP=182,483,361;AF=1.00,1.00,1.00;MQM=59	CLCNKB	synonymous	CLCNKB:ENST00000375667:synonymous_variant:LOW:exon3/13:c.369T>C:p.Cys123=:PF00654,CLCNKB:ENST00000375679:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:PF00654		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	377683 [benign DISEASE=not specified,not provided];			rs7368151	0.8301	0.9168	11434,.	0.5579,0.9485,0.9998,0.9431,0.9271	-4.5300			0.03,0.87	0.51						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376458	16376458	T	C	hom	hom	hom	off-target	QUAL=16928;DP=125,259,183;AF=0.99,1.00,1.00;MQM=60	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:exon3/12:c.461+47T>C::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon10/19:c.968+47T>C::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs7368166		0.9131	11013,.	0.5505,0.9457,0.9985,0.9398,0.9198	-4.4690			0.00,0.06	6.31						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16378649	16378649	C	G	het	wt	het	off-target	QUAL=482;DP=19,10,19;AF=0.58,0.00,0.68;MQM=60	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:exon7/12:c.902-44C>G::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon14/19:c.1409-44C>G::		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs2297726	0.1625	0.1727	421,.	0.0715,0.1591,0.2995,0.1706,0.1631	0.0970			0.05,0.21	7.57						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16378739	16378739	G	A	wt	wt	het		QUAL=107;DP=27,16,22;AF=0.00,0.00,0.36;MQM=60	CLCNKB	synonymous	CLCNKB:ENST00000375667:synonymous_variant:LOW:exon8/13:c.948G>A:p.Ala316=:PF00654,CLCNKB:ENST00000375679:synonymous_variant:LOW:exon15/20:c.1455G>A:p.Ala485=:PF00654		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	585703 [benign DISEASE=not provided];			rs34652156	0.0302	0.0371	33,.	0.0580,0.0117,0.0000,0.0274,0.0299	-2.6720			0.05,0.21	0.09						11	428						CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16380196	16380196	T	C	hom	hom	hom		QUAL=28248;DP=292,371,251;AF=1.00,1.00,1.00;MQM=51	CLCNKB	missense	CLCNKB:ENST00000375667:missense_variant:MODERATE:exon9/13:c.1178T>C:p.Met393Thr:PF00571,CLCNKB:ENST00000375679:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:PF00571		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447094 [benign DISEASE=not specified];			rs5253	0.8383	0.9347	12512,.	0.6863,0.9480,0.8076,0.9843,0.9317	-0.9230	T(0.49),T(0.46)	B(0.00),B(0.00)	0.00,0.10	4.64	0.28					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16380243	16380243	A	G	hom	hom	het		QUAL=15456;DP=134,312,232;AF=1.00,0.99,0.42;MQM=48	CLCNKB	missense	CLCNKB:ENST00000375667:missense_variant:MODERATE:exon9/13:c.1225A>G:p.Lys409Glu:PF00571,CLCNKB:ENST00000375679:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:PF00571		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447096 [benign DISEASE=not specified,not provided];	CM1514575 [CLASS=DM? MUT=ALT PHEN="Migraine without aura" GENE=CLCNKB];		rs2275166	0.7017	0.7153	8082,.	0.7975,0.5184,0.7947,0.6591,0.5830	0.8530	T(1.00),T(1.00)	B(0.00),B(0.00)	0.01,0.19	14.36	0.16					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16380252	16380252	C	T	hom	hom	het		QUAL=14345;DP=116,302,217;AF=1.00,1.00,0.43;MQM=48	CLCNKB	synonymous	CLCNKB:ENST00000375667:synonymous_variant:LOW:exon9/13:c.1234C>T:p.Leu412=:PF00571,CLCNKB:ENST00000375679:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:PF00571		602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447097 [benign DISEASE=not specified,not provided];			rs2275167		0.6412	6486,.	0.5768,0.4929,0.7894,0.6443,0.5281	0.5590			0.14,0.85	15.32			loss/acceptor/16380251-16380252/Medium/4.504692&gain/acceptor/16380252-16380253/Medium/1.970012			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16382877	16382877	A	G	hom	hom	hom	off-target	QUAL=11602;DP=50,203,147;AF=1.00,1.00,0.99;MQM=59	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:exon11/12:c.1420-40A>G::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon18/19:c.1930-40A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs7517792		0.7963	8798,.	0.7061,0.8840,0.8077,0.7871,0.8423	-2.5310			0.01,0.13	4.55			loss/donor/16382876-16382877/Medium/1.469535			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16383329	16383329	-	C	hom	hom	het	off-target	QUAL=36;DP=3,6,24;AF=0.00,0.67,0.17;MQM=45	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:exon12/12:c.1507-29dup::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon19/19:c.2017-29dup::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs138507185		0.6262	5321,.						2.74						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16383336	16383336	G	C	hom	hom	het	off-target	QUAL=36;DP=3,6,24;AF=0.00,0.67,0.17;MQM=45	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:exon12/12:c.1507-28G>C::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:exon19/19:c.2017-28G>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs12746138		0.7085	6009,.	0.4283,0.8343,0.7670,0.6997,0.7947	-1.1840			0.00,0.06	0.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16383402	16383402	C	T	het	wt	wt		QUAL=682;DP=257,143,140;AF=0.26,0.07,0.00;MQM=34	CLCNKB	synonymous	CLCNKB:ENST00000375667:synonymous_variant:LOW:exon13/13:c.1545C>T:p.Ala515=:,CLCNKB:ENST00000375679:synonymous_variant:LOW:exon20/20:c.2055C>T:p.Ala685=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs6698427		0.0880	0,.	0.0128,0.0033,0.0132,0.0013,0.0025	0.3830			0.26,0.96	13.72						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16383448	16383448	A	C	het	hom	hom		QUAL=15894;DP=220,287,241;AF=0.70,0.90,1.00;MQM=40	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*37A>C::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs10803415	0.9010	0.9041	5812,.	0.8429,0.9248,0.6951,0.9399,0.8839	-1.8510			0.00,0.05	7.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16383547	16383547	T	C	wt	het	wt		QUAL=540;DP=232,595,394;AF=0.05,0.19,0.00;MQM=31	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*136T>C::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*136T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057839		0.2174	4,.		0.0660			0.00,0.06	7.20						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16383574	16383574	A	T	het	het	wt		QUAL=887;DP=243,615,379;AF=0.13,0.20,0.00;MQM=33	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*163A>T::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*163A>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057841		0.2479	0,.		0.4380			0.07,0.16	4.57						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16383581	16383581	G	T	het	het	het		QUAL=19817;DP=244,614,378;AF=0.84,0.79,0.51;MQM=37	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*170G>T::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057844		0.4996	1874,.		-1.3730			0.03,0.14	1.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16383605	16383605	A	G	het	het	het		QUAL=19758;DP=196,647,401;AF=0.74,0.77,0.53;MQM=37	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*194A>G::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::	regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057845		0.4935	1687,.		-0.5960			0.01,0.17	7.64						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16383668	16383668	T	G	hom	hom	hom		QUAL=32754;DP=170,660,360;AF=0.99,1.00,1.00;MQM=41	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*257T>G::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::	regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs6660218		1.0000	15695,.	1.0000,1.0000,0.9998,0.9999,1.0000	0.1210			0.00,0.08	4.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16383682	16383682	G	C	het	het	wt		QUAL=4418;DP=218,649,321;AF=0.19,0.36,0.00;MQM=41	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*271G>C::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*271G>C::	regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	402540 [benign DISEASE=not specified];			rs1057854		0.3303	50,.	0.4019,0.2177,0.4238,0.3039,0.2888	-3.2740			0.01,0.12	0.39						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16383742	16383742	C	G	het	het	hom		QUAL=18327;DP=339,515,224;AF=0.54,0.53,1.00;MQM=57	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*331C>G::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::	regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057857		0.6415	4036,.	0.5897,0.6972,0.4932,0.6536,0.6177	-0.3020			0.04,0.20	7.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16383854	16383854	A	G	het	het	wt	off-target	QUAL=624;DP=102,110,56;AF=0.36,0.17,0.00;MQM=38	FAM131C,CLCNKB	downstream_gene	FAM131C:ENST00000375662:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375667:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375679:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region					rs749928769		0.0230	1,.		-0.5780			0.00,0.11	2.89						1	19						FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42), CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	17312743	17312743	C	T	het	het	hom		QUAL=710;DP=16,25,19;AF=0.44,0.44,0.95;MQM=60	ATP13A2,RP1-37C10.3	synonymous,missense,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon29/29:c.3516G>A:p.Pro1172=:,ATP13A2:ENST00000341676:missense_variant:MODERATE:exon27/27:c.3214G>A:p.Ala1072Thr:,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+7136C>T::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon29/29:c.3501G>A:p.Pro1167=:		610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128475 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs3170740	0.3313	0.4703	3029,.	0.2020,0.4851,0.2946,0.5286,0.4630	-2.5490	 ,T(0.32), , 	 ,B(0.00), , 	0.02,0.13	0.48	0.24					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42), RP1-37C10.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	17313157	17313157	G	A	het	het	hom	off-target	QUAL=9651;DP=83,293,215;AF=0.39,0.51,1.00;MQM=60	ATP13A2,RP1-37C10.3	intron,intron&non_coding_transcript	ATP13A2:ENST00000326735:intron_variant:MODIFIER:exon27/28:c.3236-30C>T::,ATP13A2:ENST00000341676:intron_variant:MODIFIER:exon26/26:c.3103+143C>T::,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+7550G>A::,ATP13A2:ENST00000452699:intron_variant:MODIFIER:exon27/28:c.3221-30C>T::	regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	559000 [benign DISEASE=not provided];			rs2076605	0.3468	0.4706	3051,.	0.2188,0.4839,0.2956,0.5242,0.4771	1.8880			0.04,0.13	5.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42), RP1-37C10.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	17313245	17313256	CCCAGGGCTCCT	-	het	het	wt	off-target	QUAL=2296;DP=56,208,167;AF=0.43,0.50,0.00;MQM=60	ATP13A2,RP1-37C10.3	intron,intron&non_coding_transcript	ATP13A2:ENST00000326735:intron_variant:MODIFIER:exon27/28:c.3235+44_3235+55del::,ATP13A2:ENST00000341676:intron_variant:MODIFIER:exon26/26:c.3103+44_3103+55del::,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+7641_187+7652del::,ATP13A2:ENST00000452699:intron_variant:MODIFIER:exon27/28:c.3220+44_3220+55del::	regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];				rs143483351	0.3059	0.2349	921,.		1.0320				7.92			gain/acceptor/17313249-17313248/Medium/9.691849			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42), RP1-37C10.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	17313343	17313343	G	A	het	het	hom		QUAL=10641;DP=90,282,199;AF=0.47,0.49,1.00;MQM=60	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon27/29:c.3192C>T:p.Ala1064=:,ATP13A2:ENST00000341676:synonymous_variant:LOW:exon26/27:c.3060C>T:p.Ala1020=:,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+7736G>A::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon27/29:c.3177C>T:p.Ala1059=:	regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128473 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs9435659	0.3385	0.4652	3048,.	0.1875,0.4783,0.2891,0.5225,0.4729	-0.5550			0.07,0.19	1.66						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42), RP1-37C10.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	17313454	17313454	G	A	het	het	wt		QUAL=2306;DP=59,177,138;AF=0.47,0.44,0.00;MQM=60	ATP13A2,RP1-37C10.3	splice_region&intron,intron&non_coding_transcript	ATP13A2:ENST00000326735:splice_region_variant&intron_variant:LOW:exon26/28:c.3084-3C>T::,ATP13A2:ENST00000341676:splice_region_variant&intron_variant:LOW:exon25/26:c.2952-3C>T::,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+7847G>A::,ATP13A2:ENST00000452699:splice_region_variant&intron_variant:LOW:exon26/28:c.3069-3C>T::	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128471 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs7531163	0.3065	0.2819	997,.	0.1706,0.3596,0.5506,0.2392,0.2307	0.9070			0.66,0.95	13.45		9.29>9.90		0.001/0.100		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42), RP1-37C10.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	17313654	17313654	C	T	het	het	hom		QUAL=10629;DP=65,279,245;AF=0.51,0.47,1.00;MQM=60	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon26/29:c.2970G>A:p.Val990=:,ATP13A2:ENST00000341676:synonymous_variant:LOW:exon25/27:c.2838G>A:p.Val946=:,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+8047C>T::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon26/29:c.2955G>A:p.Val985=:	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128470 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs761421	0.3462	0.4654	3067,.	0.2158,0.4792,0.2830,0.5203,0.4730	-0.9690			0.25,0.72	13.50						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42), RP1-37C10.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	17314702	17314702	C	T	het	het	wt		QUAL=11043;DP=279,583,493;AF=0.48,0.51,0.01;MQM=60	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon25/29:c.2790G>A:p.Ser930=:,ATP13A2:ENST00000341676:synonymous_variant:LOW:exon24/27:c.2658G>A:p.Ser886=:,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+9095C>T::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon25/29:c.2775G>A:p.Ser925=:	regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128468 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs3738815	0.2909	0.2494	847,.	0.1518,0.3342,0.5507,0.1933,0.2217	-2.3320			0.06,0.15	6.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42), RP1-37C10.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	17314942	17314942	G	A	het	het	hom		QUAL=14012;DP=294,321,260;AF=0.50,0.45,0.99;MQM=60	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon24/29:c.2637C>T:p.Gly879=:PF12710,ATP13A2:ENST00000341676:synonymous_variant:LOW:exon23/27:c.2505C>T:p.Gly835=:PF12710,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.187+9335G>A::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon24/29:c.2622C>T:p.Gly874=:PF12710	regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128466 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs9435662	0.3387	0.4633	3017,.	0.1867,0.4771,0.2888,0.5193,0.4726	-4.7600			0.06,0.67	14.31			gain/donor/17314941-17314942/Medium/0.871549			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42), RP1-37C10.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	17319011	17319011	G	A	het	het	hom		QUAL=6569;DP=78,151,128;AF=0.47,0.48,1.00;MQM=60	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon17/29:c.1815C>T:p.Pro605=:PF12710,ATP13A2:ENST00000341676:synonymous_variant:LOW:exon17/27:c.1800C>T:p.Pro600=:PF12710,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.188-12127G>A::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon17/29:c.1800C>T:p.Pro600=:PF12710		610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128465 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs2076603	0.4485	0.5563	4804,.	0.4404,0.5455,0.2863,0.6263,0.5184	0.1640			0.51,0.95	14.73						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42), RP1-37C10.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	17331268	17331268	C	T	wt	wt	het		QUAL=642;DP=134,121,74;AF=0.00,0.00,0.41;MQM=60	ATP13A2,RP1-37C10.3	synonymous,non_coding_transcript_exon	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:PF12409,ATP13A2:ENST00000341676:synonymous_variant:LOW:exon5/27:c.396G>A:p.Ala132=:PF12409,RP1-37C10.3:ENST00000446261:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.318C>T::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:PF12409	regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	293803 [uncertain significance DISEASE=Parkinson disease 9];			rs140631323		0.0001	0,.	0.0000,0.0001,0.0000,0.0001,0.0002	-4.6690			0.02,0.09	4.28					COSM4946978,COSM80893	0	6						ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42), RP1-37C10.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19198064	19198064	T	G	het	het	wt		QUAL=3438;DP=95,185,148;AF=0.53,0.47,0.00;MQM=59	ALDH4A1,RP13-279N23.2	3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:3_prime_UTR_variant:MODIFIER:exon16/16:c.*262A>C::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1275A>C::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+2893A>C::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1275A>C::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1275A>C::	regulatory_region_variant:enhancer	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294333 [likely benign DISEASE=Hyperprolinemia];			rs1138333	0.1793	0.2342	888,.		1.6090			0.00,0.14	8.32						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19198100	19198100	C	G	het	het	wt		QUAL=3396;DP=95,166,144;AF=0.55,0.49,0.00;MQM=60	ALDH4A1,RP13-279N23.2	3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:3_prime_UTR_variant:MODIFIER:exon16/16:c.*226G>C::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1239G>C::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+2857G>C::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1239G>C::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1239G>C::	regulatory_region_variant:enhancer	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294334 [likely benign DISEASE=Hyperprolinemia];			rs1138328	0.1651	0.2278	857,.		0.1130			0.00,0.11	4.25						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19198141	19198141	T	C	het	het	wt		QUAL=3409;DP=121,146,139;AF=0.53,0.48,0.00;MQM=60	ALDH4A1,RP13-279N23.2	3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:3_prime_UTR_variant:MODIFIER:exon16/16:c.*185A>G::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1198A>G::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+2816A>G::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1198A>G::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1198A>G::	regulatory_region_variant:enhancer	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294336 [likely benign DISEASE=Hyperprolinemia];			rs7366541	0.1799	0.2344	896,.		-1.2020			0.06,0.15	4.59						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19198414	19198414	G	A	het	het	wt		QUAL=4782;DP=168,196,168;AF=0.48,0.49,0.00;MQM=60	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon15/15:c.*42-130C>T::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*925C>T::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+2543C>T::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*925C>T::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*925C>T::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294341 [likely benign DISEASE=Hyperprolinemia];			rs1140477	0.1935	0.2424	908,.		0.5800			0.12,0.17	4.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19198418	19198418	C	T	het	het	wt		QUAL=4782;DP=168,196,168;AF=0.48,0.49,0.00;MQM=60	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon15/15:c.*42-134G>A::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*921G>A::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+2539G>A::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*921G>A::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*921G>A::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294342 [likely benign DISEASE=Hyperprolinemia];			rs1138269	0.1933	0.2425	908,.		0.1330			0.06,0.16	4.68						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19198576	19198576	A	G	hom	hom	hom		QUAL=29672;DP=367,311,238;AF=1.00,0.99,1.00;MQM=59	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon15/15:c.*42-292T>C::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*763T>C::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+2381T>C::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*763T>C::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*763T>C::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294344 [likely benign DISEASE=Hyperprolinemia];			rs1138267		0.6404	6551,.		-5.8090			0.01,0.12	0.95						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19198627	19198627	G	A	het	het	wt		QUAL=6360;DP=288,262,203;AF=0.49,0.45,0.00;MQM=60	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon15/15:c.*42-343C>T::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*712C>T::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+2330C>T::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*712C>T::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*712C>T::	regulatory_region_variant:CTCF_binding_site	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294346 [likely benign DISEASE=Hyperprolinemia];			rs14311	0.1935	0.2427	934,.		-0.0360			0.00,0.08	4.14						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19198637	19198637	G	A	het	het	hom		QUAL=12444;DP=236,258,205;AF=0.48,0.53,1.00;MQM=60	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon15/15:c.*42-353C>T::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*702C>T::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+2320C>T::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*702C>T::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*702C>T::	regulatory_region_variant:CTCF_binding_site	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294347 [likely benign DISEASE=Hyperprolinemia];			rs3202002	0.4744	0.3877	2537,.		-0.3560			0.09,0.20	7.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19198682	19198682	C	-	het	het	hom		QUAL=6554;DP=83,166,148;AF=0.43,0.53,0.98;MQM=60	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon15/15:c.*42-398del::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*657del::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+2275del::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*657del::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*657del::	regulatory_region_variant:CTCF_binding_site	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294349 [likely benign DISEASE=Hyperprolinemia];			rs11311839	0.4677	0.3952	2646,.		-3.2880				0.56						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19198895	19198895	A	G	het	het	wt		QUAL=5010;DP=189,247,194;AF=0.48,0.45,0.00;MQM=60	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon15/15:c.*41+403T>C::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*444T>C::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+2062T>C::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*444T>C::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*444T>C::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294353 [likely benign DISEASE=Hyperprolinemia];			rs9117	0.1102	0.1797	607,.		0.2380			0.17,0.18	6.67						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19199221	19199221	C	T	het	het	hom		QUAL=20913;DP=213,487,404;AF=0.45,0.47,1.00;MQM=60	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon15/15:c.*41+77G>A::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*118G>A::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+1736G>A::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*118G>A::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*118G>A::	regulatory_region_variant:CTCF_binding_site	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294359 [likely benign DISEASE=Hyperprolinemia];			rs11740	0.4714	0.3878	2531,.		-1.0870			0.01,0.12	0.78			gain/acceptor/19199221-19199222/Medium/5.008251			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19199473	19199473	T	A	het	het	hom	off-target	QUAL=12617;DP=147,285,227;AF=0.48,0.53,0.99;MQM=60	ALDH4A1,RP13-279N23.2	intron,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon14/15:c.1580-22A>T::,ALDH4A1:ENST00000375341:intron_variant:MODIFIER:exon14/14:c.1580-22A>T::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+1484A>T::,ALDH4A1:ENST00000538309:intron_variant:MODIFIER:exon14/14:c.1400-22A>T::,ALDH4A1:ENST00000538839:intron_variant:MODIFIER:exon13/13:c.1427-22A>T::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];				rs28700162	0.4714	0.4724	2557,.	0.2427,0.5821,0.6726,0.4245,0.5857	0.1100			0.12,0.19	4.93						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19199487	19199487	A	G	het	het	wt	off-target	QUAL=4554;DP=101,254,201;AF=0.62,0.47,0.00;MQM=60	ALDH4A1,RP13-279N23.2	intron,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon14/15:c.1580-36T>C::,ALDH4A1:ENST00000375341:intron_variant:MODIFIER:exon14/14:c.1580-36T>C::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+1470T>C::,ALDH4A1:ENST00000538309:intron_variant:MODIFIER:exon14/14:c.1400-36T>C::,ALDH4A1:ENST00000538839:intron_variant:MODIFIER:exon13/13:c.1427-36T>C::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];				rs35255325	0.1148	0.1962	614,.	0.0962,0.1974,0.0007,0.2520,0.1205	0.5300			0.05,0.16	5.63						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19200908	19200908	G	C	het	het	hom	off-target	QUAL=6969;DP=103,165,122;AF=0.55,0.47,1.00;MQM=60	ALDH4A1,RP13-279N23.2	intron,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon14/15:c.1579+49C>G::,ALDH4A1:ENST00000375341:intron_variant:MODIFIER:exon14/14:c.1579+49C>G::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon22/26:c.*1742+49C>G::,ALDH4A1:ENST00000538309:intron_variant:MODIFIER:exon14/14:c.1399+49C>G::,ALDH4A1:ENST00000538839:intron_variant:MODIFIER:exon13/13:c.1426+49C>G::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];				rs28529092	0.5485	0.5001	3159,.	0.4323,0.5988,0.6738,0.4409,0.6074	3.0650			0.64,0.60	10.76						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19201956	19201956	A	G	hom	hom	hom		QUAL=18235;DP=311,136,131;AF=1.00,1.00,1.00;MQM=59	ALDH4A1,RP13-279N23.2	synonymous,3'UTR&NMD_transcript	ALDH4A1:ENST00000290597:synonymous_variant:LOW:exon13/16:c.1380T>C:p.Asp460=:PF00171,ALDH4A1:ENST00000375341:synonymous_variant:LOW:exon13/15:c.1380T>C:p.Asp460=:PF00171,RP13-279N23.2:ENST00000494072:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon21/27:c.*1543T>C::,ALDH4A1:ENST00000538309:synonymous_variant:LOW:exon13/15:c.1200T>C:p.Asp400=:PF00171,ALDH4A1:ENST00000538839:synonymous_variant:LOW:exon12/14:c.1227T>C:p.Asp409=:	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294369 [benign DISEASE=Hyperprolinemia];			rs2230708		0.7321	7602,.	0.6880,0.8178,0.7106,0.7190,0.7577	-1.4010			0.01,0.14	1.90						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19202770	19202770	T	C	hom	hom	hom	off-target	QUAL=4001;DP=47,54,30;AF=1.00,1.00,1.00;MQM=59	ALDH4A1,RP13-279N23.2	intron,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon12/15:c.1338+39A>G::,ALDH4A1:ENST00000375341:intron_variant:MODIFIER:exon12/14:c.1338+39A>G::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon20/26:c.*1501+39A>G::,ALDH4A1:ENST00000538309:intron_variant:MODIFIER:exon12/14:c.1158+39A>G::,ALDH4A1:ENST00000538839:intron_variant:MODIFIER:exon11/13:c.1186-773A>G::	regulatory_region_variant:CTCF_binding_site	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];				rs7550822		0.9653	13484,.	0.7709,0.9760,0.9999,0.9775,0.9836	-0.2020			0.00,0.06	7.59						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19202896	19202896	G	A	hom	hom	het		QUAL=7386;DP=131,96,72;AF=0.99,0.99,0.33;MQM=60	ALDH4A1,RP13-279N23.2	synonymous,3'UTR&NMD_transcript,intron	ALDH4A1:ENST00000290597:synonymous_variant:LOW:exon12/16:c.1251C>T:p.Ala417=:PF00171,ALDH4A1:ENST00000375341:synonymous_variant:LOW:exon12/15:c.1251C>T:p.Ala417=:PF00171,RP13-279N23.2:ENST00000494072:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon20/27:c.*1414C>T::,ALDH4A1:ENST00000538309:synonymous_variant:LOW:exon12/15:c.1071C>T:p.Ala357=:PF00171,ALDH4A1:ENST00000538839:intron_variant:MODIFIER:exon11/13:c.1185+806C>T::	regulatory_region_variant:CTCF_binding_site	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294374 [likely benign DISEASE=Hyperprolinemia];			rs2230707	0.5160	0.5117	3347,.	0.4402,0.6932,0.6078,0.4697,0.4989	-9.2540			0.02,0.29	10.99						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19202917	19202917	T	C	hom	hom	hom		QUAL=7628;DP=97,87,74;AF=1.00,0.99,0.97;MQM=59	ALDH4A1,RP13-279N23.2	synonymous,3'UTR&NMD_transcript,intron	ALDH4A1:ENST00000290597:synonymous_variant:LOW:exon12/16:c.1230A>G:p.Ser410=:PF00171,ALDH4A1:ENST00000375341:synonymous_variant:LOW:exon12/15:c.1230A>G:p.Ser410=:PF00171,RP13-279N23.2:ENST00000494072:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon20/27:c.*1393A>G::,ALDH4A1:ENST00000538309:synonymous_variant:LOW:exon12/15:c.1050A>G:p.Ser350=:PF00171,ALDH4A1:ENST00000538839:intron_variant:MODIFIER:exon11/13:c.1185+785A>G::	regulatory_region_variant:CTCF_binding_site	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294375 [benign DISEASE=Hyperprolinemia];			rs7550938	0.6609	0.6986	6220,.	0.4836,0.7945,0.7121,0.6946,0.7419	-5.5180			0.02,0.60	13.12						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19202926	19202926	T	C	hom	hom	hom		QUAL=6314;DP=65,87,73;AF=1.00,0.99,0.96;MQM=59	ALDH4A1,RP13-279N23.2	synonymous,3'UTR&NMD_transcript,intron	ALDH4A1:ENST00000290597:synonymous_variant:LOW:exon12/16:c.1221A>G:p.Ala407=:PF00171,ALDH4A1:ENST00000375341:synonymous_variant:LOW:exon12/15:c.1221A>G:p.Ala407=:PF00171,RP13-279N23.2:ENST00000494072:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon20/27:c.*1384A>G::,ALDH4A1:ENST00000538309:synonymous_variant:LOW:exon12/15:c.1041A>G:p.Ala347=:PF00171,ALDH4A1:ENST00000538839:intron_variant:MODIFIER:exon11/13:c.1185+776A>G::	regulatory_region_variant:CTCF_binding_site	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294376 [benign DISEASE=Hyperprolinemia];			rs2230706		0.6978	6208,.	0.4828,0.7939,0.7102,0.6929,0.7422	0.2410			0.67,0.96	13.02						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19203997	19203997	C	G	hom	hom	hom		QUAL=7520;DP=83,107,56;AF=0.98,1.00,1.00;MQM=59	ALDH4A1,RP13-279N23.2	synonymous,3'UTR&NMD_transcript	ALDH4A1:ENST00000290597:synonymous_variant:LOW:exon10/16:c.1050G>C:p.Ala350=:PF00171,ALDH4A1:ENST00000375341:synonymous_variant:LOW:exon10/15:c.1050G>C:p.Ala350=:PF00171,RP13-279N23.2:ENST00000494072:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon18/27:c.*1213G>C::,ALDH4A1:ENST00000538309:synonymous_variant:LOW:exon10/15:c.870G>C:p.Ala290=:PF00171,ALDH4A1:ENST00000538839:synonymous_variant:LOW:exon10/14:c.1050G>C:p.Ala350=:PF00171		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294382 [benign DISEASE=Hyperprolinemia];			rs2230705		0.7199	8148,.	0.7234,0.7459,0.4494,0.7190,0.5900	1.5080			0.18,0.93	10.89						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19204154	19204154	G	A	het	wt	hom	off-target	QUAL=269;DP=14,20,8;AF=0.43,0.00,1.00;MQM=60	ALDH4A1,RP13-279N23.2	intron,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon9/15:c.941-48C>T::,ALDH4A1:ENST00000375341:intron_variant:MODIFIER:exon9/14:c.941-48C>T::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon17/26:c.*1104-48C>T::,ALDH4A1:ENST00000538309:intron_variant:MODIFIER:exon9/14:c.761-48C>T::,ALDH4A1:ENST00000538839:intron_variant:MODIFIER:exon9/13:c.941-48C>T::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];				rs6426813		0.7698	7939,.	0.6963,0.8857,0.9544,0.7067,0.8413	-0.3830			0.03,0.09	1.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19208145	19208145	-	GGTTGCCT	het	hom	hom	off-target	QUAL=728;DP=8,16,7;AF=0.88,1.00,1.00;MQM=60	ALDH4A1,RP13-279N23.2	intron,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon8/15:c.866+48_866+49insAGGCAACC::,ALDH4A1:ENST00000375341:intron_variant:MODIFIER:exon8/14:c.866+48_866+49insAGGCAACC::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon16/26:c.*1029+48_*1029+49insAGGCAACC::,ALDH4A1:ENST00000538309:intron_variant:MODIFIER:exon8/14:c.686+48_686+49insAGGCAACC::,ALDH4A1:ENST00000538839:intron_variant:MODIFIER:exon8/13:c.866+48_866+49insAGGCAACC::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];				rs112548638	0.9830	0.9957	15127,.	0.9437,0.9967,0.9999,0.9998,0.9995					2.32						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19211930	19211930	A	C	wt	wt	hom	off-target	QUAL=54;DP=4,5,7;AF=0.00,0.00,0.86;MQM=60	ALDH4A1,RP13-279N23.2	intron,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon5/15:c.453+37T>G::,ALDH4A1:ENST00000375341:intron_variant:MODIFIER:exon5/14:c.453+37T>G::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon12/26:c.*501+37T>G::,ALDH4A1:ENST00000538309:intron_variant:MODIFIER:exon5/14:c.273+37T>G::,ALDH4A1:ENST00000538839:intron_variant:MODIFIER:exon5/13:c.453+37T>G::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];			(CACCC)n (Simple_repeat)	rs752213358		0.2907	0,.	0.3541,0.4488,0.4416,0.2331,0.2196	-3.0270			0.00,0.06	0.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19211935	19211935	G	C	n/a	wt	het	off-target	QUAL=26;DP=2,6,9;AF=0.00,0.00,0.56;MQM=60	ALDH4A1,RP13-279N23.2	intron,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon5/15:c.453+32C>G::,ALDH4A1:ENST00000375341:intron_variant:MODIFIER:exon5/14:c.453+32C>G::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon12/26:c.*501+32C>G::,ALDH4A1:ENST00000538309:intron_variant:MODIFIER:exon5/14:c.273+32C>G::,ALDH4A1:ENST00000538839:intron_variant:MODIFIER:exon5/13:c.453+32C>G::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];			(CACCC)n (Simple_repeat)	rs188233802		0.3275	0,.	0.4060,0.4609,0.4566,0.2761,0.2668	-0.6220			0.06,0.16	2.84						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	19215834	19215834	T	C	hom	hom	hom	off-target	QUAL=11083;DP=120,143,95;AF=1.00,1.00,1.00;MQM=59	ALDH4A1,RP13-279N23.2	intron,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:exon3/15:c.249+22A>G::,ALDH4A1:ENST00000375341:intron_variant:MODIFIER:exon3/14:c.249+22A>G::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:exon10/26:c.*297+22A>G::,ALDH4A1:ENST00000538309:intron_variant:MODIFIER:exon3/14:c.69+22A>G::,ALDH4A1:ENST00000538839:intron_variant:MODIFIER:exon3/13:c.249+22A>G::		606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];				rs941495	0.9844	0.9677	14684,.	0.9926,0.9727,0.9999,0.9571,0.9863	-0.2240			0.00,0.06	4.80						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), RP13-279N23.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	21889635	21889635	T	C	hom	het	hom		QUAL=4758;DP=28,125,90;AF=0.96,0.52,1.00;MQM=60	ALPL	synonymous	ALPL:ENST00000374832:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:PF00245,ALPL:ENST00000374840:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:PF00245,ALPL:ENST00000425315:synonymous_variant:LOW:exon4/11:c.330T>C:p.Ser110=:PF00245,ALPL:ENST00000539907:synonymous_variant:LOW:exon3/10:c.99T>C:p.Ser33=:PF00245,ALPL:ENST00000540617:synonymous_variant:LOW:exon4/11:c.165T>C:p.Ser55=:PF00245		171760 [GENE=ALPL PHENOS=Hypophosphatasia,adult,146300,Autosomal recessive,Autosomal dominant/Hypophosphatasia,childhood,241510,Autosomal recessive/Hypophosphatasia,infantile,241500,Autosomal recessive/Odontohypophosphatasia,146300,Autosomal recessive,Autosomal dominant];	197678 [benign DISEASE=not specified];			rs1780316	0.9295	0.9472	13471,.	0.8650,0.9679,0.9864,0.9435,0.9535	-0.9200			0.01,0.95	7.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21896925	21896925	C	T	het	het	wt	off-target	QUAL=6278;DP=187,304,243;AF=0.49,0.55,0.00;MQM=60	ALPL	intron	ALPL:ENST00000374830:intron_variant:MODIFIER:exon1/3:c.-66+58C>T::,ALPL:ENST00000374832:intron_variant:MODIFIER:exon8/11:c.862+58C>T::,ALPL:ENST00000374840:intron_variant:MODIFIER:exon8/11:c.862+58C>T::,ALPL:ENST00000425315:intron_variant:MODIFIER:exon7/10:c.862+58C>T::,ALPL:ENST00000539907:intron_variant:MODIFIER:exon6/9:c.631+58C>T::,ALPL:ENST00000540617:intron_variant:MODIFIER:exon7/10:c.697+58C>T::		171760 [GENE=ALPL PHENOS=Hypophosphatasia,adult,146300,Autosomal recessive,Autosomal dominant/Hypophosphatasia,childhood,241510,Autosomal recessive/Hypophosphatasia,infantile,241500,Autosomal recessive/Odontohypophosphatasia,146300,Autosomal recessive,Autosomal dominant];				rs2275375	0.3231	0.2600	1110,.		-1.6000			0.01,0.13	0.14						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21904206	21904206	C	T	wt	wt	het		QUAL=1738;DP=59,234,173;AF=0.00,0.00,0.46;MQM=60	ALPL	3'UTR	ALPL:ENST00000374829:3_prime_UTR_variant:MODIFIER:exon4/4:c.*65C>T::,ALPL:ENST00000374830:3_prime_UTR_variant:MODIFIER:exon4/4:c.*65C>T::,ALPL:ENST00000374832:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:ENST00000374840:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:ENST00000425315:3_prime_UTR_variant:MODIFIER:exon11/11:c.*65C>T::,ALPL:ENST00000539907:3_prime_UTR_variant:MODIFIER:exon10/10:c.*65C>T::,ALPL:ENST00000540617:3_prime_UTR_variant:MODIFIER:exon11/11:c.*65C>T::		171760 [GENE=ALPL PHENOS=Hypophosphatasia,adult,146300,Autosomal recessive,Autosomal dominant/Hypophosphatasia,childhood,241510,Autosomal recessive/Hypophosphatasia,infantile,241500,Autosomal recessive/Odontohypophosphatasia,146300,Autosomal recessive,Autosomal dominant];	295558 [benign DISEASE=Hypophosphatasia];			rs1697405	0.3367	0.3519	2014,.		4.1560			0.71,0.96	12.45						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21904263	21904263	C	-	het	wt	het		QUAL=20826;DP=197,280,240;AF=0.98,1.00,0.98;MQM=59	ALPL	3'UTR	ALPL:ENST00000374829:3_prime_UTR_variant:MODIFIER:exon4/4:c.*124del::,ALPL:ENST00000374832:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:ENST00000374840:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:ENST00000425315:3_prime_UTR_variant:MODIFIER:exon11/11:c.*124del::,ALPL:ENST00000539907:3_prime_UTR_variant:MODIFIER:exon10/10:c.*124del::,ALPL:ENST00000540617:3_prime_UTR_variant:MODIFIER:exon11/11:c.*124del::		171760 [GENE=ALPL PHENOS=Hypophosphatasia,adult,146300,Autosomal recessive,Autosomal dominant/Hypophosphatasia,childhood,241510,Autosomal recessive/Hypophosphatasia,infantile,241500,Autosomal recessive/Odontohypophosphatasia,146300,Autosomal recessive,Autosomal dominant];	295560 [likely benign DISEASE=Hypophosphatasia];			rs140511985	0.0228	0.0450	46,.		1.4120				15.02						1	29						ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21904267	21904267	A	G	hom	hom	hom		QUAL=20826;DP=197,280,240;AF=0.98,1.00,0.98;MQM=59	ALPL	3'UTR	ALPL:ENST00000374829:3_prime_UTR_variant:MODIFIER:exon4/4:c.*126A>G::,ALPL:ENST00000374832:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:ENST00000374840:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:ENST00000425315:3_prime_UTR_variant:MODIFIER:exon11/11:c.*126A>G::,ALPL:ENST00000539907:3_prime_UTR_variant:MODIFIER:exon10/10:c.*126A>G::,ALPL:ENST00000540617:3_prime_UTR_variant:MODIFIER:exon11/11:c.*126A>G::		171760 [GENE=ALPL PHENOS=Hypophosphatasia,adult,146300,Autosomal recessive,Autosomal dominant/Hypophosphatasia,childhood,241510,Autosomal recessive/Hypophosphatasia,infantile,241500,Autosomal recessive/Odontohypophosphatasia,146300,Autosomal recessive,Autosomal dominant];	295561 [benign DISEASE=Hypophosphatasia];			rs1697406	0.8682	0.8703	11867,.		0.7810			0.00,0.89	16.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21904374	21904374	A	C	wt	het	wt		QUAL=2235;DP=124,197,190;AF=0.00,0.46,0.00;MQM=60	ALPL	3'UTR	ALPL:ENST00000374829:3_prime_UTR_variant:MODIFIER:exon4/4:c.*233A>C::,ALPL:ENST00000374832:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:ENST00000374840:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:ENST00000425315:3_prime_UTR_variant:MODIFIER:exon11/11:c.*233A>C::,ALPL:ENST00000539907:3_prime_UTR_variant:MODIFIER:exon10/10:c.*233A>C::,ALPL:ENST00000540617:3_prime_UTR_variant:MODIFIER:exon11/11:c.*233A>C::		171760 [GENE=ALPL PHENOS=Hypophosphatasia,adult,146300,Autosomal recessive,Autosomal dominant/Hypophosphatasia,childhood,241510,Autosomal recessive/Hypophosphatasia,infantile,241500,Autosomal recessive/Odontohypophosphatasia,146300,Autosomal recessive,Autosomal dominant];	295563 [benign DISEASE=Hypophosphatasia];			rs1772719	0.1645	0.1840	533,.		0.5040			0.48,0.95	14.68						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	22149183	22149183	G	C	het	hom	wt		QUAL=1437;DP=26,42,28;AF=0.58,1.00,0.00;MQM=60	LDLRAD2,HSPG2	3'UTR,intron	LDLRAD2:ENST00000344642:3_prime_UTR_variant:MODIFIER:exon5/5:c.*475G>C::,HSPG2:ENST00000374695:3_prime_UTR_variant:MODIFIER:exon97/97:c.*626C>G::,LDLRAD2:ENST00000543870:intron_variant:MODIFIER:exon5/5:c.*218+257G>C::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295685 [benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1];			rs1049644	0.3199	0.2993	1529,.		2.2390			0.26,0.18	6.66						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22149935	22149935	T	C	hom	hom	hom		QUAL=15086;DP=111,232,143;AF=1.00,1.00,1.00;MQM=60	LDLRAD2,HSPG2	3'UTR,synonymous,intron	LDLRAD2:ENST00000344642:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1227T>C::,HSPG2:ENST00000374695:synonymous_variant:LOW:exon97/97:c.13050A>G:p.Ser4350=:PF00054,LDLRAD2:ENST00000543870:intron_variant:MODIFIER:exon5/5:c.*219-468T>C::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295695 [benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1,not provided];			rs897467		0.8075	9865,.	0.7083,0.7501,0.8158,0.8242,0.8256	-3.5700			0.04,0.86	15.62						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22150118	22150118	C	T	wt	het	wt		QUAL=3342;DP=143,313,206;AF=0.00,0.44,0.00;MQM=60	LDLRAD2,HSPG2	3'UTR,missense,intron	LDLRAD2:ENST00000344642:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1410C>T::,HSPG2:ENST00000374695:missense_variant:MODERATE:exon96/97:c.12994G>A:p.Val4332Ile:PF00054,LDLRAD2:ENST00000543870:intron_variant:MODIFIER:exon5/5:c.*219-285C>T::	regulatory_region_variant:promoter	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295699 [benign/likely benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1,not provided];			rs1138469	0.0453	0.0571	44,.	0.0286,0.0272,0.0002,0.0622,0.1027	-1.4120	 ,T(1.00), 	 ,B(0.00), 	0.03,0.58	9.81	0.21					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22150120	22150120	C	T	het	het	wt		QUAL=5797;DP=150,317,208;AF=0.45,0.55,0.01;MQM=59	LDLRAD2,HSPG2	3'UTR,missense,intron	LDLRAD2:ENST00000344642:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1412C>T::,HSPG2:ENST00000374695:missense_variant:MODERATE:exon96/97:c.12992G>A:p.Ser4331Asn:PF00054,LDLRAD2:ENST00000543870:intron_variant:MODIFIER:exon5/5:c.*219-283C>T::	regulatory_region_variant:promoter	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295700 [benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1];			rs3736360	0.1761	0.1814	422,.	0.0825,0.1274,0.1596,0.1792,0.2850	0.0960	 ,T(0.39), 	 ,B(0.00), 	0.21,0.89	17.97	0.12					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22150160	22150160	G	T	het	het	wt		QUAL=8012;DP=290,324,205;AF=0.49,0.55,0.01;MQM=59	LDLRAD2,HSPG2	3'UTR,synonymous,intron	LDLRAD2:ENST00000344642:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1452G>T::,HSPG2:ENST00000374695:synonymous_variant:LOW:exon96/97:c.12952C>A:p.Arg4318=:PF00054,LDLRAD2:ENST00000543870:intron_variant:MODIFIER:exon5/5:c.*219-243G>T::	regulatory_region_variant:promoter	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295701 [benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1,not provided];			rs3736358		0.1781	398,.	0.0345,0.1263,0.1596,0.1793,0.2850	3.5060			0.92,0.96	18.45					COSM7262955	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22150257	22150257	C	T	het	wt	hom	off-target	QUAL=3623;DP=72,202,108;AF=0.51,0.00,0.99;MQM=60	LDLRAD2,HSPG2	3'UTR,intron	LDLRAD2:ENST00000344642:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1549C>T::,HSPG2:ENST00000374695:intron_variant:MODIFIER:exon95/96:c.12900-45G>A::,LDLRAD2:ENST00000543870:intron_variant:MODIFIER:exon5/5:c.*219-146C>T::	regulatory_region_variant:promoter	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs3736357	0.3752	0.4680	2888,.	0.1381,0.5328,0.6492,0.4898,0.3376	1.4950			0.09,0.16	4.37						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=n/a oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22154845	22154845	A	G	het	hom	wt		QUAL=1276;DP=42,32,37;AF=0.36,0.97,0.00;MQM=60	HSPG2	synonymous	HSPG2:ENST00000374695:synonymous_variant:LOW:exon89/97:c.12312T>C:p.Asp4104=:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295707 [benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1];			rs2228347	0.2572	0.2911	1099,.	0.1341,0.1842,0.1585,0.3076,0.4730	1.3460			0.11,0.83	17.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22155841	22155841	T	C	het	het	wt	off-target	QUAL=1222;DP=38,75,65;AF=0.53,0.52,0.00;MQM=59	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon87/96:c.11992+35A>G::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	618168 [benign DISEASE=not provided];			rs12042189	0.1564	0.1787	401,.	0.0343,0.1268,0.1582,0.1789,0.2840	-1.8010			0.03,0.13	0.26						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22155853	22155853	C	T	het	het	wt	off-target	QUAL=1398;DP=58,83,71;AF=0.36,0.54,0.00;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon87/96:c.11992+23G>A::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	618169 [benign DISEASE=not provided];			rs12023794	0.1715	0.1804	433,.	0.0844,0.1273,0.1652,0.1786,0.2752	-0.8760			0.03,0.15	1.37						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22157689	22157689	G	A	hom	hom	hom	off-target	QUAL=16209;DP=94,254,201;AF=1.00,1.00,1.00;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon84/96:c.11562+19C>T::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs3736355	0.7592	0.7910	9378,.	0.6961,0.7415,0.8055,0.8006,0.8091	-2.8310			0.03,0.16	0.90						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22158120	22158120	G	T	het	het	wt	off-target	QUAL=2879;DP=81,142,101;AF=0.52,0.54,0.00;MQM=59	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon82/96:c.11352+25C>A::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs2270701	0.1651	0.1812	401,.	0.0590,0.1278,0.1579,0.1796,0.2864	-2.9900			0.06,0.11	0.27						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22159774	22159774	G	A	het	het	wt		QUAL=4186;DP=134,237,207;AF=0.44,0.50,0.00;MQM=60	HSPG2	synonymous	HSPG2:ENST00000374695:synonymous_variant:LOW:exon80/97:c.11082C>T:p.Pro3694=:PF02210		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295724 [likely benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1];			rs2229486	0.0859	0.0965	181,.	0.1725,0.0410,0.0003,0.0796,0.1105	-3.3550			0.09,0.43	8.51						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22160043	22160043	C	T	het	het	wt		QUAL=5322;DP=181,284,221;AF=0.44,0.49,0.00;MQM=60	HSPG2	missense	HSPG2:ENST00000374695:missense_variant:MODERATE:exon79/97:c.10895G>A:p.Arg3632Gln:PF07679		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295727 [likely benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1];			rs2229493	0.0859	0.0967	180,.	0.1735,0.0410,0.0002,0.0796,0.1106	-0.0650	T(0.54)	B(0.03)	0.19,0.21	1.94	0.05					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22160148	22160148	C	T	het	wt	hom	off-target	QUAL=5245;DP=98,183,131;AF=0.59,0.00,1.00;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon78/96:c.10831-41G>A::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs7547731	0.3750	0.4643	2905,.	0.1375,0.5314,0.6473,0.4863,0.3319	-2.7290			0.06,0.14	0.92						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22163390	22163390	G	A	het	het	wt		QUAL=5479;DP=177,353,226;AF=0.50,0.40,0.00;MQM=60	HSPG2	synonymous	HSPG2:ENST00000374695:synonymous_variant:LOW:exon75/97:c.10260C>T:p.His3420=:PF07679		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295741 [likely benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1];			rs35444472	0.0861	0.0959	176,.	0.1701,0.0426,0.0004,0.0797,0.1119	2.3820			0.80,0.90	9.35						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22163402	22163402	G	A	wt	het	wt		QUAL=5287;DP=176,347,223;AF=0.00,0.60,0.00;MQM=60	HSPG2	synonymous	HSPG2:ENST00000374695:synonymous_variant:LOW:exon75/97:c.10248C>T:p.Ser3416=:PF07679		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295743 [likely benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1,not provided];	CS011537 [CLASS=DM? MUT=ALT PHEN="Dyssegmental dysplasia Silverman-Handmaker type" GENE=HSPG2];		rs41310390	0.0437	0.0586	44,.	0.0290,0.0287,0.0001,0.0642,0.0964	-2.4040			0.11,0.76	8.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22165901	22165901	A	G	het	het	wt		QUAL=2728;DP=83,87,39;AF=0.65,0.67,0.00;MQM=59	HSPG2	synonymous	HSPG2:ENST00000374695:synonymous_variant:LOW:exon73/97:c.9852T>C:p.Ala3284=:PF07679		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295750 [benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1,not provided];			rs2291826	0.3460	0.3320	1983,.	0.5383,0.1851,0.1598,0.2599,0.3809	-3.4070			0.02,0.12	0.26						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22167605	22167605	C	T	het	het	wt		QUAL=2022;DP=47,182,164;AF=0.45,0.41,0.00;MQM=60	HSPG2	missense	HSPG2:ENST00000374695:missense_variant:MODERATE:exon71/97:c.9502G>A:p.Ala3168Thr:PF07679	regulatory_region_variant:CTCF_binding_site	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295758 [likely benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1];			rs2228349	0.0837	0.0936	168,.	0.1609,0.0403,0.0002,0.0788,0.1103	0.9110	T(0.71)	B(0.01)	0.31,0.27	7.15	0.12					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22168216	22168216	C	T	het	wt	hom	off-target	QUAL=6287;DP=75,231,181;AF=0.47,0.00,1.00;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon69/96:c.9194-50G>A::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs7556412	0.6238	0.6519	6292,.	0.5013,0.6175,0.8146,0.6580,0.6022	-0.8510			0.08,0.23	6.70						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22168801	22168801	T	C	het	het	wt		QUAL=1436;DP=61,87,76;AF=0.46,0.43,0.00;MQM=59	HSPG2	missense	HSPG2:ENST00000374695:missense_variant:MODERATE:exon68/97:c.8983A>G:p.Ser2995Gly:PF13895		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295764 [benign/likely benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1,not provided];			rs2229491	0.0887	0.0982	189,.	0.1818,0.0411,0.0002,0.0794,0.1100	-0.0660	T(1.00)	B(0.00)	0.01,0.13	2.13	0.04					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22168845	22168845	A	T	het	het	wt		QUAL=924;DP=42,56,44;AF=0.52,0.38,0.00;MQM=60	HSPG2	missense	HSPG2:ENST00000374695:missense_variant:MODERATE:exon68/97:c.8939T>A:p.Leu2980His:PF13895		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295765 [benign/likely benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1,not provided];			rs2229489	0.0343	0.0490	31,.	0.0084,0.0237,0.0002,0.0568,0.1047	1.8860	T(1.00)	B(0.00)	0.18,0.31	14.20	0.07					21	862						HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22173144	22173144	C	T	het	het	wt	off-target	QUAL=8075;DP=101,508,376;AF=0.52,0.54,0.00;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon62/96:c.8165-52G>A::,HSPG2:ENST00000430507:intron_variant:MODIFIER:exon17/18:c.*1514-52G>A::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs34792235	0.0347	0.0493	31,.	0.0081,0.0237,0.0002,0.0568,0.1058	-1.2250			0.03,0.15	7.28						22	800						HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22173990	22173990	A	G	het	het	wt		QUAL=7175;DP=155,424,324;AF=0.55,0.49,0.00;MQM=60	HSPG2	splice_region&intron	HSPG2:ENST00000374695:splice_region_variant&intron_variant:LOW:exon61/96:c.8026-5T>C::,HSPG2:ENST00000430507:splice_region_variant&intron_variant:LOW:exon16/18:c.*1375-5T>C::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295781 [likely benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1];			rs35917892	0.0347	0.0492	31,.	0.0083,0.0237,0.0002,0.0569,0.1058	-1.2120			0.01,0.10	0.84		4.39>3.72				23	858						HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22174426	22174426	T	G	het	hom	wt	off-target	QUAL=11557;DP=183,323,310;AF=0.45,0.99,0.01;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon60/96:c.7873+25A>C::,HSPG2:ENST00000430507:intron_variant:MODIFIER:exon15/18:c.*1222+25A>C::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs2290501	0.3748	0.3671	2283,.	0.5255,0.2081,0.1694,0.3145,0.4753	-0.0010			0.01,0.13	7.83						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22174518	22174518	G	T	het	het	wt		QUAL=7404;DP=270,363,358;AF=0.43,0.51,0.00;MQM=59	HSPG2	synonymous,3'UTR	HSPG2:ENST00000374695:synonymous_variant:LOW:exon60/97:c.7806C>A:p.Val2602=:PF07679,HSPG2:ENST00000430507:3_prime_UTR_variant:MODIFIER:exon15/19:c.*1155C>A::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295785 [likely benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1];			rs12737091	0.0347	0.0491	29,.	0.0083,0.0237,0.0002,0.0567,0.1058	1.2660			0.69,0.85	7.78						22	859						HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22174600	22174600	A	G	hom	hom	hom	off-target	QUAL=17425;DP=85,247,234;AF=1.00,1.00,1.00;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon59/96:c.7738-14T>C::,HSPG2:ENST00000430507:intron_variant:MODIFIER:exon14/18:c.*1087-14T>C::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295787 [benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1];			rs3767138	0.7620	0.7946	9614,.	0.7018,0.6937,0.8172,0.8169,0.8136	0.4330			0.01,0.16	11.03		10.37>10.27				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22175096	22175096	T	C	het	het	wt	off-target	QUAL=1843;DP=60,86,56;AF=0.50,0.58,0.00;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon59/96:c.7737+40A>G::,HSPG2:ENST00000430507:intron_variant:MODIFIER:exon14/18:c.*1086+40A>G::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs34726153	0.0349	0.0494	31,.	0.0085,0.0240,0.0002,0.0573,0.1059	-1.9520			0.04,0.14	1.81						22	805						HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22178469	22178469	A	G	het	het	wt	off-target	QUAL=2481;DP=66,121,84;AF=0.61,0.53,0.02;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon53/96:c.6871-50T>C::,HSPG2:ENST00000430507:intron_variant:MODIFIER:exon8/18:c.*220-50T>C::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs34346159	0.0347	0.0491	31,.	0.0080,0.0238,0.0002,0.0567,0.1058	-0.3870			0.00,0.08	6.94						22	802						HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22179244	22179244	C	T	het	het	wt		QUAL=3493;DP=86,203,152;AF=0.43,0.51,0.00;MQM=60	HSPG2	missense,3'UTR	HSPG2:ENST00000374695:missense_variant:MODERATE:exon52/97:c.6673G>A:p.Gly2225Ser:PF07679,HSPG2:ENST00000430507:3_prime_UTR_variant:MODIFIER:exon7/19:c.*22G>A::	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295807 [likely benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1];			rs35669711	0.0347	0.0492	30,.	0.0084,0.0238,0.0002,0.0569,0.1059	-0.1820	T(0.09), 	B(0.07), 	0.13,0.20	12.78	0.23					22	854						HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22179451	22179451	C	T	het	het	wt		QUAL=5825;DP=78,434,272;AF=0.49,0.46,0.00;MQM=59	HSPG2	synonymous	HSPG2:ENST00000374695:synonymous_variant:LOW:exon51/97:c.6552G>A:p.Thr2184=:PF07679,HSPG2:ENST00000430507:synonymous_variant:LOW:exon6/19:c.390G>A:p.Thr130=:PF00047	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295810 [likely benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1];			rs34443576	0.0345	0.0493	31,.	0.0085,0.0240,0.0004,0.0568,0.1060	-10.2480			0.02,0.10	0.59						22	855						HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22180723	22180723	C	T	het	het	wt		QUAL=3031;DP=81,196,143;AF=0.46,0.51,0.00;MQM=60	HSPG2	synonymous,splice_region&intron	HSPG2:ENST00000374695:synonymous_variant:LOW:exon50/97:c.6402G>A:p.Val2134=:PF07679,HSPG2:ENST00000430507:splice_region_variant&intron_variant:LOW:exon4/18:c.249+3G>A::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	285614 [benign/likely benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1,not specified];			rs12742444	0.0345	0.0472	30,.	0.0076,0.0233,0.0002,0.0540,0.1044	0.5220			0.53,0.86	8.31		-13.40>-9.18				21	850						HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22181322	22181322	A	G	het	het	wt	off-target	QUAL=1239;DP=44,74,63;AF=0.57,0.43,0.00;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon48/96:c.6133+19T>C::,HSPG2:ENST00000430507:intron_variant:MODIFIER:exon2/18:c.-18+19T>C::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs36080251	0.0345	0.0491	30,.	0.0083,0.0239,0.0002,0.0567,0.1061	-0.7900			0.04,0.15	3.85						22	810						HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22181895	22181895	C	T	het	het	wt		QUAL=5703;DP=151,311,257;AF=0.50,0.53,0.00;MQM=60	HSPG2	missense	HSPG2:ENST00000374695:missense_variant:MODERATE:exon47/97:c.5899G>A:p.Val1967Ile:PF07679	regulatory_region_variant:CTCF_binding_site	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295823 [likely benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1];			rs2229475	0.0347	0.0487	31,.	0.0082,0.0236,0.0002,0.0562,0.1053	1.8270	T(0.17)	D(1.00)	0.81,0.94	23.30	0.24					21	854						HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22183471	22183471	A	C	hom	hom	hom	off-target	QUAL=1106;DP=20,13,7;AF=1.00,1.00,1.00;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon44/96:c.5575+37T>G::	regulatory_region_variant:promoter_flanking_region	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs12024579	0.7490	0.7884	9307,.	0.6607,0.7038,0.8137,0.8107,0.7977	-1.1730			0.01,0.11	5.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22183476	22183476	A	G	het	het	wt	off-target	QUAL=121;DP=20,13,8;AF=0.20,0.54,0.00;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon44/96:c.5575+32T>C::	regulatory_region_variant:promoter_flanking_region	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs200354565	0.0461	0.0525	32,.	0.0409,0.0256,0.0003,0.0585,0.1067	-1.9140			0.01,0.11	4.20						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22183477	22183477	G	T	het	het	wt	off-target	QUAL=121;DP=20,13,8;AF=0.20,0.54,0.00;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon44/96:c.5575+31C>A::	regulatory_region_variant:promoter_flanking_region	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs12757277	0.0461	0.0525	32,.	0.0409,0.0256,0.0003,0.0584,0.1067	-3.3630			0.04,0.12	0.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22183739	22183739	A	G	hom	het	hom	off-target	QUAL=7833;DP=97,114,119;AF=1.00,0.48,1.00;MQM=59	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon43/96:c.5394+39T>C::	regulatory_region_variant:promoter_flanking_region	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs2305562	0.4469	0.5109	4079,.	0.4198,0.4836,0.4471,0.5460,0.3863	1.6230			0.13,0.23	9.85						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22191454	22191454	G	A	het	wt	hom		QUAL=7091;DP=119,347,208;AF=0.39,0.00,1.00;MQM=59	HSPG2	missense	HSPG2:ENST00000374695:missense_variant:MODERATE:exon36/97:c.4508C>T:p.Ala1503Val:PF00052		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	291236 [benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1,not specified,not provided];			rs897471		0.7321	7924,.	0.6122,0.8067,0.8922,0.7350,0.5771	2.2610	T(0.06)	D(1.00)	0.46,0.70	22.10	0.15		gain/donor/22191453-22191454/Medium/1.427611			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22199081	22199081	A	T	hom	hom	hom	off-target	QUAL=5877;DP=51,80,80;AF=0.98,1.00,1.00;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon32/96:c.4029+32T>A::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs2501266	0.9798	0.9958	15175,.	0.9402,0.9969,1.0000,0.9997,0.9999	-0.4800			0.03,0.08	0.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22199245	22199245	C	T	het	wt	hom		QUAL=3063;DP=44,76,79;AF=0.64,0.01,1.00;MQM=60	HSPG2	synonymous	HSPG2:ENST00000374695:synonymous_variant:LOW:exon32/97:c.3897G>A:p.Val1299=:PF00053		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	285755 [benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1,not specified];			rs2229482	0.4249	0.5558	4528,.	0.2867,0.4025,0.4363,0.6384,0.5035	0.1280			0.73,0.88	9.72						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22199821	22199821	G	A	het	wt	hom	off-target	QUAL=1474;DP=44,39,32;AF=0.48,0.00,1.00;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon30/96:c.3793+47C>T::	regulatory_region_variant:open_chromatin_region	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs2454290	0.7420	0.8308	9418,.	0.4849,0.9126,0.9771,0.8489,0.7345	0.0910			0.05,0.18	4.75						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22202109	22202109	C	T	hom	hom	hom	off-target	QUAL=26126;DP=195,399,282;AF=0.98,1.00,1.00;MQM=59	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon25/96:c.3302+13G>A::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295864 [benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1];		MIRb (SINE/MIR)	rs2501265	0.9423	0.9858	14299,.	0.8166,0.9903,1.0000,0.9993,0.9996	-6.5090			0.01,0.15	1.48						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22205466	22205466	T	-	het	wt	wt	off-target	QUAL=3370;DP=36,35,49;AF=1.00,1.00,1.00;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon18/96:c.2471+21del::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs749134779		0.0003	0,.	0.0004,0.0002,0.0005,0.0003,0.0003	-0.9090				1.44						0	132						HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22205466	22205466	T	C	het	hom	hom	off-target	QUAL=3370;DP=36,35,49;AF=1.00,1.00,1.00;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon18/96:c.2471+21A>G::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs2454293		0.9890	14709,.	0.8732,0.9919,0.9977,0.9977,0.9976	-0.9090			0.02,0.13	2.77						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22206649	22206649	T	C	hom	hom	hom		QUAL=21905;DP=191,255,236;AF=1.00,1.00,1.00;MQM=60	HSPG2	missense	HSPG2:ENST00000374695:missense_variant:MODERATE:exon17/97:c.2294A>G:p.Asn765Ser:PF00053		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295881 [benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1];			rs989994		0.9845	14054,.	0.7872,0.9901,1.0000,0.9996,0.9996	0.8040	T(0.19)	B(0.02)	0.82,0.96	22.30	0.14		gain/acceptor/22206648-22206649/Medium/5.539625			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22206942	22206942	G	A	hom	hom	hom		QUAL=7762;DP=117,73,61;AF=1.00,1.00,1.00;MQM=59	HSPG2	synonymous	HSPG2:ENST00000374695:synonymous_variant:LOW:exon16/97:c.2109C>T:p.Ala703=:PF00052		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295882 [benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1];			rs1874793		0.9845	14032,.	0.7876,0.9901,1.0000,0.9996,0.9997	1.4460			0.85,0.95	12.80						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22207065	22207065	G	A	het	het	wt	off-target	QUAL=806;DP=36,52,41;AF=0.33,0.48,0.00;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon15/96:c.1999-13C>T::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295886 [uncertain significance DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1];			rs77828146	0.0082	0.0126	8,.	0.0028,0.0051,0.0000,0.0151,0.0198	-1.5230			0.08,0.19	0.89		5.42>5.43				5	227						HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22207235	22207235	T	C	hom	hom	hom		QUAL=10960;DP=155,132,73;AF=1.00,1.00,1.00;MQM=60	HSPG2	missense	HSPG2:ENST00000374695:missense_variant:MODERATE:exon15/97:c.1912A>G:p.Met638Val:PF00052		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295887 [benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1];			rs1874792	0.9736	0.9944	15029,.	0.9191,0.9964,1.0000,0.9996,1.0000	1.5570	T(1.00)	B(0.00)	0.17,0.79	11.09	0.07					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22207805	22207817	CCCAGGGTGGCAG	-	hom	hom	hom	off-target	QUAL=7636;DP=49,144,91;AF=1.00,1.00,1.00;MQM=59	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon14/96:c.1818+15_1818+27del::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs139046040	0.9597	0.9908	14629,.	0.8763,0.9931,0.9998,0.9996,0.9998	3.6790				4.63			loss/acceptor/22207814-22207813/Medium/5.067045			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22208030	22208030	C	T	het	het	hom	off-target	QUAL=4597;DP=67,122,93;AF=0.46,0.43,1.00;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon13/96:c.1655-35G>A::		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	439797 [benign DISEASE=not specified];			rs921847		0.9723	13742,.	0.7947,0.9850,1.0000,0.9843,0.9800	-0.4860			0.06,0.24	7.60						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22211222	22211222	T	C	het	het	het	off-target	QUAL=6859;DP=79,301,244;AF=0.56,0.48,0.43;MQM=60	HSPG2	intron	HSPG2:ENST00000374695:intron_variant:MODIFIER:exon12/96:c.1507+38A>G::	regulatory_region_variant:CTCF_binding_site	142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];				rs4654994	0.8964	0.9135	12824,.	0.8502,0.8797,0.9665,0.9312,0.8939	-0.9900			0.01,0.10	1.75						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22214127	22214127	A	G	hom	hom	het		QUAL=12612;DP=119,213,181;AF=1.00,1.00,0.50;MQM=60	HSPG2	synonymous	HSPG2:ENST00000374695:synonymous_variant:LOW:exon8/97:c.744T>C:p.Leu248=:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295909 [benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1,not provided];			rs2229478		0.4490	3466,.	0.6401,0.5793,0.6276,0.3342,0.4043	-0.2610			0.06,0.22	1.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22217108	22217108	G	A	hom	hom	hom		QUAL=25846;DP=219,332,276;AF=1.00,1.00,1.00;MQM=60	HSPG2	synonymous	HSPG2:ENST00000374695:synonymous_variant:LOW:exon4/97:c.324C>T:p.Phe108=:		142461 [GENE=HSPG2 PHENOS=Dyssegmental dysplasia,Silverman-Handmaker type,224410,Autosomal recessive/Schwartz-Jampel syndrome,type 1,255800,Autosomal recessive];	295913 [benign DISEASE=Dyssegmental Dysplasia,Schwartz Jampel syndrome type 1];			rs2501260	0.9481	0.9887	14430,.	0.8450,0.9934,1.0000,0.9996,0.9998	2.4590			0.81,0.94	13.48						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22779159	22779159	T	C	hom	hom	hom		QUAL=28797;DP=267,395,256;AF=1.00,1.00,1.00;MQM=60	ZBTB40	intron,5'UTR	ZBTB40:ENST00000374651:intron_variant:MODIFIER:exon1/15:c.-70+662T>C::,ZBTB40:ENST00000375647:intron_variant:MODIFIER:exon1/17:c.-70+662T>C::,ZBTB40:ENST00000404138:5_prime_UTR_variant:MODIFIER:exon2/19:c.-350T>C::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site				MER58B (DNA/hAT-Charlie)	rs10737466	0.9698	0.9779	15035,.		-1.6200			0.00,0.08	5.38						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22832743	22832743	A	T	hom	hom	het		QUAL=15557;DP=213,209,167;AF=1.00,0.99,0.56;MQM=60	ZBTB40	intron	ZBTB40:ENST00000374651:intron_variant:MODIFIER:exon4/15:c.1024+9A>T::,ZBTB40:ENST00000375647:intron_variant:MODIFIER:exon6/17:c.1360+9A>T::,ZBTB40:ENST00000404138:intron_variant:MODIFIER:exon7/18:c.1360+9A>T::						rs209732	0.7991	0.7092	8169,.	0.8973,0.8436,0.8953,0.6147,0.7058	0.8940			0.02,0.92	15.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22835677	22835677	A	G	hom	hom	het		QUAL=24823;DP=339,306,273;AF=1.00,1.00,0.53;MQM=60	ZBTB40	missense	ZBTB40:ENST00000374651:missense_variant:MODERATE:exon7/16:c.1448A>G:p.Tyr483Cys:,ZBTB40:ENST00000375647:missense_variant:MODERATE:exon9/18:c.1784A>G:p.Tyr595Cys:,ZBTB40:ENST00000404138:missense_variant:MODERATE:exon10/19:c.1784A>G:p.Tyr595Cys:						rs209729		0.7796	9652,.	0.9128,0.8838,0.8964,0.7168,0.7161	0.2230	T(0.10),D(0.03),D(0.03)	B(0.00),B(0.00),B(0.00)	0.03,0.18	12.76	0.02					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22846709	22846709	G	A	hom	hom	hom		QUAL=12141;DP=168,135,93;AF=1.00,1.00,1.00;MQM=59	ZBTB40	missense	ZBTB40:ENST00000374651:missense_variant:MODERATE:exon12/16:c.2653G>A:p.Val885Met:PF00096,ZBTB40:ENST00000375647:missense_variant:MODERATE:exon14/18:c.2989G>A:p.Val997Met:PF00096,ZBTB40:ENST00000404138:missense_variant:MODERATE:exon15/19:c.2989G>A:p.Val997Met:PF00096						rs209720	0.9984	0.9973	15609,.	0.9991,0.9974,1.0000,0.9948,0.9993	2.3020	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	0.39,0.96	20.20	0.17					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22849003	22849003	A	C	hom	hom	het	off-target	QUAL=15027;DP=171,253,196;AF=0.99,0.99,0.48;MQM=60	ZBTB40	intron	ZBTB40:ENST00000374651:intron_variant:MODIFIER:exon14/15:c.2962+47A>C::,ZBTB40:ENST00000375647:intron_variant:MODIFIER:exon16/17:c.3298+47A>C::,ZBTB40:ENST00000404138:intron_variant:MODIFIER:exon17/18:c.3298+47A>C::					MIR (SINE/MIR)	rs998978	0.3181	0.3392	1508,.	0.1520,0.1757,0.4593,0.3725,0.4202	-6.2890			0.00,0.08	0.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22852715	22852715	G	C	hom	hom	het		QUAL=10748;DP=165,140,108;AF=0.99,0.99,0.46;MQM=60	ZBTB40	synonymous	ZBTB40:ENST00000374651:synonymous_variant:LOW:exon16/16:c.3210G>C:p.Pro1070=:,ZBTB40:ENST00000375647:synonymous_variant:LOW:exon18/18:c.3546G>C:p.Pro1182=:,ZBTB40:ENST00000404138:synonymous_variant:LOW:exon19/19:c.3546G>C:p.Pro1182=:						rs881646	0.3181	0.3388	1506,.	0.1520,0.1749,0.4593,0.3724,0.4203	-1.1410			0.09,0.18	0.18						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22853141	22853141	G	A	hom	hom	het		QUAL=17220;DP=138,316,234;AF=1.00,1.00,0.50;MQM=60	ZBTB40	3'UTR	ZBTB40:ENST00000374651:3_prime_UTR_variant:MODIFIER:exon16/16:c.*252G>A::,ZBTB40:ENST00000375647:3_prime_UTR_variant:MODIFIER:exon18/18:c.*252G>A::,ZBTB40:ENST00000404138:3_prime_UTR_variant:MODIFIER:exon19/19:c.*252G>A::						rs2281354	0.2378	0.2497	1184,.		0.1290			0.03,0.16	1.18						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22855194	22855194	-	T	het	het	het		QUAL=792;DP=34,39,32;AF=0.44,0.56,0.25;MQM=59	ZBTB40	3'UTR	ZBTB40:ENST00000375647:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2320dup::,ZBTB40:ENST00000404138:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2320dup::					AluJo (SINE/Alu)	rs35637563		0.3286	1341,.						0.53						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22855194	22855194	-	TT	wt	het	wt		QUAL=792;DP=34,39,32;AF=0.06,0.18,0.00;MQM=58	ZBTB40	3'UTR	ZBTB40:ENST00000375647:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2319_*2320dup::,ZBTB40:ENST00000404138:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2319_*2320dup::					AluJo (SINE/Alu)	rs35637563		0.0027	1,.						0.52						0	1						ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22856601	22856601	T	C	hom	hom	het		QUAL=18863;DP=222,281,216;AF=0.99,1.00,0.49;MQM=60	ZBTB40	3'UTR	ZBTB40:ENST00000375647:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3712T>C::,ZBTB40:ENST00000404138:3_prime_UTR_variant:MODIFIER:exon19/19:c.*3712T>C::	regulatory_region_variant:promoter_flanking_region					rs1062663	0.3295	0.3077	1570,.		-2.6560			0.01,0.08	0.11						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22965438	22965438	A	G	het	het	n/a		QUAL=330;DP=14,5,2;AF=0.64,0.60,1.00;MQM=60	C1QA	synonymous	C1QA:ENST00000374642:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:PF01391,C1QA:ENST00000402322:synonymous_variant:LOW:exon2/2:c.276A>G:p.Gly92=:PF01391		120550 [GENE=C1QA PHENOS=C1q deficiency,613652,Autosomal recessive];				rs172378	0.6164	0.5055	4346,.	0.7372,0.6240,0.5917,0.3861,0.5848	-0.2950			0.03,0.22	3.84						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QA (inh=AR oe_syn=0.91 oe_mis=0.70 oe_lof=0.55)
chr1	22966227	22966227	T	G	het	het	het	off-target	QUAL=7780;DP=141,257,222;AF=0.52,0.47,0.54;MQM=59	C1QC,C1QA	upstream_gene,downstream_gene	C1QC:ENST00000374637:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374639:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374640:upstream_gene_variant:MODIFIER::::,C1QA:ENST00000374642:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000402322:downstream_gene_variant:MODIFIER::::					AluSq2 (SINE/Alu)	rs10917274	0.4309	0.3525	2045,.		-2.9170			0.00,0.03	0.67						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42), C1QA (inh=AR oe_syn=0.91 oe_mis=0.70 oe_lof=0.55)
chr1	22974297	22974297	C	A	wt	wt	het		QUAL=578;DP=123,94,66;AF=0.01,0.00,0.50;MQM=60	C1QC	3'UTR	C1QC:ENST00000374637:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:ENST00000374639:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:ENST00000374640:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::		120575 [GENE=C1QC PHENOS=C1q deficiency,613652,Autosomal recessive];				rs9434	0.5877	0.5051	4565,.	0.8162,0.5080,0.5875,0.3688,0.4165	0.4040			0.26,0.93	10.72						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22974380	22974396	CCACCAGATGGACTTCT	-	wt	wt	het		QUAL=67;DP=25,16,18;AF=0.00,0.00,0.50;MQM=60	C1QC	3'UTR	C1QC:ENST00000374637:3_prime_UTR_variant:MODIFIER:exon3/3:::,C1QC:ENST00000374639:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::,C1QC:ENST00000374640:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::		120575 [GENE=C1QC PHENOS=C1q deficiency,613652,Autosomal recessive];			L2d2 (LINE/L2)	rs142916975	0.3764	0.3421	1792,.		1.9050				13.52			diff/acceptor/22974385-22974386/Medium-Medium/6.430377-8.407414			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22974534	22974534	T	-	het	het	wt		QUAL=1429;DP=47,69,39;AF=0.43,0.49,0.21;MQM=59	C1QC	3'UTR	C1QC:ENST00000374639:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::,C1QC:ENST00000374640:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::		120575 [GENE=C1QC PHENOS=C1q deficiency,613652,Autosomal recessive];			L2d2 (LINE/L2)	rs71020441		0.0880	81,.		0.1990				0.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22974534	22974535	TT	-	wt	wt	het		QUAL=1429;DP=47,69,39;AF=0.13,0.10,0.26;MQM=60	C1QC	3'UTR	C1QC:ENST00000374639:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::,C1QC:ENST00000374640:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::		120575 [GENE=C1QC PHENOS=C1q deficiency,613652,Autosomal recessive];			L2d2 (LINE/L2)	rs10601144	0.6609	0.5155	3518,.		0.1990				1.28						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22974566	22974566	T	G	het	wt	wt		QUAL=58;DP=46,61,46;AF=0.35,0.07,0.04;MQM=58	C1QC	3'UTR	C1QC:ENST00000374639:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::,C1QC:ENST00000374640:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::		120575 [GENE=C1QC PHENOS=C1q deficiency,613652,Autosomal recessive];				rs1003478565		0.0017	0,.		-0.6170			0.02,0.14	6.57						0	18						C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22979655	22979655	T	G	het	het	het	off-target	QUAL=528;DP=26,16,22;AF=0.62,0.31,0.41;MQM=59	C1QB	5'UTR	C1QB:ENST00000509305:5_prime_UTR_variant:MODIFIER:exon1/3:c.-165T>G::		120570 [GENE=C1QB PHENOS=C1q deficiency,613652,Autosomal recessive];				rs291990		0.5803	5685,.		-0.0560			0.01,0.17	4.40						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22987958	22987958	A	G	hom	hom	hom		QUAL=37795;DP=401,456,346;AF=1.00,1.00,1.00;MQM=59	C1QB	3'UTR	C1QB:ENST00000314933:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000509305:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::		120570 [GENE=C1QB PHENOS=C1q deficiency,613652,Autosomal recessive];				rs10580	0.9914	0.9835	15171,.		-0.5240			0.00,0.09	5.38			gain/acceptor/22987957-22987958/Medium/2.335785			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	24122986	24122986	C	T	het	wt	het	off-target	QUAL=943;DP=82,54,48;AF=0.56,0.02,0.44;MQM=60	GALE	intron	GALE:ENST00000374497:intron_variant:MODIFIER:exon10/11:c.873+13G>A::		606953 [GENE=GALE PHENOS=Galactose epimerase deficiency,230350,Autosomal recessive];	92889 [benign DISEASE=UDPglucose-4-epimerase deficiency,not specified];		G-rich (Low_complexity)	rs760941		0.6596	3705,.	0.5444,0.7020,0.6319,0.6194,0.7364	-0.8630			0.05,0.15	3.33						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91)
chr1	24128467	24128467	C	T	hom	hom	het		QUAL=29952;DP=359,431,347;AF=1.00,1.00,0.50;MQM=59	HMGCL	3'UTR	HMGCL:ENST00000374483:3_prime_UTR_variant:MODIFIER:exon10/10:c.*486G>A::,HMGCL:ENST00000374490:3_prime_UTR_variant:MODIFIER:exon9/9:c.*486G>A::,HMGCL:ENST00000436439:3_prime_UTR_variant:MODIFIER:exon7/7:c.*486G>A::	regulatory_region_variant:promoter	613898 [GENE=HMGCL PHENOS=HMG-CoA lyase deficiency,246450,Autosomal recessive];	296841 [benign DISEASE=Deficiency of hydroxymethylglutaryl-CoA lyase,UDPglucose-4-epimerase deficiency];			rs11714	0.8834	0.9202	13296,.		-0.8980			0.00,0.11	8.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	24134721	24134721	T	C	hom	hom	het		QUAL=21709;DP=289,287,224;AF=1.00,1.00,0.53;MQM=60	HMGCL	synonymous	HMGCL:ENST00000374483:synonymous_variant:LOW:exon8/10:c.579A>G:p.Leu193=:PF00682,HMGCL:ENST00000374490:synonymous_variant:LOW:exon7/9:c.654A>G:p.Leu218=:PF00682,HMGCL:ENST00000436439:synonymous_variant:LOW:exon5/7:c.441A>G:p.Leu147=:PF00682	regulatory_region_variant:promoter_flanking_region	613898 [GENE=HMGCL PHENOS=HMG-CoA lyase deficiency,246450,Autosomal recessive];	92602 [benign DISEASE=Deficiency of hydroxymethylglutaryl-CoA lyase,not specified];			rs719400	0.8874	0.9305	13596,.	0.9678,0.8940,0.7880,0.9126,0.8738	0.8740			0.06,0.97	12.26						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	24143932	24143932	A	G	hom	hom	het	off-target	QUAL=12964;DP=186,181,116;AF=0.99,1.00,0.50;MQM=60	HMGCL	intron	HMGCL:ENST00000374483:intron_variant:MODIFIER:exon4/9:c.177+34T>C::,HMGCL:ENST00000374490:intron_variant:MODIFIER:exon3/8:c.252+34T>C::,HMGCL:ENST00000436439:intron_variant:MODIFIER:exon3/6:c.252+34T>C::		613898 [GENE=HMGCL PHENOS=HMG-CoA lyase deficiency,246450,Autosomal recessive];	255488 [benign DISEASE=not specified];			rs2076344	0.8878	0.9306	13619,.	0.9678,0.8946,0.7893,0.9132,0.8739	-1.2250			0.00,0.11	0.72						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	24151996	24151996	C	A	het	hom	het	off-target	QUAL=1438;DP=24,34,34;AF=0.29,1.00,0.47;MQM=60	HMGCL	intron	HMGCL:ENST00000374483:intron_variant:MODIFIER:exon2/9:c.-16+578G>T::	regulatory_region_variant:promoter,TF_binding_site_variant	613898 [GENE=HMGCL PHENOS=HMG-CoA lyase deficiency,246450,Autosomal recessive];				rs6697805	0.3928	0.4051	2502,.		-2.8420			0.04,0.16	0.50						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	24171543	24171543	C	G	het	hom	het	off-target	QUAL=2968;DP=103,45,47;AF=0.50,0.98,0.60;MQM=60	FUCA1	downstream_gene	FUCA1:ENST00000374479:downstream_gene_variant:MODIFIER::::						rs4649119	0.3425	0.3710	2272,.		-0.2630			0.08,0.16	1.51						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	24180807	24180807	A	-	het	wt	het	off-target	QUAL=401;DP=68,30,27;AF=0.13,0.10,0.63;MQM=60	FUCA1	intron	FUCA1:ENST00000374479:intron_variant:MODIFIER:exon5/7:c.969+43del::	regulatory_region_variant:CTCF_binding_site	612280 [GENE=FUCA1 PHENOS=Fucosidosis,230000,Autosomal recessive];			(A)n (Simple_repeat)	rs55699941		0.3054	101,.	0.2476,0.3209,0.3769,0.3017,0.3165	2.8690				1.14						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	24180962	24180962	T	C	het	hom	wt		QUAL=9714;DP=254,202,208;AF=0.50,1.00,0.00;MQM=60	FUCA1	missense	FUCA1:ENST00000374479:missense_variant:MODERATE:exon5/8:c.857A>G:p.Gln286Arg:PF01120	regulatory_region_variant:CTCF_binding_site	612280 [GENE=FUCA1 PHENOS=Fucosidosis,230000,Autosomal recessive];	691 [benign DISEASE=FU1/FU2 POLYMORPHISM,Fucosidosis,not provided];			rs13551	0.2113	0.2807	1388,.	0.1406,0.2037,0.2647,0.3358,0.1516	0.6520	D(0.02)	B(0.00)	0.09,0.29	15.57	0.06					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	24194748	24194748	G	C	wt	wt	het		QUAL=1393;DP=154,122,112;AF=0.00,0.01,0.54;MQM=60	FUCA1	missense	FUCA1:ENST00000374479:missense_variant:MODERATE:exon1/8:c.29C>G:p.Pro10Arg:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	612280 [GENE=FUCA1 PHENOS=Fucosidosis,230000,Autosomal recessive];	193053 [benign DISEASE=Fucosidosis,not specified,not provided];			rs2070956	0.1430	0.1078	190,.	0.1111,0.1145,0.1998,0.0910,0.1267	-0.0120	T(0.16)	B(0.02)	0.06,0.08	9.54	0.09					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	24194770	24194770	C	G	het	wt	het		QUAL=2473;DP=142,112,107;AF=0.46,0.00,0.45;MQM=59	FUCA1	missense	FUCA1:ENST00000374479:missense_variant:MODERATE:exon1/8:c.7G>C:p.Ala3Pro:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	612280 [GENE=FUCA1 PHENOS=Fucosidosis,230000,Autosomal recessive];	296895 [benign/likely benign DISEASE=Fucosidosis,not provided];			rs61996282	0.0134	0.0153	3,.	0.0025,0.0506,0.0000,0.0080,0.0166	-2.4990	D(0.02)	B(0.00)	0.04,0.08	14.26	0.07					2	103						FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	24194773	24194773	G	A	wt	wt	het		QUAL=1196;DP=119,113,103;AF=0.00,0.01,0.52;MQM=60	FUCA1	missense	FUCA1:ENST00000374479:missense_variant:MODERATE:exon1/8:c.4C>T:p.Arg2Trp:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	612280 [GENE=FUCA1 PHENOS=Fucosidosis,230000,Autosomal recessive];	193052 [benign DISEASE=Fucosidosis,not specified,not provided];			rs2070955	0.1430	0.1119	190,.	0.1141,0.1164,0.2051,0.0948,0.1271	-1.0160	D(0.00)	B(0.00)	0.02,0.08	17.18	0.08					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	24194788	24194788	A	G	wt	wt	het		QUAL=1136;DP=74,100,96;AF=0.00,0.01,0.52;MQM=60	CNR2,FUCA1	downstream_gene,upstream_gene	CNR2:ENST00000374472:downstream_gene_variant:MODIFIER::::,FUCA1:ENST00000374479:upstream_gene_variant:MODIFIER::::,CNR2:ENST00000536471:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	612280 [GENE=FUCA1 PHENOS=Fucosidosis,230000,Autosomal recessive];	193051 [benign/likely benign DISEASE=Fucosidosis,not specified,not provided];			rs2070954	0.1428	0.1140	187,.	0.1164,0.1167,0.2068,0.0965,0.1275	0.1910			0.00,0.04	11.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97), FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	24194862	24194862	A	C	wt	wt	het		QUAL=416;DP=25,33,49;AF=0.00,0.03,0.43;MQM=60	CNR2,FUCA1	downstream_gene,upstream_gene	CNR2:ENST00000374472:downstream_gene_variant:MODIFIER::::,FUCA1:ENST00000374479:upstream_gene_variant:MODIFIER::::,CNR2:ENST00000536471:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant		368872 [likely benign DISEASE=Fucosidosis];			rs2070953	0.1428	0.1005	196,.		-0.0750			0.09,0.08	11.11						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97), FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	24194898	24194898	C	A	wt	wt	het	off-target	QUAL=321;DP=19,20,36;AF=0.00,0.00,0.47;MQM=60	CNR2,FUCA1	downstream_gene,upstream_gene	CNR2:ENST00000374472:downstream_gene_variant:MODIFIER::::,FUCA1:ENST00000374479:upstream_gene_variant:MODIFIER::::,CNR2:ENST00000536471:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant					rs2070952	0.1428	0.1001	193,.		-0.8080			0.04,0.07	9.17						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97), FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	26131654	26131654	G	A	hom	het	hom		QUAL=15724;DP=155,332,220;AF=1.00,0.52,1.00;MQM=59	SELENON	missense	SELENON:ENST00000354177:missense_variant:MODERATE:exon3/13:c.323G>A:p.Cys108Tyr:,SELENON:ENST00000361547:missense_variant:MODERATE:exon4/13:c.425G>A:p.Cys142Tyr:,SELENON:ENST00000374315:missense_variant:MODERATE:exon3/12:c.323G>A:p.Cys108Tyr:	regulatory_region_variant:CTCF_binding_site	606210 [GENE=SELENON PHENOS=Muscular dystrophy,rigid spine,1,602771,Autosomal recessive/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	95963 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,SEPN1-Related Disorders];			rs7349185	0.8419	0.8183	9610,.	0.7779,0.9062,0.9425,0.7826,0.8772	0.9630	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	0.01,0.11	8.98	0.04					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	26138136	26138136	C	A	hom	het	hom	off-target	QUAL=18620;DP=147,381,278;AF=1.00,0.52,1.00;MQM=60	SELENON	intron	SELENON:ENST00000354177:intron_variant:MODIFIER:exon7/12:c.991-46C>A::,SELENON:ENST00000361547:intron_variant:MODIFIER:exon8/12:c.1093-46C>A::,SELENON:ENST00000374315:intron_variant:MODIFIER:exon7/11:c.991-46C>A::	regulatory_region_variant:CTCF_binding_site	606210 [GENE=SELENON PHENOS=Muscular dystrophy,rigid spine,1,602771,Autosomal recessive/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	261271 [benign DISEASE=not specified];			rs760598	0.7470	0.7903	7814,.	0.4605,0.8803,0.9652,0.7681,0.8741	0.9050			0.25,0.26	9.92						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	26138262	26138262	T	C	hom	het	hom		QUAL=24587;DP=211,488,351;AF=1.00,0.51,1.00;MQM=59	SELENON	synonymous	SELENON:ENST00000354177:synonymous_variant:LOW:exon8/13:c.1071T>C:p.Pro357=:,SELENON:ENST00000361547:synonymous_variant:LOW:exon9/13:c.1173T>C:p.Pro391=:,SELENON:ENST00000374315:synonymous_variant:LOW:exon8/12:c.1071T>C:p.Pro357=:	regulatory_region_variant:CTCF_binding_site	606210 [GENE=SELENON PHENOS=Muscular dystrophy,rigid spine,1,602771,Autosomal recessive/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	95956 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,SEPN1-Related Disorders];			rs760597		0.8099	8722,.	0.6070,0.8907,0.9651,0.7838,0.8768	0.2830			0.29,0.86	18.84						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	26139137	26139137	C	T	hom	het	hom	off-target	QUAL=2972;DP=18,70,54;AF=1.00,0.54,1.00;MQM=60	SELENON	intron	SELENON:ENST00000354177:intron_variant:MODIFIER:exon8/12:c.1180-41C>T::,SELENON:ENST00000361547:intron_variant:MODIFIER:exon9/12:c.1282-41C>T::,SELENON:ENST00000374315:intron_variant:MODIFIER:exon8/11:c.1180-41C>T::		606210 [GENE=SELENON PHENOS=Muscular dystrophy,rigid spine,1,602771,Autosomal recessive/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	261274 [benign DISEASE=not specified];			rs10902685	0.6977	0.7930	7303,.	0.2898,0.8793,0.9662,0.7870,0.8780	-0.4720			0.02,0.16	3.68						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	26140573	26140573	C	A	hom	het	hom		QUAL=21794;DP=211,438,321;AF=1.00,0.50,1.00;MQM=60	SELENON,RP1-317E23.6	missense,missense&NMD_transcript	SELENON:ENST00000354177:missense_variant:MODERATE:exon12/13:c.1404C>A:p.Asn468Lys:,SELENON:ENST00000361547:missense_variant:MODERATE:exon12/13:c.1506C>A:p.Asn502Lys:,SELENON:ENST00000374315:missense_variant:MODERATE:exon11/12:c.1404C>A:p.Asn468Lys:,RP1-317E23.6:ENST00000527604:missense_variant&NMD_transcript_variant:MODERATE:exon2/4:c.27C>A:p.Asn9Lys:		606210 [GENE=SELENON PHENOS=Muscular dystrophy,rigid spine,1,602771,Autosomal recessive/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	95959 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,SEPN1-Related Disorders];			rs2294228	0.6975	0.7864	7403,.	0.2906,0.8791,0.9655,0.7822,0.8768	0.1590	T(0.10),T(0.12),T(0.14),T(0.17)	B(0.01),B(0.00),B(0.00),B(0.00)	0.37,0.52	13.38	0.09					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), RP1-317E23.6 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	26143704	26143704	-	TTTTG	hom	het	hom		QUAL=12931;DP=148,230,187;AF=0.97,0.43,1.00;MQM=58	SELENON,RP1-317E23.3,RP1-317E23.6	3'UTR,intron&non_coding_transcript,intron&NMD_transcript	SELENON:ENST00000354177:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1511_*1515dup::,SELENON:ENST00000361547:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1511_*1515dup::,SELENON:ENST00000374315:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1511_*1515dup::,RP1-317E23.3:ENST00000442055:intron_variant&non_coding_transcript_variant:MODIFIER:exon3/3:n.304-338_304-334dup::,RP1-317E23.6:ENST00000527604:intron_variant&NMD_transcript_variant:MODIFIER:exon2/3:c.123+3051_123+3055dup::		606210 [GENE=SELENON PHENOS=Muscular dystrophy,rigid spine,1,602771,Autosomal recessive/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];			AluSx (SINE/Alu)	rs3033477		0.7102	8052,.						3.40						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), RP1-317E23.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), RP1-317E23.6 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	26143821	26143821	T	C	hom	het	hom		QUAL=16531;DP=245,268,179;AF=1.00,0.46,0.98;MQM=54	SELENON,RP1-317E23.3,RP1-317E23.6	3'UTR,intron&non_coding_transcript,intron&NMD_transcript	SELENON:ENST00000354177:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1612T>C::,SELENON:ENST00000361547:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1612T>C::,SELENON:ENST00000374315:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1612T>C::,RP1-317E23.3:ENST00000442055:intron_variant&non_coding_transcript_variant:MODIFIER:exon3/3:n.303+232A>G::,RP1-317E23.6:ENST00000527604:intron_variant&NMD_transcript_variant:MODIFIER:exon2/3:c.123+3152T>C::		606210 [GENE=SELENON PHENOS=Muscular dystrophy,rigid spine,1,602771,Autosomal recessive/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	297050 [benign DISEASE=SEPN1-Related Disorders];		AluSx (SINE/Alu)	rs3203750	0.7630	0.7113	8215,.		-0.0630			0.00,0.13	5.98						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), RP1-317E23.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), RP1-317E23.6 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	26143931	26143931	T	C	hom	het	hom		QUAL=22026;DP=334,349,228;AF=1.00,0.45,1.00;MQM=53	SELENON,RP1-317E23.3,RP1-317E23.6	3'UTR,intron&non_coding_transcript,intron&NMD_transcript	SELENON:ENST00000354177:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1722T>C::,SELENON:ENST00000361547:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1722T>C::,SELENON:ENST00000374315:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1722T>C::,RP1-317E23.3:ENST00000442055:intron_variant&non_coding_transcript_variant:MODIFIER:exon3/3:n.303+122A>G::,RP1-317E23.6:ENST00000527604:intron_variant&NMD_transcript_variant:MODIFIER:exon2/3:c.123+3262T>C::		606210 [GENE=SELENON PHENOS=Muscular dystrophy,rigid spine,1,602771,Autosomal recessive/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	297053 [benign DISEASE=SEPN1-Related Disorders];		AluSx (SINE/Alu)	rs4659383	0.8622	0.8010	10109,.		-1.2050			0.00,0.05	1.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), RP1-317E23.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), RP1-317E23.6 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	26144438	26144438	C	-	hom	het	hom		QUAL=4023;DP=65,101,72;AF=0.97,0.62,1.00;MQM=59	SELENON,RP1-317E23.3,RP1-317E23.6	3'UTR,intron&non_coding_transcript,intron&NMD_transcript	SELENON:ENST00000354177:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2236del::,SELENON:ENST00000361547:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2236del::,SELENON:ENST00000374315:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2236del::,RP1-317E23.3:ENST00000442055:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.152-234del::,RP1-317E23.6:ENST00000527604:intron_variant&NMD_transcript_variant:MODIFIER:exon2/3:c.123+3776del::	regulatory_region_variant:CTCF_binding_site	606210 [GENE=SELENON PHENOS=Muscular dystrophy,rigid spine,1,602771,Autosomal recessive/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant];	297061 [uncertain significance DISEASE=SEPN1-Related Disorders];			rs1384687304		0.7146	8260,.		-0.8160				1.53						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), RP1-317E23.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), RP1-317E23.6 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	26508293	26508293	G	A	het	wt	het	off-target	QUAL=4929;DP=208,281,206;AF=0.49,0.00,0.51;MQM=60	CNKSR1	intron	CNKSR1:ENST00000361530:intron_variant:MODIFIER:exon3/20:c.393-55G>A::,CNKSR1:ENST00000374253:intron_variant:MODIFIER:exon3/20:c.393-55G>A::,CNKSR1:ENST00000531191:intron_variant:MODIFIER:exon2/19:c.-382-55G>A::					MIRb (SINE/MIR)	rs3819033	0.2859	0.1069	443,.		0.6040			0.15,0.25	6.81						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26508480	26508480	T	C	het	wt	het	off-target	QUAL=5552;DP=211,317,243;AF=0.46,0.00,0.52;MQM=60	CNKSR1	intron	CNKSR1:ENST00000361530:intron_variant:MODIFIER:exon4/20:c.477+48T>C::,CNKSR1:ENST00000374253:intron_variant:MODIFIER:exon4/20:c.477+48T>C::,CNKSR1:ENST00000531191:intron_variant:MODIFIER:exon3/19:c.-298+48T>C::	regulatory_region_variant:enhancer					rs2275945	0.3365	0.2282	602,.	0.1604,0.4817,0.6399,0.0981,0.3757	0.2070			0.01,0.18	7.68						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26511700	26511700	A	G	hom	hom	hom	off-target	QUAL=20225;DP=159,265,212;AF=1.00,1.00,1.00;MQM=60	CNKSR1	intron	CNKSR1:ENST00000361530:intron_variant:MODIFIER:exon14/20:c.1308+23A>G::,CNKSR1:ENST00000374253:intron_variant:MODIFIER:exon14/20:c.1329+23A>G::,CNKSR1:ENST00000531191:intron_variant:MODIFIER:exon13/19:c.534+23A>G::						rs2783680		0.6818	5621,.	0.4561,0.8001,0.9695,0.5905,0.7834	-0.9530			0.05,0.15	0.30						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	27106975	27106975	C	T	wt	het	wt		QUAL=3132;DP=156,236,189;AF=0.00,0.52,0.00;MQM=60	ARID1A	synonymous	ARID1A:ENST00000324856:synonymous_variant:LOW:exon20/20:c.6586C>T:p.Leu2196=:PF12031,ARID1A:ENST00000374152:synonymous_variant:LOW:exon19/19:c.5437C>T:p.Leu1813=:PF12031,ARID1A:ENST00000457599:synonymous_variant:LOW:exon20/20:c.5935C>T:p.Leu1979=:PF12031,ARID1A:ENST00000540690:synonymous_variant:LOW:exon6/6:c.1570C>T:p.Leu524=:PF12031		603024 [GENE=ARID1A PHENOS=Coffin-Siris syndrome 2,614607,Autosomal dominant];	210262 [benign DISEASE=not specified];			rs149633292	0.0016	0.0075	3,.	0.0005,0.0008,0.0000,0.0050,0.0007	0.8780			0.77,0.93	10.62					COSM3724478	1	67		2	Prima Vista kein Anhalt f?r Splice-Defekt; 160727 [2] ahwalds1 28.07.2016			ARID1A (inh=AD oe_syn=1.08 oe_mis=0.70 oe_lof=0.02)
chr1	27107651	27107651	A	-	wt	het	het		QUAL=18;DP=51,17,9;AF=0.22,0.29,0.33;MQM=60	ARID1A	3'UTR	ARID1A:ENST00000324856:3_prime_UTR_variant:MODIFIER:exon20/20:c.*421del::		603024 [GENE=ARID1A PHENOS=Coffin-Siris syndrome 2,614607,Autosomal dominant];			(A)n (Simple_repeat)	rs533673675	0.2159	0.0451	4,.		0.0190				0.50						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ARID1A (inh=AD oe_syn=1.08 oe_mis=0.70 oe_lof=0.02)
chr1	27696011	27696011	C	T	hom	hom	hom	off-target	QUAL=25940;DP=309,311,256;AF=1.00,1.00,1.00;MQM=60	FCN3	intron	FCN3:ENST00000270879:intron_variant:MODIFIER:exon7/7:c.659-43G>A::,FCN3:ENST00000354982:intron_variant:MODIFIER:exon6/6:c.626-43G>A::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	604973 [GENE=FCN3 PHENOS=Immunodeficiency due to ficolin 3 deficiency,613860,Autosomal recessive];			MIRb (SINE/MIR)	rs10218730	0.9924	0.9981	15445,.	0.9740,0.9990,1.0000,0.9999,0.9999	-0.2710			0.00,0.13	7.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FCN3 (inh=AR oe_syn=0.74 oe_mis=0.91 oe_lof=0.45)
chr1	33245802	33245802	C	G	het	het	het		QUAL=9436;DP=257,253,186;AF=0.53,0.46,0.61;MQM=60	YARS	synonymous	YARS:ENST00000373477:synonymous_variant:LOW:exon11/13:c.1218G>C:p.Leu406=:PF01588	regulatory_region_variant:promoter_flanking_region	603623 [GENE=YARS PHENOS=Charcot-Marie-Tooth disease,dominant intermediate C,608323,Autosomal dominant];	297151 [benign DISEASE=Charcot-Marie-Tooth disease, dominant intermediate C,not specified,Charcot-Marie-Tooth, Intermediate];			rs699005	0.0875	0.1079	218,.	0.1027,0.2180,0.0003,0.0970,0.0607	3.1640			0.95,0.94	11.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS (inh=AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	33252100	33252122	CACATGCATGACTATTCCTAGCC	-	het	wt	het	off-target	QUAL=3558;DP=112,316,226;AF=0.47,0.00,0.50;MQM=60	YARS	intron	YARS:ENST00000373477:intron_variant:MODIFIER:exon7/12:c.821-74_821-52del::		603623 [GENE=YARS PHENOS=Charcot-Marie-Tooth disease,dominant intermediate C,608323,Autosomal dominant];				rs149745059	0.1412	0.1469	378,.	0.0236,0.0903,0.1858,0.1445,0.2117	1.7820				6.23						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS (inh=AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	33256884	33256884	C	A	hom	het	hom	off-target	QUAL=16303;DP=242,263,164;AF=0.99,0.52,0.99;MQM=60	YARS	intron	YARS:ENST00000373477:intron_variant:MODIFIER:exon5/12:c.592-29G>T::		603623 [GENE=YARS PHENOS=Charcot-Marie-Tooth disease,dominant intermediate C,608323,Autosomal dominant];				rs1765223	0.2911	0.3278	1734,.	0.3001,0.3504,0.2128,0.3120,0.3043	1.2300			0.00,0.09	4.11						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS (inh=AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	33276424	33276424	G	A	hom	hom	hom	off-target	QUAL=21279;DP=290,212,158;AF=1.00,1.00,1.00;MQM=60	YARS	intron	YARS:ENST00000373477:intron_variant:MODIFIER:exon2/12:c.205-57C>T::		603623 [GENE=YARS PHENOS=Charcot-Marie-Tooth disease,dominant intermediate C,608323,Autosomal dominant];				rs4951787		0.9867	15282,.		-0.3090			0.00,0.11	0.84						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS (inh=AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	33282775	33282775	C	A	het	het	het	off-target	QUAL=3037;DP=119,103,71;AF=0.46,0.44,0.51;MQM=60	YARS	intron	YARS:ENST00000373477:intron_variant:MODIFIER:exon1/12:c.57+14G>T::	regulatory_region_variant:promoter,TF_binding_site_variant	603623 [GENE=YARS PHENOS=Charcot-Marie-Tooth disease,dominant intermediate C,608323,Autosomal dominant];	297163 [benign DISEASE=not specified,Charcot-Marie-Tooth, Intermediate];			rs72654020	0.0857	0.1062	217,.	0.0965,0.2176,0.0003,0.0969,0.0607	-0.0880			0.03,0.82	8.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS (inh=AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	33283528	33283528	G	A	het	n/a	n/a		QUAL=41;DP=7,1,0;AF=0.57,0.00,;MQM=60	S100PBP,YARS	intron,5'UTR	S100PBP:ENST00000373475:intron_variant:MODIFIER:exon1/6:c.-120+238G>A::,S100PBP:ENST00000373476:intron_variant:MODIFIER:exon1/6:c.-120+328G>A::,YARS:ENST00000373477:5_prime_UTR_variant:MODIFIER:exon1/13:c.-683C>T::,S100PBP:ENST00000398243:intron_variant:MODIFIER:exon1/6:c.-120+238G>A::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	603623 [GENE=YARS PHENOS=Charcot-Marie-Tooth disease,dominant intermediate C,608323,Autosomal dominant];	297175 [benign DISEASE=Charcot-Marie-Tooth, Intermediate];			rs72654022	0.0603	0.0842	170,.		1.4860			0.02,0.44	10.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					S100PBP (inh=n/a oe_syn=1.12 oe_mis=0.99 oe_lof=0.11), YARS (inh=AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	33475639	33475639	G	A	het	het	het		QUAL=1215;DP=709,540,551;AF=0.14,0.12,0.23;MQM=33	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*791C>T::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20997G>A::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs138902451		0.4659	0,.	0.0012,0.0297,0.0227,0.0304,0.0103	2.0200			0.61,0.91	21.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33475650	33475650	T	C	het	het	het		QUAL=1329;DP=666,556,545;AF=0.13,0.13,0.24;MQM=33	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*780A>G::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20986T>C::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs141799861		0.4685	0,.	0.0021,0.0187,0.0246,0.0298,0.0073	0.0510			0.20,0.21	12.15						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33475687	33475687	C	G	het	het	het		QUAL=2556;DP=382,580,603;AF=0.11,0.16,0.29;MQM=33	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*743G>C::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20949C>G::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs201444233		0.4072	0,.	0.0016,0.0361,0.0370,0.0319,0.0107	0.3710			0.61,0.88	16.58						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33475721	33475721	G	C	het	het	het		QUAL=4062;DP=331,549,606;AF=0.11,0.20,0.31;MQM=34	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*709C>G::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20915G>C::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs139591926		0.4686	0,.	0.0181,0.0565,0.0592,0.0824,0.0132	-0.4810			0.01,0.11	4.93			gain/acceptor/33475720-33475721/Medium/6.137509			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33475750	33475750	A	G	het	het	het		QUAL=4692;DP=430,530,576;AF=0.13,0.22,0.32;MQM=39	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*680T>C::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20886A>G::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs142975905		0.4956	0,.	0.3438,0.4870,0.4964,0.4368,0.4782	1.2420			0.35,0.22	8.56						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33475767	33475767	G	A	het	het	het		QUAL=4558;DP=516,514,544;AF=0.14,0.24,0.33;MQM=40	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*663C>T::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20869G>A::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs74066436		0.4979	0,.	0.4825,0.4986,0.4998,0.4885,0.4985	0.6460			0.07,0.20	6.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33475791	33475791	A	G	het	het	het		QUAL=7325;DP=531,528,611;AF=0.20,0.27,0.37;MQM=42	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*639T>C::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20845A>G::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs6884		0.5608	1870,.	0.5995,0.6143,0.5706,0.5402,0.5566	0.9860			0.00,0.11	7.25						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33475879	33475879	C	T	het	het	het		QUAL=9232;DP=575,345,397;AF=0.28,0.31,0.41;MQM=54	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*551G>A::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20757C>T::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs61800917		0.4999	0,.	0.4993,0.5000,0.5000,0.4999,0.5000	0.3020			0.13,0.18	6.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33475967	33475967	G	A	het	het	het		QUAL=2758;DP=415,189,172;AF=0.23,0.23,0.30;MQM=48	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*463C>T::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20669G>A::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs74066437		0.4965	0,.	0.4014,0.4864,0.4884,0.4679,0.4674	-0.5360			0.02,0.16	2.87						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33475977	33475977	G	A	het	het	het		QUAL=1737;DP=341,157,150;AF=0.15,0.17,0.26;MQM=44	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*453C>T::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20659G>A::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs115408325		0.4939	0,.	0.1392,0.3326,0.3322,0.1201,0.1676	0.9610			0.00,0.06	4.23						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33475979	33475979	A	G	het	het	het		QUAL=1737;DP=341,157,150;AF=0.15,0.17,0.26;MQM=44	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*451T>C::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20657A>G::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs4045165		0.4924	0,.	0.1117,0.2470,0.2219,0.0652,0.1106	-0.1460			0.00,0.07	2.77						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33475982	33475982	C	A	het	het	het		QUAL=1737;DP=341,157,150;AF=0.15,0.17,0.26;MQM=44	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*448G>T::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20654C>A::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs114902220		0.4913	0,.	0.0825,0.1746,0.1583,0.0358,0.0684	-0.1050			0.07,0.19	4.97						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33475993	33475993	-	C	wt	het	het		QUAL=375;DP=305,155,150;AF=0.03,0.18,0.24;MQM=39	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*436dup::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20642dup::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs753076639		0.4852	0,.	0.0162,0.0451,0.0327,0.0037,0.0149					9.20						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33476032	33476032	T	C	het	het	het		QUAL=258;DP=231,153,129;AF=0.11,0.16,0.22;MQM=35	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*398A>G::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20604T>C::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs77170021		0.4904	0,.	0.0111,0.1004,0.0453,0.0318,0.0306	-0.8450			0.02,0.16	11.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33476065	33476065	G	A	het	het	het		QUAL=1062;DP=324,148,114;AF=0.23,0.12,0.20;MQM=34	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*365C>T::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20571G>A::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs143947377		0.4971	0,.	0.1568,0.4139,0.3199,0.3716,0.3520	1.5880			0.76,0.97	16.14						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33476074	33476074	A	T	het	het	het		QUAL=1132;DP=343,154,118;AF=0.23,0.10,0.19;MQM=34	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*356T>A::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20562A>T::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs199780633		0.4969	0,.	0.1455,0.4073,0.2964,0.3645,0.3485	1.1940			0.49,0.95	14.88						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33476090	33476090	T	C	het	het	het		QUAL=1440;DP=393,153,119;AF=0.25,0.12,0.16;MQM=34	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*340A>G::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20546T>C::,AK2:ENST00000548033:3_prime_UTR_variant:MODIFIER:exon6/6:c.*340A>G::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs140167370		0.4965	0,.	0.1035,0.3746,0.2373,0.3256,0.3048	-2.1700			0.01,0.14	5.18						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33476143	33476143	G	A	het	het	het		QUAL=107;DP=256,111,86;AF=0.15,0.14,0.14;MQM=36	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*287C>T::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20493G>A::,AK2:ENST00000548033:3_prime_UTR_variant:MODIFIER:exon6/6:c.*287C>T::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs201412582		0.4917	0,.	0.0026,0.0257,0.0074,0.0132,0.0111	0.5190			0.04,0.16	2.85						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33476224	33476225	AC	-	het	het	het		QUAL=1681;DP=219,74,72;AF=0.27,0.35,0.28;MQM=46	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*205_*206del::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20410_246-20409del::,AK2:ENST00000548033:3_prime_UTR_variant:MODIFIER:exon6/6:c.*205_*206del::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs67829320	0.4665	0.4991	0,.	0.2745,0.4509,0.3832,0.4501,0.4693	-0.1330				6.60						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33476239	33476239	T	C	het	het	het		QUAL=2632;DP=269,79,72;AF=0.30,0.37,0.32;MQM=47	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*191A>G::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20397T>C::,AK2:ENST00000548033:3_prime_UTR_variant:MODIFIER:exon6/6:c.*191A>G::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs74066438		0.4993	0,.	0.3834,0.4825,0.4540,0.4748,0.4879	-0.0310			0.00,0.13	4.78						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33476292	33476292	A	G	het	het	het		QUAL=4642;DP=270,118,136;AF=0.30,0.46,0.49;MQM=50	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*138T>C::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20344A>G::,AK2:ENST00000548033:3_prime_UTR_variant:MODIFIER:exon6/6:c.*138T>C::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs74066439		0.4993	0,.	0.4701,0.4886,0.4898,0.4828,0.4891	0.1450			0.03,0.16	6.88			gain/acceptor/33476291-33476292/Medium/6.701918			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33476353	33476353	C	T	het	het	het		QUAL=2482;DP=231,143,155;AF=0.17,0.33,0.41;MQM=47	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*77G>A::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20283C>T::,AK2:ENST00000548033:3_prime_UTR_variant:MODIFIER:exon6/6:c.*77G>A::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs66599471		0.4992	1,.	0.2505,0.1430,0.1915,0.2371,0.1579	-0.0210			0.49,0.95	15.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33476385	33476385	C	G	het	het	het		QUAL=1849;DP=229,137,141;AF=0.20,0.27,0.37;MQM=48	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*45G>C::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20251C>G::,AK2:ENST00000467905:3_prime_UTR_variant:MODIFIER:exon8/8:c.*94G>C::,AK2:ENST00000548033:3_prime_UTR_variant:MODIFIER:exon6/6:c.*45G>C::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs76881767		0.4957	0,.	0.0649,0.0106,0.0261,0.0577,0.0143	0.0630			0.25,0.95	17.99						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33476387	33476387	C	T	het	het	het		QUAL=1849;DP=229,137,141;AF=0.20,0.27,0.37;MQM=48	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*43G>A::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20249C>T::,AK2:ENST00000467905:3_prime_UTR_variant:MODIFIER:exon8/8:c.*92G>A::,AK2:ENST00000548033:3_prime_UTR_variant:MODIFIER:exon6/6:c.*43G>A::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs201842558		0.4952	0,.	0.0529,0.0087,0.0213,0.0484,0.0123	-0.0090			0.07,0.90	17.17						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33476396	33476396	G	A	het	het	het		QUAL=1729;DP=230,136,132;AF=0.20,0.23,0.35;MQM=47	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*34C>T::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20240G>A::,AK2:ENST00000467905:3_prime_UTR_variant:MODIFIER:exon8/8:c.*83C>T::,AK2:ENST00000548033:3_prime_UTR_variant:MODIFIER:exon6/6:c.*34C>T::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs79824855		0.4891	0,.	0.0220,0.0029,0.0075,0.0218,0.0043	2.0110			0.68,0.97	21.60						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33476404	33476404	T	G	het	het	het		QUAL=1397;DP=219,132,128;AF=0.21,0.23,0.32;MQM=47	AK2,RP1-117O3.2	3'UTR,intron&non_coding_transcript	AK2:ENST00000373449:3_prime_UTR_variant:MODIFIER:exon7/7:c.*26A>C::,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-20232T>G::,AK2:ENST00000467905:3_prime_UTR_variant:MODIFIER:exon8/8:c.*75A>C::,AK2:ENST00000548033:3_prime_UTR_variant:MODIFIER:exon6/6:c.*26A>C::		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs76230073		0.4784	0,.	0.0150,0.0019,0.0038,0.0149,0.0025	1.6190			0.03,0.92	18.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33478931	33478931	G	C	het	wt	wt		QUAL=523;DP=658,594,475;AF=0.17,0.02,0.04;MQM=35	AK2,RP1-117O3.2	missense,intron&non_coding_transcript,3'UTR	AK2:ENST00000354858:missense_variant:MODERATE:exon6/6:c.571C>G:p.His191Asp:PF00406,AK2:ENST00000373449:missense_variant:MODERATE:exon6/7:c.571C>G:p.His191Asp:PF00406,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-17705G>C::,AK2:ENST00000467905:missense_variant:MODERATE:exon6/8:c.571C>G:p.His191Asp:PF00406,AK2:ENST00000480134:3_prime_UTR_variant:MODIFIER:exon5/5:c.*74C>G::,AK2:ENST00000548033:missense_variant:MODERATE:exon5/6:c.445C>G:p.His149Asp:PF00406		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];	529737 [benign DISEASE=Reticular dysgenesis];			rs80324279		0.0346	0,.	0.0514,0.0241,0.0262,0.0454,0.0179	9.8310	D(0.01),D(0.01), ,D(0.01), ,D(0.01)	B(0.44),B(0.31), ,B(0.44), ,P(0.88)	1.00,1.00	23.70	0.78					0	471						AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	33478959	33478959	C	G	het	wt	wt		QUAL=661;DP=632,555,421;AF=0.17,0.02,0.03;MQM=36	AK2,RP1-117O3.2	missense,intron&non_coding_transcript,3'UTR	AK2:ENST00000354858:missense_variant:MODERATE:exon6/6:c.543G>C:p.Lys181Asn:PF00406,AK2:ENST00000373449:missense_variant:MODERATE:exon6/7:c.543G>C:p.Lys181Asn:PF00406,RP1-117O3.2:ENST00000427524:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.246-17677C>G::,AK2:ENST00000467905:missense_variant:MODERATE:exon6/8:c.543G>C:p.Lys181Asn:PF00406,AK2:ENST00000480134:3_prime_UTR_variant:MODIFIER:exon5/5:c.*46G>C::,AK2:ENST00000548033:missense_variant:MODERATE:exon5/6:c.417G>C:p.Lys139Asn:PF00406		103020 [GENE=AK2 PHENOS=Reticular dysgenesis,267500,Autosomal recessive];				rs72884305		0.1114	0,.	0.1538,0.0784,0.0983,0.1469,0.0605	-0.4040	D(0.03),D(0.03), ,D(0.03), ,D(0.03)	B(0.09),B(0.03), ,B(0.09), ,B(0.05)	0.39,0.96	22.60	0.19					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68), RP1-117O3.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	35246848	35246848	-	C	wt	het	wt		QUAL=150;DP=8,14,10;AF=0.00,0.57,0.00;MQM=60	GJB3,RP1-34M23.5	5'UTR,intron&non_coding_transcript	GJB3:ENST00000373366:5_prime_UTR_variant:MODIFIER:exon1/2:c.-551dup::,RP1-34M23.5:ENST00000542839:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.110+6740dup::	regulatory_region_variant:promoter	603324 [GENE=GJB3 PHENOS=Deafness,autosomal dominant 2B,612644,Autosomal dominant/Deafness,autosomal dominant,with peripheral neuropathy/Deafness,autosomal recessive/Deafness,digenic,GJB2/GJB3,220290,Autosomal recessive/Erythrokeratodermia variabilis et progressiva 1,133200,Autosomal recessive,Autosomal dominant];				rs3831969		0.2675	1266,.						10.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJB3 (inh=AR+AD oe_syn=0.87 oe_mis=1.11 oe_lof=0.63), RP1-34M23.5 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	35251229	35251229	G	A	wt	het	het		QUAL=9699;DP=257,376,357;AF=0.00,0.50,0.54;MQM=59	GJB3,RP1-34M23.5	3'UTR,intron&non_coding_transcript	GJB3:ENST00000373362:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJB3:ENST00000373366:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,RP1-34M23.5:ENST00000542839:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.110+2360C>T::	regulatory_region_variant:CTCF_binding_site	603324 [GENE=GJB3 PHENOS=Deafness,autosomal dominant 2B,612644,Autosomal dominant/Deafness,autosomal dominant,with peripheral neuropathy/Deafness,autosomal recessive/Deafness,digenic,GJB2/GJB3,220290,Autosomal recessive/Erythrokeratodermia variabilis et progressiva 1,133200,Autosomal recessive,Autosomal dominant];	297196 [benign DISEASE=Erythrokeratodermia variabilis,Nonsyndromic Hearing Loss, Dominant];			rs476220	0.4040	0.4918	3958,.		0.0710			0.11,0.23	5.43						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJB3 (inh=AR+AD oe_syn=0.87 oe_mis=1.11 oe_lof=0.63), RP1-34M23.5 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	39491927	39491927	G	C	het	het	hom	off-target	QUAL=4596;DP=72,102,84;AF=0.47,0.50,1.00;MQM=60	NDUFS5	upstream_gene	NDUFS5:ENST00000372967:upstream_gene_variant:MODIFIER::::,NDUFS5:ENST00000372969:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant					rs1984600	0.5395	0.7164	8465,.		-0.2810			0.00,0.64	10.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39492080	39492080	G	T	het	het	hom		QUAL=4638;DP=91,111,91;AF=0.51,0.47,1.00;MQM=60	NDUFS5	intron,splice_region&intron	NDUFS5:ENST00000372967:intron_variant:MODIFIER:exon1/2:c.-3+10G>T::,NDUFS5:ENST00000372969:splice_region_variant&intron_variant:LOW:exon1/2:c.-3+6G>T::	regulatory_region_variant:promoter					rs1122472	0.5377	0.7143	8426,.		-1.2950			0.01,0.69	8.61		6.53>7.92		0.000/0.028		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	40539076	40539076	C	T	hom	het	het		QUAL=18413;DP=389,252,206;AF=1.00,0.50,0.39;MQM=60	PPT1	3'UTR	PPT1:ENST00000433473:3_prime_UTR_variant:MODIFIER:exon9/9:c.*657G>A::		600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];	297230 [benign DISEASE=Neuronal Ceroid-Lipofuscinosis, Recessive];			rs1126973	0.6673	0.7070	7874,.		0.4520			0.11,0.66	10.54						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40539203	40539203	-	TGAT	hom	het	het		QUAL=19972;DP=340,458,362;AF=0.99,0.47,0.45;MQM=60	PPT1	3'UTR	PPT1:ENST00000433473:3_prime_UTR_variant:MODIFIER:exon9/9:c.*526_*529dup::		600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];	297233 [benign DISEASE=Neuronal Ceroid-Lipofuscinosis, Recessive];			rs1475500814		0.6646	7053,.						3.56						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40539228	40539228	G	C	hom	het	het		QUAL=29567;DP=530,540,423;AF=1.00,0.48,0.46;MQM=59	PPT1	3'UTR	PPT1:ENST00000433473:3_prime_UTR_variant:MODIFIER:exon9/9:c.*505C>G::		600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];	297234 [benign DISEASE=Neuronal Ceroid-Lipofuscinosis, Recessive];			rs1126972		0.7024	7787,.		-0.6320			0.02,0.13	0.36						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40539448	40539448	A	C	hom	het	het		QUAL=39098;DP=853,464,415;AF=1.00,0.45,0.53;MQM=60	PPT1	3'UTR	PPT1:ENST00000433473:3_prime_UTR_variant:MODIFIER:exon9/9:c.*285T>G::		600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];	297240 [benign DISEASE=Neuronal Ceroid-Lipofuscinosis, Recessive];			rs1126970	0.6611	0.7028	7812,.		1.4180			0.33,0.40	8.33						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40539572	40539572	A	G	het	het	wt		QUAL=7497;DP=342,267,237;AF=0.46,0.48,0.00;MQM=60	PPT1	3'UTR	PPT1:ENST00000433473:3_prime_UTR_variant:MODIFIER:exon9/9:c.*161T>C::,PPT1:ENST00000449045:3_prime_UTR_variant:MODIFIER:exon6/6:c.*161T>C::		600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];	297242 [likely benign DISEASE=Neuronal Ceroid-Lipofuscinosis, Recessive];			rs11552578	0.1514	0.1179	231,.		2.4320			0.75,0.92	14.81						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40546209	40546209	C	T	het	het	wt	off-target	QUAL=6235;DP=233,288,222;AF=0.49,0.49,0.00;MQM=60	PPT1	intron	PPT1:ENST00000433473:intron_variant:MODIFIER:exon5/8:c.537-50G>A::,PPT1:ENST00000449045:intron_variant:MODIFIER:exon2/5:c.228-50G>A::,PPT1:ENST00000530076:intron_variant:MODIFIER:exon1/4:c.-121-50G>A::	regulatory_region_variant:promoter_flanking_region	600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];				rs77623018	0.0881	0.0862	97,.	0.0162,0.1045,0.1396,0.0569,0.1362	-1.7000			0.02,0.12	0.31						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40556942	40556942	A	T	wt	wt	het	off-target	QUAL=2666;DP=152,216,207;AF=0.00,0.00,0.51;MQM=60	PPT1	intron	PPT1:ENST00000433473:intron_variant:MODIFIER:exon4/8:c.433+59T>A::,PPT1:ENST00000449045:intron_variant:MODIFIER:exon1/5:c.125-1758T>A::		600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];				rs56654546	0.1154	0.0898	133,.		0.8540			0.00,0.11	4.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40557033	40557033	A	G	het	het	wt		QUAL=9318;DP=431,349,344;AF=0.44,0.48,0.00;MQM=59	PPT1	missense,intron	PPT1:ENST00000433473:missense_variant:MODERATE:exon4/9:c.401T>C:p.Ile134Thr:PF02089,PPT1:ENST00000449045:intron_variant:MODIFIER:exon1/5:c.125-1849T>C::		600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];	130022 [benign/likely benign DISEASE=History of neurodevelopmental disorder,not specified,Neuronal Ceroid-Lipofuscinosis, Recessive,not provided];			rs1800205	0.0739	0.0659	72,.	0.0097,0.0357,0.1235,0.0483,0.1213	0.5750	T(0.37), 	B(0.04), 	0.86,0.97	17.46	0.20					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40562993	40562993	T	C	hom	hom	hom		QUAL=5692;DP=36,97,56;AF=1.00,1.00,1.00;MQM=60	PPT1	5'UTR	PPT1:ENST00000433473:5_prime_UTR_variant:MODIFIER:exon1/9:c.-83A>G::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];	297250 [benign DISEASE=Neuronal Ceroid-Lipofuscinosis, Recessive];			rs6600313	0.8327	0.8462	11305,.		-0.7110			0.01,0.11	9.63						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40563019	40563019	G	T	het	het	wt		QUAL=1550;DP=30,82,46;AF=0.60,0.54,0.02;MQM=60	PPT1	5'UTR	PPT1:ENST00000433473:5_prime_UTR_variant:MODIFIER:exon1/9:c.-109C>A::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	600722 [GENE=PPT1 PHENOS=Ceroid lipofuscinosis,neuronal,1,256730,Autosomal recessive];	297251 [likely benign DISEASE=Neuronal Ceroid-Lipofuscinosis, Recessive];			rs41301070	0.1138	0.0926	180,.		-0.6360			0.04,0.12	4.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40735817	40735817	T	G	wt	wt	het	off-target	QUAL=327;DP=99,62,43;AF=0.00,0.00,0.40;MQM=60	ZMPSTE24	intron	ZMPSTE24:ENST00000372759:intron_variant:MODIFIER:exon5/9:c.627+18T>G::	regulatory_region_variant:promoter_flanking_region	606480 [GENE=ZMPSTE24 PHENOS=Mandibuloacral dysplasia with type B lipodystrophy,608612,Autosomal recessive/Restrictive dermopathy,lethal,275210,Autosomal recessive];	140531 [benign DISEASE=not specified,not provided];			rs16827109	0.1154	0.1068	116,.	0.0627,0.1451,0.1617,0.0893,0.1472	0.1420			0.25,0.24	9.40						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZMPSTE24 (inh=AR oe_syn=0.88 oe_mis=0.93 oe_lof=0.94)
chr1	40737516	40737516	T	G	hom	hom	hom	off-target	QUAL=11360;DP=124,126,105;AF=1.00,1.00,1.00;MQM=60	ZMPSTE24	intron	ZMPSTE24:ENST00000372759:intron_variant:MODIFIER:exon5/9:c.628-50T>G::		606480 [GENE=ZMPSTE24 PHENOS=Mandibuloacral dysplasia with type B lipodystrophy,608612,Autosomal recessive/Restrictive dermopathy,lethal,275210,Autosomal recessive];	140535 [benign DISEASE=not specified,not provided];			rs6677717		0.9851	15190,.	0.9983,0.9974,0.9999,0.9870,0.9859	-0.4140			0.00,0.07	3.81						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZMPSTE24 (inh=AR oe_syn=0.88 oe_mis=0.93 oe_lof=0.94)
chr1	43198722	43198722	C	T	het	n/a	n/a	off-target	QUAL=167;DP=14,1,0;AF=0.64,1.00,;MQM=52	CLDN19	downstream_gene	CLDN19:ENST00000296387:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000372539:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000539749:downstream_gene_variant:MODIFIER::::					AluSg (SINE/Alu)	rs11210707		0.6374	6185,.		-0.2940			0.00,0.09	2.54						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	43199024	43199024	C	T	het	het	wt		QUAL=6593;DP=211,332,253;AF=0.51,0.51,0.00;MQM=59	CLDN19	3'UTR	CLDN19:ENST00000296387:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1733G>A::,CLDN19:ENST00000539749:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2409G>A::		610036 [GENE=CLDN19 PHENOS=Hypomagnesemia 5,renal,with ocular involvement,248190,Autosomal recessive];	297316 [likely benign DISEASE=Renal Hypomagnesemia, Recessive];		AluSx1 (SINE/Alu)	rs112310775	0.1254	0.1267	247,.		-0.6940			0.00,0.06	0.67						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	43199115	43199115	A	G	het	het	wt		QUAL=10803;DP=398,441,353;AF=0.49,0.50,0.00;MQM=60	CLDN19	3'UTR	CLDN19:ENST00000296387:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1642T>C::,CLDN19:ENST00000539749:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2318T>C::		610036 [GENE=CLDN19 PHENOS=Hypomagnesemia 5,renal,with ocular involvement,248190,Autosomal recessive];	297318 [benign DISEASE=Renal Hypomagnesemia, Recessive];			rs56345167	0.1907	0.1884	614,.		0.4220			0.04,0.36	5.65						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	43200526	43200526	T	C	het	het	het		QUAL=4983;DP=133,142,127;AF=0.49,0.51,0.43;MQM=60	CLDN19	3'UTR	CLDN19:ENST00000296387:3_prime_UTR_variant:MODIFIER:exon5/5:c.*231A>G::,CLDN19:ENST00000539749:3_prime_UTR_variant:MODIFIER:exon3/3:c.*907A>G::	regulatory_region_variant:enhancer	610036 [GENE=CLDN19 PHENOS=Hypomagnesemia 5,renal,with ocular involvement,248190,Autosomal recessive];	297335 [benign DISEASE=Renal Hypomagnesemia, Recessive];			rs912075	0.6068	0.5875	5473,.		-1.2490			0.00,0.06	4.81						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	43200855	43200855	G	A	het	het	het		QUAL=7192;DP=115,253,210;AF=0.53,0.47,0.55;MQM=59	CLDN19	intron,3'UTR	CLDN19:ENST00000296387:intron_variant:MODIFIER:exon4/4:c.627-50C>T::,CLDN19:ENST00000372539:3_prime_UTR_variant:MODIFIER:exon4/4:c.*684C>T::,CLDN19:ENST00000539749:3_prime_UTR_variant:MODIFIER:exon3/3:c.*578C>T::		610036 [GENE=CLDN19 PHENOS=Hypomagnesemia 5,renal,with ocular involvement,248190,Autosomal recessive];				rs74885359	0.0387	0.1031	227,.	0.0235,0.0526,0.0003,0.1380,0.0400	-0.7360			0.06,0.18	1.90						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	43201216	43201216	A	C	het	het	het		QUAL=10376;DP=185,353,284;AF=0.45,0.49,0.49;MQM=60	CLDN19	intron,3'UTR	CLDN19:ENST00000296387:intron_variant:MODIFIER:exon4/4:c.626+333T>G::,CLDN19:ENST00000372539:3_prime_UTR_variant:MODIFIER:exon4/4:c.*323T>G::,CLDN19:ENST00000539749:3_prime_UTR_variant:MODIFIER:exon3/3:c.*217T>G::	regulatory_region_variant:promoter_flanking_region	610036 [GENE=CLDN19 PHENOS=Hypomagnesemia 5,renal,with ocular involvement,248190,Autosomal recessive];			L2b (LINE/L2)	rs12141833		0.5415	4773,.		-0.6380			0.00,0.11	2.72						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	43201534	43201534	G	A	het	het	wt		QUAL=4021;DP=85,242,175;AF=0.44,0.56,0.01;MQM=59	CLDN19	intron,3'UTR,missense	CLDN19:ENST00000296387:intron_variant:MODIFIER:exon4/4:c.626+15C>T::,CLDN19:ENST00000372539:3_prime_UTR_variant:MODIFIER:exon4/4:c.*5C>T::,CLDN19:ENST00000539749:missense_variant:MODERATE:exon3/3:c.556C>T:p.Arg186Cys:	regulatory_region_variant:promoter_flanking_region	610036 [GENE=CLDN19 PHENOS=Hypomagnesemia 5,renal,with ocular involvement,248190,Autosomal recessive];	297339 [benign DISEASE=Renal Hypomagnesemia, Recessive];			rs4660658	0.1905	0.1803	533,.	0.2412,0.2467,0.2450,0.1585,0.1289	-1.1640	 , ,T(0.07)	 , ,B(0.00)	0.02,0.20	1.72	0.12					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	43212111	43212111	C	T	het	het	het		QUAL=9084;DP=295,206,180;AF=0.49,0.48,0.54;MQM=59	P3H1	3'UTR	P3H1:ENST00000236040:3_prime_UTR_variant:MODIFIER:exon14/14:c.*472G>A::,P3H1:ENST00000296388:3_prime_UTR_variant:MODIFIER:exon15/15:c.*257G>A::,P3H1:ENST00000397054:3_prime_UTR_variant:MODIFIER:exon15/15:c.*393G>A::		610339 [GENE=P3H1 PHENOS=Osteogenesis imperfecta,type VIII,610915,Autosomal recessive];				rs6882	0.6625	0.6421	6503,.		0.1860			0.07,0.19	8.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	43212431	43212431	A	G	hom	hom	hom		QUAL=23135;DP=220,335,211;AF=1.00,1.00,1.00;MQM=59	P3H1	3'UTR,synonymous	P3H1:ENST00000236040:3_prime_UTR_variant:MODIFIER:exon14/14:c.*152T>C::,P3H1:ENST00000296388:synonymous_variant:LOW:exon15/15:c.2148T>C:p.Gly716=:,P3H1:ENST00000397054:3_prime_UTR_variant:MODIFIER:exon15/15:c.*73T>C::		610339 [GENE=P3H1 PHENOS=Osteogenesis imperfecta,type VIII,610915,Autosomal recessive];	194558 [likely benign DISEASE=not specified];			rs4660662		1.0000	15690,.	0.9999,1.0000,1.0000,0.9998,1.0000	-0.1550			0.00,0.10	6.36					COSM5745623	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	43212869	43212869	A	T	het	het	wt		QUAL=2969;DP=110,126,74;AF=0.48,0.50,0.00;MQM=60	P3H1	missense,intron	P3H1:ENST00000236040:missense_variant:MODERATE:exon14/14:c.2129T>A:p.Phe710Tyr:,P3H1:ENST00000296388:intron_variant:MODIFIER:exon14/14:c.2055+74T>A::,P3H1:ENST00000397054:intron_variant:MODIFIER:exon14/14:c.2074+55T>A::	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	610339 [GENE=P3H1 PHENOS=Osteogenesis imperfecta,type VIII,610915,Autosomal recessive];				rs3738496	0.1210	0.1309	213,.	0.0737,0.2078,0.2524,0.1144,0.0733	-0.0100	T(0.73), , 	B(0.03), , 	0.03,0.15	2.95	0.02					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	43213499	43213499	C	T	het	het	het	off-target	QUAL=5991;DP=175,218,135;AF=0.47,0.48,0.49;MQM=60	P3H1	intron	P3H1:ENST00000236040:intron_variant:MODIFIER:exon12/13:c.1839-30G>A::,P3H1:ENST00000296388:intron_variant:MODIFIER:exon12/14:c.1839-30G>A::,P3H1:ENST00000397054:intron_variant:MODIFIER:exon12/14:c.1839-30G>A::		610339 [GENE=P3H1 PHENOS=Osteogenesis imperfecta,type VIII,610915,Autosomal recessive];				rs3738499	0.5541	0.6021	4705,.	0.3579,0.6219,0.6767,0.5938,0.6960	-0.8330			0.12,0.23	4.71						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	43228189	43228189	T	A	hom	hom	hom	off-target	QUAL=19122;DP=190,255,212;AF=0.99,1.00,1.00;MQM=60	P3H1	intron	P3H1:ENST00000236040:intron_variant:MODIFIER:exon1/13:c.466-43A>T::,P3H1:ENST00000296388:intron_variant:MODIFIER:exon1/14:c.466-43A>T::,P3H1:ENST00000397054:intron_variant:MODIFIER:exon1/14:c.466-43A>T::		610339 [GENE=P3H1 PHENOS=Osteogenesis imperfecta,type VIII,610915,Autosomal recessive];				rs2816593		0.9866	15260,.	0.9973,0.9974,1.0000,0.9816,0.9927	-0.1870			0.00,0.08	4.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	43232798	43232798	G	T	wt	wt	het	off-target	QUAL=349;DP=8,19,27;AF=0.00,0.00,0.67;MQM=60	P3H1,C1orf50	upstream_gene	P3H1:ENST00000236040:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000296388:upstream_gene_variant:MODIFIER::::,C1orf50:ENST00000372525:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000397054:upstream_gene_variant:MODIFIER::::,C1orf50:ENST00000536543:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site					rs11210712	0.1384	0.2142	888,.		-0.0780			0.05,0.67	3.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91), C1orf50 (inh=n/a oe_syn=0.92 oe_mis=1.08 oe_lof=0.41)
chr1	43232807	43232807	C	G	het	het	het	off-target	QUAL=605;DP=11,17,22;AF=0.73,0.59,0.64;MQM=60	P3H1,C1orf50	upstream_gene	P3H1:ENST00000236040:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000296388:upstream_gene_variant:MODIFIER::::,C1orf50:ENST00000372525:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000397054:upstream_gene_variant:MODIFIER::::,C1orf50:ENST00000536543:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant					rs3738504	0.6496	0.5958	5582,.		0.9360			0.10,0.71	7.97						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91), C1orf50 (inh=n/a oe_syn=0.92 oe_mis=1.08 oe_lof=0.41)
chr1	43392250	43392250	C	G	wt	wt	het		QUAL=2155;DP=289,266,227;AF=0.00,0.00,0.41;MQM=60	SLC2A1	3'UTR	SLC2A1:ENST00000426263:3_prime_UTR_variant:MODIFIER:exon10/10:c.*462G>C::		138140 [GENE=SLC2A1 PHENOS=Dystonia 9,601042,Autosomal dominant/Epilepsy,idiopathic generalized,susceptibility to,12,614847,Autosomal dominant/GLUT1 deficiency syndrome 1,infantile onset,severe,606777,Autosomal recessive,Autosomal dominant/GLUT1 deficiency syndrome 2,childhood onset,612126,Autosomal dominant/Stomatin-deficient cryohydrocytosis with neurologic defects,608885,Autosomal dominant];	297374 [benign DISEASE=Dystonia,Glucose transporter type 1 deficiency syndrome];			rs4658	0.3834	0.3369	2160,.		-0.3280			0.01,0.08	0.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	43393245	43393245	-	GGTGAGAAAT	wt	het	het	off-target	QUAL=908;DP=177,81,98;AF=0.00,0.38,0.36;MQM=60	SLC2A1	intron	SLC2A1:ENST00000426263:intron_variant:MODIFIER:exon9/9:c.1278+30_1278+31insATTTCTCACC::		138140 [GENE=SLC2A1 PHENOS=Dystonia 9,601042,Autosomal dominant/Epilepsy,idiopathic generalized,susceptibility to,12,614847,Autosomal dominant/GLUT1 deficiency syndrome 1,infantile onset,severe,606777,Autosomal recessive,Autosomal dominant/GLUT1 deficiency syndrome 2,childhood onset,612126,Autosomal dominant/Stomatin-deficient cryohydrocytosis with neurologic defects,608885,Autosomal dominant];				rs11282849	0.6174	0.5517	4915,.						3.07						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	43395635	43395635	C	T	wt	wt	het		QUAL=1558;DP=115,232,160;AF=0.00,0.00,0.43;MQM=60	SLC2A1	intron,synonymous	SLC2A1:ENST00000415851:intron_variant:MODIFIER:exon4/4:c.352-441G>A::,SLC2A1:ENST00000426263:synonymous_variant:LOW:exon5/10:c.588G>A:p.Pro196=:PF00083		138140 [GENE=SLC2A1 PHENOS=Dystonia 9,601042,Autosomal dominant/Epilepsy,idiopathic generalized,susceptibility to,12,614847,Autosomal dominant/GLUT1 deficiency syndrome 1,infantile onset,severe,606777,Autosomal recessive,Autosomal dominant/GLUT1 deficiency syndrome 2,childhood onset,612126,Autosomal dominant/Stomatin-deficient cryohydrocytosis with neurologic defects,608885,Autosomal dominant];	95414 [benign DISEASE=Dystonia,Glucose transporter type 1 deficiency syndrome,History of neurodevelopmental disorder,GLUT1 deficiency syndrome 1,not specified];			rs2229682	0.1196	0.1845	470,.	0.0418,0.1995,0.0761,0.2078,0.1880	-4.4130			0.10,0.48	11.45			gain/acceptor/43395635-43395636/Medium/6.532418			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	43396414	43396414	G	A	wt	wt	het		QUAL=2460;DP=252,166,154;AF=0.00,0.01,0.62;MQM=59	SLC2A1	synonymous,intron	SLC2A1:ENST00000372500:synonymous_variant:LOW:exon4/4:c.399C>T:p.Cys133=:PF00083,SLC2A1:ENST00000415851:intron_variant:MODIFIER:exon4/4:c.351+48C>T::,SLC2A1:ENST00000426263:synonymous_variant:LOW:exon4/10:c.399C>T:p.Cys133=:PF00083	regulatory_region_variant:CTCF_binding_site	138140 [GENE=SLC2A1 PHENOS=Dystonia 9,601042,Autosomal dominant/Epilepsy,idiopathic generalized,susceptibility to,12,614847,Autosomal dominant/GLUT1 deficiency syndrome 1,infantile onset,severe,606777,Autosomal recessive,Autosomal dominant/GLUT1 deficiency syndrome 2,childhood onset,612126,Autosomal dominant/Stomatin-deficient cryohydrocytosis with neurologic defects,608885,Autosomal dominant];	95411 [benign DISEASE=Dystonia,Glucose transporter type 1 deficiency syndrome,History of neurodevelopmental disorder,not specified,not provided];			rs11537641	0.1414	0.1897	499,.	0.0925,0.2031,0.0999,0.2048,0.1983	-1.1810			0.20,0.77	9.74						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	43408966	43408966	G	A	het	wt	het		QUAL=7402;DP=289,487,349;AF=0.44,0.00,0.52;MQM=60	SLC2A1	synonymous	SLC2A1:ENST00000372500:synonymous_variant:LOW:exon2/4:c.45C>T:p.Ala15=:,SLC2A1:ENST00000415851:synonymous_variant:LOW:exon2/5:c.45C>T:p.Ala15=:,SLC2A1:ENST00000426263:synonymous_variant:LOW:exon2/10:c.45C>T:p.Ala15=:	TF_binding_site_variant	138140 [GENE=SLC2A1 PHENOS=Dystonia 9,601042,Autosomal dominant/Epilepsy,idiopathic generalized,susceptibility to,12,614847,Autosomal dominant/GLUT1 deficiency syndrome 1,infantile onset,severe,606777,Autosomal recessive,Autosomal dominant/GLUT1 deficiency syndrome 2,childhood onset,612126,Autosomal dominant/Stomatin-deficient cryohydrocytosis with neurologic defects,608885,Autosomal dominant];	95413 [benign DISEASE=Dystonia,Glucose transporter type 1 deficiency syndrome,History of neurodevelopmental disorder,GLUT1 deficiency syndrome 1,not specified];			rs1385129	0.2404	0.2416	757,.	0.1769,0.3054,0.2876,0.2187,0.2675	-2.2290			0.12,0.61	14.55						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	43812075	43812075	G	A	het	het	wt	off-target	QUAL=3879;DP=138,148,111;AF=0.58,0.53,0.01;MQM=60	MPL	intron	MPL:ENST00000372470:intron_variant:MODIFIER:exon6/11:c.981-41G>A::,MPL:ENST00000413998:intron_variant:MODIFIER:exon6/9:c.981-41G>A::	regulatory_region_variant:promoter_flanking_region	159530 [GENE=MPL PHENOS=Myelofibrosis with myeloid metaplasia,somatic,254450/Thrombocythemia 2,601977,Autosomal dominant,Somatic mutation/Thrombocytopenia,congenital amegakaryocytic,604498,Autosomal recessive];	259760 [benign DISEASE=not specified];			rs1760670	0.2097	0.3034	1540,.	0.2200,0.3028,0.0676,0.3792,0.1450	0.6670			0.02,0.18	5.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPL (inh=AR+AD oe_syn=0.74 oe_mis=0.94 oe_lof=0.53)
chr1	43820193	43820193	G	A	wt	wt	het	off-target	QUAL=1536;DP=182,119,121;AF=0.00,0.01,0.51;MQM=60	CDC20,MPL,RP1-92O14.3	upstream_gene,downstream_gene	CDC20:ENST00000310955:upstream_gene_variant:MODIFIER::::,CDC20:ENST00000372462:upstream_gene_variant:MODIFIER::::,MPL:ENST00000372470:downstream_gene_variant:MODIFIER::::,MPL:ENST00000413998:downstream_gene_variant:MODIFIER::::,RP1-92O14.3:ENST00000424948:downstream_gene_variant:MODIFIER::::						rs79064184	0.0296	0.0403	43,.		0.0230			0.00,0.07	0.52						1	18						CDC20 (inh=n/a oe_syn=0.86 oe_mis=0.70 oe_lof=0.54), MPL (inh=AR+AD oe_syn=0.74 oe_mis=0.94 oe_lof=0.53), RP1-92O14.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	44290530	44290530	A	G	het	hom	het		QUAL=7873;DP=265,112,116;AF=0.46,0.98,0.41;MQM=60	ST3GAL3	missense,intron	ST3GAL3:ENST00000262915:missense_variant:MODERATE:exon5/13:c.382A>G:p.Thr128Ala:,ST3GAL3:ENST00000330208:intron_variant:MODIFIER:exon4/6:c.209+9925A>G::,ST3GAL3:ENST00000332628:intron_variant:MODIFIER:exon3/9:c.209+9925A>G::,ST3GAL3:ENST00000335430:intron_variant:MODIFIER:exon3/9:c.161+9925A>G::,ST3GAL3:ENST00000347631:intron_variant:MODIFIER:exon4/11:c.254+9925A>G::,ST3GAL3:ENST00000351035:missense_variant:MODERATE:exon4/12:c.289A>G:p.Thr97Ala:,ST3GAL3:ENST00000353126:intron_variant:MODIFIER:exon4/9:c.209+9925A>G::,ST3GAL3:ENST00000361392:intron_variant:MODIFIER:exon4/11:c.209+9925A>G::,ST3GAL3:ENST00000361400:intron_variant:MODIFIER:exon3/10:c.161+9925A>G::,ST3GAL3:ENST00000361746:missense_variant:MODERATE:exon4/12:c.382A>G:p.Thr128Ala:,ST3GAL3:ENST00000361812:intron_variant:MODIFIER:exon3/5:c.254+9925A>G::,ST3GAL3:ENST00000372362:intron_variant:MODIFIER:exon3/5:c.209+9925A>G::,ST3GAL3:ENST00000372365:intron_variant:MODIFIER:exon3/7:c.209+9925A>G::,ST3GAL3:ENST00000372366:intron_variant:MODIFIER:exon2/6:c.206+9925A>G::,ST3GAL3:ENST00000372367:intron_variant:MODIFIER:exon2/6:c.206+9925A>G::,ST3GAL3:ENST00000372368:missense_variant:MODERATE:exon4/12:c.337A>G:p.Thr113Ala:,ST3GAL3:ENST00000372369:intron_variant:MODIFIER:exon3/10:c.209+9925A>G::,ST3GAL3:ENST00000372372:missense_variant:MODERATE:exon3/11:c.289A>G:p.Thr97Ala:,ST3GAL3:ENST00000372374:intron_variant:MODIFIER:exon4/10:c.209+9925A>G::,ST3GAL3:ENST00000372375:missense_variant:MODERATE:exon5/13:c.337A>G:p.Thr113Ala:,ST3GAL3:ENST00000372377:intron_variant:MODIFIER:exon4/8:c.209+9925A>G::,ST3GAL3:ENST00000528371:intron_variant:MODIFIER:exon2/6:c.161+9925A>G::,ST3GAL3:ENST00000531451:intron_variant:MODIFIER:exon2/4:c.161+9925A>G::,ST3GAL3:ENST00000531816:intron_variant:MODIFIER:exon2/3:c.161+9925A>G::,ST3GAL3:ENST00000531993:intron_variant:MODIFIER:exon2/7:c.161+9925A>G::,ST3GAL3:ENST00000533933:intron_variant:MODIFIER:exon3/8:c.209+9925A>G::,ST3GAL3:ENST00000545417:intron_variant:MODIFIER:exon4/6:c.254+9925A>G::	regulatory_region_variant:enhancer	606494 [GENE=ST3GAL3 PHENOS=Epileptic encephalopathy,early infantile,15,615006,Autosomal recessive/Mental retardation,autosomal recessive 12,611090,Autosomal recessive];	130378 [benign DISEASE=not specified,not provided];		MER5B (DNA/hAT-Charlie)	rs37458	0.2364	0.3200	1653,.	0.3232,0.2169,0.1363,0.3575,0.1441	-0.1510	T(0.74), , , , ,T(0.74), , , ,T(0.74), , , , , ,T(0.70), ,T(0.74), ,T(0.70), , , , , , , 	B(0.00), , , , ,B(0.00), , , ,B(0.00), , , , , ,B(0.00), ,B(0.00), ,B(0.00), , , , , , , 	0.00,0.06	0.10	0.01					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	44365457	44365457	A	G	het	het	wt	off-target	QUAL=3652;DP=139,157,106;AF=0.48,0.56,0.00;MQM=60	ST3GAL3	intron	ST3GAL3:ENST00000262915:intron_variant:MODIFIER:exon10/12:c.951+58A>G::,ST3GAL3:ENST00000330208:intron_variant:MODIFIER:exon6/6:c.397+5308A>G::,ST3GAL3:ENST00000332628:intron_variant:MODIFIER:exon7/9:c.651+58A>G::,ST3GAL3:ENST00000335430:intron_variant:MODIFIER:exon7/9:c.509+522A>G::,ST3GAL3:ENST00000347631:intron_variant:MODIFIER:exon9/11:c.789+58A>G::,ST3GAL3:ENST00000351035:intron_variant:MODIFIER:exon9/11:c.858+58A>G::,ST3GAL3:ENST00000353126:intron_variant:MODIFIER:exon9/9:c.744+58A>G::,ST3GAL3:ENST00000361392:intron_variant:MODIFIER:exon9/11:c.744+58A>G::,ST3GAL3:ENST00000361400:intron_variant:MODIFIER:exon8/10:c.696+58A>G::,ST3GAL3:ENST00000361746:intron_variant:MODIFIER:exon9/11:c.951+58A>G::,ST3GAL3:ENST00000361812:intron_variant:MODIFIER:exon5/5:c.442+5308A>G::,ST3GAL3:ENST00000372362:intron_variant:MODIFIER:exon5/5:c.397+5308A>G::,ST3GAL3:ENST00000372365:intron_variant:MODIFIER:exon7/7:c.*22+496A>G::,ST3GAL3:ENST00000372366:intron_variant:MODIFIER:exon6/6:c.*22+496A>G::,ST3GAL3:ENST00000372367:intron_variant:MODIFIER:exon6/6:c.554+522A>G::,ST3GAL3:ENST00000372368:intron_variant:MODIFIER:exon9/11:c.906+58A>G::,ST3GAL3:ENST00000372369:intron_variant:MODIFIER:exon8/10:c.744+58A>G::,ST3GAL3:ENST00000372372:intron_variant:MODIFIER:exon8/10:c.858+58A>G::,ST3GAL3:ENST00000372374:intron_variant:MODIFIER:exon8/10:c.651+58A>G::,ST3GAL3:ENST00000372375:intron_variant:MODIFIER:exon10/12:c.906+58A>G::,ST3GAL3:ENST00000372377:intron_variant:MODIFIER:exon6/8:c.397+5308A>G::,ST3GAL3:ENST00000528371:intron_variant:MODIFIER:exon6/6:c.509+522A>G::,ST3GAL3:ENST00000531451:intron_variant:MODIFIER:exon4/4:c.349+5308A>G::,ST3GAL3:ENST00000531816:intron_variant:MODIFIER:exon3/3:c.255-30347A>G::,ST3GAL3:ENST00000531993:intron_variant:MODIFIER:exon7/7:c.696+58A>G::,ST3GAL3:ENST00000533933:intron_variant:MODIFIER:exon8/8:c.744+58A>G::,ST3GAL3:ENST00000545417:intron_variant:MODIFIER:exon6/6:c.442+5308A>G::		606494 [GENE=ST3GAL3 PHENOS=Epileptic encephalopathy,early infantile,15,615006,Autosomal recessive/Mental retardation,autosomal recessive 12,611090,Autosomal recessive];				rs783304	0.2804	0.2240	1009,.		-0.1060			0.01,0.09	5.31						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	44386615	44386615	A	G	hom	hom	hom	off-target	QUAL=11934;DP=76,210,127;AF=0.99,1.00,0.98;MQM=60	ST3GAL3	intron	ST3GAL3:ENST00000262915:intron_variant:MODIFIER:exon12/12:c.1245+15A>G::,ST3GAL3:ENST00000330208:intron_variant:MODIFIER:exon6/6:c.398-9189A>G::,ST3GAL3:ENST00000332628:intron_variant:MODIFIER:exon9/9:c.945+15A>G::,ST3GAL3:ENST00000335430:intron_variant:MODIFIER:exon9/9:c.*116+15A>G::,ST3GAL3:ENST00000347631:intron_variant:MODIFIER:exon11/11:c.1083+15A>G::,ST3GAL3:ENST00000351035:intron_variant:MODIFIER:exon11/11:c.1152+15A>G::,ST3GAL3:ENST00000353126:intron_variant:MODIFIER:exon9/9:c.745-9189A>G::,ST3GAL3:ENST00000361392:intron_variant:MODIFIER:exon11/11:c.1038+15A>G::,ST3GAL3:ENST00000361400:intron_variant:MODIFIER:exon10/10:c.990+15A>G::,ST3GAL3:ENST00000361746:intron_variant:MODIFIER:exon11/11:c.1245+15A>G::,ST3GAL3:ENST00000361812:intron_variant:MODIFIER:exon5/5:c.443-9189A>G::,ST3GAL3:ENST00000372362:intron_variant:MODIFIER:exon5/5:c.398-9189A>G::,ST3GAL3:ENST00000372365:intron_variant:MODIFIER:exon7/7:c.*23-9189A>G::,ST3GAL3:ENST00000372366:intron_variant:MODIFIER:exon6/6:c.*23-9189A>G::,ST3GAL3:ENST00000372367:intron_variant:MODIFIER:exon6/6:c.555-9189A>G::,ST3GAL3:ENST00000372368:intron_variant:MODIFIER:exon11/11:c.1200+15A>G::,ST3GAL3:ENST00000372369:intron_variant:MODIFIER:exon10/10:c.948+15A>G::,ST3GAL3:ENST00000372372:intron_variant:MODIFIER:exon10/10:c.1152+15A>G::,ST3GAL3:ENST00000372374:intron_variant:MODIFIER:exon10/10:c.945+15A>G::,ST3GAL3:ENST00000372375:intron_variant:MODIFIER:exon12/12:c.1200+15A>G::,ST3GAL3:ENST00000372377:intron_variant:MODIFIER:exon8/8:c.*235+15A>G::,ST3GAL3:ENST00000528371:intron_variant:MODIFIER:exon6/6:c.510-9189A>G::,ST3GAL3:ENST00000531451:intron_variant:MODIFIER:exon4/4:c.350-9189A>G::,ST3GAL3:ENST00000531816:intron_variant:MODIFIER:exon3/3:c.255-9189A>G::,ST3GAL3:ENST00000531993:intron_variant:MODIFIER:exon7/7:c.697-9189A>G::,ST3GAL3:ENST00000533933:intron_variant:MODIFIER:exon8/8:c.745-9189A>G::,ST3GAL3:ENST00000545417:intron_variant:MODIFIER:exon6/6:c.443-9189A>G::	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site	606494 [GENE=ST3GAL3 PHENOS=Epileptic encephalopathy,early infantile,15,615006,Autosomal recessive/Mental retardation,autosomal recessive 12,611090,Autosomal recessive];	262909 [benign DISEASE=not specified];			rs3120803		0.8813	11468,.	0.6951,0.8484,0.8544,0.9213,0.8667	-1.1910			0.00,0.06	0.73						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	44386642	44386642	G	C	het	het	wt	off-target	QUAL=3455;DP=84,157,94;AF=0.52,0.64,0.00;MQM=60	ST3GAL3	intron	ST3GAL3:ENST00000262915:intron_variant:MODIFIER:exon12/12:c.1245+42G>C::,ST3GAL3:ENST00000330208:intron_variant:MODIFIER:exon6/6:c.398-9162G>C::,ST3GAL3:ENST00000332628:intron_variant:MODIFIER:exon9/9:c.945+42G>C::,ST3GAL3:ENST00000335430:intron_variant:MODIFIER:exon9/9:c.*116+42G>C::,ST3GAL3:ENST00000347631:intron_variant:MODIFIER:exon11/11:c.1083+42G>C::,ST3GAL3:ENST00000351035:intron_variant:MODIFIER:exon11/11:c.1152+42G>C::,ST3GAL3:ENST00000353126:intron_variant:MODIFIER:exon9/9:c.745-9162G>C::,ST3GAL3:ENST00000361392:intron_variant:MODIFIER:exon11/11:c.1038+42G>C::,ST3GAL3:ENST00000361400:intron_variant:MODIFIER:exon10/10:c.990+42G>C::,ST3GAL3:ENST00000361746:intron_variant:MODIFIER:exon11/11:c.1245+42G>C::,ST3GAL3:ENST00000361812:intron_variant:MODIFIER:exon5/5:c.443-9162G>C::,ST3GAL3:ENST00000372362:intron_variant:MODIFIER:exon5/5:c.398-9162G>C::,ST3GAL3:ENST00000372365:intron_variant:MODIFIER:exon7/7:c.*23-9162G>C::,ST3GAL3:ENST00000372366:intron_variant:MODIFIER:exon6/6:c.*23-9162G>C::,ST3GAL3:ENST00000372367:intron_variant:MODIFIER:exon6/6:c.555-9162G>C::,ST3GAL3:ENST00000372368:intron_variant:MODIFIER:exon11/11:c.1200+42G>C::,ST3GAL3:ENST00000372369:intron_variant:MODIFIER:exon10/10:c.948+42G>C::,ST3GAL3:ENST00000372372:intron_variant:MODIFIER:exon10/10:c.1152+42G>C::,ST3GAL3:ENST00000372374:intron_variant:MODIFIER:exon10/10:c.945+42G>C::,ST3GAL3:ENST00000372375:intron_variant:MODIFIER:exon12/12:c.1200+42G>C::,ST3GAL3:ENST00000372377:intron_variant:MODIFIER:exon8/8:c.*235+42G>C::,ST3GAL3:ENST00000528371:intron_variant:MODIFIER:exon6/6:c.510-9162G>C::,ST3GAL3:ENST00000531451:intron_variant:MODIFIER:exon4/4:c.350-9162G>C::,ST3GAL3:ENST00000531816:intron_variant:MODIFIER:exon3/3:c.255-9162G>C::,ST3GAL3:ENST00000531993:intron_variant:MODIFIER:exon7/7:c.697-9162G>C::,ST3GAL3:ENST00000533933:intron_variant:MODIFIER:exon8/8:c.745-9162G>C::,ST3GAL3:ENST00000545417:intron_variant:MODIFIER:exon6/6:c.443-9162G>C::	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site	606494 [GENE=ST3GAL3 PHENOS=Epileptic encephalopathy,early infantile,15,615006,Autosomal recessive/Mental retardation,autosomal recessive 12,611090,Autosomal recessive];				rs3764833	0.0687	0.0556	61,.	0.0891,0.0490,0.1303,0.0398,0.0432	0.2340			0.03,0.16	7.95						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	44395786	44395786	C	T	het	het	hom	off-target	QUAL=10360;DP=170,258,184;AF=0.44,0.47,1.00;MQM=60	ST3GAL3	intron	ST3GAL3:ENST00000262915:intron_variant:MODIFIER:exon12/12:c.1246-18C>T::,ST3GAL3:ENST00000330208:intron_variant:MODIFIER:exon6/6:c.398-18C>T::,ST3GAL3:ENST00000332628:intron_variant:MODIFIER:exon9/9:c.946-18C>T::,ST3GAL3:ENST00000335430:intron_variant:MODIFIER:exon9/9:c.*117-18C>T::,ST3GAL3:ENST00000347631:intron_variant:MODIFIER:exon11/11:c.1084-18C>T::,ST3GAL3:ENST00000351035:intron_variant:MODIFIER:exon11/11:c.1153-18C>T::,ST3GAL3:ENST00000353126:intron_variant:MODIFIER:exon9/9:c.745-18C>T::,ST3GAL3:ENST00000361392:intron_variant:MODIFIER:exon11/11:c.1039-18C>T::,ST3GAL3:ENST00000361400:intron_variant:MODIFIER:exon10/10:c.991-18C>T::,ST3GAL3:ENST00000361746:intron_variant:MODIFIER:exon11/11:c.1246-18C>T::,ST3GAL3:ENST00000361812:intron_variant:MODIFIER:exon5/5:c.443-18C>T::,ST3GAL3:ENST00000372362:intron_variant:MODIFIER:exon5/5:c.398-18C>T::,ST3GAL3:ENST00000372365:intron_variant:MODIFIER:exon7/7:c.*23-18C>T::,ST3GAL3:ENST00000372366:intron_variant:MODIFIER:exon6/6:c.*23-18C>T::,ST3GAL3:ENST00000372367:intron_variant:MODIFIER:exon6/6:c.555-18C>T::,ST3GAL3:ENST00000372368:intron_variant:MODIFIER:exon11/11:c.1201-18C>T::,ST3GAL3:ENST00000372369:intron_variant:MODIFIER:exon10/10:c.949-18C>T::,ST3GAL3:ENST00000372372:intron_variant:MODIFIER:exon10/10:c.1153-18C>T::,ST3GAL3:ENST00000372374:intron_variant:MODIFIER:exon10/10:c.946-18C>T::,ST3GAL3:ENST00000372375:intron_variant:MODIFIER:exon12/12:c.1201-18C>T::,ST3GAL3:ENST00000372377:intron_variant:MODIFIER:exon8/8:c.*236-18C>T::,ST3GAL3:ENST00000528371:intron_variant:MODIFIER:exon6/6:c.510-18C>T::,ST3GAL3:ENST00000531451:intron_variant:MODIFIER:exon4/4:c.350-18C>T::,ST3GAL3:ENST00000531816:intron_variant:MODIFIER:exon3/3:c.255-18C>T::,ST3GAL3:ENST00000531993:intron_variant:MODIFIER:exon7/7:c.697-18C>T::,ST3GAL3:ENST00000533933:intron_variant:MODIFIER:exon8/8:c.745-18C>T::,ST3GAL3:ENST00000545417:intron_variant:MODIFIER:exon6/6:c.443-18C>T::		606494 [GENE=ST3GAL3 PHENOS=Epileptic encephalopathy,early infantile,15,615006,Autosomal recessive/Mental retardation,autosomal recessive 12,611090,Autosomal recessive];	262910 [benign DISEASE=not specified];		L3 (LINE/CR1)	rs2108202	0.5188	0.6753	6777,.	0.2202,0.5744,0.6408,0.7772,0.6130	1.2100			0.03,0.21	12.00		9.65>10.17				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	44396196	44396196	A	G	het	het	wt		QUAL=3124;DP=152,118,75;AF=0.43,0.49,0.00;MQM=60	ST3GAL3	3'UTR	ST3GAL3:ENST00000262915:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000330208:3_prime_UTR_variant:MODIFIER:exon7/7:c.*322A>G::,ST3GAL3:ENST00000335430:3_prime_UTR_variant:MODIFIER:exon10/10:c.*509A>G::,ST3GAL3:ENST00000351035:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000353126:3_prime_UTR_variant:MODIFIER:exon10/10:c.*303A>G::,ST3GAL3:ENST00000361392:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000361400:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000372374:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000372375:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000372377:3_prime_UTR_variant:MODIFIER:exon9/9:c.*628A>G::,ST3GAL3:ENST00000545417:3_prime_UTR_variant:MODIFIER:exon7/7:c.*322A>G::	regulatory_region_variant:CTCF_binding_site	606494 [GENE=ST3GAL3 PHENOS=Epileptic encephalopathy,early infantile,15,615006,Autosomal recessive/Mental retardation,autosomal recessive 12,611090,Autosomal recessive];				rs12561948	0.0507	0.0383	28,.		1.5480			0.70,0.94	18.54			gain/donor/44396196-44396197/Medium/1.679437			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	44396646	44396646	C	G	het	het	hom		QUAL=13485;DP=225,263,221;AF=0.49,0.54,1.00;MQM=60	ST3GAL3	3'UTR	ST3GAL3:ENST00000262915:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000330208:3_prime_UTR_variant:MODIFIER:exon7/7:c.*772C>G::,ST3GAL3:ENST00000335430:3_prime_UTR_variant:MODIFIER:exon10/10:c.*959C>G::,ST3GAL3:ENST00000351035:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:ENST00000353126:3_prime_UTR_variant:MODIFIER:exon10/10:c.*753C>G::,ST3GAL3:ENST00000361392:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:ENST00000361400:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000372374:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000372375:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000372377:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1078C>G::,ST3GAL3:ENST00000545417:3_prime_UTR_variant:MODIFIER:exon7/7:c.*772C>G::	regulatory_region_variant:CTCF_binding_site	606494 [GENE=ST3GAL3 PHENOS=Epileptic encephalopathy,early infantile,15,615006,Autosomal recessive/Mental retardation,autosomal recessive 12,611090,Autosomal recessive];				rs6801	0.5188	0.6104	6779,.		0.1600			0.06,0.22	7.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	45285534	45285534	A	C	wt	wt	het		QUAL=164;DP=127,28,26;AF=0.00,0.00,0.42;MQM=60	PTCH2	3'UTR	PTCH2:ENST00000447098:3_prime_UTR_variant:MODIFIER:exon23/23:c.*827T>G::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	603673 [GENE=PTCH2 PHENOS=Basal cell carcinoma,somatic,605462/Basal cell nevus syndrome,109400,Autosomal dominant/Medulloblastoma,somatic,155255];				rs181782534	0.0104	0.0122	1,.		-0.4960			0.00,0.36	1.04						0	19						PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	45285648	45285648	C	T	hom	het	het		QUAL=19743;DP=507,176,167;AF=0.99,0.49,0.54;MQM=59	RNU5E-6P,PTCH2	non_coding_transcript_exon,3'UTR	RNU5E-6P:ENST00000365574:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.22G>A::,PTCH2:ENST00000447098:3_prime_UTR_variant:MODIFIER:exon23/23:c.*713G>A::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	603673 [GENE=PTCH2 PHENOS=Basal cell carcinoma,somatic,605462/Basal cell nevus syndrome,109400,Autosomal dominant/Medulloblastoma,somatic,155255];			U5 (snRNA)	rs41269085	0.2290	0.2273	918,.		-0.3180			0.00,0.39	1.73						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RNU5E-6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	45292866	45292866	G	A	hom	het	het		QUAL=8952;DP=160,208,147;AF=0.99,0.50,0.51;MQM=59	PTCH2	synonymous	PTCH2:ENST00000372192:synonymous_variant:LOW:exon16/22:c.2487C>T:p.Asp829=:,PTCH2:ENST00000447098:synonymous_variant:LOW:exon16/23:c.2487C>T:p.Asp829=:	regulatory_region_variant:CTCF_binding_site	603673 [GENE=PTCH2 PHENOS=Basal cell carcinoma,somatic,605462/Basal cell nevus syndrome,109400,Autosomal dominant/Medulloblastoma,somatic,155255];				rs2295996	0.1478	0.1624	352,.	0.0810,0.1773,0.2106,0.1669,0.1589	0.7970			0.70,0.93	13.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	45293518	45293518	A	G	hom	het	het		QUAL=12995;DP=194,323,269;AF=0.99,0.48,0.48;MQM=60	PTCH2	synonymous	PTCH2:ENST00000372192:synonymous_variant:LOW:exon14/22:c.2055T>C:p.Ala685=:,PTCH2:ENST00000447098:synonymous_variant:LOW:exon14/23:c.2055T>C:p.Ala685=:	regulatory_region_variant:CTCF_binding_site	603673 [GENE=PTCH2 PHENOS=Basal cell carcinoma,somatic,605462/Basal cell nevus syndrome,109400,Autosomal dominant/Medulloblastoma,somatic,155255];				rs7525308	0.4455	0.4339	3094,.	0.5872,0.4169,0.4801,0.3461,0.3545	2.0950			0.06,0.81	9.81						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	45294156	45294156	T	C	hom	het	het	off-target	QUAL=21852;DP=233,682,518;AF=1.00,0.48,0.53;MQM=60	PTCH2	intron	PTCH2:ENST00000372192:intron_variant:MODIFIER:exon12/21:c.1590+22A>G::,PTCH2:ENST00000447098:intron_variant:MODIFIER:exon12/22:c.1590+22A>G::	regulatory_region_variant:CTCF_binding_site	603673 [GENE=PTCH2 PHENOS=Basal cell carcinoma,somatic,605462/Basal cell nevus syndrome,109400,Autosomal dominant/Medulloblastoma,somatic,155255];				rs2273940	0.4433	0.4321	3050,.	0.5776,0.4168,0.4807,0.3456,0.3543	-1.9150			0.00,0.09	4.48						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	45307506	45307506	G	A	hom	het	het	off-target	QUAL=7530;DP=81,212,183;AF=0.99,0.55,0.51;MQM=60	PTCH2	intron	PTCH2:ENST00000372192:intron_variant:MODIFIER:exon2/21:c.265+13C>T::,PTCH2:ENST00000447098:intron_variant:MODIFIER:exon2/22:c.265+13C>T::	regulatory_region_variant:promoter	603673 [GENE=PTCH2 PHENOS=Basal cell carcinoma,somatic,605462/Basal cell nevus syndrome,109400,Autosomal dominant/Medulloblastoma,somatic,155255];				rs3795720	0.3720	0.3744	1961,.	0.3300,0.5242,0.4336,0.3463,0.3434	1.7090			0.03,0.33	9.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	45340282	45340282	C	T	hom	het	het		QUAL=20686;DP=402,314,252;AF=1.00,0.48,0.48;MQM=60	EIF2B3	intron,3'UTR	EIF2B3:ENST00000360403:intron_variant:MODIFIER:exon10/11:c.1202+68G>A::,EIF2B3:ENST00000372183:3_prime_UTR_variant:MODIFIER:exon10/10:c.*31G>A::		606273 [GENE=EIF2B3 PHENOS=Leukoencephalopathy with vanishing white matter,603896,Autosomal recessive];			HAL1 (LINE/L1)	rs9988451	0.4517	0.4353	3074,.	0.5880,0.5364,0.4362,0.3537,0.3517	0.6900			0.00,0.04	5.79						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	45345446	45345446	T	A	hom	het	het	off-target	QUAL=4385;DP=102,64,44;AF=1.00,0.48,0.57;MQM=60	EIF2B3	intron	EIF2B3:ENST00000360403:intron_variant:MODIFIER:exon8/11:c.975+44A>T::,EIF2B3:ENST00000372183:intron_variant:MODIFIER:exon8/9:c.975+44A>T::		606273 [GENE=EIF2B3 PHENOS=Leukoencephalopathy with vanishing white matter,603896,Autosomal recessive];	261223 [benign DISEASE=not specified];			rs3738248	0.1448	0.1619	364,.	0.1145,0.1545,0.1655,0.1739,0.1604	0.2890			0.19,0.27	8.72						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	45362992	45362992	T	C	hom	het	het	off-target	QUAL=6665;DP=142,91,71;AF=1.00,0.57,0.52;MQM=60	EIF2B3	intron	EIF2B3:ENST00000360403:intron_variant:MODIFIER:exon6/11:c.656+35A>G::,EIF2B3:ENST00000372183:intron_variant:MODIFIER:exon6/9:c.656+35A>G::		606273 [GENE=EIF2B3 PHENOS=Leukoencephalopathy with vanishing white matter,603896,Autosomal recessive];	261222 [benign DISEASE=not specified];			rs263978	0.7911	0.6850	7788,.	0.9083,0.7886,0.9742,0.5467,0.6533	-0.9150			0.00,0.07	1.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	45452227	45452227	G	C	hom	het	het		QUAL=6869;DP=126,187,107;AF=1.00,0.43,0.43;MQM=60	EIF2B3	5'UTR	EIF2B3:ENST00000360403:5_prime_UTR_variant:MODIFIER:exon1/12:c.-72C>G::,EIF2B3:ENST00000372183:5_prime_UTR_variant:MODIFIER:exon1/10:c.-72C>G::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	606273 [GENE=EIF2B3 PHENOS=Leukoencephalopathy with vanishing white matter,603896,Autosomal recessive];	297453 [benign DISEASE=Leukoencephalopathy with vanishing white matter];			rs489676	0.4806	0.4807	3725,.		-3.3680			0.00,0.12	3.45						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	45975089	45975089	T	-	het	het	het		QUAL=418;DP=63,112,106;AF=0.19,0.10,0.26;MQM=59	MMACHC	3'UTR	MMACHC:ENST00000401061:3_prime_UTR_variant:MODIFIER:exon4/4:c.*217del::		609831 [GENE=MMACHC PHENOS=Methylmalonic aciduria and homocystinuria,cblC type,277400,Autosomal recessive];			AluSg7 (SINE/Alu)	rs1207558767		0.0419	25,.		-2.0510				0.02						2	2						MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21)
chr1	45975166	45975166	A	G	wt	het	wt		QUAL=1064;DP=195,142,122;AF=0.00,0.38,0.00;MQM=59	MMACHC	3'UTR	MMACHC:ENST00000401061:3_prime_UTR_variant:MODIFIER:exon4/4:c.*279A>G::		609831 [GENE=MMACHC PHENOS=Methylmalonic aciduria and homocystinuria,cblC type,277400,Autosomal recessive];	297502 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluSg7 (SINE/Alu)	rs9729395	0.2634	0.2156	729,.		0.6090			0.01,0.06	1.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21)
chr1	45975300	45975300	G	A	wt	wt	het		QUAL=2022;DP=182,194,135;AF=0.01,0.01,0.59;MQM=59	MMACHC	3'UTR	MMACHC:ENST00000401061:3_prime_UTR_variant:MODIFIER:exon4/4:c.*413G>A::		609831 [GENE=MMACHC PHENOS=Methylmalonic aciduria and homocystinuria,cblC type,277400,Autosomal recessive];	297505 [likely benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluSg7 (SINE/Alu)	rs12021717	0.1184	0.1908	600,.		0.1590			0.02,0.09	3.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21)
chr1	45975740	45975741	CT	-	wt	het	wt		QUAL=1744;DP=234,184,174;AF=0.00,0.49,0.01;MQM=58	MMACHC	3'UTR	MMACHC:ENST00000401061:3_prime_UTR_variant:MODIFIER:exon4/4:c.*855_*856del::		609831 [GENE=MMACHC PHENOS=Methylmalonic aciduria and homocystinuria,cblC type,277400,Autosomal recessive];	297512 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluSx4 (SINE/Alu)	rs1356492884		0.6567	6035,.		0.2120				2.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21)
chr1	45975749	45975749	A	-	het	het	het		QUAL=424;DP=106,84,83;AF=0.18,0.15,0.25;MQM=59	MMACHC	3'UTR	MMACHC:ENST00000401061:3_prime_UTR_variant:MODIFIER:exon4/4:c.*877del::		609831 [GENE=MMACHC PHENOS=Methylmalonic aciduria and homocystinuria,cblC type,277400,Autosomal recessive];			AluSx4 (SINE/Alu)	rs1175589414		0.1046	106,.		0.0860				1.76						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21)
chr1	45976147	45976147	G	A	wt	het	wt		QUAL=4632;DP=342,402,281;AF=0.00,0.49,0.00;MQM=60	MMACHC	3'UTR	MMACHC:ENST00000401061:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1260G>A::		609831 [GENE=MMACHC PHENOS=Methylmalonic aciduria and homocystinuria,cblC type,277400,Autosomal recessive];	297522 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluJr (SINE/Alu)	rs882803		0.6553	6779,.		-3.5650			0.00,0.05	1.59						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21)
chr1	45976263	45976263	-	T	wt	het	wt		QUAL=3891;DP=313,316,259;AF=0.01,0.47,0.00;MQM=60	MMACHC	3'UTR	MMACHC:ENST00000401061:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1376_*1377insT::		609831 [GENE=MMACHC PHENOS=Methylmalonic aciduria and homocystinuria,cblC type,277400,Autosomal recessive];	297525 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs5773883	0.7438	0.6549	6752,.						2.23						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21)
chr1	45976587	45976587	A	G	wt	het	wt		QUAL=2462;DP=264,171,153;AF=0.00,0.56,0.00;MQM=60	MMACHC	3'UTR	MMACHC:ENST00000401061:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1700A>G::		609831 [GENE=MMACHC PHENOS=Methylmalonic aciduria and homocystinuria,cblC type,277400,Autosomal recessive];	297529 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs1044717	0.8255	0.7252	8336,.		-0.7830			0.00,0.14	3.99						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21)
chr1	46164390	46164399	TTTTTTTTTT	-	hom	hom	n/a		QUAL=986;DP=29,5,1;AF=1.00,1.00,1.00;MQM=59	IPP	3'UTR	IPP:ENST00000396478:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1239_*1248del::					AluJb (SINE/Alu)	rs199546340		0.3325	1113,.		0.6660				1.22						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	46164846	46164846	A	T	hom	hom	het		QUAL=21003;DP=305,299,179;AF=0.99,1.00,0.47;MQM=60	IPP	3'UTR	IPP:ENST00000396478:3_prime_UTR_variant:MODIFIER:exon9/9:c.*792T>A::						rs10749856	0.3249	0.2851	1307,.		1.4050			0.25,0.25	8.55						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	46165875	46165875	-	A	hom	hom	het	off-target	QUAL=9583;DP=140,200,188;AF=0.86,0.89,0.40;MQM=59	IPP	intron	IPP:ENST00000396478:intron_variant:MODIFIER:exon8/8:c.1531-14dup::						rs550999501		0.3258	1150,.	0.2497,0.3549,0.3603,0.3157,0.3748					15.07						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	46195375	46195375	T	C	hom	hom	het		QUAL=10558;DP=230,65,60;AF=1.00,0.97,0.57;MQM=60	IPP	missense	IPP:ENST00000396478:missense_variant:MODERATE:exon4/9:c.791A>G:p.Lys264Arg:	regulatory_region_variant:enhancer					rs28375469	0.3149	0.3037	1259,.	0.2374,0.3238,0.3392,0.2946,0.3608	7.6250	T(0.22)	B(0.00)	0.98,0.99	22.20	0.19					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	46206540	46206540	A	G	hom	hom	het	off-target	QUAL=9700;DP=268,37,25;AF=1.00,1.00,0.68;MQM=60	IPP	intron	IPP:ENST00000396478:intron_variant:MODIFIER:exon3/8:c.724+33T>C::						rs28507722	0.3149	0.2999	1256,.	0.2384,0.3223,0.3345,0.2944,0.3666	2.9420			0.24,0.19	7.39						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	46655158	46655158	T	C	hom	hom	hom		QUAL=12725;DP=140,129,141;AF=0.99,1.00,1.00;MQM=60	POMGNT1	missense,missense&splice_region,3'UTR	POMGNT1:ENST00000371984:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000371986:missense_variant&splice_region_variant:MODERATE:exon21/23:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000371992:missense_variant&splice_region_variant:MODERATE:exon21/23:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000396420:3_prime_UTR_variant:MODIFIER:exon18/19:c.*1536A>G::,POMGNT1:ENST00000535522:missense_variant:MODERATE:exon20/22:c.1801A>G:p.Met601Val:		606822 [GENE=POMGNT1 PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,3,253280,Autosomal recessive/Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,3,613151,Autosomal recessive/Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,3,613157,Autosomal recessive/Retinitis pigmentosa 76,617123,Autosomal recessive];	167524 [benign DISEASE=not specified];			rs6659553	0.9425	0.9868	14228,.	0.8186,0.9914,1.0000,0.9996,0.9997	5.7560		B(0.00),B(0.00),B(0.00), ,B(0.00)	0.18,0.92	22.90	0.33	2.63>0.43				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46659104	46659104	T	C	hom	het	hom	off-target	QUAL=40584;DP=345,796,624;AF=1.00,0.49,1.00;MQM=60	POMGNT1	intron,3'UTR	POMGNT1:ENST00000371984:intron_variant:MODIFIER:exon11/21:c.1027-44A>G::,POMGNT1:ENST00000371986:intron_variant:MODIFIER:exon11/22:c.1027-44A>G::,POMGNT1:ENST00000371992:intron_variant:MODIFIER:exon11/22:c.1027-44A>G::,POMGNT1:ENST00000396420:3_prime_UTR_variant:MODIFIER:exon9/19:c.*652A>G::,POMGNT1:ENST00000535522:intron_variant:MODIFIER:exon10/21:c.961-44A>G::		606822 [GENE=POMGNT1 PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,3,253280,Autosomal recessive/Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,3,613151,Autosomal recessive/Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,3,613157,Autosomal recessive/Retinitis pigmentosa 76,617123,Autosomal recessive];	260869 [benign DISEASE=not specified];			rs7527668	0.3670	0.3895	2479,.	0.4473,0.3957,0.1454,0.3563,0.4455	-1.4020			0.01,0.14	6.87						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46659363	46659363	T	C	hom	het	hom	off-target	QUAL=23613;DP=296,329,318;AF=0.99,0.55,1.00;MQM=59	POMGNT1	intron,3'UTR	POMGNT1:ENST00000371984:intron_variant:MODIFIER:exon10/21:c.951-52A>G::,POMGNT1:ENST00000371986:intron_variant:MODIFIER:exon10/22:c.951-52A>G::,POMGNT1:ENST00000371992:intron_variant:MODIFIER:exon10/22:c.951-52A>G::,POMGNT1:ENST00000396420:3_prime_UTR_variant:MODIFIER:exon9/19:c.*393A>G::,POMGNT1:ENST00000535522:intron_variant:MODIFIER:exon9/21:c.885-52A>G::		606822 [GENE=POMGNT1 PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,3,253280,Autosomal recessive/Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,3,613151,Autosomal recessive/Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,3,613157,Autosomal recessive/Retinitis pigmentosa 76,617123,Autosomal recessive];				rs7527935	0.3335	0.3605	2118,.	0.3463,0.3885,0.1456,0.3530,0.4452	-0.0920			0.07,0.18	7.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46660295	46660295	T	C	hom	het	hom		QUAL=17425;DP=255,303,198;AF=1.00,0.45,0.99;MQM=60	POMGNT1	synonymous,missense	POMGNT1:ENST00000371984:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:ENST00000371986:synonymous_variant:LOW:exon8/23:c.681A>G:p.Lys227=:,POMGNT1:ENST00000371992:synonymous_variant:LOW:exon8/23:c.681A>G:p.Lys227=:,POMGNT1:ENST00000396420:missense_variant:MODERATE:exon7/19:c.563A>G:p.Asn188Ser:,POMGNT1:ENST00000535522:synonymous_variant:LOW:exon7/22:c.615A>G:p.Lys205=:		606822 [GENE=POMGNT1 PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies),type A,3,253280,Autosomal recessive/Muscular dystrophy-dystroglycanopathy (congenital with mental retardation),type B,3,613151,Autosomal recessive/Muscular dystrophy-dystroglycanopathy (limb-girdle),type C,3,613157,Autosomal recessive/Retinitis pigmentosa 76,617123,Autosomal recessive];	95761 [benign/likely benign DISEASE=not specified,Congenital Muscular Dystrophy, alpha-dystroglycan related,Limb-Girdle Muscular Dystrophy, Recessive,not provided];			rs2292487	0.3335	0.3607	2127,.	0.3470,0.3886,0.1448,0.3532,0.4458	0.5750		 , , ,B(0.06), 	0.24,0.90	12.91	0.05					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	47716041	47716042	AA	-	het	wt	het		QUAL=5043;DP=237,164,162;AF=0.52,0.00,0.51;MQM=55	STIL	3'UTR	STIL:ENST00000337817:3_prime_UTR_variant:MODIFIER:exon17/17:c.*766_*767del::,STIL:ENST00000360380:3_prime_UTR_variant:MODIFIER:exon18/18:c.*766_*767del::,STIL:ENST00000371877:3_prime_UTR_variant:MODIFIER:exon17/17:c.*766_*767del::		181590 [GENE=STIL PHENOS=Microcephaly 7,primary,autosomal recessive,612703,Autosomal recessive];	297544 [benign DISEASE=Primary Microcephaly, Recessive];			rs75930208	0.3926	0.4371	3477,.		1.6250				5.93						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47717189	47717189	A	G	het	wt	het		QUAL=8416;DP=442,305,231;AF=0.50,0.01,0.40;MQM=60	STIL	synonymous	STIL:ENST00000243182:synonymous_variant:LOW:exon17/17:c.3483T>C:p.Pro1161=:,STIL:ENST00000337817:synonymous_variant:LOW:exon17/17:c.3483T>C:p.Pro1161=:,STIL:ENST00000360380:synonymous_variant:LOW:exon18/18:c.3483T>C:p.Pro1161=:,STIL:ENST00000371877:synonymous_variant:LOW:exon17/17:c.3486T>C:p.Pro1162=:,STIL:ENST00000396221:synonymous_variant:LOW:exon17/17:c.3432T>C:p.Pro1144=:		181590 [GENE=STIL PHENOS=Microcephaly 7,primary,autosomal recessive,612703,Autosomal recessive];	94095 [benign DISEASE=Primary autosomal recessive microcephaly 7,not specified,Primary Microcephaly, Recessive,not provided];			rs2758735	0.3934	0.5020	3526,.	0.1611,0.4426,0.4497,0.5248,0.5374	0.0230			0.08,0.22	2.65						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47726087	47726087	T	C	het	het	het		QUAL=6456;DP=211,176,117;AF=0.51,0.47,0.47;MQM=60	STIL	missense	STIL:ENST00000243182:missense_variant:MODERATE:exon16/17:c.2951A>G:p.His984Arg:,STIL:ENST00000337817:missense_variant:MODERATE:exon16/17:c.2951A>G:p.His984Arg:,STIL:ENST00000360380:missense_variant:MODERATE:exon17/18:c.2951A>G:p.His984Arg:,STIL:ENST00000371877:missense_variant:MODERATE:exon16/17:c.2954A>G:p.His985Arg:,STIL:ENST00000396221:missense_variant:MODERATE:exon16/17:c.2900A>G:p.His967Arg:		181590 [GENE=STIL PHENOS=Microcephaly 7,primary,autosomal recessive,612703,Autosomal recessive];	94094 [benign/likely benign DISEASE=Primary autosomal recessive microcephaly 7,not specified,Primary Microcephaly, Recessive,not provided];			rs13376679	0.1783	0.2478	1070,.	0.2040,0.1450,0.0230,0.3086,0.2306	0.0410	T(0.53),T(0.53),T(0.53),T(0.53),T(0.58)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.09,0.25	3.70	0.03					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47735280	47735280	T	C	het	n/a	n/a	off-target	QUAL=66;DP=5,0,0;AF=0.60,,;MQM=60	STIL	intron	STIL:ENST00000243182:intron_variant:MODIFIER:exon14/16:c.2615+27A>G::,STIL:ENST00000337817:intron_variant:MODIFIER:exon14/16:c.2615+27A>G::,STIL:ENST00000360380:intron_variant:MODIFIER:exon15/17:c.2615+27A>G::,STIL:ENST00000371877:intron_variant:MODIFIER:exon14/16:c.2615+27A>G::,STIL:ENST00000396221:intron_variant:MODIFIER:exon14/16:c.2615+27A>G::		181590 [GENE=STIL PHENOS=Microcephaly 7,primary,autosomal recessive,612703,Autosomal recessive];	160057 [likely benign DISEASE=not specified];			rs2742104	0.3944	0.5026	3520,.	0.1611,0.4436,0.4519,0.5254,0.5374	-0.1350			0.02,0.11	0.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47767914	47767914	G	A	het	hom	het		QUAL=13749;DP=245,258,185;AF=0.51,0.99,0.54;MQM=60	STIL	missense	STIL:ENST00000243182:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:PF15253,STIL:ENST00000337817:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:PF15253,STIL:ENST00000360380:missense_variant:MODERATE:exon5/18:c.257C>T:p.Ala86Val:PF15253,STIL:ENST00000371877:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:PF15253,STIL:ENST00000396221:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:PF15253		181590 [GENE=STIL PHENOS=Microcephaly 7,primary,autosomal recessive,612703,Autosomal recessive];	21354 [benign DISEASE=Primary autosomal recessive microcephaly 7,not specified,Primary Microcephaly, Recessive,not provided];			rs3125630		0.5621	5451,.	0.8412,0.5552,0.5487,0.4763,0.4630	5.1810	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.02,0.93	15.92	0.17					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	51066088	51066088	T	C	het	wt	het		QUAL=3510;DP=166,172,136;AF=0.43,0.00,0.48;MQM=60	FAF1	intron	FAF1:ENST00000371778:intron_variant:MODIFIER:exon9/19:c.745-4200A>G::,FAF1:ENST00000396153:intron_variant:MODIFIER:exon8/18:c.745-4200A>G::,FAF1:ENST00000545823:intron_variant:MODIFIER:exon1/11:c.19-4200A>G::					Charlie1a (DNA/hAT-Charlie)	rs6679854	0.1695	0.2093	738,.		0.3230			0.01,0.11	5.80						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FAF1 (inh=n/a oe_syn=0.86 oe_mis=0.68 oe_lof=0.12)
chr1	53662823	53662823	C	A	het	het	wt	off-target	QUAL=1516;DP=12,106,61;AF=0.42,0.60,0.00;MQM=60	CPT2	intron	CPT2:ENST00000371486:intron_variant:MODIFIER:exon1/4:c.152+56C>A::	regulatory_region_variant:promoter	600650 [GENE=CPT2 PHENOS=CPT II deficiency,infantile,600649,Autosomal recessive/CPT II deficiency,lethal neonatal,608836,Autosomal recessive/CPT II deficiency,myopathic,stress-induced,255110,Autosomal recessive,Autosomal dominant/Encephalopathy,acute,infection-induced,4,susceptibility to,614212,Autosomal recessive,Autosomal dominant];				rs72673121	0.0889	0.1372	382,.		0.0470			0.06,0.41	7.45						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78)
chr1	53676448	53676448	G	A	het	hom	wt		QUAL=11049;DP=284,230,215;AF=0.52,1.00,0.00;MQM=60	CPT2,RP5-1024G6.2	missense,intron&non_coding_transcript	CPT2:ENST00000371486:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:PF00755,RP5-1024G6.2:ENST00000452466:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.436-232C>T::		600650 [GENE=CPT2 PHENOS=CPT II deficiency,infantile,600649,Autosomal recessive/CPT II deficiency,lethal neonatal,608836,Autosomal recessive/CPT II deficiency,myopathic,stress-induced,255110,Autosomal recessive,Autosomal dominant/Encephalopathy,acute,infection-induced,4,susceptibility to,614212,Autosomal recessive,Autosomal dominant];	92429 [benign DISEASE=Carnitine palmitoyltransferase II deficiency,not specified,not provided]; 30118 [risk factor DISEASE=Encephalopathy, acute, infection-induced, 4, susceptibility to];	CM139511 [CLASS=DP MUT=ALT PHEN="Infuenza infection-associated encephalopathy" GENE=CPT2];		rs1799821	0.4131	0.4877	3742,.	0.2816,0.4382,0.7280,0.5441,0.2629	-0.0530	T(1.00), 	B(0.00), 	0.11,0.33	6.33	0.23					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), RP5-1024G6.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	53679229	53679229	A	G	het	het	wt		QUAL=6114;DP=265,238,177;AF=0.48,0.46,0.00;MQM=60	CPT2,RP5-1024G6.2	missense,non_coding_transcript_exon	CPT2:ENST00000371486:missense_variant:MODERATE:exon5/5:c.1939A>G:p.Met647Val:PF00755,RP5-1024G6.2:ENST00000452466:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.219T>C::		600650 [GENE=CPT2 PHENOS=CPT II deficiency,infantile,600649,Autosomal recessive/CPT II deficiency,lethal neonatal,608836,Autosomal recessive/CPT II deficiency,myopathic,stress-induced,255110,Autosomal recessive,Autosomal dominant/Encephalopathy,acute,infection-induced,4,susceptibility to,614212,Autosomal recessive,Autosomal dominant];	92433 [benign/likely benign DISEASE=Carnitine palmitoyltransferase II deficiency,Carnitine palmitoyltransferase II deficiency, infantile,Carnitine palmitoyltransferase II deficiency, lethal neonatal,not specified];	CM1720321 [CLASS=DM? MUT=ALT PHEN="Carnitine palmitoyltransferase 2 deficiency" GENE=CPT2];		rs1799822	0.1004	0.1644	409,.	0.0460,0.1283,0.0839,0.2198,0.1010	7.4480	D(0.01), 	B(0.01), 	0.99,0.99	23.70	0.29					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), RP5-1024G6.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	53679878	53679878	T	C	wt	het	wt		QUAL=693;DP=104,47,48;AF=0.00,0.60,0.00;MQM=60	CZIB	3'UTR	CZIB:ENST00000294360:3_prime_UTR_variant:MODIFIER:exon8/8:c.*453A>G::		600650 [GENE=CPT2 PHENOS=CPT II deficiency,infantile,600649,Autosomal recessive/CPT II deficiency,lethal neonatal,608836,Autosomal recessive/CPT II deficiency,myopathic,stress-induced,255110,Autosomal recessive,Autosomal dominant/Encephalopathy,acute,infection-induced,4,susceptibility to,614212,Autosomal recessive,Autosomal dominant];	368876 [benign DISEASE=Carnitine palmitoyltransferase II deficiency];			rs1056438	0.2282	0.2730	1433,.		-0.2740			0.00,0.11	1.88						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	55315351	55315351	T	C	hom	hom	hom		QUAL=17057;DP=245,156,129;AF=1.00,1.00,1.00;MQM=59	DHCR24	3'UTR	DHCR24:ENST00000371269:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2555A>G::	regulatory_region_variant:promoter_flanking_region	606418 [GENE=DHCR24 PHENOS=Desmosterolosis,602398,Autosomal recessive];	297612 [benign DISEASE=Desmosterolosis];			rs657688	0.9998	0.9994	15674,.		-0.6960			0.01,0.12	4.38						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	55315941	55315941	G	T	het	het	wt		QUAL=10531;DP=445,385,318;AF=0.47,0.50,0.00;MQM=60	DHCR24	3'UTR	DHCR24:ENST00000371269:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1965C>A::	regulatory_region_variant:promoter_flanking_region	606418 [GENE=DHCR24 PHENOS=Desmosterolosis,602398,Autosomal recessive];	297621 [likely benign DISEASE=Desmosterolosis];			rs11555500	0.0102	0.0239	15,.		0.8540			0.17,0.20	3.79						0	12						DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	55316082	55316082	A	C	hom	hom	hom		QUAL=25091;DP=317,256,190;AF=1.00,1.00,1.00;MQM=60	DHCR24	3'UTR	DHCR24:ENST00000371269:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1824T>G::	regulatory_region_variant:promoter_flanking_region	606418 [GENE=DHCR24 PHENOS=Desmosterolosis,602398,Autosomal recessive];	297623 [benign DISEASE=Desmosterolosis];			rs654561		0.9906	15413,.		-0.2950			0.03,0.14	1.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	55319902	55319902	A	G	hom	hom	hom		QUAL=600;DP=7,9,3;AF=1.00,1.00,1.00;MQM=60	DHCR24	synonymous	DHCR24:ENST00000371269:synonymous_variant:LOW:exon7/9:c.1026T>C:p.Ile342=:,DHCR24:ENST00000535035:synonymous_variant:LOW:exon7/9:c.903T>C:p.Ile301=:,DHCR24:ENST00000537443:synonymous_variant:LOW:exon4/6:c.378T>C:p.Ile126=:		606418 [GENE=DHCR24 PHENOS=Desmosterolosis,602398,Autosomal recessive];	297654 [benign DISEASE=Desmosterolosis];			rs718265	0.6276	0.6725	7164,.	0.6163,0.5374,0.3983,0.6914,0.8057	1.6080			0.28,0.87	11.43						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	55464743	55464743	T	C	hom	het	hom		QUAL=35498;DP=340,647,531;AF=0.99,0.49,1.00;MQM=60	BSND	5'UTR	BSND:ENST00000371265:5_prime_UTR_variant:MODIFIER:exon1/4:c.-117T>C::	regulatory_region_variant:TF_binding_site	606412 [GENE=BSND PHENOS=Bartter syndrome,type 4a,602522,Autosomal recessive/Sensorineural deafness with mild renal dysfunction,602522,Autosomal recessive];	297673 [benign DISEASE=Bartter syndrome];			rs2500340	0.5941	0.6621	7170,.		-0.9270			0.00,0.09	1.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	55464790	55464790	C	G	hom	het	hom		QUAL=37623;DP=335,756,570;AF=0.99,0.49,1.00;MQM=60	BSND	5'UTR	BSND:ENST00000371265:5_prime_UTR_variant:MODIFIER:exon1/4:c.-70C>G::		606412 [GENE=BSND PHENOS=Bartter syndrome,type 4a,602522,Autosomal recessive/Sensorineural deafness with mild renal dysfunction,602522,Autosomal recessive];	297674 [benign DISEASE=Bartter syndrome];			rs2500341		0.6627	7169,.		-0.5640			0.00,0.09	2.87						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	55474325	55474325	A	C	het	hom	wt		QUAL=18368;DP=293,451,321;AF=0.56,1.00,0.01;MQM=59	BSND	3'UTR	BSND:ENST00000371265:3_prime_UTR_variant:MODIFIER:exon4/4:c.*24A>C::		606412 [GENE=BSND PHENOS=Bartter syndrome,type 4a,602522,Autosomal recessive/Sensorineural deafness with mild renal dysfunction,602522,Autosomal recessive];	297681 [benign DISEASE=Bartter syndrome];			rs6682884	0.3624	0.4330	3004,.	0.4963,0.2002,0.3039,0.4267,0.2805	0.5630			0.06,0.17	2.83						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	55474476	55474476	C	G	het	hom	wt	off-target	QUAL=5167;DP=167,124,81;AF=0.43,1.00,0.00;MQM=60	BSND	3'UTR	BSND:ENST00000371265:3_prime_UTR_variant:MODIFIER:exon4/4:c.*175C>G::		606412 [GENE=BSND PHENOS=Bartter syndrome,type 4a,602522,Autosomal recessive/Sensorineural deafness with mild renal dysfunction,602522,Autosomal recessive];	368877 [benign DISEASE=Bartter syndrome];			rs4339899	0.4299	0.4664	3545,.		-1.0850			0.02,0.09	0.15						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	57340727	57340727	C	A	het	wt	hom		QUAL=5777;DP=134,210,141;AF=0.43,0.00,0.99;MQM=60	C8A	missense	C8A:ENST00000361249:missense_variant:MODERATE:exon3/11:c.277C>A:p.Gln93Lys:		120950 [GENE=C8A PHENOS=C8 deficiency,type I,613790,Autosomal recessive];	17039 [benign DISEASE=COMPLEMENT COMPONENT 8, ALPHA SUBUNIT, A/B POLYMORPHISM,not specified];			rs652785	0.3437	0.3653	1749,.	0.2062,0.2106,0.4662,0.3818,0.4981	0.1090	T(0.67)	B(0.01)	0.05,0.25	9.08	0.10					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	57383358	57383358	C	T	wt	het	wt		QUAL=6229;DP=364,465,376;AF=0.00,0.53,0.00;MQM=60	C8A	missense	C8A:ENST00000361249:missense_variant:MODERATE:exon11/11:c.1724C>T:p.Pro575Leu:PF00090	regulatory_region_variant:enhancer	120950 [GENE=C8A PHENOS=C8 deficiency,type I,613790,Autosomal recessive];				rs17300936	0.0613	0.0932	137,.	0.0305,0.0374,0.0763,0.1263,0.0758	0.7210	T(0.48)	B(0.00)	0.05,0.22	9.58	0.02					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	57395020	57395020	A	G	het	wt	het		QUAL=14105;DP=534,781,529;AF=0.52,0.00,0.49;MQM=60	C8B	3'UTR	C8B:ENST00000371237:3_prime_UTR_variant:MODIFIER:exon12/12:c.*57T>C::,C8B:ENST00000543257:3_prime_UTR_variant:MODIFIER:exon13/13:c.*57T>C::		120960 [GENE=C8B PHENOS=C8 deficiency,type II,613789,Autosomal recessive];				rs2795	0.3672	0.3172	1662,.		0.0350			0.01,0.16	5.58						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	57395251	57395251	T	C	hom	hom	hom	off-target	QUAL=25362;DP=271,294,249;AF=1.00,1.00,1.00;MQM=60	C8B	intron	C8B:ENST00000371237:intron_variant:MODIFIER:exon11/11:c.1622-20A>G::,C8B:ENST00000535057:intron_variant:MODIFIER:exon12/12:c.1436-20A>G::,C8B:ENST00000543257:intron_variant:MODIFIER:exon12/12:c.1466-20A>G::		120960 [GENE=C8B PHENOS=C8 deficiency,type II,613789,Autosomal recessive];				rs605648		0.8858	11359,.	0.7906,0.9243,0.9403,0.8559,0.9700	-1.5990			0.01,0.13	1.94		8.84>8.35				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	57409329	57409329	A	G	wt	wt	het	off-target	QUAL=2747;DP=186,229,187;AF=0.00,0.00,0.58;MQM=60	C8B	intron	C8B:ENST00000371237:intron_variant:MODIFIER:exon8/11:c.1234+40T>C::,C8B:ENST00000535057:intron_variant:MODIFIER:exon9/12:c.1048+40T>C::,C8B:ENST00000543257:intron_variant:MODIFIER:exon9/12:c.1078+40T>C::		120960 [GENE=C8B PHENOS=C8 deficiency,type II,613789,Autosomal recessive];				rs72670361	0.0168	0.0306	19,.	0.0074,0.0201,0.0001,0.0475,0.0065	0.1490			0.00,0.11	1.03						16	548						C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	57422484	57422484	C	T	hom	hom	hom		QUAL=26256;DP=294,267,249;AF=1.00,1.00,1.00;MQM=60	C8B	missense	C8B:ENST00000371237:missense_variant:MODERATE:exon3/12:c.349G>A:p.Gly117Arg:,C8B:ENST00000535057:missense_variant:MODERATE:exon4/13:c.163G>A:p.Gly55Arg:,C8B:ENST00000543257:missense_variant:MODERATE:exon4/13:c.193G>A:p.Gly65Arg:		120960 [GENE=C8B PHENOS=C8 deficiency,type II,613789,Autosomal recessive];				rs1013579	0.9864	0.9777	15018,.	0.9943,0.9755,0.9999,0.9684,0.9896	0.5340	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	0.10,0.93	15.11	0.04					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	63881552	63881552	C	T	het	hom	het		QUAL=7279;DP=245,87,64;AF=0.56,1.00,0.44;MQM=60	ALG6	missense	ALG6:ENST00000263440:missense_variant:MODERATE:exon10/14:c.917C>T:p.Ser306Phe:PF03155,ALG6:ENST00000371108:missense_variant:MODERATE:exon11/15:c.911C>T:p.Ser304Phe:PF03155		604566 [GENE=ALG6 PHENOS=Congenital disorder of glycosylation,type Ic,603147,Autosomal recessive];	95531 [benign/likely benign DISEASE=Congenital disorder of glycosylation,not specified];			rs4630153	0.8305	0.7535	8792,.	0.8699,0.8233,0.8607,0.6835,0.8564	0.9670	T(0.32),T(0.32)	B(0.00),B(0.00)	0.01,0.25	15.85	0.19					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63903452	63903452	T	C	het	hom	het		QUAL=2121;DP=96,21,14;AF=0.53,1.00,0.57;MQM=60	ALG6	3'UTR	ALG6:ENST00000371108:3_prime_UTR_variant:MODIFIER:exon15/15:c.*761T>C::		604566 [GENE=ALG6 PHENOS=Congenital disorder of glycosylation,type Ic,603147,Autosomal recessive];	297858 [benign DISEASE=Congenital disorder of glycosylation];			rs3009572	0.6847	0.5866	5763,.		-0.2370			0.02,0.15	4.39						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	67465791	67465791	G	A	het	wt	wt		QUAL=58;DP=111,44,25;AF=0.23,0.00,0.04;MQM=59	SLC35D1	3'UTR	SLC35D1:ENST00000235345:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4232C>T::	regulatory_region_variant:promoter_flanking_region	610804 [GENE=SLC35D1 PHENOS=Schneckenbecken dysplasia,269250,Autosomal recessive];			AluJr (SINE/Alu)	rs901342235		0.0043	0,.		-0.2840			0.00,0.05	0.42						3	12						SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67465969	67465969	C	T	hom	wt	hom		QUAL=113;DP=18,4,5;AF=0.28,0.00,0.00;MQM=60	SLC35D1	3'UTR	SLC35D1:ENST00000235345:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4054G>A::	regulatory_region_variant:promoter_flanking_region	610804 [GENE=SLC35D1 PHENOS=Schneckenbecken dysplasia,269250,Autosomal recessive];			AluJr (SINE/Alu)	rs954300836					-3.5290			0.00,0.01	0.01						0	9						SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67465988	67465988	A	T	hom	wt	hom		QUAL=113;DP=18,4,5;AF=0.28,0.00,0.00;MQM=60	SLC35D1	3'UTR	SLC35D1:ENST00000235345:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4035T>A::	regulatory_region_variant:promoter_flanking_region	610804 [GENE=SLC35D1 PHENOS=Schneckenbecken dysplasia,269250,Autosomal recessive];				rs7540819		0.6285	4314,.		-0.6180			0.00,0.09	1.11						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67512903	67512903	G	T	hom	hom	hom	off-target	QUAL=12448;DP=171,112,106;AF=1.00,1.00,1.00;MQM=60	SLC35D1	intron	SLC35D1:ENST00000235345:intron_variant:MODIFIER:exon7/11:c.636+45C>A::,SLC35D1:ENST00000506472:intron_variant:MODIFIER:exon6/10:c.399+45C>A::		610804 [GENE=SLC35D1 PHENOS=Schneckenbecken dysplasia,269250,Autosomal recessive];				rs1024229	0.7095	0.6800	7324,.	0.7697,0.6619,0.6296,0.6613,0.7501	-1.0460			0.01,0.12	0.52						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67512920	67512920	A	C	hom	hom	hom	off-target	QUAL=13958;DP=180,139,121;AF=1.00,1.00,1.00;MQM=60	SLC35D1	intron	SLC35D1:ENST00000235345:intron_variant:MODIFIER:exon7/11:c.636+28T>G::,SLC35D1:ENST00000506472:intron_variant:MODIFIER:exon6/10:c.399+28T>G::		610804 [GENE=SLC35D1 PHENOS=Schneckenbecken dysplasia,269250,Autosomal recessive];				rs1024230		0.6799	7325,.	0.7700,0.6625,0.6304,0.6618,0.7505	-0.3190			0.03,0.20	5.89						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67520060	67520061	CA	-	het	hom	het		QUAL=473;DP=22,12,8;AF=0.41,1.00,0.50;MQM=60	SLC35D1	upstream_gene	SLC35D1:ENST00000235345:upstream_gene_variant:MODIFIER::::,SLC35D1:ENST00000506472:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site					rs3840439	0.6562	0.6043	5748,.		0.3240				8.66			gain/donor/67520060-67520061/Medium/3.822382			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67520083	67520083	C	T	het	wt	het		QUAL=195;DP=11,7,6;AF=0.82,0.00,0.50;MQM=60	SLC35D1	upstream_gene	SLC35D1:ENST00000235345:upstream_gene_variant:MODIFIER::::,SLC35D1:ENST00000506472:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site					rs3806321	0.1567	0.1575	458,.		-0.6850			0.03,0.68	5.26						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67520140	67520140	T	G	hom	hom	n/a	off-target	QUAL=244;DP=4,3,2;AF=1.00,1.00,1.00;MQM=60	SLC35D1	upstream_gene	SLC35D1:ENST00000235345:upstream_gene_variant:MODIFIER::::,SLC35D1:ENST00000506472:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant					rs2025087	0.8001	0.7543	8937,.		-1.1290			0.00,0.60	6.63						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	76190216	76190216	G	A	hom	het	het		QUAL=2073;DP=15,99,70;AF=0.93,0.43,0.50;MQM=59	ACADM	5'UTR	ACADM:ENST00000370841:5_prime_UTR_variant:MODIFIER:exon1/12:c.-257G>A::	regulatory_region_variant:promoter	607008 [GENE=ACADM PHENOS=Acyl-CoA dehydrogenase,medium chain,deficiency of,201450,Autosomal recessive];	298063 [likely benign DISEASE=Medium-chain acyl-coenzyme A dehydrogenase deficiency];			rs17848068	0.2043	0.2666	1167,.		-0.4080			0.03,0.12	8.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	76194230	76194230	T	-	hom	hom	hom	off-target	QUAL=16008;DP=169,191,151;AF=1.00,1.00,1.00;MQM=60	ACADM	intron	ACADM:ENST00000370834:intron_variant:MODIFIER:exon2/12:c.118+60del::,ACADM:ENST00000370841:intron_variant:MODIFIER:exon2/11:c.118+60del::,ACADM:ENST00000420607:intron_variant:MODIFIER:exon2/11:c.130+60del::,ACADM:ENST00000541113:intron_variant:MODIFIER:exon1/10:c.10+3731del::,ACADM:ENST00000543667:intron_variant:MODIFIER:exon1/8:c.-268+3731del::		607008 [GENE=ACADM PHENOS=Acyl-CoA dehydrogenase,medium chain,deficiency of,201450,Autosomal recessive];	226050 [benign DISEASE=Medium-chain acyl-coenzyme A dehydrogenase deficiency];			rs1242587397		1.0000	15704,.		0.0000				0.45						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	76229326	76229326	T	C	wt	het	het		QUAL=125;DP=31,10,6;AF=0.03,0.70,0.17;MQM=60	ACADM	3'UTR	ACADM:ENST00000370841:3_prime_UTR_variant:MODIFIER:exon12/12:c.*878T>C::		607008 [GENE=ACADM PHENOS=Acyl-CoA dehydrogenase,medium chain,deficiency of,201450,Autosomal recessive];	298081 [benign DISEASE=Medium-chain acyl-coenzyme A dehydrogenase deficiency];			rs1146587	0.6917	0.6526	6704,.		-1.2010			0.00,0.09	7.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	92940411	92940411	C	T	het	het	wt		QUAL=6135;DP=277,165,118;AF=0.55,0.49,0.00;MQM=60	GFI1	3'UTR	GFI1:ENST00000294702:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:ENST00000370332:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:ENST00000427103:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::	regulatory_region_variant:promoter_flanking_region	600871 [GENE=GFI1 PHENOS=Neutropenia,nonimmune chronic idiopathic,of adults,607847,Autosomal dominant/Neutropenia,severe congenital 2,autosomal dominant,613107,Autosomal dominant];	298158 [benign DISEASE=Severe congenital neutropenia];			rs41313373	0.0673	0.0930	192,.		2.6380			0.62,0.93	13.26						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92941357	92941357	A	G	wt	wt	het		QUAL=3081;DP=443,280,226;AF=0.00,0.00,0.52;MQM=60	GFI1	3'UTR	GFI1:ENST00000294702:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:ENST00000370332:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:ENST00000427103:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::		600871 [GENE=GFI1 PHENOS=Neutropenia,nonimmune chronic idiopathic,of adults,607847,Autosomal dominant/Neutropenia,severe congenital 2,autosomal dominant,613107,Autosomal dominant];	298175 [benign DISEASE=Severe congenital neutropenia];			rs4970714	0.8083	0.7128	8099,.		-2.7500			0.04,0.14	0.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92944314	92944314	-	AGAGAG	wt	wt	het		QUAL=5362;DP=60,154,97;AF=0.70,0.41,0.70;MQM=60	GFI1	splice_region&intron	GFI1:ENST00000294702:splice_region_variant&intron_variant:LOW:exon5/6:c.925-10_925-5dup::,GFI1:ENST00000370332:splice_region_variant&intron_variant:LOW:exon5/6:c.925-10_925-5dup::,GFI1:ENST00000427103:splice_region_variant&intron_variant:LOW:exon5/6:c.925-10_925-5dup::		600871 [GENE=GFI1 PHENOS=Neutropenia,nonimmune chronic idiopathic,of adults,607847,Autosomal dominant/Neutropenia,severe congenital 2,autosomal dominant,613107,Autosomal dominant];			(AG)n (Simple_repeat)	rs371078453		0.3561	1613,.						8.10						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92944315	92944316	AG	-	wt	het	wt		QUAL=5362;DP=60,154,97;AF=0.70,0.75,0.71;MQM=60	GFI1	splice_region&intron	GFI1:ENST00000294702:splice_region_variant&intron_variant:LOW:exon5/6:c.925-6_925-5del::,GFI1:ENST00000370332:splice_region_variant&intron_variant:LOW:exon5/6:c.925-6_925-5del::,GFI1:ENST00000427103:splice_region_variant&intron_variant:LOW:exon5/6:c.925-6_925-5del::		600871 [GENE=GFI1 PHENOS=Neutropenia,nonimmune chronic idiopathic,of adults,607847,Autosomal dominant/Neutropenia,severe congenital 2,autosomal dominant,613107,Autosomal dominant];	298182 [likely benign(replaced by megSAP based on classifications:1x1,2x3) DISEASE=Severe congenital neutropenia];		(AG)n (Simple_repeat)	rs768494519		0.1425	301,.		3.1710				12.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92944315	92944320	AGAGAG	-	hom	het	het		QUAL=5362;DP=60,154,97;AF=0.00,0.34,0.26;MQM=60	GFI1	splice_region&intron	GFI1:ENST00000294702:splice_region_variant&intron_variant:LOW:exon5/6:c.925-10_925-5del::,GFI1:ENST00000370332:splice_region_variant&intron_variant:LOW:exon5/6:c.925-10_925-5del::,GFI1:ENST00000427103:splice_region_variant&intron_variant:LOW:exon5/6:c.925-10_925-5del::		600871 [GENE=GFI1 PHENOS=Neutropenia,nonimmune chronic idiopathic,of adults,607847,Autosomal dominant/Neutropenia,severe congenital 2,autosomal dominant,613107,Autosomal dominant];	298185 [benign DISEASE=Severe congenital neutropenia];		(AG)n (Simple_repeat)	rs200902533		0.1257	244,.		3.1710				12.18			gain/acceptor/92944317-92944318/High/18.123070			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92948938	92948938	C	T	het	wt	het		QUAL=3291;DP=92,322,265;AF=0.47,0.00,0.46;MQM=59	GFI1	missense	GFI1:ENST00000294702:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:ENST00000370332:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:ENST00000427103:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:	regulatory_region_variant:promoter	600871 [GENE=GFI1 PHENOS=Neutropenia,nonimmune chronic idiopathic,of adults,607847,Autosomal dominant/Neutropenia,severe congenital 2,autosomal dominant,613107,Autosomal dominant];	259699 [benign DISEASE=Severe congenital neutropenia,Severe congenital neutropenia 2, autosomal dominant,not specified];			rs34631763	0.0194	0.0426	45,.	0.0094,0.0282,0.0000,0.0564,0.0089	4.3850	T(0.53),T(0.53),T(0.53)	B(0.02),B(0.02),B(0.02)	0.90,0.96	21.40	0.06					20	582						GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92951657	92951657	-	A	het	het	het	off-target	QUAL=2394;DP=78,103,63;AF=0.60,0.35,0.49;MQM=60	GFI1	intron	GFI1:ENST00000294702:intron_variant:MODIFIER:exon1/6:c.-100+625dup::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	600871 [GENE=GFI1 PHENOS=Neutropenia,nonimmune chronic idiopathic,of adults,607847,Autosomal dominant/Neutropenia,severe congenital 2,autosomal dominant,613107,Autosomal dominant];				rs112925059		0.1272	180,.						16.51						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	97543752	97543752	G	A	het	het	het		QUAL=15972;DP=469,438,323;AF=0.48,0.48,0.50;MQM=60	DPYD	3'UTR	DPYD:ENST00000370192:3_prime_UTR_variant:MODIFIER:exon23/23:c.*780C>T::		612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];	100064 [likely benign DISEASE=Dihydropyrimidine dehydrogenase deficiency,not provided];			rs291593	0.3850	0.3011	1586,.		-0.6800			0.00,0.09	1.27						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97543764	97543764	C	T	het	het	het		QUAL=15430;DP=401,461,340;AF=0.49,0.47,0.50;MQM=60	DPYD	3'UTR	DPYD:ENST00000370192:3_prime_UTR_variant:MODIFIER:exon23/23:c.*768G>A::		612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];	100065 [benign DISEASE=Dihydropyrimidine dehydrogenase deficiency,not provided];			rs291592	0.5775	0.4485	3485,.		0.1790			0.03,0.16	3.10						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97543959	97543959	C	T	het	wt	het		QUAL=7027;DP=325,285,212;AF=0.53,0.00,0.44;MQM=60	DPYD	3'UTR	DPYD:ENST00000370192:3_prime_UTR_variant:MODIFIER:exon23/23:c.*573G>A::		612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];	100067 [likely benign DISEASE=Dihydropyrimidine dehydrogenase deficiency,not provided];			rs1042482	0.0895	0.0665	73,.		0.1710			0.04,0.17	4.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97547831	97547831	G	A	hom	hom	hom	off-target	QUAL=15063;DP=185,164,126;AF=1.00,1.00,1.00;MQM=60	DPYD	intron	DPYD:ENST00000370192:intron_variant:MODIFIER:exon22/22:c.2907+55C>T::	regulatory_region_variant:open_chromatin_region	612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];				rs290854		1.0000	15699,.		0.2900			0.02,0.17	4.93						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97915624	97915624	A	G	het	het	wt		QUAL=4777;DP=203,187,150;AF=0.45,0.52,0.00;MQM=60	DPYD	synonymous	DPYD:ENST00000370192:synonymous_variant:LOW:exon14/23:c.1896T>C:p.Phe632=:PF01180		612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];	100088 [benign/likely benign DISEASE=Dihydropyrimidine dehydrogenase deficiency,not specified,not provided];			rs17376848	0.0521	0.0510	50,.	0.0218,0.0873,0.1256,0.0411,0.0347	0.2800			0.52,0.94	4.58						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97981242	97981242	T	C	hom	hom	het	off-target	QUAL=8035;DP=188,54,44;AF=1.00,1.00,0.45;MQM=60	DPYD	intron	DPYD:ENST00000370192:intron_variant:MODIFIER:exon13/22:c.1740+40A>G::		612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];	100090 [not provided DISEASE=not provided];			rs2811178	0.6518	0.6357	5852,.	0.6347,0.7027,0.7442,0.5962,0.6264	-0.0290			0.12,0.17	2.38						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	98144726	98144726	T	C	wt	het	wt		QUAL=586;DP=168,55,36;AF=0.01,0.47,0.00;MQM=60	DPYD	missense	DPYD:ENST00000370192:missense_variant:MODERATE:exon8/23:c.775A>G:p.Lys259Glu:		612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];	235464 [benign/likely benign DISEASE=not specified,not provided];	CM033369 [CLASS=DM MUT=ALT PHEN="Dihydropyrimidine dehydrogenase deficiency" GENE=DPYD];		rs45589337	0.0044	0.0062	4,.	0.0015,0.0032,0.0000,0.0082,0.0050	4.4920	D(0.00)	B(0.29)	0.92,0.98	23.20	0.61					1	131		1	[3] Stephan Waldm?ller 18.11.2015 [n/a] comment imported from detected variant: HGMD: DM f?r Dihydropyrimidine dehydrogenase deficiency, Literatur nicht ?berzeugend, VUS3, swal 151118 [1] ahbuchr1 26.09.2016 MAF>1%, homozygote in ExAC			DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	98185527	98185527	A	G	hom	hom	hom		QUAL=15788;DP=206,150,123;AF=1.00,1.00,1.00;MQM=60	DPYD	3'UTR,intron	DPYD:ENST00000306031:3_prime_UTR_variant:MODIFIER:exon6/6:c.*917T>C::,DPYD:ENST00000370192:intron_variant:MODIFIER:exon5/22:c.483+1539T>C::,DPYD:ENST00000423006:intron_variant:MODIFIER:exon4/6:c.372+1539T>C::		612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];				rs2151562		0.9952	15528,.		0.4030			0.00,0.07	1.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	98186077	98186077	T	C	hom	hom	hom		QUAL=20030;DP=281,192,136;AF=1.00,1.00,1.00;MQM=60	DPYD	3'UTR,intron	DPYD:ENST00000306031:3_prime_UTR_variant:MODIFIER:exon6/6:c.*367A>G::,DPYD:ENST00000370192:intron_variant:MODIFIER:exon5/22:c.483+989A>G::,DPYD:ENST00000423006:intron_variant:MODIFIER:exon4/6:c.372+989A>G::		612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];				rs1333718	0.9978	0.9952	15531,.		0.7060			0.01,0.92	16.92						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	98348885	98348885	G	A	hom	het	hom		QUAL=15071;DP=217,215,162;AF=1.00,0.52,1.00;MQM=60	DPYD	missense,intron	DPYD:ENST00000306031:missense_variant:MODERATE:exon2/6:c.85C>T:p.Arg29Cys:,DPYD:ENST00000370192:missense_variant:MODERATE:exon2/23:c.85C>T:p.Arg29Cys:,DPYD:ENST00000423006:intron_variant:MODIFIER:exon1/6:c.39+37555C>T::		612779 [GENE=DPYD PHENOS=Dihydropyrimidine dehydrogenase deficiency,274270,Autosomal recessive/5-fluorouracil toxicity,274270,Autosomal recessive];	100123 [not provided DISEASE=not provided];			rs1801265	0.7398	0.7718	8229,.	0.5869,0.7887,0.9280,0.7774,0.7450	2.2360	T(0.18),T(0.18), 	P(0.66),B(0.01), 	0.52,0.96	23.20	0.31					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	98454469	98454469	G	T	wt	het	wt		QUAL=706;DP=245,74,71;AF=0.00,0.42,0.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region					rs41285694	0.0962	0.1257	332,.		0.4890			0.03,0.27	6.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98455128	98455128	A	-	het	het	het		QUAL=752;DP=78,27,17;AF=0.38,0.22,0.24;MQM=59		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region				AluSp (SINE/Alu)	rs543197080	0.1797	0.0487	26,.		-0.9110				1.89						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98455957	98455957	G	A	wt	het	wt		QUAL=1441;DP=173,145,115;AF=0.00,0.42,0.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					L1PA13 (LINE/L1)	rs61785886	0.0966	0.1259	334,.		-1.2470			0.00,0.04	0.56						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98456643	98456643	G	A	wt	het	wt		QUAL=661;DP=145,76,45;AF=0.00,0.39,0.00;MQM=58		intergenic	::intergenic_variant:MODIFIER::::					AluY (SINE/Alu)	rs61785887	0.0737	0.0918	158,.		-0.3260			0.00,0.04	1.08						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98456731	98456731	C	T	wt	het	wt		QUAL=964;DP=215,114,57;AF=0.00,0.39,0.00;MQM=59		intergenic	::intergenic_variant:MODIFIER::::					AluY (SINE/Alu)	rs61785888	0.0964	0.1264	331,.		0.3940			0.00,0.05	3.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98456907	98456907	C	A	wt	het	wt		QUAL=1314;DP=192,96,87;AF=0.00,0.53,0.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs4573558	0.1060	0.1353	344,.		-1.1730			0.00,0.08	0.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98457303	98457303	C	G	wt	het	wt		QUAL=2096;DP=278,175,105;AF=0.00,0.47,0.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs2893376	0.1492	0.1731	496,.		-1.0480			0.00,0.07	1.37						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98457523	98457523	A	T	wt	het	wt		QUAL=1562;DP=205,125,63;AF=0.00,0.49,0.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs2391873	0.1378	0.1620	428,.		-0.1440			0.07,0.95	16.88						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98460060	98460060	A	C	het	het	wt		QUAL=2971;DP=160,88,63;AF=0.48,0.51,0.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					AluSx (SINE/Alu)						-0.3560			0.01,0.10	4.15						0	2						 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98460106	98460106	G	A	hom	het	hom		QUAL=9106;DP=167,125,85;AF=1.00,0.53,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					AluSx (SINE/Alu)	rs9440288	0.8552	0.8328	10887,.		-1.3490			0.00,0.05	0.27						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98461132	98461132	G	C	hom	het	hom		QUAL=22294;DP=266,366,282;AF=1.00,0.47,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					L2a (LINE/L2)	rs9324380	0.9267	0.9083	12972,.		-4.7750			0.00,0.04	0.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98461257	98461257	-	TTGT	hom	het	hom		QUAL=16392;DP=228,265,206;AF=0.99,0.44,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs10655213	0.8936	0.8635	11706,.						1.25						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98461443	98461443	C	T	het	het	het		QUAL=4940;DP=163,103,96;AF=0.52,0.52,0.47;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs9662365	0.4657	0.4794	3583,.		-0.0300			0.29,0.95	16.12						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98461954	98461954	T	C	hom	het	hom		QUAL=5955;DP=150,33,26;AF=0.99,0.58,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs1938570	0.8936	0.8559	11556,.		-0.4170			0.01,0.11	1.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98462921	98462921	C	A	het	het	wt		QUAL=5235;DP=252,183,155;AF=0.50,0.48,0.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs146033831	0.0176	0.0063	11,.		-0.1570			0.14,0.84	10.23						0	5						 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98465528	98465528	G	A	hom	het	hom		QUAL=22741;DP=309,336,252;AF=1.00,0.50,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:enhancer					rs2154403	0.9034	0.8736	12050,.		0.9340			0.00,0.07	4.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98465840	98465840	G	A	het	wt	het		QUAL=5669;DP=282,308,224;AF=0.48,0.00,0.42;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:enhancer				L2a (LINE/L2)	rs116319667	0.0046	0.0092	3,.		-0.3330			0.00,0.06	1.29						0	29						 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98466786	98466786	T	C	wt	wt	het		QUAL=1949;DP=337,175,144;AF=0.01,0.00,0.51;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs12138817	0.1697	0.2159	881,.		-0.8380			0.01,0.13	3.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98468539	98468540	TA	-	hom	het	hom		QUAL=16027;DP=303,196,140;AF=0.99,0.54,1.00;MQM=59		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:enhancer					rs5776390	0.8920	0.8633	11719,.		0.0920				0.70						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98469687	98469687	A	-	het	het	wt		QUAL=6764;DP=205,309,243;AF=0.50,0.50,0.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site					rs564190891	0.0036	0.0016	3,.		1.9190				12.46						0	3						 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98470051	98470051	-	AT	hom	het	hom		QUAL=23742;DP=514,229,128;AF=1.00,0.48,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region					rs141251091		0.8387	11018,.						0.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98470605	98470605	A	G	hom	het	hom		QUAL=6776;DP=178,25,20;AF=1.00,0.44,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region					rs10747495	0.9022	0.8733	12044,.		0.6230			0.00,0.07	6.14						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98471787	98471787	C	A	wt	wt	het		QUAL=230;DP=278,89,55;AF=0.00,0.00,0.33;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					L1ME4a (LINE/L1)	rs55635742	0.0106	0.0191	9,.		-0.4440			0.03,0.11	0.39						1	36						 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98472208	98472208	A	G	het	het	wt		QUAL=2964;DP=167,97,75;AF=0.45,0.41,0.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					(ATTAC)n (Simple_repeat)	rs78878051	0.0633	0.0172	35,.		0.8530			0.04,0.13	2.14						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98472879	98472879	C	T	hom	het	hom		QUAL=20981;DP=326,254,193;AF=1.00,0.56,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs1938564	0.8137	0.7962	10003,.		-0.3770			0.02,0.14	2.02						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98472958	98472958	T	A	hom	het	hom		QUAL=15848;DP=223,183,170;AF=1.00,0.55,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs1938563	0.9014	0.8724	11985,.		0.7930			0.00,0.06	7.43						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98473716	98473716	T	A	hom	het	hom		QUAL=18861;DP=395,129,116;AF=1.00,0.55,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs1938562	0.9014	0.8724	11980,.		1.0500			0.00,0.06	4.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98474767	98474767	C	T	hom	het	hom		QUAL=15281;DP=289,162,116;AF=1.00,0.49,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs2391902		0.8031	10138,.		0.3170			0.02,0.91	13.40						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98475522	98475522	T	C	hom	het	hom		QUAL=16397;DP=305,172,118;AF=1.00,0.52,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs2154402	0.9255	0.9080	12952,.		0.0780			0.00,0.38	8.58						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98475913	98475913	G	A	hom	het	hom		QUAL=14298;DP=297,125,87;AF=1.00,0.55,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs9324381		0.8381	11005,.		0.6210			0.27,0.19	3.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98476718	98476718	G	A	hom	het	hom		QUAL=26002;DP=417,278,218;AF=1.00,0.60,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs1938561	0.9022	0.8733	12035,.		0.2940			0.00,0.10	3.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98476950	98476950	T	C	hom	het	hom		QUAL=25126;DP=338,328,267;AF=1.00,0.55,1.00;MQM=59		intergenic	::intergenic_variant:MODIFIER::::					L2c (LINE/L2)	rs9440293	0.9024	0.8697	11849,.		-1.1440			0.00,0.08	2.60						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98476958	98476958	C	T	hom	het	hom		QUAL=25418;DP=342,337,268;AF=1.00,0.55,1.00;MQM=59		intergenic	::intergenic_variant:MODIFIER::::					L2c (LINE/L2)	rs9727941	0.8614	0.8351	10865,.		-0.2260			0.01,0.12	4.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98476966	98476966	G	C	hom	het	hom		QUAL=25193;DP=342,340,264;AF=1.00,0.56,1.00;MQM=59		intergenic	::intergenic_variant:MODIFIER::::					L2c (LINE/L2)	rs9724773		0.8350	10859,.		0.3340			0.06,0.15	2.93						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98478159	98478159	-	AC	het	het	hom		QUAL=11084;DP=250,168,115;AF=0.84,0.49,0.93;MQM=59		intergenic	::intergenic_variant:MODIFIER::::					MIRb (SINE/MIR)&(AC)n (Simple_repeat)	rs112555829		0.7584	8397,.						1.95						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98478544	98478544	A	T	hom	het	hom		QUAL=29725;DP=408,452,332;AF=1.00,0.48,1.00;MQM=59		intergenic	::intergenic_variant:MODIFIER::::					L2c (LINE/L2)	rs1938565	0.9024	0.8733	12041,.		0.0650			0.00,0.05	7.94						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98478981	98478981	C	T	hom	het	hom		QUAL=5312;DP=127,28,22;AF=1.00,0.43,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs1938566	0.8247	0.8032	10142,.		-1.0060			0.01,0.09	0.17						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98480128	98480128	T	C	hom	het	hom		QUAL=22015;DP=405,218,193;AF=1.00,0.49,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					MER102b (DNA/hAT-Charlie)	rs1938567	0.8772	0.8531	11333,.		-0.9290			0.00,0.21	8.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98480212	98480212	C	T	het	wt	het		QUAL=7933;DP=427,199,146;AF=0.53,0.01,0.49;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					MER102b (DNA/hAT-Charlie)	rs11165944	0.3331	0.2970	1537,.		-1.1520			0.01,0.14	3.15						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98481750	98481750	C	T	het	wt	het		QUAL=6516;DP=334,298,216;AF=0.45,0.01,0.47;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs6683447	0.3187	0.2735	1392,.		-0.8880			0.03,0.13	1.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98482580	98482580	G	A	hom	het	hom		QUAL=14209;DP=266,171,104;AF=1.00,0.50,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					L1MB1 (LINE/L1)	rs2391903	0.9259	0.9078	12956,.		0.1850			0.00,0.05	3.50						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98482693	98482693	A	G	hom	het	hom		QUAL=16859;DP=242,245,159;AF=1.00,0.54,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					L1MB1 (LINE/L1)	rs1892549	0.8710	0.8475	11287,.		-0.1970			0.01,0.10	3.53						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98482828	98482828	A	G	hom	het	hom		QUAL=15796;DP=301,139,122;AF=1.00,0.44,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					L1MB1 (LINE/L1)	rs1892550	0.8710	0.8475	11298,.		-1.2570			0.05,0.13	0.66						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98482961	98482961	C	T	hom	het	hom		QUAL=14104;DP=278,134,97;AF=1.00,0.45,0.99;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					L1MB1 (LINE/L1)	rs1892551		0.8473	11262,.		0.8730			0.00,0.11	1.90						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98483035	98483035	G	A	hom	het	hom		QUAL=9831;DP=215,75,54;AF=1.00,0.48,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs1892552	0.8710	0.8480	11291,.		-0.1400			0.00,0.12	3.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98483150	98483150	A	G	hom	het	hom		QUAL=6153;DP=147,34,19;AF=1.00,0.62,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs2391904		0.8475	11289,.		-0.2660			0.00,0.07	3.97						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98483230	98483230	T	A	wt	wt	het		QUAL=148;DP=225,54,29;AF=0.00,0.00,0.41;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs116414424	0.0152	0.0252	14,.		-1.0500			0.02,0.16	8.86						1	13						 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98483322	98483322	T	C	hom	het	hom		QUAL=6597;DP=154,49,33;AF=1.00,0.31,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs9324382	0.8692	0.8466	11256,.		0.6070			0.04,0.38	10.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98484152	98484152	T	C	hom	het	hom		QUAL=7912;DP=166,91,53;AF=1.00,0.35,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs1938571		0.7961	10010,.		-0.2760			0.02,0.10	1.26						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98484291	98484291	G	A	hom	het	hom		QUAL=11134;DP=208,108,97;AF=1.00,0.36,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs4447033		0.8476	11290,.		0.0630			0.00,0.05	2.20						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98484474	98484474	T	C	hom	het	hom		QUAL=3395;DP=58,39,40;AF=1.00,0.36,1.00;MQM=57		intergenic	::intergenic_variant:MODIFIER::::					AluSx1 (SINE/Alu)	rs1938572	0.8710	0.8474	11238,.		-2.8460			0.00,0.02	0.31						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98484617	98484617	C	T	hom	het	hom		QUAL=3204;DP=79,27,12;AF=1.00,0.41,1.00;MQM=59		intergenic	::intergenic_variant:MODIFIER::::					AluSx1 (SINE/Alu)	rs1938573		0.8504	11143,.		-0.0880			0.00,0.07	1.17						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98484954	98484954	G	T	hom	het	hom		QUAL=19082;DP=334,222,156;AF=1.00,0.47,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs1938558	0.8708	0.8473	11292,.		1.1760			0.54,0.64	9.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98485102	98485102	G	A	hom	het	hom		QUAL=13923;DP=249,154,126;AF=1.00,0.43,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					MIR (SINE/MIR)	rs1938559	0.8710	0.8474	11292,.		0.7790			0.03,0.15	3.84						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98485192	98485192	C	T	hom	het	hom		QUAL=22242;DP=509,138,106;AF=1.00,0.43,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					MIR (SINE/MIR)	rs1938560	0.8710	0.8475	11294,.		0.0080			0.00,0.05	3.87						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98485573	98485573	C	T	hom	het	hom		QUAL=8876;DP=148,74,88;AF=1.00,0.64,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs9324383	0.8710	0.8480	11294,.		0.5250			0.00,0.12	3.22						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98485698	98485698	-	TT	het	n/a	n/a		QUAL=199;DP=21,2,2;AF=0.43,0.00,1.00;MQM=58		intergenic	::intergenic_variant:MODIFIER::::					AluSx1 (SINE/Alu)	rs10637296		0.0502	111,.						1.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98485698	98485698	-	TTT	het	n/a	n/a		QUAL=199;DP=21,2,2;AF=0.24,0.00,0.00;MQM=58		intergenic	::intergenic_variant:MODIFIER::::					AluSx1 (SINE/Alu)	rs10637296		0.7857	8107,.						0.98						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98485927	98485927	T	C	hom	het	hom		QUAL=7027;DP=106,108,82;AF=1.00,0.44,1.00;MQM=58		intergenic	::intergenic_variant:MODIFIER::::					AluSx1 (SINE/Alu)	rs9725319	0.8710	0.8477	11265,.		-1.8120			0.00,0.03	3.30						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98485991	98485991	C	T	het	het	wt		QUAL=2529;DP=109,159,136;AF=0.38,0.45,0.00;MQM=59		intergenic	::intergenic_variant:MODIFIER::::					AluSx1 (SINE/Alu)	rs74829086	0.0527	0.0136	21,.		-1.7340			0.00,0.09	0.33						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98486162	98486162	T	C	hom	het	hom		QUAL=7539;DP=149,73,66;AF=1.00,0.36,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs4477335		0.8475	11276,.		-0.2590			0.00,0.09	4.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98486242	98486242	-	A	hom	het	hom		QUAL=3760;DP=104,22,18;AF=0.95,0.41,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs61381274		0.8474	11224,.						0.67						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98486370	98486370	G	A	hom	het	hom		QUAL=4962;DP=101,41,32;AF=1.00,0.46,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs4480407	0.8928	0.8647	11763,.		0.8280			0.00,0.05	3.26						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98486694	98486694	A	C	wt	wt	het		QUAL=1902;DP=497,183,160;AF=0.00,0.00,0.50;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs79792869	0.0152	0.0251	14,.		0.1050			0.05,0.17	4.09						1	13						 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98487080	98487080	A	G	wt	wt	het		QUAL=3007;DP=491,218,177;AF=0.00,0.00,0.62;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs77482155	0.0222	0.0364	19,.		2.9440			0.37,0.59	12.83						1	17						 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98487333	98487333	A	G	hom	het	hom		QUAL=20752;DP=273,282,220;AF=1.00,0.57,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs9659624		0.8475	11283,.		0.7480			0.07,0.32	14.36						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98487510	98487510	C	A	hom	het	hom		QUAL=20776;DP=389,203,161;AF=1.00,0.55,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs5005705		0.8465	11249,.		-1.3280			0.02,0.16	0.91						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98487566	98487566	C	T	hom	het	hom		QUAL=13838;DP=234,144,129;AF=1.00,0.53,0.99;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs9324384		0.8476	11285,.		-0.7030			0.01,0.17	3.83						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98487763	98487763	G	A	hom	het	hom		QUAL=18165;DP=308,181,165;AF=1.00,0.50,0.99;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs4634961		0.8478	11291,.		-0.3680			0.01,0.15	2.37						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98487899	98487899	C	A	hom	het	hom		QUAL=19909;DP=273,262,232;AF=1.00,0.52,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs9324385		0.8477	11290,.		-0.0390			0.00,0.11	2.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98487959	98487959	G	A	hom	het	hom		QUAL=26112;DP=376,327,265;AF=1.00,0.51,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs9324386	0.8710	0.8479	11293,.		-0.0420			0.00,0.08	6.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98488030	98488030	G	A	hom	het	hom		QUAL=22549;DP=330,330,214;AF=1.00,0.50,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs9324387	0.8712	0.8474	11286,.		-0.1070			0.04,0.18	4.62						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98488155	98488155	G	A	hom	het	hom		QUAL=17805;DP=284,197,169;AF=1.00,0.46,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs9324388	0.8710	0.8477	11290,.		0.2610			0.04,0.18	2.72						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98488863	98488863	A	G	hom	het	hom		QUAL=16756;DP=319,131,127;AF=1.00,0.64,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs9659996		0.8474	11285,.		1.6450			0.13,0.18	5.88						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98488895	98488895	C	T	hom	het	hom		QUAL=10332;DP=169,92,101;AF=1.00,0.58,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs9658841	0.8710	0.8476	11292,.		-0.3150			0.01,0.12	0.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98489080	98489080	G	A	hom	het	hom		QUAL=7306;DP=173,38,26;AF=1.00,0.61,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs9661157		0.8477	11285,.		-0.5770			0.00,0.07	2.30						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98489277	98489277	-	TACTT	hom	het	hom		QUAL=5940;DP=119,88,54;AF=0.99,0.36,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs142603792	0.8708	0.8460	11156,.						11.36						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98489330	98489330	C	T	hom	het	hom		QUAL=9459;DP=219,81,52;AF=1.00,0.31,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs10747496	0.8710	0.8478	11262,.		0.3090			0.00,0.07	1.52						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98489478	98489478	A	G	hom	het	hom		QUAL=19513;DP=400,163,125;AF=1.00,0.42,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs4584446		0.8474	11276,.		-0.0160			0.01,0.13	4.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98489735	98489735	T	C	hom	het	hom		QUAL=14511;DP=325,130,58;AF=1.00,0.51,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs2391905	0.8710	0.8475	11281,.		0.2230			0.04,0.13	2.80						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98490012	98490013	TT	-	hom	het	hom		QUAL=10011;DP=271,88,75;AF=0.92,0.57,0.93;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					L2a (LINE/L2)	rs55633609	0.8706	0.8382	9529,.		0.4430				0.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98490165	98490165	C	T	hom	het	hom		QUAL=8594;DP=179,72,46;AF=1.00,0.44,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs4950117	0.8940	0.8653	11768,.		0.2440			0.00,0.06	4.35						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98490358	98490358	G	T	hom	het	hom		QUAL=16020;DP=258,169,154;AF=1.00,0.51,0.99;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs4950118		0.8470	11263,.		0.5330			0.65,0.96	16.63						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98490636	98490636	T	C	hom	het	hom		QUAL=18235;DP=372,172,121;AF=0.99,0.48,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs10783082		0.8476	11275,.		0.1180			0.02,0.17	14.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98490770	98490770	-	TTAAGTAT	hom	het	hom		QUAL=14037;DP=234,151,153;AF=0.96,0.56,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs5776392		0.8428	11022,.						1.77						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98491248	98491248	A	C	hom	het	hom		QUAL=18370;DP=338,192,140;AF=1.00,0.45,1.00;MQM=59		intergenic	::intergenic_variant:MODIFIER::::					MIR3 (SINE/MIR)	rs4950119	0.8682	0.8347	10978,.		-0.6670			0.00,0.06	2.32						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98491382	98491382	G	A	hom	het	hom		QUAL=14539;DP=269,175,105;AF=1.00,0.44,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					MIRb (SINE/MIR)	rs4950120	0.8710	0.8476	11262,.		0.1710			0.00,0.04	7.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98491473	98491473	A	C	hom	het	hom		QUAL=17765;DP=354,173,116;AF=1.00,0.50,0.99;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					MIRb (SINE/MIR)	rs4245673	0.8710	0.8472	11279,.		0.9410			0.09,0.16	5.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98491732	98491732	T	C	hom	het	hom		QUAL=18295;DP=252,284,193;AF=1.00,0.49,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs1938568	0.8710	0.8474	11281,.		0.6250			0.47,0.94	11.43						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98492462	98492462	C	T	hom	het	hom		QUAL=22556;DP=420,198,185;AF=1.00,0.46,0.99;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs9440393	0.8710	0.8476	11282,.		-0.7830			0.00,0.06	0.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98492580	98492580	A	G	het	het	het		QUAL=13337;DP=470,283,260;AF=0.49,0.50,0.48;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs9440302	0.4575	0.4750	3497,.		0.5010			0.07,0.20	4.83						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98492854	98492854	T	C	hom	het	hom		QUAL=16861;DP=354,113,95;AF=1.00,0.50,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs9324389	0.8710	0.8477	11274,.		-2.2810			0.03,0.17	5.28						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98492901	98492901	G	A	wt	wt	het		QUAL=1388;DP=320,90,92;AF=0.00,0.00,0.59;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs74700717	0.0106	0.0192	9,.		-1.3510			0.03,0.19	4.69						1	36						 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98493263	98493263	A	G	hom	het	hom		QUAL=13381;DP=216,187,123;AF=1.00,0.45,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs1938569	0.8706	0.8474	11262,.		0.7980			0.11,0.31	6.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98493785	98493785	G	A	hom	het	hom		QUAL=3213;DP=63,14,11;AF=0.98,0.36,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs2022864	0.8712	0.8484	10915,.		-0.8400			0.01,0.10	0.38						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98493789	98493789	A	G	hom	het	hom		QUAL=3213;DP=63,14,11;AF=0.98,0.36,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs2022865	0.8712	0.8479	10917,.		0.3550			0.02,0.26	6.10						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98494185	98494185	G	A	hom	het	hom		QUAL=12902;DP=215,153,104;AF=1.00,0.55,0.99;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs10875124	0.8710	0.8471	11177,.		0.8860			0.00,0.08	5.56						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98494200	98494200	A	C	hom	het	hom		QUAL=12408;DP=218,140,97;AF=1.00,0.53,0.99;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs10875125		0.8470	11180,.		0.2010			0.04,0.19	4.98						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98494388	98494388	-	A	hom	het	hom		QUAL=7372;DP=156,79,48;AF=0.99,0.43,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs11404556	0.8700	0.8475	11240,.						7.14						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98494606	98494606	A	G	hom	het	hom		QUAL=14526;DP=242,151,132;AF=1.00,0.44,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs1198574	0.8712	0.8474	11249,.		0.7390			0.72,0.96	17.54						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98495513	98495513	T	C	hom	het	hom		QUAL=10064;DP=153,129,96;AF=1.00,0.54,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs1198573		0.8475	11228,.		3.3540			0.32,0.20	8.59						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98496512	98496512	T	-	het	wt	het		QUAL=3249;DP=195,125,93;AF=0.47,0.03,0.59;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs377025796		0.0118	7,.		0.8290				0.33						0	25						 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98497176	98497176	A	C	hom	het	hom		QUAL=6032;DP=157,15,15;AF=1.00,0.67,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs1198572		0.8175	10496,.		-0.4370			0.01,0.11	10.02						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98497355	98497355	A	G	het	wt	het		QUAL=776;DP=53,9,13;AF=0.51,0.00,0.62;MQM=58		intergenic	::intergenic_variant:MODIFIER::::						rs188465986	0.0022	0.0078	2,.		0.0570			0.04,0.14	3.44						0	25						 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98497364	98497367	ACAC	-	wt	wt	het		QUAL=30;DP=21,6,9;AF=0.00,0.00,0.44;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					(AC)n (Simple_repeat)	rs1256756192		0.0436	25,.		0.3450				3.37						7	1						 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98497672	98497672	A	G	hom	het	hom		QUAL=4984;DP=120,35,21;AF=1.00,0.37,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs1198571	0.8706	0.8475	11258,.		0.1410			0.00,0.07	3.75						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98498339	98498339	C	T	wt	wt	het		QUAL=2114;DP=592,248,195;AF=0.00,0.00,0.47;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region					rs17371457	0.1374	0.1686	568,.		-0.6140			0.02,0.18	4.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98498898	98498898	C	A	hom	het	hom		QUAL=23929;DP=421,268,189;AF=1.00,0.47,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region					rs1782815	0.8686	0.8467	11260,.		0.1660			0.02,0.22	1.78						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98499590	98499590	A	-	het	het	wt		QUAL=1629;DP=86,36,30;AF=0.58,0.53,0.00;MQM=57		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region				(AGAA)n (Simple_repeat)	rs143336786		0.0299	11,.		-0.4760				0.34						0	8						 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98499651	98499651	G	A	het	het	het		QUAL=1262;DP=67,14,18;AF=0.54,0.36,0.44;MQM=53		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region				(AGAA)n (Simple_repeat)	rs1782814		0.2214	453,.		0.3370			0.00,0.06	3.24						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98499659	98499659	G	A	wt	het	hom		QUAL=713;DP=17,7,12;AF=0.94,0.29,0.92;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region				(AGAA)n (Simple_repeat)	rs58126792		0.1112	78,.		-0.5470			0.00,0.10	0.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98499663	98499663	-	AAAG	hom	wt	wt		QUAL=713;DP=17,7,12;AF=0.00,0.29,0.83;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region				(AGAA)n (Simple_repeat)	rs780129382		0.2583	886,.						0.57						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98499663	98499663	A	G	wt	het	hom		QUAL=713;DP=17,7,12;AF=0.94,0.00,0.08;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region				(AGAA)n (Simple_repeat)	rs60475427		0.0840	88,.		-0.2610			0.00,0.04	2.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98499843	98499843	T	C	hom	het	hom		QUAL=10094;DP=169,158,94;AF=0.99,0.46,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region					rs1782813		0.8587	11586,.		-0.1880			0.01,0.18	3.12						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98500045	98500045	G	C	het	wt	het		QUAL=6853;DP=389,168,132;AF=0.50,0.01,0.45;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region				UCON1 (Unknown)	rs7554283	0.3195	0.2740	1395,.		1.4460			0.81,0.98	17.32						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98501011	98501011	T	C	het	wt	het		QUAL=7064;DP=316,249,202;AF=0.49,0.00,0.53;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region					rs4950101	0.2772	0.2414	1082,.		1.6260			0.78,0.97	14.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98501984	98501984	T	C	hom	het	hom		QUAL=13795;DP=275,106,84;AF=0.99,0.59,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::						rs1702294		0.8112	10358,.		-0.3760			0.01,0.10	0.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98502159	98502159	G	C	hom	het	hom		QUAL=29059;DP=322,438,361;AF=1.00,0.51,1.00;MQM=59		intergenic	::intergenic_variant:MODIFIER::::					Tigger3a (DNA/TcMar-Tigger)	rs1702293		0.9079	12952,.		-2.1860			0.00,0.03	0.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98502340	98502340	G	A	hom	het	hom		QUAL=18808;DP=240,243,231;AF=1.00,0.48,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region				Tigger3a (DNA/TcMar-Tigger)	rs1782810		0.7719	9397,.		0.6560			0.01,0.06	0.49						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98502410	98502410	A	C	hom	het	hom		QUAL=21494;DP=275,295,249;AF=1.00,0.51,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::					Tigger3a (DNA/TcMar-Tigger)	rs1782811	0.9026	0.8731	12032,.		-2.7760			0.00,0.04	0.64						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98502594	98502594	A	C	hom	het	hom		QUAL=18000;DP=241,270,208;AF=1.00,0.49,1.00;MQM=59		intergenic	::intergenic_variant:MODIFIER::::						rs1628294	0.9257	0.9079	12953,.		-0.4680			0.00,0.10	5.28						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98502934	98502934	G	T	hom	het	hom		QUAL=10741;DP=212,108,74;AF=1.00,0.38,1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::				CR159174 [CLASS=DP MUT=ALT PHEN="Schizophrenia increased risk" GENE=MIR137HG];		rs1625579	0.7969	0.7716	9378,.		-0.3210			0.00,0.06	0.15						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98506110	98506110	A	-	het	het	het		QUAL=577;DP=167,129,99;AF=0.20,0.17,0.13;MQM=60	MIR137HG	downstream_gene	MIR137HG:ENST00000580305:downstream_gene_variant:MODIFIER::::						rs879525945		0.0297	0,.		-1.7420				0.08						0	8						MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98506616	98506616	-	TTCATTCA	het	het	wt		QUAL=2428;DP=83,37,19;AF=0.82,0.51,1.00;MQM=60	MIR137HG	downstream_gene	MIR137HG:ENST00000580305:downstream_gene_variant:MODIFIER::::					(TTCA)n (Simple_repeat)	rs71988022		0.1491	422,.						0.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98506616	98506616	-	TTCATTCATTCA	het	wt	het		QUAL=2428;DP=83,37,19;AF=0.82,0.51,1.00;MQM=57	MIR137HG	downstream_gene	MIR137HG:ENST00000580305:downstream_gene_variant:MODIFIER::::					(TTCA)n (Simple_repeat)	rs71988022	0.3163	0.5487	4645,.						0.08						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98506616	98506616	-	TTCATTCATTCATTCA	wt	wt	het		QUAL=2428;DP=83,37,19;AF=0.82,0.51,1.00;MQM=60	MIR137HG	downstream_gene	MIR137HG:ENST00000580305:downstream_gene_variant:MODIFIER::::					(TTCA)n (Simple_repeat)	rs71988022		0.1144	224,.						0.07						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98507696	98507696	A	G	hom	het	hom		QUAL=6050;DP=154,35,15;AF=0.99,0.43,1.00;MQM=60	MIR137HG	downstream_gene	MIR137HG:ENST00000385223:downstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter					rs4292998	0.8129	0.7828	9644,.		-0.0470			0.06,0.20	11.32						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98507718	98507718	C	A	hom	het	hom		QUAL=7219;DP=183,38,18;AF=1.00,0.45,1.00;MQM=60	MIR137HG	downstream_gene	MIR137HG:ENST00000385223:downstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter					rs4411173	0.8896	0.8585	11604,.		0.5560			0.00,0.07	4.76						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98508258	98508258	C	T	hom	het	hom		QUAL=39501;DP=575,500,411;AF=1.00,0.52,1.00;MQM=60	MIR137HG	downstream_gene	MIR137HG:ENST00000385223:downstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter					rs2802535	0.8097	0.7814	9588,.		-0.6370			0.03,0.11	0.26						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98508488	98508488	G	A	het	het	wt		QUAL=8630;DP=418,196,173;AF=0.50,0.56,0.00;MQM=60	MIR137HG	downstream_gene	MIR137HG:ENST00000385223:downstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter					rs78924727	0.0527	0.0135	21,.		-0.2230			0.01,0.20	1.31						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98512127	98512127	G	T	hom	het	hom		QUAL=32947;DP=408,496,411;AF=1.00,0.48,1.00;MQM=60	MIR137HG	upstream_gene	MIR137HG:ENST00000385223:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter					rs2660304	0.8468	0.8165	10449,.		1.2090			0.55,0.64	15.31						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98513144	98513144	T	A	hom	het	hom		QUAL=13166;DP=231,132,116;AF=1.00,0.53,1.00;MQM=60	MIR137HG	upstream_gene	MIR137HG:ENST00000385223:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter					rs2660303	0.9259	0.9069	12917,.		-0.2550			0.02,0.15	0.59						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98513676	98513676	-	CA	wt	het	wt		QUAL=781;DP=10,72,15;AF=0.00,0.00,0.20;MQM=60	MIR137HG	upstream_gene	MIR137HG:ENST00000385223:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter				(CA)n (Simple_repeat)	rs150117500									1.31						4	3						MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98513676	98513676	-	CGCACACACA	hom	wt	hom		QUAL=781;DP=10,72,15;AF=0.00,0.51,0.00;MQM=60	MIR137HG	upstream_gene	MIR137HG:ENST00000385223:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter				(CA)n (Simple_repeat)	rs150117500									1.06						4	124						MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98513712	98513712	-	CACC	hom	wt	hom		QUAL=781;DP=10,72,15;AF=0.00,0.51,0.20;MQM=60	MIR137HG	upstream_gene	MIR137HG:ENST00000385223:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter				(CA)n (Simple_repeat)	rs750747213		0.0020	2,.						5.20						0	0						MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98513845	98513845	G	A	hom	het	hom		QUAL=13232;DP=147,260,183;AF=1.00,0.47,0.99;MQM=60	MIR137HG	upstream_gene	MIR137HG:ENST00000385223:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant					rs61786696	0.9263	0.9079	12965,.		0.4930			0.00,0.19	7.36						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98513959	98513959	A	G	hom	het	hom		QUAL=18002;DP=246,275,207;AF=1.00,0.49,1.00;MQM=59	MIR137HG	upstream_gene	MIR137HG:ENST00000385223:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant					rs61786697	0.9261	0.9078	12956,.		2.5710			0.00,0.84	14.67						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98514590	98514590	-	CT	wt	het	wt		QUAL=286;DP=82,88,79;AF=0.02,0.36,0.00;MQM=60	MIR137HG	upstream_gene	MIR137HG:ENST00000385223:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000580305:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter				(CT)n (Simple_repeat)	rs1324403545		0.0143	4,.						10.22						1	14						MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	100316589	100316589	A	G	wt	wt	het		QUAL=1881;DP=310,144,107;AF=0.00,0.01,0.66;MQM=60	AGL	5'UTR,splice_acceptor	AGL:ENST00000294724:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:ENST00000361302:5_prime_UTR_variant:MODIFIER:exon1/34:c.-201A>G::,AGL:ENST00000361915:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:ENST00000370163:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:ENST00000370165:splice_acceptor_variant:HIGH:exon1/33:c.-8-2A>G::	regulatory_region_variant:promoter	610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];	195096 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2307130	0.4271	0.4694	2843,.	0.2635,0.4393,0.5339,0.4925,0.5368	0.3640			0.07,0.39	13.33		3.27>-4.68		0.000/0.000		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100318093	100318093	T	-	het	het	wt	off-target	QUAL=270;DP=15,14,7;AF=0.33,0.50,0.14;MQM=58	AGL	intron	AGL:ENST00000294724:intron_variant:MODIFIER:exon2/33:c.82+1432del::,AGL:ENST00000361302:intron_variant:MODIFIER:exon1/33:c.-109-5del::,AGL:ENST00000361915:intron_variant:MODIFIER:exon2/33:c.82+1432del::,AGL:ENST00000370163:intron_variant:MODIFIER:exon2/33:c.82+1432del::,AGL:ENST00000370165:intron_variant:MODIFIER:exon2/33:c.82+1432del::	regulatory_region_variant:promoter	610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];			AluJo (SINE/Alu)	rs1483037066		0.0021	0,.		-0.2470				3.99						8	4						AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100318093	100318094	TT	-	het	wt	het	off-target	QUAL=270;DP=15,14,7;AF=0.20,0.14,0.29;MQM=60	AGL	intron	AGL:ENST00000294724:intron_variant:MODIFIER:exon2/33:c.82+1431_82+1432del::,AGL:ENST00000361302:intron_variant:MODIFIER:exon1/33:c.-109-6_-109-5del::,AGL:ENST00000361915:intron_variant:MODIFIER:exon2/33:c.82+1431_82+1432del::,AGL:ENST00000370163:intron_variant:MODIFIER:exon2/33:c.82+1431_82+1432del::,AGL:ENST00000370165:intron_variant:MODIFIER:exon2/33:c.82+1431_82+1432del::	regulatory_region_variant:promoter	610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];			AluJo (SINE/Alu)			0.0004	0,.		-0.2470				3.97						0	0						AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100327026	100327026	C	T	het	het	het		QUAL=12691;DP=435,300,201;AF=0.53,0.46,0.48;MQM=60	AGL	intron,5'UTR	AGL:ENST00000294724:intron_variant:MODIFIER:exon2/33:c.83-33C>T::,AGL:ENST00000361302:intron_variant:MODIFIER:exon2/33:c.35-33C>T::,AGL:ENST00000361522:5_prime_UTR_variant:MODIFIER:exon1/32:c.-2C>T::,AGL:ENST00000361915:intron_variant:MODIFIER:exon2/33:c.83-33C>T::,AGL:ENST00000370161:intron_variant:MODIFIER:exon1/32:c.35-33C>T::,AGL:ENST00000370163:intron_variant:MODIFIER:exon2/33:c.83-33C>T::,AGL:ENST00000370165:intron_variant:MODIFIER:exon2/33:c.83-33C>T::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];	256750 [benign DISEASE=not specified];			rs2307129	0.2272	0.2331	1048,.	0.3863,0.1314,0.1224,0.1714,0.1899	-0.3770			0.05,0.14	2.48						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100329889	100329889	G	C	het	het	hom	off-target	QUAL=2599;DP=96,50,33;AF=0.54,0.38,1.00;MQM=60	AGL	intron	AGL:ENST00000294724:intron_variant:MODIFIER:exon4/33:c.461-53G>C::,AGL:ENST00000361302:intron_variant:MODIFIER:exon4/33:c.413-53G>C::,AGL:ENST00000361522:intron_variant:MODIFIER:exon2/31:c.410-53G>C::,AGL:ENST00000361915:intron_variant:MODIFIER:exon4/33:c.461-53G>C::,AGL:ENST00000370161:intron_variant:MODIFIER:exon3/32:c.413-53G>C::,AGL:ENST00000370163:intron_variant:MODIFIER:exon4/33:c.461-53G>C::,AGL:ENST00000370165:intron_variant:MODIFIER:exon4/33:c.461-53G>C::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];				rs535461		0.7230	8277,.		-0.0930			0.09,0.16	0.28						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100336361	100336361	C	T	het	het	hom		QUAL=8617;DP=341,117,98;AF=0.43,0.51,1.00;MQM=60	AGL	synonymous	AGL:ENST00000294724:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701,AGL:ENST00000361302:synonymous_variant:LOW:exon7/34:c.846C>T:p.Leu282=:PF14701,AGL:ENST00000361522:synonymous_variant:LOW:exon5/32:c.843C>T:p.Leu281=:PF14701,AGL:ENST00000361915:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701,AGL:ENST00000370161:synonymous_variant:LOW:exon6/33:c.846C>T:p.Leu282=:PF14701,AGL:ENST00000370163:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701,AGL:ENST00000370165:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];	198432 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2230306		0.7559	9100,.	0.9171,0.6906,0.6850,0.7028,0.7519	1.3620			0.80,0.95	11.55						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100340225	100340225	G	A	het	het	hom	off-target	QUAL=11583;DP=218,229,169;AF=0.50,0.54,1.00;MQM=60	AGL	intron	AGL:ENST00000294724:intron_variant:MODIFIER:exon7/33:c.959-18G>A::,AGL:ENST00000361302:intron_variant:MODIFIER:exon7/33:c.911-18G>A::,AGL:ENST00000361522:intron_variant:MODIFIER:exon5/31:c.908-18G>A::,AGL:ENST00000361915:intron_variant:MODIFIER:exon7/33:c.959-18G>A::,AGL:ENST00000370161:intron_variant:MODIFIER:exon6/32:c.911-18G>A::,AGL:ENST00000370163:intron_variant:MODIFIER:exon7/33:c.959-18G>A::,AGL:ENST00000370165:intron_variant:MODIFIER:exon7/33:c.959-18G>A::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];	256751 [benign DISEASE=not specified,not provided];			rs634880	0.7434	0.7326	8461,.	0.8453,0.6822,0.7106,0.7096,0.7330	-1.0390			0.00,0.06	0.41		10.97>11.37				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100343153	100343153	A	G	wt	wt	het	off-target	QUAL=302;DP=175,41,22;AF=0.00,0.00,0.68;MQM=60	AGL	intron	AGL:ENST00000294724:intron_variant:MODIFIER:exon11/33:c.1424-44A>G::,AGL:ENST00000361302:intron_variant:MODIFIER:exon11/33:c.1376-44A>G::,AGL:ENST00000361522:intron_variant:MODIFIER:exon9/31:c.1373-44A>G::,AGL:ENST00000361915:intron_variant:MODIFIER:exon11/33:c.1424-44A>G::,AGL:ENST00000370161:intron_variant:MODIFIER:exon10/32:c.1376-44A>G::,AGL:ENST00000370163:intron_variant:MODIFIER:exon11/33:c.1424-44A>G::,AGL:ENST00000370165:intron_variant:MODIFIER:exon11/33:c.1424-44A>G::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];	256722 [benign DISEASE=not specified];			rs2291638	0.2843	0.3515	1766,.	0.0899,0.3604,0.4446,0.3883,0.3040	-0.3690			0.13,0.25	11.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100346741	100346741	T	C	wt	wt	het		QUAL=2696;DP=287,284,209;AF=0.00,0.00,0.51;MQM=60	AGL	splice_region&intron	AGL:ENST00000294724:splice_region_variant&intron_variant:LOW:exon15/33:c.2001+8T>C::,AGL:ENST00000361302:splice_region_variant&intron_variant:LOW:exon15/33:c.1953+8T>C::,AGL:ENST00000361522:splice_region_variant&intron_variant:LOW:exon13/31:c.1950+8T>C::,AGL:ENST00000361915:splice_region_variant&intron_variant:LOW:exon15/33:c.2001+8T>C::,AGL:ENST00000370161:splice_region_variant&intron_variant:LOW:exon14/32:c.1953+8T>C::,AGL:ENST00000370163:splice_region_variant&intron_variant:LOW:exon15/33:c.2001+8T>C::,AGL:ENST00000370165:splice_region_variant&intron_variant:LOW:exon15/33:c.2001+8T>C::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];	256725 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs3736296	0.5585	0.5541	4328,.	0.4313,0.6220,0.6604,0.5444,0.5893	2.1680			0.60,0.41	6.49				0.000/0.002		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100353675	100353675	G	A	het	het	hom	off-target	QUAL=12230;DP=172,264,206;AF=0.53,0.47,1.00;MQM=60	AGL	intron	AGL:ENST00000294724:intron_variant:MODIFIER:exon21/33:c.2812+11G>A::,AGL:ENST00000361302:intron_variant:MODIFIER:exon21/33:c.2764+11G>A::,AGL:ENST00000361522:intron_variant:MODIFIER:exon19/31:c.2761+11G>A::,AGL:ENST00000361915:intron_variant:MODIFIER:exon21/33:c.2812+11G>A::,AGL:ENST00000370161:intron_variant:MODIFIER:exon20/32:c.2764+11G>A::,AGL:ENST00000370163:intron_variant:MODIFIER:exon21/33:c.2812+11G>A::,AGL:ENST00000370165:intron_variant:MODIFIER:exon21/33:c.2812+11G>A::	regulatory_region_variant:open_chromatin_region	610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];	256730 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs555929	0.6811	0.6904	7013,.	0.5852,0.7226,0.6885,0.6936,0.7307	-0.7550			0.00,0.17	1.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100357141	100357141	T	A	wt	wt	het	off-target	QUAL=1409;DP=198,186,121;AF=0.00,0.00,0.47;MQM=60	AGL	intron	AGL:ENST00000294724:intron_variant:MODIFIER:exon22/33:c.2950-21T>A::,AGL:ENST00000361302:intron_variant:MODIFIER:exon22/33:c.2902-21T>A::,AGL:ENST00000361522:intron_variant:MODIFIER:exon20/31:c.2899-21T>A::,AGL:ENST00000361915:intron_variant:MODIFIER:exon22/33:c.2950-21T>A::,AGL:ENST00000370161:intron_variant:MODIFIER:exon21/32:c.2902-21T>A::,AGL:ENST00000370163:intron_variant:MODIFIER:exon22/33:c.2950-21T>A::,AGL:ENST00000370165:intron_variant:MODIFIER:exon22/33:c.2950-21T>A::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];	256733 [benign DISEASE=not specified];			rs2035961		0.5367	3795,.	0.3801,0.6127,0.6593,0.5275,0.5855	0.0470			0.07,0.25	6.23						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100358103	100358103	C	T	het	het	het		QUAL=8363;DP=251,223,182;AF=0.49,0.51,0.47;MQM=60	AGL	missense	AGL:ENST00000294724:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000361302:missense_variant:MODERATE:exon24/34:c.3151C>T:p.Pro1051Ser:,AGL:ENST00000361522:missense_variant:MODERATE:exon22/32:c.3148C>T:p.Pro1050Ser:,AGL:ENST00000361915:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000370161:missense_variant:MODERATE:exon23/33:c.3151C>T:p.Pro1051Ser:,AGL:ENST00000370163:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000370165:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];	256734 [benign/likely benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs3753494	0.1106	0.1366	347,.	0.1169,0.0998,0.0294,0.1496,0.1452	7.2300	D(0.04),D(0.03),D(0.03),D(0.04),D(0.03),D(0.04),D(0.04)	B(0.10),B(0.05),B(0.05),B(0.10),B(0.05),B(0.10),B(0.10)	0.98,0.99	22.10	0.30					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100358200	100358200	G	A	het	het	hom	off-target	QUAL=5718;DP=136,117,88;AF=0.46,0.49,1.00;MQM=60	AGL	intron	AGL:ENST00000294724:intron_variant:MODIFIER:exon24/33:c.3259+37G>A::,AGL:ENST00000361302:intron_variant:MODIFIER:exon24/33:c.3211+37G>A::,AGL:ENST00000361522:intron_variant:MODIFIER:exon22/31:c.3208+37G>A::,AGL:ENST00000361915:intron_variant:MODIFIER:exon24/33:c.3259+37G>A::,AGL:ENST00000370161:intron_variant:MODIFIER:exon23/32:c.3211+37G>A::,AGL:ENST00000370163:intron_variant:MODIFIER:exon24/33:c.3259+37G>A::,AGL:ENST00000370165:intron_variant:MODIFIER:exon24/33:c.3259+37G>A::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];	256735 [benign DISEASE=not specified];			rs594249	0.6815	0.6911	7026,.	0.5841,0.7229,0.6889,0.6939,0.7346	-1.3340			0.00,0.05	0.30						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100366446	100366446	G	T	het	wt	wt	off-target	QUAL=1468;DP=78,49,49;AF=0.28,0.43,0.80;MQM=56	AGL	intron	AGL:ENST00000294724:intron_variant:MODIFIER:exon26/33:c.3588+29G>T::,AGL:ENST00000361302:intron_variant:MODIFIER:exon26/33:c.3540+29G>T::,AGL:ENST00000361522:intron_variant:MODIFIER:exon24/31:c.3537+29G>T::,AGL:ENST00000361915:intron_variant:MODIFIER:exon26/33:c.3588+29G>T::,AGL:ENST00000370161:intron_variant:MODIFIER:exon25/32:c.3540+29G>T::,AGL:ENST00000370163:intron_variant:MODIFIER:exon26/33:c.3588+29G>T::,AGL:ENST00000370165:intron_variant:MODIFIER:exon26/33:c.3588+29G>T::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];			(T)n (Simple_repeat)	rs201885902	0.0083	0.0169	0,.	0.0243,0.0180,0.0202,0.0153,0.0173	-0.1580			0.03,0.11	0.25						113	334		2	[2] auto-classification 22.09.2017  			AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100366447	100366448	TT	-	wt	het	hom	off-target	QUAL=1468;DP=78,49,49;AF=0.26,0.04,0.02;MQM=59	AGL	intron	AGL:ENST00000294724:intron_variant:MODIFIER:exon26/33:c.3588+43_3588+44del::,AGL:ENST00000361302:intron_variant:MODIFIER:exon26/33:c.3540+43_3540+44del::,AGL:ENST00000361522:intron_variant:MODIFIER:exon24/31:c.3537+43_3537+44del::,AGL:ENST00000361915:intron_variant:MODIFIER:exon26/33:c.3588+43_3588+44del::,AGL:ENST00000370161:intron_variant:MODIFIER:exon25/32:c.3540+43_3540+44del::,AGL:ENST00000370163:intron_variant:MODIFIER:exon26/33:c.3588+43_3588+44del::,AGL:ENST00000370165:intron_variant:MODIFIER:exon26/33:c.3588+43_3588+44del::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];			(T)n (Simple_repeat)	rs35956186		0.5178	3116,.	0.3430,0.3746,0.3694,0.4285,0.3509	2.7560				0.94						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100376448	100376448	G	A	wt	wt	het	off-target	QUAL=2102;DP=102,266,176;AF=0.00,0.00,0.49;MQM=60	AGL	intron	AGL:ENST00000294724:intron_variant:MODIFIER:exon28/33:c.3836+45G>A::,AGL:ENST00000361302:intron_variant:MODIFIER:exon28/33:c.3788+45G>A::,AGL:ENST00000361522:intron_variant:MODIFIER:exon26/31:c.3785+45G>A::,AGL:ENST00000361915:intron_variant:MODIFIER:exon28/33:c.3836+45G>A::,AGL:ENST00000370161:intron_variant:MODIFIER:exon27/32:c.3788+45G>A::,AGL:ENST00000370163:intron_variant:MODIFIER:exon28/33:c.3836+45G>A::,AGL:ENST00000370165:intron_variant:MODIFIER:exon28/33:c.3836+45G>A::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];	256744 [benign DISEASE=not specified];			rs2274570	0.4613	0.4822	3533,.	0.3712,0.5710,0.5425,0.5001,0.3654	-0.8020			0.00,0.07	2.20						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100376456	100376456	T	A	wt	wt	het	off-target	QUAL=2113;DP=106,261,173;AF=0.00,0.00,0.50;MQM=60	AGL	intron	AGL:ENST00000294724:intron_variant:MODIFIER:exon28/33:c.3836+53T>A::,AGL:ENST00000361302:intron_variant:MODIFIER:exon28/33:c.3788+53T>A::,AGL:ENST00000361522:intron_variant:MODIFIER:exon26/31:c.3785+53T>A::,AGL:ENST00000361915:intron_variant:MODIFIER:exon28/33:c.3836+53T>A::,AGL:ENST00000370161:intron_variant:MODIFIER:exon27/32:c.3788+53T>A::,AGL:ENST00000370163:intron_variant:MODIFIER:exon28/33:c.3836+53T>A::,AGL:ENST00000370165:intron_variant:MODIFIER:exon28/33:c.3836+53T>A::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];				rs1541041	0.4599	0.4754	3532,.		0.4470			0.00,0.12	3.17						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100387479	100387479	G	T	wt	wt	het		QUAL=1097;DP=305,95,85;AF=0.00,0.00,0.52;MQM=60	AGL	3'UTR	AGL:ENST00000294724:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000361302:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000361522:3_prime_UTR_variant:MODIFIER:exon32/32:c.*272G>T::,AGL:ENST00000361915:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000370161:3_prime_UTR_variant:MODIFIER:exon33/33:c.*272G>T::,AGL:ENST00000370163:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000370165:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];	291351 [benign DISEASE=Glycogen storage disease type III];			rs1804808	0.3321	0.3328	1993,.		0.1010			0.02,0.18	2.27						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100387939	100387939	C	T	het	het	hom		QUAL=4301;DP=173,53,41;AF=0.49,0.45,1.00;MQM=59	AGL	3'UTR	AGL:ENST00000294724:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000361302:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000361522:3_prime_UTR_variant:MODIFIER:exon32/32:c.*732C>T::,AGL:ENST00000361915:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000370161:3_prime_UTR_variant:MODIFIER:exon33/33:c.*732C>T::,AGL:ENST00000370163:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000370165:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];	291359 [benign DISEASE=Glycogen storage disease type III];			rs3766600	0.5905	0.6324	6251,.		1.0200			0.00,0.11	2.33						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100388235	100388235	C	T	wt	wt	het		QUAL=258;DP=191,61,42;AF=0.01,0.00,0.38;MQM=60	AGL	3'UTR	AGL:ENST00000294724:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000361302:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000361522:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1028C>T::,AGL:ENST00000361915:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000370161:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1028C>T::,AGL:ENST00000370163:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000370165:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];	291363 [benign DISEASE=Glycogen storage disease type III];			rs3766601	0.4683	0.4869	3732,.		1.1110			0.00,0.06	3.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100388503	100388503	A	C	wt	wt	het		QUAL=895;DP=221,69,61;AF=0.00,0.00,0.57;MQM=60	AGL	3'UTR	AGL:ENST00000294724:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000361302:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000361522:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1296A>C::,AGL:ENST00000361915:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000370161:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1296A>C::,AGL:ENST00000370163:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000370165:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];	291368 [benign DISEASE=Glycogen storage disease type III];			rs1804809	0.3758	0.3837	2457,.		0.3860			0.07,0.13	1.32						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100388748	100388748	T	C	wt	wt	het		QUAL=1706;DP=266,168,123;AF=0.00,0.01,0.54;MQM=60	AGL	3'UTR	AGL:ENST00000294724:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000361302:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000361522:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1541T>C::,AGL:ENST00000361915:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000370161:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1541T>C::,AGL:ENST00000370163:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000370165:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::		610860 [GENE=AGL PHENOS=Glycogen storage disease IIIa,232400,Autosomal recessive/Glycogen storage disease IIIb,232400,Autosomal recessive];	291369 [benign DISEASE=Glycogen storage disease type III];			rs3766603	0.4018	0.4073	2624,.		-1.4470			0.00,0.09	2.36						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100652729	100652729	G	A	wt	wt	het		QUAL=324;DP=111,41,37;AF=0.00,0.02,0.43;MQM=60	DBT	3'UTR	DBT:ENST00000370132:3_prime_UTR_variant:MODIFIER:exon11/11:c.*9082C>T::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	291375 [likely benign DISEASE=Maple syrup urine disease];			rs72728160	0.0577	0.1192	285,.		0.3270			0.15,0.62	6.65						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100653257	100653257	T	-	het	het	het		QUAL=151;DP=17,10,6;AF=0.35,0.30,0.33;MQM=59	DBT	3'UTR	DBT:ENST00000370132:3_prime_UTR_variant:MODIFIER:exon11/11:c.*8554del::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];			AluJb (SINE/Alu)	rs1171402030		0.0183	0,.		-1.4320				0.89						5	23						DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100654908	100654908	A	-	het	n/a	wt		QUAL=985;DP=42,1,8;AF=0.86,1.00,0.38;MQM=56	DBT	3'UTR	DBT:ENST00000370132:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6903del::	regulatory_region_variant:promoter_flanking_region	248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	291391 [uncertain significance DISEASE=Maple syrup urine disease];		AluSz (SINE/Alu)	rs886044943		0.7932	8066,.		0.0000				0.56						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100654908	100654908	A	T	het	n/a	hom		QUAL=985;DP=42,1,8;AF=0.86,1.00,0.38;MQM=58	DBT	3'UTR	DBT:ENST00000370132:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6903T>A::	regulatory_region_variant:promoter_flanking_region	248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	291392 [benign DISEASE=Maple syrup urine disease];		AluSz (SINE/Alu)	rs10783125	0.9339	0.1297	346,.		0.0000			0.01,0.09	1.85						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100654909	100654909	A	T	het	n/a	wt		QUAL=985;DP=42,1,8;AF=0.86,1.00,0.38;MQM=56	DBT	3'UTR	DBT:ENST00000370132:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6902T>A::	regulatory_region_variant:promoter_flanking_region	248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];			AluSz (SINE/Alu)	rs200943386		0.7589	7371,.		0.0000			0.01,0.09	1.84						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100655583	100655583	T	A	hom	hom	hom		QUAL=4321;DP=104,13,15;AF=1.00,1.00,1.00;MQM=59	DBT	3'UTR	DBT:ENST00000370132:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6228A>T::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	291395 [benign DISEASE=Maple syrup urine disease];		MER3 (DNA/hAT-Charlie)	rs4281338	0.7668	0.7572	9498,.		-0.7070			0.01,0.07	0.14						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100655696	100655697	AA	-	het	het	wt		QUAL=3367;DP=176,89,57;AF=0.48,0.64,0.02;MQM=60	DBT	3'UTR	DBT:ENST00000370132:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6114_*6115del::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	291396 [uncertain significance DISEASE=Maple syrup urine disease];		MLT1J2 (LTR/ERVL-MaLR)	rs3081711		0.1791	610,.		0.5040				2.77						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100656265	100656265	C	T	hom	hom	hom		QUAL=13984;DP=174,140,105;AF=0.99,1.00,1.00;MQM=60	DBT	3'UTR	DBT:ENST00000370132:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5546G>A::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	291404 [benign DISEASE=Maple syrup urine disease];			rs11166412	0.8007	0.7963	10252,.		-0.8580			0.00,0.07	0.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100656494	100656494	A	G	wt	wt	het		QUAL=1899;DP=403,261,187;AF=0.00,0.00,0.43;MQM=60	DBT	3'UTR	DBT:ENST00000370132:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5317T>C::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	291406 [benign DISEASE=Maple syrup urine disease];			rs11166413	0.2638	0.3123	1890,.		0.7090			0.03,0.11	1.74						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100656661	100656661	T	C	hom	hom	hom		QUAL=24021;DP=361,207,156;AF=1.00,1.00,1.00;MQM=60	DBT	3'UTR	DBT:ENST00000370132:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5150A>G::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	291407 [benign DISEASE=Maple syrup urine disease];			rs6701655	0.7696	0.7588	9531,.		0.1170			0.01,0.11	3.57						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100657304	100657329	ATACACACACACACACACACACACAC	-	het	het	wt		QUAL=1703;DP=24,48,25;AF=0.46,0.40,0.80;MQM=57	DBT	3'UTR	DBT:ENST00000370132:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4482_*4507del::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];			(AC)n (Simple_repeat)	rs1418854977		0.0482	92,.		0.6450				0.33						4	8						DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100657304	100657331	ATACACACACACACACACACACACACAC	-	het	het	hom		QUAL=1703;DP=24,48,25;AF=0.29,0.52,0.04;MQM=58	DBT	3'UTR	DBT:ENST00000370132:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4480_*4507del::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];			(AC)n (Simple_repeat)	rs140341302		0.6543	6177,.		0.6450				0.31						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100658578	100658578	G	A	hom	hom	hom		QUAL=34733;DP=334,473,320;AF=0.99,1.00,1.00;MQM=60	DBT	3'UTR	DBT:ENST00000370132:3_prime_UTR_variant:MODIFIER:exon11/11:c.*3233C>T::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	291424 [benign DISEASE=Maple syrup urine disease];			rs2784174		0.7588	9526,.		0.1820			0.01,0.11	1.63						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100671866	100671866	T	A	wt	wt	het		QUAL=781;DP=281,111,76;AF=0.01,0.00,0.49;MQM=60	DBT	intron	DBT:ENST00000370132:intron_variant:MODIFIER:exon9/10:c.1210-9A>T::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	93987 [benign DISEASE=Maple syrup urine disease,not specified];			rs34229137	0.2687	0.4005	1550,.	0.1865,0.4504,0.3281,0.4141,0.3893	0.7540			0.00,0.16	3.41		6.05>7.40		0.000/0.000		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100672060	100672060	T	C	hom	hom	hom		QUAL=28873;DP=341,301,245;AF=1.00,1.00,1.00;MQM=60	DBT	missense	DBT:ENST00000370132:missense_variant:MODERATE:exon9/11:c.1150A>G:p.Ser384Gly:PF00198		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];	128885 [benign DISEASE=not specified];			rs12021720		0.9174	12280,.	0.7628,0.9547,0.9692,0.9082,0.9519	1.9050	T(1.00)	B(0.00)	0.02,0.23	14.30	0.12					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100680593	100680593	-	T	het	het	het	off-target	QUAL=1284;DP=88,21,23;AF=0.58,0.57,0.52;MQM=60	DBT	intron	DBT:ENST00000370131:intron_variant:MODIFIER:exon6/7:c.773-55dup::,DBT:ENST00000370132:intron_variant:MODIFIER:exon6/10:c.773-55dup::		248610 [GENE=DBT PHENOS=Maple syrup urine disease,type II,248600,Autosomal recessive];				rs11431894		0.7411	6915,.						1.15						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100715454	100715454	G	A	hom	hom	hom	off-target	QUAL=12905;DP=44,276,190;AF=1.00,1.00,0.99;MQM=60	DBT,RP11-305E17.4	upstream_gene,downstream_gene	DBT:ENST00000370131:upstream_gene_variant:MODIFIER::::,DBT:ENST00000370132:upstream_gene_variant:MODIFIER::::,RP11-305E17.4:ENST00000435545:downstream_gene_variant:MODIFIER::::,RP11-305E17.4:ENST00000595511:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant					rs3806235		0.7289	9069,.		-1.2120			0.01,0.42	3.94			gain/donor/100715453-100715454/Medium/0.569291			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50), RP11-305E17.4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	109771063	109771063	T	C	hom	hom	hom		QUAL=21702;DP=237,230,204;AF=1.00,1.00,1.00;MQM=60	SARS	intron	SARS:ENST00000234677:intron_variant:MODIFIER:exon3/10:c.288+9T>C::,SARS:ENST00000369923:intron_variant:MODIFIER:exon3/11:c.288+9T>C::	regulatory_region_variant:promoter_flanking_region	607529 [GENE=SARS PHENOS=Neurodevelopmental disorder with microcephaly,ataxia,and seizures,617709,Autosomal recessive];				rs683182	0.6799	0.7679	8188,.	0.4629,0.8116,0.8993,0.7960,0.6581	-0.8580			0.04,0.16	0.63						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	109778577	109778577	T	C	hom	hom	hom	off-target	QUAL=18676;DP=176,262,160;AF=1.00,1.00,1.00;MQM=60	SARS	intron	SARS:ENST00000234677:intron_variant:MODIFIER:exon7/10:c.970-22T>C::,SARS:ENST00000369923:intron_variant:MODIFIER:exon7/11:c.970-22T>C::		607529 [GENE=SARS PHENOS=Neurodevelopmental disorder with microcephaly,ataxia,and seizures,617709,Autosomal recessive];				rs658092		0.7692	8276,.	0.4870,0.8138,0.8988,0.7962,0.6586	0.8080			0.02,0.33	10.58						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	110709719	110709719	T	C	het	hom	het		QUAL=19100;DP=262,391,330;AF=0.46,1.00,0.54;MQM=60	SLC6A17,RP5-1028L10.1	synonymous,non_coding_transcript_exon	SLC6A17:ENST00000331565:synonymous_variant:LOW:exon2/12:c.168T>C:p.Asp56=:,RP5-1028L10.1:ENST00000418579:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.168A>G::,RP5-1028L10.1:ENST00000430098:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.87A>G::,RP5-1028L10.1:ENST00000443008:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.507A>G::		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs7527375	0.3930	0.5132	4049,.	0.5055,0.2634,0.2103,0.5324,0.3637	-5.4670			0.02,0.13	8.91						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), RP5-1028L10.1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110709720	110709720	G	A	het	hom	wt		QUAL=19100;DP=262,391,330;AF=0.46,1.00,0.54;MQM=60	SLC6A17,RP5-1028L10.1	missense,non_coding_transcript_exon	SLC6A17:ENST00000331565:missense_variant:MODERATE:exon2/12:c.169G>A:p.Ala57Thr:,RP5-1028L10.1:ENST00000418579:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.167C>T::,RP5-1028L10.1:ENST00000430098:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.86C>T::,RP5-1028L10.1:ENST00000443008:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.506C>T::		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs12737742	0.2502	0.3725	2387,.	0.0887,0.2113,0.2096,0.4562,0.3459	0.5370	T(0.47), , , 	B(0.05), , , 	0.14,0.32	13.13	0.08					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), RP5-1028L10.1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110709734	110709734	G	A	wt	wt	het		QUAL=4212;DP=250,374,312;AF=0.00,0.00,0.55;MQM=60	SLC6A17,RP5-1028L10.1	synonymous,non_coding_transcript_exon	SLC6A17:ENST00000331565:synonymous_variant:LOW:exon2/12:c.183G>A:p.Pro61=:PF00209,RP5-1028L10.1:ENST00000418579:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.153C>T::,RP5-1028L10.1:ENST00000430098:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.72C>T::,RP5-1028L10.1:ENST00000443008:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.492C>T::		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs41281364	0.0389	0.0561	58,.	0.0526,0.0342,0.0002,0.0745,0.0145	-3.2570			0.03,0.14	9.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), RP5-1028L10.1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110738296	110738296	G	A	het	het	het		QUAL=16309;DP=295,543,382;AF=0.50,0.53,0.53;MQM=60	SLC6A17	synonymous	SLC6A17:ENST00000331565:synonymous_variant:LOW:exon10/12:c.1581G>A:p.Ser527=:PF00209		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs2784140	0.2897	0.4162	2765,.	0.0971,0.3307,0.2726,0.4960,0.3911	-1.7640			0.08,0.67	9.52						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110740273	110740273	G	T	het	het	het	off-target	QUAL=4588;DP=239,72,57;AF=0.54,0.58,0.40;MQM=60	SLC6A17	intron	SLC6A17:ENST00000331565:intron_variant:MODIFIER:exon11/11:c.1815+52G>T::	regulatory_region_variant:CTCF_binding_site	610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs2603581	0.3165	0.4147	2867,.	0.1791,0.3314,0.2731,0.4937,0.3907	-0.2040			0.00,0.06	4.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110740688	110740688	C	T	het	het	het	off-target	QUAL=8830;DP=177,329,255;AF=0.46,0.47,0.50;MQM=60	SLC6A17	intron	SLC6A17:ENST00000331565:intron_variant:MODIFIER:exon11/11:c.1816-10C>T::	regulatory_region_variant:CTCF_binding_site	610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs2761445	0.3195	0.4263	2946,.	0.1831,0.3383,0.2739,0.5055,0.3988	-0.2780			0.01,0.14	4.45		0.77>0.84		0.000/		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110741081	110741081	C	G	het	wt	het		QUAL=2473;DP=137,157,119;AF=0.50,0.01,0.34;MQM=59	SLC6A17	3'UTR	SLC6A17:ENST00000331565:3_prime_UTR_variant:MODIFIER:exon12/12:c.*15C>G::		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs2761446	0.0170	0.0371	25,.	0.0071,0.0140,0.0000,0.0516,0.0315	0.1420			0.22,0.37	7.38						32	716						SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110741086	110741086	C	T	wt	wt	het		QUAL=1786;DP=136,207,140;AF=0.00,0.00,0.54;MQM=60	SLC6A17	3'UTR	SLC6A17:ENST00000331565:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20C>T::		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs41306175	0.0497	0.0815	96,.	0.0844,0.0451,0.0045,0.1070,0.0165	-2.8590			0.03,0.27	6.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110741349	110741349	G	T	het	het	hom		QUAL=17024;DP=355,331,269;AF=0.46,0.57,1.00;MQM=60	SLC6A17	3'UTR	SLC6A17:ENST00000331565:3_prime_UTR_variant:MODIFIER:exon12/12:c.*283G>T::	regulatory_region_variant:CTCF_binding_site	610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs2603580	0.5425	0.6458	6707,.		-0.1760			0.00,0.05	0.38						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110741583	110741583	C	G	het	het	hom		QUAL=10074;DP=169,215,176;AF=0.39,0.53,1.00;MQM=60	SLC6A17	3'UTR	SLC6A17:ENST00000331565:3_prime_UTR_variant:MODIFIER:exon12/12:c.*517C>G::	regulatory_region_variant:CTCF_binding_site	610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs2784141	0.5447	0.6455	6703,.		-1.4930			0.00,0.06	0.57						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110742085	110742085	T	C	het	het	hom		QUAL=27420;DP=284,680,502;AF=0.45,0.49,1.00;MQM=59	SLC6A17	3'UTR	SLC6A17:ENST00000331565:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1019T>C::		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs2603579	0.5449	0.6465	6721,.		0.6680			0.35,0.79	9.22						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110742502	110742502	A	G	het	het	het		QUAL=1509;DP=163,101,83;AF=0.31,0.26,0.25;MQM=58	SLC6A17	3'UTR	SLC6A17:ENST00000331565:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1436A>G::	regulatory_region_variant:CTCF_binding_site	610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];			(GATG)n (Simple_repeat)	rs2361044	0.2883	0.3791	2112,.		-0.8410			0.00,0.06	0.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110742615	110742615	A	G	het	het	het		QUAL=2485;DP=123,105,70;AF=0.42,0.43,0.34;MQM=60	SLC6A17	3'UTR	SLC6A17:ENST00000331565:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1549A>G::		610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];			GA-rich (Low_complexity)	rs12133992	0.2867	0.3696	2551,.		0.2940			0.01,0.18	3.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110742992	110742992	T	G	het	het	het		QUAL=7221;DP=171,266,180;AF=0.50,0.45,0.53;MQM=60	SLC6A17	3'UTR	SLC6A17:ENST00000331565:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1926T>G::	regulatory_region_variant:CTCF_binding_site	610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs2784142	0.3079	0.3968	2828,.		1.1030			0.00,0.08	2.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110743588	110743588	G	C	het	het	wt		QUAL=8342;DP=163,474,387;AF=0.53,0.52,0.00;MQM=60	SLC6A17	3'UTR	SLC6A17:ENST00000331565:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2522G>C::	regulatory_region_variant:enhancer	610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs151008748	0.0132	0.0218	14,.		-0.6950			0.03,0.15	8.09						1	10						SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110743835	110743835	G	A	wt	wt	het		QUAL=2274;DP=217,183,164;AF=0.00,0.00,0.54;MQM=60	SLC6A17	3'UTR	SLC6A17:ENST00000331565:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2769G>A::	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site	610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs12138403	0.0491	0.0812	100,.		0.1620			0.02,0.14	1.81						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110744181	110744181	C	T	wt	wt	het		QUAL=1082;DP=97,123,96;AF=0.01,0.00,0.46;MQM=60	SLC6A17	3'UTR	SLC6A17:ENST00000331565:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3115C>T::	regulatory_region_variant:enhancer	610299 [GENE=SLC6A17 PHENOS=Mental retardation,autosomal recessive 48,616269,Autosomal recessive];				rs62621393	0.0491	0.0813	100,.		-4.4330			0.00,0.10	0.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110744874	110744874	G	A	wt	het	wt	off-target	QUAL=1732;DP=60,162,110;AF=0.00,0.46,0.00;MQM=60	SLC6A17	downstream_gene	SLC6A17:ENST00000331565:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site					rs45445195	0.0138	0.0195	10,.		-0.8180			0.00,0.08	0.55						1	31						SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	115247750	115247750	A	-	wt	wt	het		QUAL=984;DP=201,113,75;AF=0.00,0.01,0.59;MQM=60	NRAS	3'UTR	NRAS:ENST00000369535:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2965del::		164790 [GENE=NRAS PHENOS=Colorectal cancer,somatic,114500/Epidermal nevus,somatic,162900/Melanocytic nevus syndrome,congenital,somatic,137550/Neurocutaneous melanosis,somatic,249400/Noonan syndrome 6,613224,Autosomal dominant/RAS-associated autoimmune lymphoproliferative syndrome type IV,somatic,614470/Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200/Thyroid carcinoma,follicular,somatic,188470];	291946 [likely benign DISEASE=Noonan syndrome];			rs61652108	0.1518	0.2081	778,.		-0.3110				8.75						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19)
chr1	115249843	115249843	G	A	wt	wt	het		QUAL=1560;DP=407,196,125;AF=0.00,0.01,0.51;MQM=60	NRAS	3'UTR	NRAS:ENST00000369535:3_prime_UTR_variant:MODIFIER:exon7/7:c.*872C>T::		164790 [GENE=NRAS PHENOS=Colorectal cancer,somatic,114500/Epidermal nevus,somatic,162900/Melanocytic nevus syndrome,congenital,somatic,137550/Neurocutaneous melanosis,somatic,249400/Noonan syndrome 6,613224,Autosomal dominant/RAS-associated autoimmune lymphoproliferative syndrome type IV,somatic,614470/Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200/Thyroid carcinoma,follicular,somatic,188470];	291967 [likely benign DISEASE=Noonan syndrome];			rs14804	0.1510	0.2080	775,.		0.3800			0.00,0.06	3.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19)
chr1	115259401	115259401	C	T	het	het	wt		QUAL=3644;DP=181,128,111;AF=0.60,0.38,0.00;MQM=60	NRAS	5'UTR	NRAS:ENST00000369535:5_prime_UTR_variant:MODIFIER:exon1/7:c.-140G>A::	regulatory_region_variant:promoter,TF_binding_site_variant	164790 [GENE=NRAS PHENOS=Colorectal cancer,somatic,114500/Epidermal nevus,somatic,162900/Melanocytic nevus syndrome,congenital,somatic,137550/Neurocutaneous melanosis,somatic,249400/Noonan syndrome 6,613224,Autosomal dominant/RAS-associated autoimmune lymphoproliferative syndrome type IV,somatic,614470/Schimmelpenning-Feuerstein-Mims syndrome,somatic mosaic,163200/Thyroid carcinoma,follicular,somatic,188470];									3.7740			0.91,0.81	22.80						0	2						NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19)
chr1	115572365	115572365	A	G	het	het	hom	off-target	QUAL=8224;DP=163,179,123;AF=0.48,0.48,1.00;MQM=60	TSHB	upstream_gene	TSHB:ENST00000256592:upstream_gene_variant:MODIFIER::::,TSHB:ENST00000369517:upstream_gene_variant:MODIFIER::::						rs1321108	0.3894	0.4260	2989,.		1.2590			0.72,0.96	16.18						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115576023	115576023	A	G	hom	hom	hom		QUAL=17927;DP=259,149,135;AF=1.00,1.00,1.00;MQM=60	TSHB	missense	TSHB:ENST00000256592:missense_variant:MODERATE:exon2/3:c.40A>G:p.Thr14Ala:,TSHB:ENST00000369517:missense_variant:MODERATE:exon1/2:c.40A>G:p.Thr14Ala:		188540 [GENE=TSHB PHENOS=Hypothyroidism,congenital,nongoitrous 4,275100,Autosomal recessive];	256640 [benign DISEASE=Congenital hypothyroidism,Secondary hypothyroidism,not specified];			rs10776792		0.9747	14915,.	0.9947,0.9916,0.9999,0.9634,0.9611	0.2250	T(0.63),T(0.63)	B(0.00),B(0.00)	0.01,0.15	0.12	0.05					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115829313	115829313	G	A	hom	hom	het		QUAL=20236;DP=184,388,276;AF=0.99,0.99,0.51;MQM=60	NGF,RP4-663N10.1	missense,intron&non_coding_transcript	NGF:ENST00000369512:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:,RP4-663N10.1:ENST00000425449:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.207+3452G>A::		162030 [GENE=NGF PHENOS=Neuropathy,hereditary sensory and autonomic,type V,608654,Autosomal recessive];	291993 [benign DISEASE=Congenital sensory neuropathy with selective loss of small myelinated fibers];			rs6330	0.2474	0.3715	2407,.	0.1882,0.3459,0.1629,0.4483,0.2346	2.2990	D(0.04), 	B(0.00), 	0.90,0.98	22.90	0.10					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NGF (inh=AR oe_syn=1.17 oe_mis=0.80 oe_lof=0.00), NGF-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	119965519	119965519	C	T	het	het	wt		QUAL=10711;DP=464,355,297;AF=0.54,0.41,0.00;MQM=59	HSD3B2	3'UTR	HSD3B2:ENST00000369416:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::,HSD3B2:ENST00000543831:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::		613890 [GENE=HSD3B2 PHENOS=Adrenal hyperplasia,congenital,due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency,201810,Autosomal recessive];	292274 [benign DISEASE=Congenital adrenal hyperplasia];			rs1819698	0.3101	0.2236	1237,.		0.8090			0.00,0.03	3.18						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD3B2 (inh=AR oe_syn=1.33 oe_mis=0.87 oe_lof=0.99)
chr1	119965564	119965564	C	G	het	het	wt		QUAL=10562;DP=434,354,291;AF=0.54,0.42,0.00;MQM=60	HSD3B2	3'UTR	HSD3B2:ENST00000369416:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::,HSD3B2:ENST00000543831:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::		613890 [GENE=HSD3B2 PHENOS=Adrenal hyperplasia,congenital,due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency,201810,Autosomal recessive];	292275 [likely benign DISEASE=Congenital adrenal hyperplasia];			rs1361530	0.2560	0.1749	646,.		-0.9650			0.01,0.09	3.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD3B2 (inh=AR oe_syn=1.33 oe_mis=0.87 oe_lof=0.99)
chr1	147228529	147228529	G	A	wt	wt	het		QUAL=1650;DP=347,217,145;AF=0.00,0.00,0.46;MQM=60	GJA5	3'UTR	GJA5:ENST00000271348:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1741C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];						0.0001	0,.		0.4560			0.08,0.32	7.79						0	2						GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147228874	147228874	C	T	het	wt	het		QUAL=6202;DP=264,300,193;AF=0.51,0.00,0.54;MQM=60	GJA5	3'UTR	GJA5:ENST00000271348:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1396G>A::	regulatory_region_variant:promoter_flanking_region	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];				rs11240121	0.4073	0.2990	1644,.		-0.2330			0.00,0.09	5.48						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147229299	147229299	G	A	hom	het	hom		QUAL=12788;DP=214,161,133;AF=1.00,0.50,1.00;MQM=59	GJA5	3'UTR	GJA5:ENST00000271348:3_prime_UTR_variant:MODIFIER:exon2/2:c.*971C>T::	regulatory_region_variant:promoter_flanking_region	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];				rs1043806	0.8662	0.8006	10064,.		0.7320			0.00,0.38	10.63						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147229382	147229382	G	A	hom	hom	hom		QUAL=22608;DP=249,277,196;AF=1.00,1.00,1.00;MQM=60	GJA5	3'UTR	GJA5:ENST00000271348:3_prime_UTR_variant:MODIFIER:exon2/2:c.*888C>T::,GJA5:ENST00000369237:3_prime_UTR_variant:MODIFIER:exon2/2:c.*888C>T::	regulatory_region_variant:promoter_flanking_region	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];				rs10900395	0.9886	0.9883	15335,.		1.1850			0.00,0.11	6.08						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147229563	147229563	G	A	het	wt	het		QUAL=7561;DP=348,382,316;AF=0.43,0.00,0.48;MQM=60	GJA5,RP11-433J22.2	3'UTR,non_coding_transcript_exon	GJA5:ENST00000271348:3_prime_UTR_variant:MODIFIER:exon2/2:c.*707C>T::,GJA5:ENST00000369237:3_prime_UTR_variant:MODIFIER:exon2/2:c.*707C>T::,RP11-433J22.2:ENST00000428911:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.138G>A::	regulatory_region_variant:promoter_flanking_region	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];				rs1043802	0.3191	0.2495	997,.		0.3440			0.01,0.20	7.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39), RP11-433J22.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	147229628	147229628	-	GGGCATTTGCCAGAGGTACATACCA	het	het	het		QUAL=8500;DP=217,375,286;AF=0.27,0.46,0.44;MQM=60	GJA5,RP11-433J22.2	3'UTR,non_coding_transcript_exon	GJA5:ENST00000271348:3_prime_UTR_variant:MODIFIER:exon2/2:c.*617_*641dup::,GJA5:ENST00000369237:3_prime_UTR_variant:MODIFIER:exon2/2:c.*617_*641dup::,RP11-433J22.2:ENST00000428911:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.204_228dup::	regulatory_region_variant:promoter_flanking_region	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];	292439 [likely benign DISEASE=Familial atrial fibrillation];			rs11267274	0.4667								3.91						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39), RP11-433J22.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	147229662	147229662	G	A	wt	het	wt		QUAL=5482;DP=438,519,384;AF=0.00,0.42,0.00;MQM=60	GJA5,RP11-433J22.2	3'UTR,non_coding_transcript_exon	GJA5:ENST00000271348:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::,GJA5:ENST00000369237:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::,RP11-433J22.2:ENST00000428911:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.237G>A::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];	292441 [likely benign DISEASE=Familial atrial fibrillation];			rs36005900	0.0675	0.1515	482,.		0.4910			0.15,0.80	13.85						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39), RP11-433J22.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	147230217	147230217	T	C	hom	het	hom		QUAL=19574;DP=315,233,191;AF=1.00,0.54,0.99;MQM=60	GJA5,RP11-433J22.2	3'UTR,intron&non_coding_transcript	GJA5:ENST00000271348:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53A>G::,GJA5:ENST00000369237:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53A>G::,RP11-433J22.2:ENST00000428911:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.455-245T>C::	regulatory_region_variant:promoter_flanking_region	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];				rs1692141	0.8804	0.8145	10432,.		-0.1160			0.01,0.24	5.43						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39), RP11-433J22.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	147232555	147232555	T	C	hom	hom	hom	off-target	QUAL=16890;DP=151,240,159;AF=1.00,1.00,1.00;MQM=59	GJA5	intron	GJA5:ENST00000271348:intron_variant:MODIFIER:exon1/1:c.-33-1176A>G::,GJA5:ENST00000369237:intron_variant:MODIFIER:exon1/1:c.-34+52A>G::		121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];			L2c (LINE/L2)	rs791278	0.9852	0.9850	15237,.		-1.3250			0.00,0.11	1.52						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147232646	147232646	G	A	wt	wt	het		QUAL=3087;DP=306,364,250;AF=0.00,0.00,0.52;MQM=60	GJA5	intron,5'UTR	GJA5:ENST00000271348:intron_variant:MODIFIER:exon1/1:c.-33-1267C>T::,GJA5:ENST00000369237:5_prime_UTR_variant:MODIFIER:exon1/2:c.-73C>T::		121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];			L2c (LINE/L2)	rs191717313	0.0004	0.0017	0,.		-0.0120			0.03,0.19	11.25			gain/donor/147232645-147232646/Medium/2.651307			0	6						GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147232740	147232740	C	T	het	het	het	off-target	QUAL=6566;DP=193,236,169;AF=0.50,0.42,0.44;MQM=60	GJA5	intron	GJA5:ENST00000271348:intron_variant:MODIFIER:exon1/1:c.-33-1361G>A::		121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];			L2c (LINE/L2)	rs10465885		0.5496	4755,.		-0.1700			0.02,0.18	1.68						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147245324	147245324	T	C	hom	hom	hom	off-target	QUAL=15875;DP=197,169,140;AF=1.00,1.00,1.00;MQM=60	GJA5	intron	GJA5:ENST00000271348:intron_variant:MODIFIER:exon1/1:c.-34+32A>G::	regulatory_region_variant:promoter	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];				rs1692137	0.9748	0.9821	15139,.		1.3810			0.10,0.15	4.40						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147245474	147245474	G	C	hom	hom	hom		QUAL=20917;DP=216,279,183;AF=1.00,1.00,1.00;MQM=60	GJA5	5'UTR	GJA5:ENST00000271348:5_prime_UTR_variant:MODIFIER:exon1/2:c.-152C>G::	regulatory_region_variant:promoter	121013 [GENE=GJA5 PHENOS=Atrial fibrillation,familial,11,614049,Autosomal dominant/Atrial standstill,digenic (GJA5/SCN5A),108770,Autosomal dominant];	368828 [likely benign DISEASE=Familial atrial fibrillation];			rs791286		0.9822	15139,.		0.7030			0.01,0.87	18.81						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	150771703	150771703	T	C	hom	hom	hom		QUAL=34866;DP=351,363,341;AF=1.00,1.00,1.00;MQM=60	CTSK	synonymous	CTSK:ENST00000271651:synonymous_variant:LOW:exon7/8:c.831A>G:p.Ala277=:PF00112		601105 [GENE=CTSK PHENOS=Pycnodysostosis,265800,Autosomal recessive];				rs10788796	0.9633	0.9897	15064,.	0.9221,0.9930,0.9930,0.9987,0.9776	-6.7590			0.02,0.13	9.50						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTSK (inh=AR oe_syn=0.89 oe_mis=0.79 oe_lof=0.55)
chr1	151313774	151313774	A	G	het	wt	hom		QUAL=6567;DP=284,137,90;AF=0.49,0.01,1.00;MQM=60	RFX5,RP11-126K1.8	3'UTR,intron&non_coding_transcript	RFX5:ENST00000290524:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RP11-126K1.8:ENST00000422153:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.255+396A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	601863 [GENE=RFX5 PHENOS=Bare lymphocyte syndrome,type II,complementation group C,209920,Autosomal recessive/Bare lymphocyte syndrome,type II,complementation group E,209920,Autosomal recessive];	292600 [benign DISEASE=Bare lymphocyte syndrome 2];			rs7552906	0.6280	0.6236	6096,.		0.2260			0.07,0.13	6.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR+AD oe_syn=0.75 oe_mis=0.93 oe_lof=0.76), RP11-126K1.8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	151314379	151314379	T	C	het	het	hom		QUAL=8302;DP=199,157,113;AF=0.56,0.47,1.00;MQM=60	RFX5,RP11-126K1.8	3'UTR,non_coding_transcript_exon	RFX5:ENST00000290524:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:ENST00000368870:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RP11-126K1.8:ENST00000422153:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.295T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	601863 [GENE=RFX5 PHENOS=Bare lymphocyte syndrome,type II,complementation group C,209920,Autosomal recessive/Bare lymphocyte syndrome,type II,complementation group E,209920,Autosomal recessive];	292605 [benign DISEASE=Bare lymphocyte syndrome 2];		MLT1K (LTR/ERVL-MaLR)	rs1752387	0.7644	0.7673	9246,.		-1.3700			0.00,0.16	6.87						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR+AD oe_syn=0.75 oe_mis=0.93 oe_lof=0.76), RP11-126K1.8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	151315287	151315287	G	C	het	wt	het		QUAL=3187;DP=117,186,137;AF=0.50,0.00,0.51;MQM=60	RFX5	missense	RFX5:ENST00000290524:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621,RFX5:ENST00000368870:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621,RFX5:ENST00000452513:missense_variant:MODERATE:exon10/10:c.1106C>G:p.Pro369Arg:PF14621,RFX5:ENST00000452671:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621		601863 [GENE=RFX5 PHENOS=Bare lymphocyte syndrome,type II,complementation group C,209920,Autosomal recessive/Bare lymphocyte syndrome,type II,complementation group E,209920,Autosomal recessive];	292612 [benign/likely benign DISEASE=Bare lymphocyte syndrome 2,not specified];			rs2233854	0.0635	0.1172	299,.	0.0253,0.0720,0.0004,0.1665,0.0990	1.7470	D(0.00),D(0.00),D(0.00),D(0.00)	B(0.11),B(0.11),B(0.12),B(0.11)	0.59,0.64	17.94	0.03					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR+AD oe_syn=0.75 oe_mis=0.93 oe_lof=0.76)
chr1	151316161	151316161	G	A	hom	hom	hom		QUAL=13222;DP=186,132,94;AF=1.00,1.00,1.00;MQM=59	RFX5	synonymous	RFX5:ENST00000290524:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:ENST00000368870:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:ENST00000452513:synonymous_variant:LOW:exon8/10:c.633C>T:p.Leu211=:,RFX5:ENST00000452671:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:		601863 [GENE=RFX5 PHENOS=Bare lymphocyte syndrome,type II,complementation group C,209920,Autosomal recessive/Bare lymphocyte syndrome,type II,complementation group E,209920,Autosomal recessive];	403373 [benign DISEASE=not specified];			rs1752386		0.9945	15024,.	0.9251,0.9964,1.0000,0.9999,0.9998	0.2350			0.18,0.34	13.43						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR+AD oe_syn=0.75 oe_mis=0.93 oe_lof=0.76)
chr1	152274685	152274685	T	A	hom	hom	hom		QUAL=8564;DP=95,107,63;AF=1.00,1.00,1.00;MQM=60	FLG,FLG-AS1	3'UTR,intron&non_coding_transcript	FLG:ENST00000368799:3_prime_UTR_variant:MODIFIER:exon3/3:c.*491A>T::,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+376T>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+376T>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs1933061	0.9994	0.9981	15639,.		-2.2810			0.00,0.16	2.95						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152276149	152276149	C	T	het	het	het		QUAL=43694;DP=466,1868,1276;AF=0.49,0.51,0.50;MQM=59	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.11213G>A:p.Arg3738His:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+1840C>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+1840C>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs77422831	0.2869	0.2423	479,.	0.0294,0.4284,0.5593,0.1422,0.3682	-2.2520	T(0.43), , 	B(0.07), , 	0.01,0.11	6.78	0.02		gain/donor/152276148-152276149/Medium/0.649087			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152276377	152276377	C	G	wt	het	het		QUAL=10016;DP=493,2040,1476;AF=0.05,0.31,0.19;MQM=28	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.10985G>C:p.Ser3662Thr:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+2068C>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+2068C>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs75235053		0.0173	0,.	0.0002,0.0292,0.0645,0.0041,0.0201	-0.7420	D(0.01), , 	P(0.76), , 	0.07,0.17	14.47	0.03					0	1539						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152276459	152276459	C	T	wt	het	het		QUAL=17382;DP=411,2202,1550;AF=0.10,0.38,0.22;MQM=30	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.10903G>A:p.Asp3635Asn:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+2150C>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+2150C>T::	regulatory_region_variant:CTCF_binding_site	135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs75448155		0.0941	0,.	0.0104,0.1571,0.2732,0.0600,0.1449	1.6290	D(0.00), , 	D(0.97), , 	0.16,0.38	23.00	0.10					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152276583	152276583	C	G	het	het	het		QUAL=11127;DP=349,632,898;AF=0.15,0.69,0.19;MQM=33	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.10779G>C:p.Glu3593Asp:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+2274C>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+2274C>G::	regulatory_region_variant:CTCF_binding_site	135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs12083389	0.3614	0.1541	369,.	0.4017,0.1810,0.2813,0.0226,0.1261	0.3080	T(1.00), , 	B(0.01), , 	0.00,0.06	6.07	0.04					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152276598	152276598	G	A	wt	hom	het		QUAL=11623;DP=373,428,807;AF=0.08,0.98,0.21;MQM=31	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.10764C>T:p.His3588=:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+2289G>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+2289G>A::	regulatory_region_variant:CTCF_binding_site	135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs12742178	0.0887	0.0655	77,.	0.0246,0.1379,0.3089,0.0141,0.1036	-2.1460			0.00,0.05	0.11						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152276626	152276626	G	C	het	hom	het		QUAL=6371;DP=434,313,753;AF=0.12,0.98,0.15;MQM=33	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.10736C>G:p.Thr3579Arg:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+2317G>C::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+2317G>C::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs3126075	0.4778	0.1863	938,.	0.4692,0.1227,0.3199,0.0121,0.0769	-5.4480	T(0.57), , 	B(0.00), , 	0.00,0.05	0.86	0.01					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152276671	152276671	C	T	wt	het	het		QUAL=1734;DP=599,488,883;AF=0.10,0.26,0.13;MQM=44	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.10691G>A:p.Arg3564His:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+2362C>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+2362C>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs7518080	0.2564	0.0886	0,.	0.2098,0.2029,0.3318,0.0226,0.1590	-1.3060	T(1.00), , 	B(0.00), , 	0.00,0.04	0.38	0.01					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152276699	152276699	A	G	het	het	het		QUAL=7957;DP=508,552,893;AF=0.26,0.55,0.14;MQM=35	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.10663T>C:p.Trp3555Arg:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+2390A>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+2390A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs12728605		0.1233	4,.	0.2392,0.2063,0.3023,0.0353,0.1825	-1.1810	T(0.58), , 	B(0.12), , 	0.00,0.03	3.13	0.01					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152276772	152276772	C	A	het	het	het		QUAL=31894;DP=405,675,1141;AF=0.44,0.86,0.44;MQM=56	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.10590G>T:p.Arg3530Ser:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+2463C>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+2463C>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs72697000	0.2905	0.2461	322,.	0.0291,0.4311,0.5574,0.1447,0.3866	-5.0060	T(0.73), , 	D(1.00), , 	0.00,0.09	9.71	0.06		gain/donor/152276771-152276772/Medium/1.344219			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152276871	152276871	A	G	het	hom	het		QUAL=38320;DP=523,642,1125;AF=0.41,0.99,0.47;MQM=58	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.10491T>C:p.Asp3497=:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+2562A>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+2562A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs3126066	0.4471	0.2836	1497,.	0.4821,0.4531,0.5950,0.1468,0.3918	-3.4900			0.00,0.05	0.92					COSM6876905	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152276889	152276889	A	G	het	hom	het		QUAL=37842;DP=525,632,1141;AF=0.41,0.99,0.46;MQM=58	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.10473T>C:p.Asn3491=:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+2580A>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+2580A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs3126067		0.3268	2653,.	0.7179,0.4684,0.5971,0.1488,0.3926	-4.3620			0.00,0.05	4.33						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152277055	152277055	C	G	het	hom	het		QUAL=26799;DP=475,534,850;AF=0.37,0.91,0.46;MQM=53	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.10307G>C:p.Gly3436Ala:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+2746C>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+2746C>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs2065955	0.5142	0.3179	2474,.	0.7135,0.4648,0.5895,0.1467,0.3798	-0.5970	T(0.08), , 	P(0.75), , 	0.02,0.14	10.16	0.03					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152277168	152277168	A	G	het	hom	het		QUAL=44808;DP=507,908,1061;AF=0.46,0.99,0.46;MQM=50	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.10194T>C:p.Ser3398=:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+2859A>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+2859A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs3091276	0.4736	0.2925	1639,.	0.5216,0.4581,0.6032,0.1510,0.4066	-2.0220			0.00,0.08	0.87			loss/acceptor/152277168-152277169/Medium/1.455535			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152277309	152277309	G	A	wt	het	wt		QUAL=25909;DP=618,2025,1358;AF=0.00,0.51,0.00;MQM=53	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.10053C>T:p.Asp3351=:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+3000G>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+3000G>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs34687484	0.0028	0.0039	0,.	0.0006,0.0035,0.0001,0.0051,0.0057	-6.2540			0.00,0.06	0.07						1	85						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152277345	152277345	C	T	het	het	het		QUAL=47006;DP=550,1986,1335;AF=0.45,0.48,0.48;MQM=58	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.10017G>A:p.Gln3339=:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+3036C>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+3036C>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs2065956	0.2875	0.2428	490,.	0.0290,0.4286,0.5598,0.1423,0.3712	-1.0760			0.01,0.11	3.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152277396	152277396	T	C	het	hom	het		QUAL=80655;DP=508,1869,1283;AF=0.45,0.99,0.49;MQM=58	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.9966A>G:p.Gln3322=:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+3087T>C::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+3087T>C::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs6681433	0.3411	0.2728	644,.	0.1272,0.4468,0.5789,0.1653,0.4282	-1.7460			0.01,0.05	0.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152277554	152277554	G	A	wt	het	wt		QUAL=19238;DP=489,1540,1192;AF=0.00,0.49,0.00;MQM=59	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.9808C>T:p.Arg3270Cys:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+3245G>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+3245G>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs35621145	0.0250	0.0228	6,.	0.0041,0.0137,0.0191,0.0225,0.0564	-0.5000	D(0.04), , 	P(0.84), , 	0.00,0.09	15.58	0.11				COSM2185013	8	295						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152277717	152277717	C	A	het	hom	het		QUAL=41611;DP=275,1115,914;AF=0.33,1.00,0.36;MQM=48	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.9645G>T:p.Val3215=:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+3408C>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+3408C>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs9436066	0.4696	0.3044	1518,.	0.4829,0.4618,0.6400,0.1669,0.4309	-6.2400			0.00,0.06	0.27						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152277822	152277822	T	C	het	hom	wt		QUAL=12347;DP=343,401,685;AF=0.22,0.98,0.04;MQM=38	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.9540A>G:p.Ser3180=:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+3513T>C::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+3513T>C::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs3126069	0.2238	0.1309	350,.	0.0331,0.2724,0.4288,0.0439,0.2553	-4.3740			0.00,0.03	0.01					COSM896103	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152277826	152277826	A	C	het	hom	wt		QUAL=12347;DP=343,401,685;AF=0.22,0.98,0.04;MQM=38	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.9536T>G:p.Val3179Gly:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+3517A>C::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+3517A>C::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs2065957	0.3936	0.2372	1155,.	0.4397,0.3037,0.4669,0.0473,0.2644	-0.6040	T(1.00), , 	B(0.00), , 	0.00,0.04	4.52	0.03					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152278434	152278434	T	G	het	wt	het		QUAL=2701;DP=447,551,489;AF=0.23,0.00,0.24;MQM=39	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.8928A>C:p.Glu2976Asp:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+4125T>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+4125T>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs61816760	0.2873	0.3872	107,.	0.3544,0.3002,0.1149,0.3919,0.3118	-1.3040	T(0.54), , 	B(0.25), , 	0.03,0.15	4.28	0.02					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152278484	152278484	C	T	wt	het	wt		QUAL=3338;DP=441,878,702;AF=0.00,0.25,0.00;MQM=39	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.8878G>A:p.Gly2960Ser:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+4175C>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+4175C>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs61690342		0.0323	2,.	0.0988,0.0148,0.0170,0.0185,0.0459	-1.1860	T(0.29), , 	B(0.00), , 	0.01,0.12	0.29	0.04					0	314						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152278555	152278555	T	C	het	het	het		QUAL=26955;DP=438,1612,1309;AF=0.26,0.50,0.25;MQM=45	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.8807A>G:p.Asp2936Gly:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+4246T>C::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+4246T>C::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs80221306		0.2073	2,.	0.0902,0.3298,0.4025,0.1353,0.3092	-0.3860	T(0.38), , 	B(0.01), , 	0.01,0.15	10.26	0.02					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152278689	152278689	C	A	het	hom	het		QUAL=148641;DP=679,3377,2541;AF=0.56,1.00,0.55;MQM=50	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.8673G>T:p.Val2891=:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+4380C>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+4380C>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs57672167	0.3964	0.2792	993,.	0.2106,0.4529,0.5810,0.1651,0.4244	-5.7280			0.00,0.03	0.22						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152278814	152278814	C	T	wt	het	het		QUAL=19826;DP=1071,4165,2985;AF=0.07,0.24,0.18;MQM=38	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.8548G>A:p.Gly2850Ser:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+4505C>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+4505C>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs2184952		0.0725	0,.	0.0452,0.1831,0.2761,0.0226,0.1603	-2.5340	T(0.85), , 	B(0.12), , 	0.00,0.05	0.85	0.02					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152278856	152278856	T	G	het	het	het		QUAL=16239;DP=828,3914,2685;AF=0.23,0.18,0.21;MQM=50	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.8506A>C:p.Ser2836Arg:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+4547T>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+4547T>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs11582087		0.1781	0,.	0.0255,0.3147,0.3953,0.1105,0.2619	-1.7590	D(0.04), , 	B(0.09), , 	0.00,0.09	12.75	0.03					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152279019	152279019	G	A	het	het	het		QUAL=8464;DP=982,4110,2430;AF=0.15,0.17,0.19;MQM=35	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.8343C>T:p.Asp2781=:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+4710G>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+4710G>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs57670307		0.1244	0,.	0.0176,0.2495,0.3700,0.0663,0.1923	-5.5940			0.00,0.07	0.23					COSM6264547	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152279729	152279729	C	T	het	hom	het		QUAL=71023;DP=572,1542,1193;AF=0.47,0.99,0.53;MQM=58	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.7633G>A:p.Gly2545Arg:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+5420C>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+5420C>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs3126072	0.4748	0.3025	1693,.	0.5242,0.4626,0.6041,0.1658,0.4260	-1.5600	T(0.45), , 	B(0.00), , 	0.00,0.05	8.33	0.02					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152279841	152279841	G	C	het	hom	het		QUAL=72424;DP=472,1575,1191;AF=0.49,1.00,0.52;MQM=58	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.7521C>G:p.His2507Gln:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+5532G>C::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+5532G>C::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs3126074	0.4623	0.2999	1539,.	0.4833,0.4609,0.6037,0.1658,0.4261	-7.9550	T(1.00), , 	B(0.00), , 	0.00,0.04	0.27	0.02					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152279920	152279920	A	G	het	hom	het		QUAL=75416;DP=453,1663,1211;AF=0.49,1.00,0.53;MQM=59	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.7442T>C:p.Leu2481Ser:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+5611A>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+5611A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs55650366	0.3425	0.2723	640,.	0.1323,0.4464,0.5791,0.1649,0.4241	-1.3450	T(1.00), , 	B(0.00), , 	0.00,0.05	0.36	0.01					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152279964	152279964	C	T	wt	het	wt		QUAL=22740;DP=615,1675,1225;AF=0.00,0.52,0.00;MQM=59	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.7398G>A:p.Pro2466=:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+5655C>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+5655C>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs71625199	0.0248	0.0227	5,.	0.0034,0.0137,0.0191,0.0225,0.0559	-8.7560			0.00,0.05	0.11						4	296						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152280032	152280032	T	C	het	hom	het		QUAL=82527;DP=547,1840,1327;AF=0.48,1.00,0.51;MQM=58	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.7330A>G:p.Lys2444Glu:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+5723T>C::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+5723T>C::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs71625200	0.3431	0.2723	642,.	0.1324,0.4465,0.5790,0.1647,0.4240	-0.8890	T(1.00), , 	B(0.00), , 	0.00,0.08	7.42	0.03					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152280170	152280170	C	G	het	hom	het		QUAL=56454;DP=452,1441,1160;AF=0.44,0.97,0.44;MQM=47	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.7192G>C:p.Glu2398Gln:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+5861C>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+5861C>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs71625201	0.3305	0.2585	229,.	0.1263,0.4148,0.5201,0.1622,0.4039	-1.3100	T(0.37), , 	B(0.01), , 	0.01,0.12	0.54	0.02					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152280265	152280265	C	G	het	het	het		QUAL=34895;DP=502,1084,1100;AF=0.38,0.86,0.31;MQM=38	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.7097G>C:p.Ser2366Thr:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+5956C>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+5956C>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs71625202		0.2131	55,.	0.0305,0.3389,0.4093,0.1431,0.3311	0.0300	D(0.01), , 	D(0.97), , 	0.07,0.22	18.11	0.09					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152280347	152280347	C	T	het	het	het		QUAL=29874;DP=473,1015,1153;AF=0.35,0.79,0.29;MQM=37	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.7015G>A:p.Asp2339Asn:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+6038C>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+6038C>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs139476473		0.1505	228,.	0.0218,0.2926,0.3790,0.0742,0.2640	1.6910	D(0.02), , 	D(0.94), , 	0.15,0.66	22.80	0.14					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152280372	152280372	G	A	het	hom	het		QUAL=40959;DP=507,1039,1117;AF=0.48,0.99,0.34;MQM=36	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.6990C>T:p.His2330=:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+6063G>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+6063G>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs6664985	0.4535	0.2725	1496,.	0.4379,0.4447,0.6132,0.1053,0.4062	-3.4130			0.01,0.14	0.60						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152280471	152280471	C	G	het	het	het		QUAL=9709;DP=656,1873,1348;AF=0.23,0.29,0.14;MQM=36	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.6891G>C:p.Glu2297Asp:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+6162C>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+6162C>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs78179835		0.1955	16,.	0.0979,0.3197,0.3852,0.1256,0.3042	-1.8340	T(1.00), , 	B(0.00), , 	0.00,0.07	0.16	0.03					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152280685	152280685	C	A	het	het	wt		QUAL=2916;DP=433,1820,1260;AF=0.11,0.17,0.08;MQM=56	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.6677G>T:p.Gly2226Val:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+6376C>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+6376C>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs544807449	0.1833	0.0214	0,.	0.0573,0.0448,0.1537,0.0034,0.0303	0.1350	T(0.07), , 	B(0.37), , 	0.03,0.11	9.55	0.17				COSM675348	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152280687	152280687	C	T	het	het	wt		QUAL=2916;DP=433,1820,1260;AF=0.11,0.17,0.08;MQM=56	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.6675G>A:p.Val2225=:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+6378C>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+6378C>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs564482396	0.1833	0.0235	0,.	0.0637,0.0529,0.1703,0.0039,0.0338	-1.6180			0.00,0.05	0.05					COSM423886	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152280688	152280688	A	G	het	het	wt		QUAL=2916;DP=433,1820,1260;AF=0.11,0.17,0.08;MQM=56	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.6674T>C:p.Val2225Ala:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+6379A>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+6379A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs116918835	0.1833	0.0334	0,.	0.0770,0.0904,0.2047,0.0070,0.0495	-0.5260	T(0.52), , 	B(0.00), , 	0.00,0.08	2.33	0.04					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152280691	152280691	A	T	het	het	wt		QUAL=2916;DP=433,1820,1260;AF=0.11,0.17,0.08;MQM=56	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.6671T>A:p.Leu2224Gln:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+6382A>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+6382A>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs117945779	0.1915	0.0410	0,.	0.1132,0.1120,0.2285,0.0089,0.0603	-1.9610	T(0.99), , 	B(0.00), , 	0.00,0.05	3.54	0.03		loss/acceptor/152280691-152280692/Medium/6.202680			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152280736	152280736	T	C	het	het	het		QUAL=23562;DP=782,2383,1501;AF=0.32,0.33,0.18;MQM=55	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.6626A>G:p.His2209Arg:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+6427T>C::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+6427T>C::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs66977240		0.2191	0,.	0.3443,0.3420,0.4132,0.1283,0.3119	-5.2630	T(0.75), , 	B(0.00), , 	0.00,0.04	2.56	0.01					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152280759	152280759	A	G	het	het	het		QUAL=36173;DP=855,2668,1554;AF=0.34,0.40,0.23;MQM=54	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.6603T>C:p.Asp2201=:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+6450A>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+6450A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs2338554	0.3672	0.2427	519,.	0.4274,0.3505,0.4200,0.1478,0.3295	-2.2170			0.00,0.05	0.67						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152280782	152280782	A	G	het	hom	het		QUAL=131363;DP=872,2788,1653;AF=0.65,1.00,0.63;MQM=56	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.6580T>C:p.Tyr2194His:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+6473A>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+6473A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs2184953	0.5397	0.3395	2718,.	0.7165,0.4761,0.6055,0.1680,0.4295	-2.7490	T(0.34), , 	B(0.00), , 	0.00,0.04	0.23	0.01					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152280788	152280788	T	G	het	het	het		QUAL=71473;DP=881,2825,1658;AF=0.32,0.73,0.27;MQM=54	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.6574A>C:p.Lys2192Gln:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.462+6479T>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.376+6479T>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs66954353		0.2410	5,.	0.3644,0.3513,0.4198,0.1511,0.3321	0.4010	T(1.00), , 	B(0.00), , 	0.00,0.04	5.92	0.02					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152280864	152280864	A	G	het	hom	het		QUAL=111820;DP=509,2559,1512;AF=0.61,1.00,0.66;MQM=54	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.6498T>C:p.Ser2166=:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-6518A>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-6518A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs2184954	0.4637	0.3000	1566,.	0.4840,0.4611,0.6040,0.1658,0.4263	-4.5190			0.00,0.03	0.28						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152280900	152280900	T	G	het	het	het		QUAL=31612;DP=690,2362,1471;AF=0.32,0.36,0.31;MQM=51	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.6462A>C:p.Gln2154His:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-6482T>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-6482T>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs74129452	0.3438	0.2384	0,.	0.3643,0.3503,0.4198,0.1470,0.3280	-3.3330	T(1.00), , 	B(0.00), , 	0.00,0.02	0.25	0.11					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152281007	152281007	A	G	het	het	het		QUAL=30320;DP=828,2308,1585;AF=0.29,0.30,0.30;MQM=59	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.6355T>C:p.Tyr2119His:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-6375A>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-6375A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs7512553	0.3277	0.2255	0,.	0.3638,0.3437,0.4134,0.1326,0.2979	-0.3240	T(1.00), , 	B(0.00), , 	0.00,0.04	2.44	0.04					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152281008	152281008	A	G	het	het	het		QUAL=30320;DP=828,2308,1585;AF=0.29,0.30,0.30;MQM=59	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.6354T>C:p.His2118=:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-6374A>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-6374A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs7512554	0.3277	0.2255	0,.	0.3638,0.3437,0.4134,0.1326,0.2979	-1.6980			0.00,0.07	3.93			gain/acceptor/152281007-152281008/Medium/1.296260			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152281039	152281039	G	A	het	het	het		QUAL=33326;DP=929,2391,1648;AF=0.30,0.32,0.32;MQM=59	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.6323C>T:p.Ala2108Val:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-6343G>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-6343G>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs7522925		0.2256	0,.	0.3649,0.3438,0.4134,0.1327,0.2980	-3.7960	T(0.06), , 	B(0.02), , 	0.01,0.09	0.07	0.07					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152281228	152281228	C	G	het	het	het		QUAL=37985;DP=731,2612,1965;AF=0.25,0.33,0.35;MQM=53	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.6134G>C:p.Ser2045Thr:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-6154C>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-6154C>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs7546186		0.2182	0,.	0.3448,0.3391,0.4078,0.1243,0.2958	1.5140	T(0.09), , 	P(0.72), , 	0.12,0.22	13.91	0.09		gain/acceptor/152281227-152281228/Medium/3.683495			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152281290	152281290	A	G	het	het	het		QUAL=35652;DP=666,2593,1989;AF=0.24,0.33,0.34;MQM=50	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.6072T>C:p.His2024=:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-6092A>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-6092A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs80353812	0.3281	0.2236	0,.	0.3573,0.3430,0.4129,0.1309,0.2980	-6.8960			0.00,0.08	0.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152281304	152281304	A	C	het	het	het		QUAL=37146;DP=670,2605,1966;AF=0.28,0.34,0.34;MQM=51	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.6058T>G:p.Ser2020Ala:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-6078A>C::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-6078A>C::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs7512857		0.2234	0,.	0.3420,0.3425,0.4133,0.1323,0.2975	0.3910	T(0.18), , 	D(0.93), , 	0.01,0.16	14.66	0.03					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152281317	152281317	G	T	wt	het	wt		QUAL=21149;DP=799,2641,2029;AF=0.00,0.34,0.00;MQM=59	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.6045C>A:p.Asp2015Glu:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-6065G>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-6065G>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs71626704	0.0248	0.0227	5,.	0.0034,0.0136,0.0190,0.0224,0.0559	0.0400	T(0.20), , 	B(0.23), , 	0.06,0.49	9.84	0.05					4	297						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152281479	152281479	G	T	het	hom	het		QUAL=105768;DP=877,1992,1621;AF=0.60,1.00,0.68;MQM=56	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.5883C>A:p.His1961Gln:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-5903G>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-5903G>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs3126079		0.3389	2717,.	0.7162,0.4760,0.6056,0.1679,0.4270	-4.7170	T(0.81), , 	B(0.00), , 	0.00,0.04	0.02	0.02					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152281523	152281523	A	C	het	het	het		QUAL=20145;DP=809,1834,1555;AF=0.19,0.30,0.30;MQM=48	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.5839T>G:p.Trp1947Gly:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-5859A>C::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-5859A>C::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs80059102		0.1979	0,.	0.3165,0.3198,0.4060,0.1120,0.2686	-0.5520	T(0.31), , 	B(0.00), , 	0.01,0.14	9.61	0.01					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152281534	152281534	A	T	het	het	het		QUAL=17148;DP=756,1780,1514;AF=0.18,0.28,0.28;MQM=48	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.5828T>A:p.Leu1943His:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-5848A>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-5848A>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs113544881	0.3135	0.1808	0,.	0.2351,0.2815,0.3878,0.0756,0.2233	-2.7300	T(1.00), , 	B(0.00), , 	0.00,0.04	2.38	0.05					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152281690	152281690	C	T	het	het	het		QUAL=41124;DP=535,1369,1169;AF=0.47,0.53,0.51;MQM=59	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.5672G>A:p.Arg1891Gln:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-5692C>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-5692C>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs12407748	0.2875	0.2422	477,.	0.0292,0.4282,0.5601,0.1421,0.3676	-4.3630	T(0.46), , 	B(0.17), , 	0.00,0.06	0.12	0.05					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152281691	152281691	G	A	wt	het	wt		QUAL=16106;DP=553,1370,1171;AF=0.00,0.46,0.00;MQM=59	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.5671C>T:p.Arg1891Trp:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-5691G>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-5691G>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs36006086	0.0250	0.0227	4,.	0.0041,0.0136,0.0190,0.0225,0.0559	-0.6350	D(0.01), , 	D(0.98), , 	0.00,0.10	18.10	0.04				COSM4887424	4	297						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152281745	152281745	G	T	wt	het	wt		QUAL=16152;DP=627,1417,1185;AF=0.00,0.45,0.00;MQM=59	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.5617C>A:p.Gln1873Lys:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-5637G>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-5637G>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs62623409	0.0250	0.0227	5,.	0.0041,0.0136,0.0189,0.0224,0.0557	-0.9500	T(0.09), , 	B(0.04), , 	0.01,0.10	8.47	0.04					4	297						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152281907	152281907	A	G	wt	het	wt		QUAL=1163;DP=446,1615,1044;AF=0.00,0.12,0.00;MQM=47	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.5455T>C:p.Ser1819Pro:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-5475A>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-5475A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs754699295		0.0007	0,.	0.0000,0.0001,0.0000,0.0001,0.0000	0.7130	T(0.09), , 	P(0.70), , 	0.02,0.19	15.55	0.02				COSM2185276	0	10						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152281911	152281911	T	C	wt	het	wt		QUAL=1163;DP=446,1615,1044;AF=0.00,0.12,0.00;MQM=47	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.5451A>G:p.Pro1817=:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-5471T>C::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-5471T>C::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs546421577	0.0020	0.0023	0,.	0.0030,0.0004,0.0001,0.0002,0.0002	-7.4340			0.00,0.06	0.03						0	12						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152281948	152281948	G	A	het	het	het		QUAL=37413;DP=454,1966,1117;AF=0.48,0.39,0.51;MQM=58	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.5414C>T:p.Ala1805Val:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-5434G>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-5434G>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs12405241	0.2875	0.2422	481,.	0.0290,0.4278,0.5603,0.1421,0.3679	-5.6240	T(0.20), , 	D(0.96), , 	0.00,0.11	7.05	0.10					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152282092	152282092	T	C	wt	het	wt		QUAL=2512;DP=510,1981,1241;AF=0.00,0.17,0.00;MQM=52	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.5270A>G:p.Glu1757Gly:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-5290T>C::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-5290T>C::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs778942937		0.0029	0,.	0.0000,0.0000,0.0000,0.0001,0.0001	0.7390	T(0.11), , 	B(0.08), , 	0.02,0.24	14.36	0.03					0	18						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152282101	152282101	T	C	wt	het	wt		QUAL=219;DP=485,1871,1242;AF=0.00,0.12,0.00;MQM=49	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.5261A>G:p.Gln1754Arg:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-5281T>C::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-5281T>C::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs761680413		0.0015	0,.	0.0000,0.0001,0.0001,0.0001,0.0002	-0.7090	T(0.83), , 	B(0.01), , 	0.02,0.15	1.10	0.03				COSM6289746	0	5						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152282104	152282104	C	T	wt	het	wt		QUAL=219;DP=485,1871,1242;AF=0.00,0.12,0.00;MQM=49	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.5258G>A:p.Gly1753Asp:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-5278C>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-5278C>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs762948644		0.0011	0,.	0.0000,0.0000,0.0000,0.0000,0.0000	-0.1810	D(0.02), , 	D(0.99), , 	0.01,0.12	15.90	0.03					0	6						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152282267	152282267	G	A	het	het	het		QUAL=36046;DP=404,1515,1224;AF=0.47,0.48,0.47;MQM=60	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.5095C>T:p.Arg1699Cys:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-5115G>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-5115G>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs12405278	0.2877	0.2422	481,.	0.0290,0.4279,0.5603,0.1421,0.3680	0.1370	D(0.02), , 	D(0.91), , 	0.03,0.15	18.99	0.05					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152282311	152282311	C	T	het	het	het		QUAL=39140;DP=505,1507,1234;AF=0.46,0.51,0.48;MQM=59	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.5051G>A:p.Arg1684His:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-5071C>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-5071C>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs12407807	0.2967	0.2447	498,.	0.0644,0.4288,0.5603,0.1421,0.3681	-2.4830	T(0.55), , 	D(0.97), , 	0.00,0.08	11.50	0.07					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152282522	152282522	C	T	wt	wt	het		QUAL=11065;DP=550,1242,1009;AF=0.00,0.00,0.48;MQM=60	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.4840G>A:p.Ala1614Thr:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-4860C>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-4860C>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];									-1.2150	T(0.20), , 	B(0.16), , 	0.00,0.08	6.59	0.03				COSM244545	0	1						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152282794	152282794	G	A	wt	het	wt		QUAL=16935;DP=438,1463,1151;AF=0.00,0.48,0.00;MQM=59	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.4568C>T:p.Thr1523Ile:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-4588G>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-4588G>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs12750081	0.0250	0.0227	4,.	0.0041,0.0136,0.0190,0.0225,0.0559	-0.3320	D(0.04), , 	B(0.04), , 	0.01,0.11	10.73	0.01					4	296						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152282910	152282910	G	C	wt	het	wt		QUAL=18554;DP=484,1491,1078;AF=0.00,0.49,0.00;MQM=59	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.4452C>G:p.Asp1484Glu:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-4472G>C::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-4472G>C::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs71626706	0.0248	0.0227	5,.	0.0034,0.0136,0.0190,0.0225,0.0560	-5.4290	T(1.00), , 	B(0.00), , 	0.00,0.06	0.08	0.05					4	298						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152282917	152282917	G	T	het	het	het		QUAL=37973;DP=476,1520,1069;AF=0.50,0.50,0.49;MQM=59	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.4445C>A:p.Ser1482Tyr:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-4465G>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-4465G>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs11204978	0.2871	0.2422	480,.	0.0290,0.4279,0.5602,0.1420,0.3678	0.2480	D(0.00), , 	B(0.34), , 	0.02,0.13	13.39	0.06					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152282952	152282952	A	G	wt	het	wt		QUAL=19659;DP=535,1568,1140;AF=0.00,0.49,0.00;MQM=59	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.4410T>C:p.His1470=:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-4430A>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-4430A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs12732920	0.0250	0.0227	4,.	0.0034,0.0136,0.0190,0.0225,0.0562	-8.9450			0.00,0.05	0.03						4	300						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152283053	152283053	G	A	wt	het	wt		QUAL=20685;DP=583,1685,1195;AF=0.00,0.49,0.00;MQM=59	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.4309C>T:p.Arg1437Cys:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-4329G>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-4329G>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs12750571	0.0048	0.0050	0,.	0.0006,0.0049,0.0002,0.0067,0.0066	-0.2710	D(0.01), , 	P(0.64), , 	0.01,0.11	17.16	0.04					1	130						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152283236	152283236	T	C	het	hom	het		QUAL=75991;DP=524,1679,1305;AF=0.48,1.00,0.49;MQM=55	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.4126A>G:p.Arg1376Gly:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-4146T>C::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-4146T>C::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs11581433	0.3431	0.2728	646,.	0.1321,0.4483,0.5792,0.1650,0.4241	-2.3740	T(1.00), , 	B(0.00), , 	0.00,0.09	0.92	0.01					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152283283	152283283	C	T	het	het	het		QUAL=40070;DP=520,1651,1245;AF=0.49,0.49,0.50;MQM=53	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.4079G>A:p.Arg1360His:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-4099C>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-4099C>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs11586631	0.2877	0.2423	482,.	0.0295,0.4279,0.5602,0.1420,0.3678	-6.3060	T(0.83), , 	B(0.05), , 	0.00,0.10	0.16	0.02					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152283862	152283862	G	C	het	hom	het		QUAL=64835;DP=535,1458,1103;AF=0.49,1.00,0.50;MQM=53	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.3500C>G:p.Ala1167Gly:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-3520G>C::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-3520G>C::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs58001094	0.5341	0.3362	2665,.	0.6886,0.4595,0.5991,0.1656,0.4086	-3.6180	T(1.00), , 	B(0.01), , 	0.00,0.05	0.03	0.05					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152283975	152283975	A	G	het	hom	het		QUAL=75261;DP=572,1698,1205;AF=0.51,1.00,0.50;MQM=51	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.3387T>C:p.Ser1129=:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-3407A>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-3407A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs66831674	0.4631	0.2998	1537,.	0.4836,0.4608,0.6036,0.1657,0.4260	-3.4180			0.00,0.05	0.03			loss/acceptor/152283975-152283976/Medium/1.463853			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152284377	152284377	G	A	het	het	wt		QUAL=30498;DP=575,1607,1315;AF=0.53,0.55,0.02;MQM=55	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.2985C>T:p.His995=:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-3005G>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-3005G>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs373872833		0.0001	0,.	0.0000,0.0004,0.0001,0.0001,0.0001	-0.6480			0.00,0.11	2.73					COSM6304259	0	10						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152284424	152284424	G	C	wt	het	wt		QUAL=22833;DP=720,1701,1328;AF=0.02,0.53,0.04;MQM=53	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.2938C>G:p.His980Asp:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-2958G>C::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-2958G>C::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];	402869 [benign DISEASE=not specified];			rs12756586	0.0339	0.0236	5,.	0.0149,0.0140,0.0190,0.0225,0.0565	-1.1170	T(1.00), , 	B(0.00), , 	0.00,0.06	0.02	0.02					5	328						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152284478	152284478	A	G	wt	het	wt		QUAL=1801;DP=530,1837,1307;AF=0.02,0.16,0.07;MQM=35	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.2884T>C:p.Trp962Arg:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-2904A>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-2904A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs199888588		0.0265	0,.	0.0127,0.0002,0.0002,0.0001,0.0001	-0.8190	T(0.91), , 	B(0.00), , 	0.00,0.03	0.10	0.02					0	155						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152284497	152284497	A	G	wt	het	wt		QUAL=3137;DP=510,1996,1346;AF=0.02,0.18,0.07;MQM=35	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.2865T>C:p.His955=:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-2885A>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-2885A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs144437056	0.0513	0.0376	0,.	0.0280,0.0002,0.0003,0.0001,0.0001	-5.3240			0.00,0.03	0.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152284505	152284505	C	G	wt	het	wt		QUAL=3495;DP=539,2052,1376;AF=0.02,0.18,0.07;MQM=35	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.2857G>C:p.Glu953Gln:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-2877C>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-2877C>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs201137357	0.1368	0.0502	11,.	0.1388,0.0031,0.0004,0.0005,0.0003	-0.3120	T(0.10), , 	P(0.89), , 	0.02,0.14	14.62	0.06					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152284576	152284576	C	A	wt	het	wt		QUAL=1452;DP=580,2113,1428;AF=0.03,0.15,0.05;MQM=36	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.2786G>T:p.Gly929Val:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-2806C>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-2806C>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs143382793		0.0189	0,.	0.0037,0.0001,0.0001,0.0001,0.0001	-0.1670	D(0.04), , 	P(0.85), , 	0.01,0.10	15.94	0.03					0	368						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152284854	152284854	A	G	het	hom	het		QUAL=57122;DP=474,1244,874;AF=0.48,0.99,0.51;MQM=58	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.2508T>C:p.Asp836=:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-2528A>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-2528A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs3120653	0.4732	0.3030	1584,.	0.5223,0.4630,0.6035,0.1663,0.4245	-0.0990			0.00,0.07	0.54					COSM6265107	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152285099	152285099	C	T	het	hom	het		QUAL=86281;DP=491,1884,1419;AF=0.52,1.00,0.50;MQM=59	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.2263G>A:p.Glu755Lys:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-2283C>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-2283C>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];	377878 [benign DISEASE=not specified];			rs74129461	0.3277	0.2681	583,.	0.0746,0.4437,0.5790,0.1649,0.4238	-0.3090	D(0.03), , 	B(0.22), , 	0.01,0.14	14.82	0.03					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152285181	152285181	G	T	wt	het	wt		QUAL=22870;DP=468,1842,1375;AF=0.00,0.48,0.00;MQM=59	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.2181C>A:p.His727Gln:PF03516,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-2201G>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-2201G>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs7512779	0.0250	0.0227	6,.	0.0041,0.0137,0.0190,0.0225,0.0558	-2.7370	T(0.07), , 	B(0.15), , 	0.00,0.09	0.02	0.01					5	297						FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152285930	152285930	G	A	het	hom	het		QUAL=70157;DP=510,1569,1174;AF=0.51,0.99,0.49;MQM=59	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.1432C>T:p.Pro478Ser:,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-1452G>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-1452G>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];		CM084968 [CLASS=DP MUT=ALT PHEN="Psoriasis increased risk association with" GENE=FLG];		rs11584340	0.3446	0.2726	649,.	0.1354,0.4467,0.5789,0.1649,0.4241	-1.8930	T(1.00), , 	B(0.03), , 	0.00,0.05	0.37	0.04					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152286002	152286002	T	C	het	hom	het		QUAL=68415;DP=450,1577,1149;AF=0.48,0.99,0.49;MQM=59	FLG,FLG-AS1	missense,non_coding_transcript_exon,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.1360A>G:p.Thr454Ala:,FLG-AS1:ENST00000392688:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.68T>C::,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-1380T>C::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-1380T>C::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];		CM1611993 [CLASS=R MUT=ALT PHEN="Ichthyosis vulgaris" GENE=FLG];		rs2011331	0.4641	0.3006	1560,.	0.4865,0.4623,0.6050,0.1660,0.4262	-2.8550	T(1.00), , , 	B(0.01), , , 	0.00,0.05	0.16	0.08					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152286032	152286032	C	T	het	het	het		QUAL=40536;DP=561,1562,1210;AF=0.47,0.46,0.50;MQM=59	FLG,FLG-AS1	missense,non_coding_transcript_exon,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.1330G>A:p.Gly444Arg:,FLG-AS1:ENST00000392688:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.98C>T::,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-1350C>T::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-1350C>T::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs11588170	0.2871	0.2421	472,.	0.0290,0.4281,0.5599,0.1419,0.3677	-0.6390	T(0.18), , , 	P(0.82), , , 	0.01,0.11	11.94	0.04					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152286126	152286126	A	G	het	wt	het		QUAL=20470;DP=459,1513,1204;AF=0.49,0.00,0.50;MQM=60	FLG,FLG-AS1	synonymous,non_coding_transcript_exon,intron&non_coding_transcript	FLG:ENST00000368799:synonymous_variant:LOW:exon3/3:c.1236T>C:p.Arg412=:PF03516,FLG-AS1:ENST00000392688:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.192A>G::,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-1256A>G::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-1256A>G::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs11582620	0.0861	0.1159	177,.	0.0178,0.0931,0.1025,0.1188,0.2011	-1.9280			0.00,0.08	0.10						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152286367	152286367	C	A	het	hom	het		QUAL=59318;DP=561,1279,911;AF=0.51,1.00,0.50;MQM=59	FLG,FLG-AS1	missense,non_coding_transcript_exon,intron&non_coding_transcript	FLG:ENST00000368799:missense_variant:MODERATE:exon3/3:c.995G>T:p.Gly332Val:,FLG-AS1:ENST00000392688:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.433C>A::,FLG-AS1:ENST00000420707:intron_variant&non_coding_transcript_variant:MODIFIER:exon4/8:n.463-1015C>A::,FLG-AS1:ENST00000593011:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.377-1015C>A::		135940 [GENE=FLG PHENOS=Dermatitis,atopic,susceptibility to,2,605803/Ichthyosis vulgaris,146700,Autosomal dominant];				rs41267154	0.3407	0.2719	634,.	0.1270,0.4463,0.5787,0.1648,0.4240	-1.0190	D(0.04), , , 	D(1.00), , , 	0.03,0.18	16.53	0.02					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG (inh=AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42), FLG-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154128672	154128672	G	A	wt	wt	het		QUAL=796;DP=183,125,86;AF=0.01,0.00,0.45;MQM=60	TPM3	3'UTR	TPM3:ENST00000368533:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1443C>T::		191030 [GENE=TPM3 PHENOS=CAP myopathy 1,609284,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant/Nemaline myopathy 1,autosomal dominant or recessive,609284,Autosomal recessive,Autosomal dominant];			AluSq2 (SINE/Alu)	rs4540651		0.6039	5968,.		-0.8210			0.00,0.04	1.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37)
chr1	154129265	154129265	A	G	wt	wt	het		QUAL=131;DP=105,19,11;AF=0.00,0.00,0.73;MQM=59	TPM3	3'UTR	TPM3:ENST00000328159:3_prime_UTR_variant:MODIFIER:exon9/9:c.*929T>C::,TPM3:ENST00000330188:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:ENST00000341372:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:ENST00000341485:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:ENST00000368533:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::		191030 [GENE=TPM3 PHENOS=CAP myopathy 1,609284,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant/Nemaline myopathy 1,autosomal dominant or recessive,609284,Autosomal recessive,Autosomal dominant];				rs1051370	0.3229	0.3023	1550,.		-0.4070			0.02,0.38	14.91						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37)
chr1	154134557	154134557	A	C	wt	wt	het		QUAL=1951;DP=454,366,217;AF=0.00,0.00,0.44;MQM=60	TPM3	intron	TPM3:ENST00000271850:intron_variant:MODIFIER:exon8/8:c.776-4360T>G::,TPM3:ENST00000302206:intron_variant:MODIFIER:exon7/7:c.395-4360T>G::,TPM3:ENST00000323144:intron_variant:MODIFIER:exon7/7:c.665-3033T>G::,TPM3:ENST00000328159:intron_variant:MODIFIER:exon8/8:c.744-4360T>G::,TPM3:ENST00000330188:intron_variant:MODIFIER:exon7/7:c.665-4360T>G::,TPM3:ENST00000341372:intron_variant:MODIFIER:exon7/7:c.590-4360T>G::,TPM3:ENST00000341485:intron_variant:MODIFIER:exon7/7:c.617-4360T>G::,TPM3:ENST00000368531:intron_variant:MODIFIER:exon7/7:c.665-3033T>G::,TPM3:ENST00000368533:intron_variant:MODIFIER:exon7/7:c.665-4360T>G::		191030 [GENE=TPM3 PHENOS=CAP myopathy 1,609284,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant/Nemaline myopathy 1,autosomal dominant or recessive,609284,Autosomal recessive,Autosomal dominant];	292625 [benign DISEASE=Nemaline myopathy,Congenital fiber-type disproportion];			rs3196889	0.3215	0.2972	1476,.		0.4210			0.01,0.22	7.59						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37)
chr1	154138228	154138228	G	A	wt	wt	het		QUAL=640;DP=198,56,37;AF=0.01,0.00,0.76;MQM=60	TPM3	intron	TPM3:ENST00000271850:intron_variant:MODIFIER:exon8/8:c.775+4648C>T::,TPM3:ENST00000302206:intron_variant:MODIFIER:exon7/7:c.394+4648C>T::,TPM3:ENST00000323144:intron_variant:MODIFIER:exon7/7:c.664+4648C>T::,TPM3:ENST00000328159:intron_variant:MODIFIER:exon8/8:c.743+3553C>T::,TPM3:ENST00000330188:intron_variant:MODIFIER:exon7/7:c.664+4648C>T::,TPM3:ENST00000341372:intron_variant:MODIFIER:exon7/7:c.589+4648C>T::,TPM3:ENST00000341485:intron_variant:MODIFIER:exon7/7:c.616+4648C>T::,TPM3:ENST00000368531:intron_variant:MODIFIER:exon7/7:c.664+4648C>T::,TPM3:ENST00000368533:intron_variant:MODIFIER:exon7/7:c.664+4648C>T::		191030 [GENE=TPM3 PHENOS=CAP myopathy 1,609284,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant/Nemaline myopathy 1,autosomal dominant or recessive,609284,Autosomal recessive,Autosomal dominant];	292666 [benign DISEASE=Nemaline myopathy,Congenital fiber-type disproportion];		AluSq2 (SINE/Alu)	rs10908723	0.3201	0.2995	1381,.		-0.0270			0.01,0.08	2.48						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37)
chr1	154138266	154138266	A	-	het	het	het		QUAL=195;DP=47,24,18;AF=0.32,0.42,0.22;MQM=60	TPM3	intron	TPM3:ENST00000271850:intron_variant:MODIFIER:exon8/8:c.775+4610del::,TPM3:ENST00000302206:intron_variant:MODIFIER:exon7/7:c.394+4610del::,TPM3:ENST00000323144:intron_variant:MODIFIER:exon7/7:c.664+4610del::,TPM3:ENST00000328159:intron_variant:MODIFIER:exon8/8:c.743+3515del::,TPM3:ENST00000330188:intron_variant:MODIFIER:exon7/7:c.664+4610del::,TPM3:ENST00000341372:intron_variant:MODIFIER:exon7/7:c.589+4610del::,TPM3:ENST00000341485:intron_variant:MODIFIER:exon7/7:c.616+4610del::,TPM3:ENST00000368531:intron_variant:MODIFIER:exon7/7:c.664+4610del::,TPM3:ENST00000368533:intron_variant:MODIFIER:exon7/7:c.664+4610del::		191030 [GENE=TPM3 PHENOS=CAP myopathy 1,609284,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant/Nemaline myopathy 1,autosomal dominant or recessive,609284,Autosomal recessive,Autosomal dominant];	292667 [likely benign DISEASE=Nemaline myopathy,Congenital fiber-type disproportion];		AluSq2 (SINE/Alu)	rs68185418	0.2664	0.2921	236,.		-1.6610				0.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37)
chr1	154139165	154139165	-	T	wt	wt	het		QUAL=91;DP=160,37,34;AF=0.04,0.00,0.32;MQM=60	TPM3	intron	TPM3:ENST00000271850:intron_variant:MODIFIER:exon8/8:c.775+3710dup::,TPM3:ENST00000302206:intron_variant:MODIFIER:exon7/7:c.394+3710dup::,TPM3:ENST00000323144:intron_variant:MODIFIER:exon7/7:c.664+3710dup::,TPM3:ENST00000328159:intron_variant:MODIFIER:exon8/8:c.743+2615dup::,TPM3:ENST00000330188:intron_variant:MODIFIER:exon7/7:c.664+3710dup::,TPM3:ENST00000341372:intron_variant:MODIFIER:exon7/7:c.589+3710dup::,TPM3:ENST00000341485:intron_variant:MODIFIER:exon7/7:c.616+3710dup::,TPM3:ENST00000368531:intron_variant:MODIFIER:exon7/7:c.664+3710dup::,TPM3:ENST00000368533:intron_variant:MODIFIER:exon7/7:c.664+3710dup::		191030 [GENE=TPM3 PHENOS=CAP myopathy 1,609284,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant/Nemaline myopathy 1,autosomal dominant or recessive,609284,Autosomal recessive,Autosomal dominant];	292677 [benign DISEASE=Nemaline myopathy,Congenital fiber-type disproportion];		AluSx1 (SINE/Alu)	rs373439338	0.3409	0.4201	2332,.						3.14						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37)
chr1	154139381	154139381	A	C	wt	wt	het		QUAL=552;DP=146,71,61;AF=0.00,0.01,0.44;MQM=60	TPM3	intron	TPM3:ENST00000271850:intron_variant:MODIFIER:exon8/8:c.775+3495T>G::,TPM3:ENST00000302206:intron_variant:MODIFIER:exon7/7:c.394+3495T>G::,TPM3:ENST00000323144:intron_variant:MODIFIER:exon7/7:c.664+3495T>G::,TPM3:ENST00000328159:intron_variant:MODIFIER:exon8/8:c.743+2400T>G::,TPM3:ENST00000330188:intron_variant:MODIFIER:exon7/7:c.664+3495T>G::,TPM3:ENST00000341372:intron_variant:MODIFIER:exon7/7:c.589+3495T>G::,TPM3:ENST00000341485:intron_variant:MODIFIER:exon7/7:c.616+3495T>G::,TPM3:ENST00000368531:intron_variant:MODIFIER:exon7/7:c.664+3495T>G::,TPM3:ENST00000368533:intron_variant:MODIFIER:exon7/7:c.664+3495T>G::		191030 [GENE=TPM3 PHENOS=CAP myopathy 1,609284,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant/Nemaline myopathy 1,autosomal dominant or recessive,609284,Autosomal recessive,Autosomal dominant];	292682 [benign DISEASE=Nemaline myopathy,Congenital fiber-type disproportion];		AluSx1 (SINE/Alu)	rs6673171	0.3229	0.2982	1481,.		0.7440			0.01,0.09	4.25						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37)
chr1	154141908	154141908	A	G	wt	wt	het	off-target	QUAL=3012;DP=183,303,249;AF=0.00,0.00,0.49;MQM=60	TPM3	intron	TPM3:ENST00000271850:intron_variant:MODIFIER:exon8/8:c.775+968T>C::,TPM3:ENST00000302206:intron_variant:MODIFIER:exon7/7:c.394+968T>C::,TPM3:ENST00000323144:intron_variant:MODIFIER:exon7/7:c.664+968T>C::,TPM3:ENST00000328159:intron_variant:MODIFIER:exon7/8:c.665-49T>C::,TPM3:ENST00000330188:intron_variant:MODIFIER:exon7/7:c.664+968T>C::,TPM3:ENST00000341372:intron_variant:MODIFIER:exon7/7:c.589+968T>C::,TPM3:ENST00000341485:intron_variant:MODIFIER:exon7/7:c.616+968T>C::,TPM3:ENST00000368530:intron_variant:MODIFIER:exon8/9:c.776-49T>C::,TPM3:ENST00000368531:intron_variant:MODIFIER:exon7/7:c.664+968T>C::,TPM3:ENST00000368533:intron_variant:MODIFIER:exon7/7:c.664+968T>C::		191030 [GENE=TPM3 PHENOS=CAP myopathy 1,609284,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion,255310,Autosomal recessive,Autosomal dominant/Nemaline myopathy 1,autosomal dominant or recessive,609284,Autosomal recessive,Autosomal dominant];	262627 [benign DISEASE=not specified];			rs4845364	0.7322	0.6193	6334,.	0.8127,0.7172,0.8686,0.5117,0.6475	1.4390			0.41,0.82	20.50						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37)
chr1	154245142	154245142	T	G	wt	het	wt		QUAL=2985;DP=377,244,166;AF=0.00,0.50,0.02;MQM=60	HAX1	5'UTR	HAX1:ENST00000328703:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::,HAX1:ENST00000457918:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::,HAX1:ENST00000483970:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	605998 [GENE=HAX1 PHENOS=Neutropenia,severe congenital 3,autosomal recessive,610738,Autosomal recessive];	292700 [benign DISEASE=Severe congenital neutropenia];			rs11265425	0.2098	0.2338	1053,.		-2.2010			0.01,0.29	6.12						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HAX1 (inh=AR oe_syn=0.87 oe_mis=0.97 oe_lof=0.85)
chr1	154548721	154548721	T	C	hom	het	hom		QUAL=8897;DP=113,108,126;AF=0.98,0.52,1.00;MQM=59	CHRNB2	3'UTR	CHRNB2:ENST00000368476:3_prime_UTR_variant:MODIFIER:exon6/6:c.*313T>C::		118507 [GENE=CHRNB2 PHENOS=Epilepsy,nocturnal frontal lobe,3,605375];				rs2072660		0.7078	7965,.		-1.8830			0.04,0.11	1.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46)
chr1	154548880	154548880	G	A	wt	het	wt		QUAL=1186;DP=76,106,62;AF=0.00,0.48,0.02;MQM=60	CHRNB2	3'UTR	CHRNB2:ENST00000368476:3_prime_UTR_variant:MODIFIER:exon6/6:c.*472G>A::		118507 [GENE=CHRNB2 PHENOS=Epilepsy,nocturnal frontal lobe,3,605375];	375660 [drug response DISEASE=nicotine response - Efficacy, Toxicity/ADR];			rs2072661	0.2646	0.2513	974,.		0.6430			0.07,0.13	4.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46)
chr1	154549470	154549470	T	C	wt	het	wt		QUAL=3420;DP=301,299,241;AF=0.00,0.45,0.00;MQM=60	CHRNB2	3'UTR	CHRNB2:ENST00000368476:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1062T>C::		118507 [GENE=CHRNB2 PHENOS=Epilepsy,nocturnal frontal lobe,3,605375];				rs12130403	0.2859	0.2945	1363,.		-0.0760			0.09,0.11	3.33						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46)
chr1	154550944	154550945	AG	-	wt	het	wt		QUAL=3305;DP=271,267,211;AF=0.00,0.48,0.00;MQM=60	CHRNB2	3'UTR	CHRNB2:ENST00000368476:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2538_*2539del::	regulatory_region_variant:open_chromatin_region	118507 [GENE=CHRNB2 PHENOS=Epilepsy,nocturnal frontal lobe,3,605375];				rs3841062	0.2668	0.2716	1152,.		0.4860				5.88						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46)
chr1	154552010	154552010	C	G	het	wt	het		QUAL=8354;DP=295,411,336;AF=0.56,0.00,0.48;MQM=59	CHRNB2,RP11-61L14.6	3'UTR,intron&non_coding_transcript	CHRNB2:ENST00000368476:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3602C>G::,RP11-61L14.6:ENST00000421866:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.47+83G>C::		118507 [GENE=CHRNB2 PHENOS=Epilepsy,nocturnal frontal lobe,3,605375];				rs1049998302		0.0001	0,.		-0.4130			0.14,0.15	3.36						0	2						CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46), RP11-61L14.6 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	155205669	155205669	G	T	hom	hom	hom	off-target	QUAL=19892;DP=92,334,251;AF=1.00,1.00,1.00;MQM=52	GBA	intron	GBA:ENST00000327247:intron_variant:MODIFIER:exon9/11:c.1225-34C>A::,GBA:ENST00000368373:intron_variant:MODIFIER:exon8/10:c.1225-34C>A::,GBA:ENST00000427500:intron_variant:MODIFIER:exon7/9:c.1078-34C>A::,GBA:ENST00000428024:intron_variant:MODIFIER:exon7/9:c.964-34C>A::,GBA:ENST00000536770:intron_variant:MODIFIER:exon6/8:c.886-34C>A::	regulatory_region_variant:promoter_flanking_region	606463 [GENE=GBA PHENOS=Gaucher disease,perinatal lethal,608013,Autosomal recessive/Gaucher disease,type I,230800,Autosomal recessive/Gaucher disease,type II,230900,Autosomal recessive/Gaucher disease,type III,231000,Autosomal recessive/Gaucher disease,type IIIC,231005,Autosomal recessive/Lewy body dementia,susceptibility to,127750,Autosomal dominant/Parkinson disease,late-onset,susceptibility to,168600,Autosomal dominant,Multifactorial];	256871 [benign DISEASE=not specified,not provided];			rs3115534		0.9866	14293,.	0.8399,0.9923,0.9996,0.9975,0.9983	0.6620			0.00,0.04	8.68						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GBA (inh=AR oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155207387	155207387	A	T	het	wt	het	off-target	QUAL=3984;DP=187,174,140;AF=0.51,0.00,0.54;MQM=53	GBA	intron	GBA:ENST00000327247:intron_variant:MODIFIER:exon7/11:c.762-18T>A::,GBA:ENST00000368373:intron_variant:MODIFIER:exon6/10:c.762-18T>A::,GBA:ENST00000427500:intron_variant:MODIFIER:exon5/9:c.615-18T>A::,GBA:ENST00000428024:intron_variant:MODIFIER:exon5/9:c.501-18T>A::,GBA:ENST00000536770:intron_variant:MODIFIER:exon4/8:c.423-18T>A::		606463 [GENE=GBA PHENOS=Gaucher disease,perinatal lethal,608013,Autosomal recessive/Gaucher disease,type I,230800,Autosomal recessive/Gaucher disease,type II,230900,Autosomal recessive/Gaucher disease,type III,231000,Autosomal recessive/Gaucher disease,type IIIC,231005,Autosomal recessive/Lewy body dementia,susceptibility to,127750,Autosomal dominant/Parkinson disease,late-onset,susceptibility to,168600,Autosomal dominant,Multifactorial];	198756 [benign DISEASE=not specified,not provided];			rs140335079	0.0018	0.0090	2,.	0.0026,0.0034,0.0001,0.0130,0.0014	-0.0700			0.03,0.11	1.74		10.84>7.92				1	228						GBA (inh=AR oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155724315	155724315	G	T	het	wt	het	off-target	QUAL=233;DP=56,82,47;AF=0.43,0.04,0.11;MQM=49	GON4L	intron	GON4L:ENST00000271883:intron_variant:MODIFIER:exon27/31:c.5518-36C>A::,GON4L:ENST00000368331:intron_variant:MODIFIER:exon27/31:c.5518-36C>A::,GON4L:ENST00000437809:intron_variant:MODIFIER:exon27/31:c.5518-36C>A::						rs200722936		0.0585		0.0370,0.0498,0.0430,0.0547,0.0982	0.1270			0.01,0.16	1.38						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155737385	155737385	C	T	hom	hom	hom	off-target	QUAL=8265;DP=37,156,118;AF=1.00,1.00,1.00;MQM=44	GON4L	intron	GON4L:ENST00000271883:intron_variant:MODIFIER:exon19/31:c.2647-53G>A::,GON4L:ENST00000361040:intron_variant:MODIFIER:exon19/20:c.2647-53G>A::,GON4L:ENST00000368331:intron_variant:MODIFIER:exon19/31:c.2647-53G>A::,GON4L:ENST00000437809:intron_variant:MODIFIER:exon19/31:c.2647-53G>A::						rs849712	0.9279	0.9356	13897,.		0.2140			0.00,0.08	1.37						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155755097	155755097	G	A	hom	hom	hom	off-target	QUAL=25676;DP=234,305,248;AF=1.00,1.00,1.00;MQM=60	GON4L	intron	GON4L:ENST00000271883:intron_variant:MODIFIER:exon13/31:c.1788+28C>T::,GON4L:ENST00000361040:intron_variant:MODIFIER:exon13/20:c.1788+28C>T::,GON4L:ENST00000368331:intron_variant:MODIFIER:exon13/31:c.1788+28C>T::,GON4L:ENST00000437809:intron_variant:MODIFIER:exon13/31:c.1788+28C>T::						rs822021		0.9836	13914,.	0.7734,0.9901,0.9999,0.9996,0.9996	-0.2560			0.01,0.12	6.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155785579	155785582	AACT	-	hom	hom	hom	off-target	QUAL=22977;DP=244,292,223;AF=1.00,1.00,1.00;MQM=60	GON4L	intron	GON4L:ENST00000271883:intron_variant:MODIFIER:exon8/31:c.1161+14_1161+17del::,GON4L:ENST00000361040:intron_variant:MODIFIER:exon8/20:c.1161+14_1161+17del::,GON4L:ENST00000368331:intron_variant:MODIFIER:exon8/31:c.1161+14_1161+17del::,GON4L:ENST00000437809:intron_variant:MODIFIER:exon8/31:c.1161+14_1161+17del::						rs148569012,rs3028172	0.8626	0.9332	11938,.	0.6358,0.9666,0.9991,0.9504,0.9506	-0.3330				11.71						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	156025096	156025096	C	T	wt	wt	het		QUAL=1260;DP=86,167,108;AF=0.00,0.00,0.51;MQM=60	LAMTOR2	synonymous	LAMTOR2:ENST00000368302:synonymous_variant:LOW:exon2/4:c.111C>T:p.Tyr37=:PF03259,LAMTOR2:ENST00000368304:synonymous_variant:LOW:exon2/3:c.111C>T:p.Tyr37=:PF03259,LAMTOR2:ENST00000368305:synonymous_variant:LOW:exon2/4:c.111C>T:p.Tyr37=:PF03259	regulatory_region_variant:promoter	610389 [GENE=LAMTOR2 PHENOS=Immunodeficiency due to defect in MAPBP-interacting protein,610798,Autosomal recessive];				rs7541	0.0717	0.1214	220,.	0.0514,0.0910,0.0004,0.1614,0.0814	-0.9570			0.11,0.74	18.30						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMTOR2 (inh=AR oe_syn=1.11 oe_mis=0.57 oe_lof=0.30)
chr1	156105028	156105028	T	C	wt	wt	het		QUAL=341;DP=90,54,36;AF=0.01,0.00,0.47;MQM=60	LMNA	synonymous	LMNA:ENST00000347559:synonymous_variant:LOW:exon5/11:c.861T>C:p.Ala287=:PF00038,LMNA:ENST00000361308:synonymous_variant:LOW:exon5/10:c.861T>C:p.Ala287=:PF00038,LMNA:ENST00000368297:synonymous_variant:LOW:exon6/11:c.618T>C:p.Ala206=:PF00038,LMNA:ENST00000368299:synonymous_variant:LOW:exon5/12:c.861T>C:p.Ala287=:PF00038,LMNA:ENST00000368300:synonymous_variant:LOW:exon5/12:c.861T>C:p.Ala287=:PF00038,LMNA:ENST00000368301:synonymous_variant:LOW:exon8/13:c.861T>C:p.Ala287=:PF00038,LMNA:ENST00000392353:synonymous_variant:LOW:exon5/10:c.618T>C:p.Ala206=:PF00038,LMNA:ENST00000448611:synonymous_variant:LOW:exon5/13:c.525T>C:p.Ala175=:PF00038,LMNA:ENST00000473598:synonymous_variant:LOW:exon6/13:c.564T>C:p.Ala188=:PF00038	regulatory_region_variant:promoter_flanking_region	150330 [GENE=LMNA PHENOS=Cardiomyopathy,dilated,1A,115200,Autosomal dominant/Charcot-Marie-Tooth disease,type 2B1,605588,Autosomal recessive/Emery-Dreifuss muscular dystrophy 2,autosomal dominant,181350,Autosomal dominant/Emery-Dreifuss muscular dystrophy 3,autosomal recessive,616516,Autosomal recessive/Heart-hand syndrome,Slovenian type,610140,Autosomal dominant/Hutchinson-Gilford progeria,176670,Autosomal recessive,Autosomal dominant/Lipodystrophy,familial partial,type 2,151660,Autosomal dominant/Malouf syndrome,212112,Autosomal dominant/Mandibuloacral dysplasia,248370,Autosomal recessive/Muscular dystrophy,congenital,613205,Autosomal dominant/Restrictive dermopathy,lethal,275210,Autosomal recessive];	48088 [benign DISEASE=Hutchinson-Gilford syndrome,Charcot-Marie-Tooth disease, type 2,Familial partial lipodystrophy,Lethal tight skin contracture syndrome,Emery-Dreifuss muscular dystrophy,Congenital muscular dystrophy, LMNA-related,Mandibuloacral dysplasia,not specified,Cardiovascular phenotype,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules,Dilated Cardiomyopathy, Dominant,Limb-Girdle Muscular Dystrophy, Recessive,not provided];			rs538089	0.1931	0.1720	923,.	0.4582,0.0653,0.0191,0.0722,0.1383	-7.5170			0.04,0.13	9.40						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156105928	156105928	G	A	wt	wt	het	off-target	QUAL=3072;DP=90,311,261;AF=0.01,0.00,0.49;MQM=60	LMNA	intron	LMNA:ENST00000347559:intron_variant:MODIFIER:exon6/10:c.1157+16G>A::,LMNA:ENST00000361308:intron_variant:MODIFIER:exon6/9:c.1157+16G>A::,LMNA:ENST00000368297:intron_variant:MODIFIER:exon7/10:c.914+16G>A::,LMNA:ENST00000368299:intron_variant:MODIFIER:exon6/11:c.1157+16G>A::,LMNA:ENST00000368300:intron_variant:MODIFIER:exon6/11:c.1157+16G>A::,LMNA:ENST00000368301:intron_variant:MODIFIER:exon9/12:c.1157+16G>A::,LMNA:ENST00000392353:intron_variant:MODIFIER:exon6/9:c.914+16G>A::,LMNA:ENST00000448611:intron_variant:MODIFIER:exon6/12:c.821+16G>A::,LMNA:ENST00000473598:intron_variant:MODIFIER:exon7/12:c.860+16G>A::	regulatory_region_variant:promoter_flanking_region	150330 [GENE=LMNA PHENOS=Cardiomyopathy,dilated,1A,115200,Autosomal dominant/Charcot-Marie-Tooth disease,type 2B1,605588,Autosomal recessive/Emery-Dreifuss muscular dystrophy 2,autosomal dominant,181350,Autosomal dominant/Emery-Dreifuss muscular dystrophy 3,autosomal recessive,616516,Autosomal recessive/Heart-hand syndrome,Slovenian type,610140,Autosomal dominant/Hutchinson-Gilford progeria,176670,Autosomal recessive,Autosomal dominant/Lipodystrophy,familial partial,type 2,151660,Autosomal dominant/Malouf syndrome,212112,Autosomal dominant/Mandibuloacral dysplasia,248370,Autosomal recessive/Muscular dystrophy,congenital,613205,Autosomal dominant/Restrictive dermopathy,lethal,275210,Autosomal recessive];	36474 [benign/likely benign DISEASE=Primary dilated cardiomyopathy,not specified,not provided];			rs534807	0.1923	0.1712	919,.	0.4589,0.0650,0.0191,0.0713,0.1322	-0.1280			0.23,0.23	1.57						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156106185	156106185	T	C	wt	wt	het		QUAL=1107;DP=44,140,108;AF=0.00,0.00,0.46;MQM=60	LMNA	synonymous	LMNA:ENST00000347559:synonymous_variant:LOW:exon7/11:c.1338T>C:p.Asp446=:PF00932,LMNA:ENST00000361308:synonymous_variant:LOW:exon7/10:c.1338T>C:p.Asp446=:PF00932,LMNA:ENST00000368297:synonymous_variant:LOW:exon8/11:c.1095T>C:p.Asp365=:PF00932,LMNA:ENST00000368299:synonymous_variant:LOW:exon7/12:c.1338T>C:p.Asp446=:PF00932,LMNA:ENST00000368300:synonymous_variant:LOW:exon7/12:c.1338T>C:p.Asp446=:PF00932,LMNA:ENST00000368301:synonymous_variant:LOW:exon10/13:c.1338T>C:p.Asp446=:PF00932,LMNA:ENST00000392353:synonymous_variant:LOW:exon7/10:c.1095T>C:p.Asp365=:PF00932,LMNA:ENST00000448611:synonymous_variant:LOW:exon7/13:c.1002T>C:p.Asp334=:PF00932,LMNA:ENST00000473598:synonymous_variant:LOW:exon8/13:c.1041T>C:p.Asp347=:PF00932	regulatory_region_variant:promoter_flanking_region	150330 [GENE=LMNA PHENOS=Cardiomyopathy,dilated,1A,115200,Autosomal dominant/Charcot-Marie-Tooth disease,type 2B1,605588,Autosomal recessive/Emery-Dreifuss muscular dystrophy 2,autosomal dominant,181350,Autosomal dominant/Emery-Dreifuss muscular dystrophy 3,autosomal recessive,616516,Autosomal recessive/Heart-hand syndrome,Slovenian type,610140,Autosomal dominant/Hutchinson-Gilford progeria,176670,Autosomal recessive,Autosomal dominant/Lipodystrophy,familial partial,type 2,151660,Autosomal dominant/Malouf syndrome,212112,Autosomal dominant/Mandibuloacral dysplasia,248370,Autosomal recessive/Muscular dystrophy,congenital,613205,Autosomal dominant/Restrictive dermopathy,lethal,275210,Autosomal recessive];	48037 [benign DISEASE=Hutchinson-Gilford syndrome,Charcot-Marie-Tooth disease, type 2,Familial partial lipodystrophy,Lethal tight skin contracture syndrome,Emery-Dreifuss muscular dystrophy,Limb-girdle muscular dystrophy, type 1B,Charcot-Marie-Tooth disease type 2B1,Emery-Dreifuss muscular dystrophy 3, autosomal recessive,Congenital muscular dystrophy, LMNA-related,Mandibuloacral dysplasia,not specified,Cardiovascular phenotype,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules,Dilated Cardiomyopathy, Dominant,Limb-Girdle Muscular Dystrophy, Recessive,not provided];			rs505058	0.2492	0.2239	1805,.	0.6399,0.0747,0.0198,0.0734,0.1436	-0.3620			0.17,0.86	10.71						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156106863	156106863	C	T	wt	wt	het	off-target	QUAL=2834;DP=180,371,240;AF=0.00,0.00,0.53;MQM=60	LMNA	intron	LMNA:ENST00000347559:intron_variant:MODIFIER:exon8/10:c.1489-41C>T::,LMNA:ENST00000361308:intron_variant:MODIFIER:exon8/9:c.1489-41C>T::,LMNA:ENST00000368297:intron_variant:MODIFIER:exon9/10:c.1246-41C>T::,LMNA:ENST00000368299:intron_variant:MODIFIER:exon8/11:c.1489-41C>T::,LMNA:ENST00000368300:intron_variant:MODIFIER:exon8/11:c.1489-41C>T::,LMNA:ENST00000368301:intron_variant:MODIFIER:exon11/12:c.1489-41C>T::,LMNA:ENST00000392353:intron_variant:MODIFIER:exon8/9:c.1246-41C>T::,LMNA:ENST00000448611:intron_variant:MODIFIER:exon8/12:c.1153-41C>T::,LMNA:ENST00000473598:intron_variant:MODIFIER:exon9/12:c.1192-41C>T::	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site	150330 [GENE=LMNA PHENOS=Cardiomyopathy,dilated,1A,115200,Autosomal dominant/Charcot-Marie-Tooth disease,type 2B1,605588,Autosomal recessive/Emery-Dreifuss muscular dystrophy 2,autosomal dominant,181350,Autosomal dominant/Emery-Dreifuss muscular dystrophy 3,autosomal recessive,616516,Autosomal recessive/Heart-hand syndrome,Slovenian type,610140,Autosomal dominant/Hutchinson-Gilford progeria,176670,Autosomal recessive,Autosomal dominant/Lipodystrophy,familial partial,type 2,151660,Autosomal dominant/Malouf syndrome,212112,Autosomal dominant/Mandibuloacral dysplasia,248370,Autosomal recessive/Muscular dystrophy,congenital,613205,Autosomal dominant/Restrictive dermopathy,lethal,275210,Autosomal recessive];	66834 [benign DISEASE=not specified,not provided];			rs553016	0.1823	0.1637	809,.	0.4276,0.0634,0.0192,0.0716,0.1376	0.3060			0.22,0.27	2.98						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156107534	156107534	C	T	het	het	wt		QUAL=6846;DP=148,346,262;AF=0.61,0.54,0.00;MQM=60	LMNA	intron,synonymous,splice_region&synonymous	LMNA:ENST00000347559:intron_variant:MODIFIER:exon9/10:c.1608+511C>T::,LMNA:ENST00000361308:synonymous_variant:LOW:exon10/10:c.1698C>T:p.His566=:,LMNA:ENST00000368297:synonymous_variant:LOW:exon11/11:c.1455C>T:p.His485=:,LMNA:ENST00000368299:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:ENST00000368300:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:ENST00000368301:synonymous_variant:LOW:exon13/13:c.1698C>T:p.His566=:,LMNA:ENST00000392353:synonymous_variant:LOW:exon10/10:c.1455C>T:p.His485=:,LMNA:ENST00000448611:splice_region_variant&synonymous_variant:LOW:exon10/13:c.1362C>T:p.His454=:,LMNA:ENST00000473598:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1401C>T:p.His467=:	regulatory_region_variant:promoter_flanking_region	150330 [GENE=LMNA PHENOS=Cardiomyopathy,dilated,1A,115200,Autosomal dominant/Charcot-Marie-Tooth disease,type 2B1,605588,Autosomal recessive/Emery-Dreifuss muscular dystrophy 2,autosomal dominant,181350,Autosomal dominant/Emery-Dreifuss muscular dystrophy 3,autosomal recessive,616516,Autosomal recessive/Heart-hand syndrome,Slovenian type,610140,Autosomal dominant/Hutchinson-Gilford progeria,176670,Autosomal recessive,Autosomal dominant/Lipodystrophy,familial partial,type 2,151660,Autosomal dominant/Malouf syndrome,212112,Autosomal dominant/Mandibuloacral dysplasia,248370,Autosomal recessive/Muscular dystrophy,congenital,613205,Autosomal dominant/Restrictive dermopathy,lethal,275210,Autosomal recessive];	48048 [benign DISEASE=Hutchinson-Gilford syndrome,Charcot-Marie-Tooth disease, type 2,Familial partial lipodystrophy,Lethal tight skin contracture syndrome,Emery-Dreifuss muscular dystrophy,Limb-girdle muscular dystrophy, type 1B,Charcot-Marie-Tooth disease type 2B1,Emery-Dreifuss muscular dystrophy 3, autosomal recessive,Congenital muscular dystrophy, LMNA-related,Mandibuloacral dysplasia,not specified,Cardiovascular phenotype,Mandibuloacral dysplasia with type A lipodystrophy,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules,Dilated Cardiomyopathy, Dominant,Limb-Girdle Muscular Dystrophy, Recessive,not provided];	CM003892 [CLASS=DP MUT=ALT PHEN="Metabolic syndrome association with" GENE=LMNA];		rs4641	0.2202	0.2627	710,.	0.0906,0.3237,0.2650,0.2651,0.2933	-1.2430			0.31,0.89	10.92		9.30>7.83				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156108976	156108976	G	C	wt	wt	het		QUAL=36;DP=68,15,7;AF=0.00,0.00,0.57;MQM=60	LMNA	3'UTR,intron	LMNA:ENST00000347559:3_prime_UTR_variant:MODIFIER:exon11/11:c.*79G>C::,LMNA:ENST00000368299:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:ENST00000368300:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:ENST00000448611:intron_variant:MODIFIER:exon12/12:c.1655+83G>C::,LMNA:ENST00000473598:3_prime_UTR_variant:MODIFIER:exon13/13:c.*79G>C::	regulatory_region_variant:promoter_flanking_region	150330 [GENE=LMNA PHENOS=Cardiomyopathy,dilated,1A,115200,Autosomal dominant/Charcot-Marie-Tooth disease,type 2B1,605588,Autosomal recessive/Emery-Dreifuss muscular dystrophy 2,autosomal dominant,181350,Autosomal dominant/Emery-Dreifuss muscular dystrophy 3,autosomal recessive,616516,Autosomal recessive/Heart-hand syndrome,Slovenian type,610140,Autosomal dominant/Hutchinson-Gilford progeria,176670,Autosomal recessive,Autosomal dominant/Lipodystrophy,familial partial,type 2,151660,Autosomal dominant/Malouf syndrome,212112,Autosomal dominant/Mandibuloacral dysplasia,248370,Autosomal recessive/Muscular dystrophy,congenital,613205,Autosomal dominant/Restrictive dermopathy,lethal,275210,Autosomal recessive];	66756 [not provided DISEASE=not provided];			rs7339	0.1853	0.1661	831,.		-0.0730			0.01,0.12	7.84						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156109094	156109094	-	A	wt	wt	het		QUAL=50;DP=57,51,33;AF=0.00,0.04,0.24;MQM=60	LMNA	3'UTR,intron	LMNA:ENST00000347559:3_prime_UTR_variant:MODIFIER:exon11/11:c.*211dup::,LMNA:ENST00000368299:3_prime_UTR_variant:MODIFIER:exon12/12:::,LMNA:ENST00000368300:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:ENST00000448611:intron_variant:MODIFIER:exon12/12:c.1655+215dup::		150330 [GENE=LMNA PHENOS=Cardiomyopathy,dilated,1A,115200,Autosomal dominant/Charcot-Marie-Tooth disease,type 2B1,605588,Autosomal recessive/Emery-Dreifuss muscular dystrophy 2,autosomal dominant,181350,Autosomal dominant/Emery-Dreifuss muscular dystrophy 3,autosomal recessive,616516,Autosomal recessive/Heart-hand syndrome,Slovenian type,610140,Autosomal dominant/Hutchinson-Gilford progeria,176670,Autosomal recessive,Autosomal dominant/Lipodystrophy,familial partial,type 2,151660,Autosomal dominant/Malouf syndrome,212112,Autosomal dominant/Mandibuloacral dysplasia,248370,Autosomal recessive/Muscular dystrophy,congenital,613205,Autosomal dominant/Restrictive dermopathy,lethal,275210,Autosomal recessive];				rs535843454	0.0990	0.1370	281,.						14.57						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156785617	156785617	G	A	hom	hom	hom		QUAL=22354;DP=196,298,210;AF=1.00,1.00,1.00;MQM=59	SH2D2A,NTRK1	intron,5'UTR	SH2D2A:ENST00000368198:intron_variant:MODIFIER:exon2/8:c.69+181C>T::,SH2D2A:ENST00000368199:intron_variant:MODIFIER:exon2/8:c.123+181C>T::,NTRK1:ENST00000392302:5_prime_UTR_variant:MODIFIER:exon1/17:c.-5G>A::,SH2D2A:ENST00000392306:intron_variant:MODIFIER:exon2/8:c.123+181C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter	191315 [GENE=NTRK1 PHENOS=Insensitivity to pain,congenital,with anhidrosis,256800,Autosomal recessive/Medullary thyroid carcinoma,familial,155240,Autosomal dominant];	380853 [benign DISEASE=not specified];			rs1800601		0.6740	6230,.	0.4989,0.6951,0.8177,0.6775,0.6549	-1.8140			0.00,0.07	1.76						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SH2D2A (inh=n/a oe_syn=0.86 oe_mis=0.91 oe_lof=0.68), NTRK1 (inh=AR+AD oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156845492	156845492	-	GT	wt	het	wt	off-target	QUAL=1026;DP=19,47,43;AF=0.16,0.83,0.02;MQM=59	NTRK1	intron	NTRK1:ENST00000358660:intron_variant:MODIFIER:exon11/15:c.1483+69_1483+70dup::,NTRK1:ENST00000368196:intron_variant:MODIFIER:exon11/15:c.1483+69_1483+70dup::,NTRK1:ENST00000392302:intron_variant:MODIFIER:exon12/16:c.1393+69_1393+70dup::,NTRK1:ENST00000524377:intron_variant:MODIFIER:exon12/16:c.1501+69_1501+70dup::		191315 [GENE=NTRK1 PHENOS=Insensitivity to pain,congenital,with anhidrosis,256800,Autosomal recessive/Medullary thyroid carcinoma,familial,155240,Autosomal dominant];			(GT)n (Simple_repeat)	rs144271100		0.1037	304,.						4.55						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR+AD oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156845492	156845492	-	GTGT	het	het	wt	off-target	QUAL=1026;DP=19,47,43;AF=0.26,0.83,0.60;MQM=60	NTRK1	intron	NTRK1:ENST00000358660:intron_variant:MODIFIER:exon11/15:c.1483+67_1483+70dup::,NTRK1:ENST00000368196:intron_variant:MODIFIER:exon11/15:c.1483+67_1483+70dup::,NTRK1:ENST00000392302:intron_variant:MODIFIER:exon12/16:c.1393+67_1393+70dup::,NTRK1:ENST00000524377:intron_variant:MODIFIER:exon12/16:c.1501+67_1501+70dup::		191315 [GENE=NTRK1 PHENOS=Insensitivity to pain,congenital,with anhidrosis,256800,Autosomal recessive/Medullary thyroid carcinoma,familial,155240,Autosomal dominant];			(GT)n (Simple_repeat)	rs144271100		0.4936	3529,.						4.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR+AD oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156845493	156845494	GT	-	wt	wt	het	off-target	QUAL=1026;DP=19,47,43;AF=0.16,0.30,0.60;MQM=60	NTRK1	intron	NTRK1:ENST00000358660:intron_variant:MODIFIER:exon11/15:c.1483+69_1483+70del::,NTRK1:ENST00000368196:intron_variant:MODIFIER:exon11/15:c.1483+69_1483+70del::,NTRK1:ENST00000392302:intron_variant:MODIFIER:exon12/16:c.1393+69_1393+70del::,NTRK1:ENST00000524377:intron_variant:MODIFIER:exon12/16:c.1501+69_1501+70del::		191315 [GENE=NTRK1 PHENOS=Insensitivity to pain,congenital,with anhidrosis,256800,Autosomal recessive/Medullary thyroid carcinoma,familial,155240,Autosomal dominant];			(GT)n (Simple_repeat)	rs766543019		0.1493	323,.		1.6560				4.65						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR+AD oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156846233	156846233	G	A	het	wt	hom		QUAL=6450;DP=147,146,147;AF=0.51,0.00,1.00;MQM=60	NTRK1	synonymous	NTRK1:ENST00000358660:synonymous_variant:LOW:exon13/16:c.1665G>A:p.Gln555=:PF07714,NTRK1:ENST00000368196:synonymous_variant:LOW:exon13/16:c.1656G>A:p.Gln552=:PF07714,NTRK1:ENST00000392302:synonymous_variant:LOW:exon14/17:c.1566G>A:p.Gln522=:PF07714,NTRK1:ENST00000524377:synonymous_variant:LOW:exon14/17:c.1674G>A:p.Gln558=:PF07714	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	191315 [GENE=NTRK1 PHENOS=Insensitivity to pain,congenital,with anhidrosis,256800,Autosomal recessive/Medullary thyroid carcinoma,familial,155240,Autosomal dominant];	292889 [benign DISEASE=Hereditary insensitivity to pain with anhidrosis,not specified];			rs6334	0.2129	0.2203	610,.	0.1314,0.2163,0.3494,0.2144,0.2352	0.2840			0.84,0.91	16.22						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR+AD oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156848995	156848995	C	T	het	hom	wt		QUAL=3877;DP=48,128,104;AF=0.33,0.97,0.01;MQM=59	NTRK1	synonymous	NTRK1:ENST00000358660:synonymous_variant:LOW:exon14/16:c.1878C>T:p.Ala626=:PF07714,NTRK1:ENST00000368196:synonymous_variant:LOW:exon14/16:c.1869C>T:p.Ala623=:PF07714,NTRK1:ENST00000392302:synonymous_variant:LOW:exon15/17:c.1779C>T:p.Ala593=:PF07714,NTRK1:ENST00000524377:synonymous_variant:LOW:exon15/17:c.1887C>T:p.Ala629=:PF07714		191315 [GENE=NTRK1 PHENOS=Insensitivity to pain,congenital,with anhidrosis,256800,Autosomal recessive/Medullary thyroid carcinoma,familial,155240,Autosomal dominant];	138564 [benign DISEASE=Hereditary insensitivity to pain with anhidrosis,not specified];			rs6337	0.3341	0.5779	5628,.	0.1981,0.5752,0.0396,0.7242,0.3929	-4.5650			0.07,0.92	7.23						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR+AD oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	160009121	160009121	A	C	het	wt	het		QUAL=3009;DP=171,80,68;AF=0.50,0.00,0.46;MQM=59	KCNJ10	3'UTR	KCNJ10:ENST00000368089:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2062T>G::		602208 [GENE=KCNJ10 PHENOS=Enlarged vestibular aqueduct,digenic,600791,Autosomal recessive/SESAME syndrome,612780,Autosomal recessive];	293090 [likely benign DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed];			rs1053074	0.4810	0.4435	3285,.		1.4870			0.77,0.94	8.23						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160009143	160009143	G	C	hom	hom	hom		QUAL=8475;DP=141,69,59;AF=1.00,1.00,0.97;MQM=59	KCNJ10	3'UTR	KCNJ10:ENST00000368089:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2040C>G::		602208 [GENE=KCNJ10 PHENOS=Enlarged vestibular aqueduct,digenic,600791,Autosomal recessive/SESAME syndrome,612780,Autosomal recessive];	293091 [benign DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed];			rs2486254		0.9973	15459,.		0.2730			0.00,0.12	2.74						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160009164	160009165	AC	-	wt	het	wt		QUAL=884;DP=13,41,37;AF=0.38,0.66,0.84;MQM=60	KCNJ10	3'UTR	KCNJ10:ENST00000368089:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2018_*2019del::		602208 [GENE=KCNJ10 PHENOS=Enlarged vestibular aqueduct,digenic,600791,Autosomal recessive/SESAME syndrome,612780,Autosomal recessive];	293094 [uncertain significance DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed];		(AC)n (Simple_repeat)	rs72013077		0.1185	190,.		-0.0330				1.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160009164	160009167	ACAC	-	wt	wt	het		QUAL=884;DP=13,41,37;AF=0.38,0.66,0.84;MQM=59	KCNJ10	3'UTR	KCNJ10:ENST00000368089:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2016_*2019del::		602208 [GENE=KCNJ10 PHENOS=Enlarged vestibular aqueduct,digenic,600791,Autosomal recessive/SESAME syndrome,612780,Autosomal recessive];	293095 [likely benign DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed];		(AC)n (Simple_repeat)	rs374594439	0.2965	0.1638	381,.		-0.0330				1.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160009164	160009169	ACACAC	-	hom	wt	het		QUAL=884;DP=13,41,37;AF=0.38,0.66,0.84;MQM=60	KCNJ10	3'UTR	KCNJ10:ENST00000368089:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2014_*2019del::		602208 [GENE=KCNJ10 PHENOS=Enlarged vestibular aqueduct,digenic,600791,Autosomal recessive/SESAME syndrome,612780,Autosomal recessive];	293097 [uncertain significance DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed];		(AC)n (Simple_repeat)	rs886045404		0.0968	156,.		-0.0330				1.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160009419	160009419	A	C	hom	hom	hom		QUAL=31885;DP=366,345,263;AF=1.00,1.00,1.00;MQM=60	KCNJ10	3'UTR	KCNJ10:ENST00000368089:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1764T>G::		602208 [GENE=KCNJ10 PHENOS=Enlarged vestibular aqueduct,digenic,600791,Autosomal recessive/SESAME syndrome,612780,Autosomal recessive];	293102 [benign DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed];			rs2486253		0.8131	10378,.		0.4040			0.12,0.26	10.81						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160010151	160010151	C	T	wt	wt	het		QUAL=2264;DP=333,282,195;AF=0.00,0.00,0.50;MQM=60	KCNJ10	3'UTR	KCNJ10:ENST00000368089:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1032G>A::		602208 [GENE=KCNJ10 PHENOS=Enlarged vestibular aqueduct,digenic,600791,Autosomal recessive/SESAME syndrome,612780,Autosomal recessive];				rs17375748	0.0244	0.0431	31,.		0.1640			0.05,0.19	3.77						1	29						KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160246990	160246990	T	-	het	het	het		QUAL=1014;DP=253,184,134;AF=0.17,0.15,0.22;MQM=59	PEX19,DCAF8	3'UTR,intron	PEX19:ENST00000368072:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2351del::,DCAF8:ENST00000556710:intron_variant:MODIFIER:exon6/17:c.436+931del::,DCAF8:ENST00000608310:intron_variant:MODIFIER:exon6/17:c.436+931del::	regulatory_region_variant:CTCF_binding_site	615820 [GENE=DCAF8 PHENOS=Giant axonal neuropathy 2,autosomal dominant,610100,Autosomal dominant],600279 [GENE=PEX19 PHENOS=Peroxisome biogenesis disorder 12A (Zellweger),614886,Autosomal recessive];			Charlie10 (DNA/hAT-Charlie)	rs751979135		0.2519	0,.	0.2253,0.2326,0.2514,0.2578,0.2549	-0.2200				1.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52), DCAF8 (inh=AD oe_syn=0.91 oe_mis=0.63 oe_lof=0.14)
chr1	160247185	160247185	G	C	het	hom	wt		QUAL=10233;DP=282,217,165;AF=0.44,1.00,0.01;MQM=60	PEX19,DCAF8	3'UTR,intron	PEX19:ENST00000368072:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2156C>G::,DCAF8:ENST00000556710:intron_variant:MODIFIER:exon6/17:c.436+736C>G::,DCAF8:ENST00000608310:intron_variant:MODIFIER:exon6/17:c.436+736C>G::		615820 [GENE=DCAF8 PHENOS=Giant axonal neuropathy 2,autosomal dominant,610100,Autosomal dominant],600279 [GENE=PEX19 PHENOS=Peroxisome biogenesis disorder 12A (Zellweger),614886,Autosomal recessive];	293196 [benign DISEASE=Zellweger syndrome];		Charlie10 (DNA/hAT-Charlie)	rs10594	0.4523	0.4950	3119,.	0.3382,0.4808,0.3476,0.5072,0.6152	0.4560			0.17,0.16	0.74						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52), DCAF8 (inh=AD oe_syn=0.91 oe_mis=0.63 oe_lof=0.14)
chr1	160251792	160251792	A	G	het	hom	wt	off-target	QUAL=6832;DP=209,148,91;AF=0.44,1.00,0.00;MQM=60	PEX19,DCAF8	intron	PEX19:ENST00000368072:intron_variant:MODIFIER:exon5/7:c.594+37T>C::,PEX19:ENST00000440949:intron_variant:MODIFIER:exon5/7:c.324+37T>C::,DCAF8:ENST00000556710:intron_variant:MODIFIER:exon3/17:c.153+37T>C::,DCAF8:ENST00000608310:intron_variant:MODIFIER:exon3/17:c.153+37T>C::		615820 [GENE=DCAF8 PHENOS=Giant axonal neuropathy 2,autosomal dominant,610100,Autosomal dominant],600279 [GENE=PEX19 PHENOS=Peroxisome biogenesis disorder 12A (Zellweger),614886,Autosomal recessive];				rs2795067	0.6703	0.6290	6548,.	0.8687,0.5589,0.4645,0.5555,0.7045	-1.5860			0.01,0.10	2.36						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52), DCAF8 (inh=AD oe_syn=0.91 oe_mis=0.63 oe_lof=0.14)
chr1	161140278	161140278	A	-	het	het	wt		QUAL=6406;DP=227,376,326;AF=0.46,0.45,0.00;MQM=59	PPOX	frameshift,intron	PPOX:ENST00000352210:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:PF01593,PPOX:ENST00000367999:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:PF01593,PPOX:ENST00000432542:frameshift_variant:HIGH:exon4/6:c.302del:p.Gln101ArgfsTer10:PF01593,PPOX:ENST00000535223:intron_variant:MODIFIER:exon2/3:c.88-132del::,PPOX:ENST00000544598:intron_variant:MODIFIER:exon3/5:c.223-132del::		600923 [GENE=PPOX PHENOS=Porphyria variegata,176200,Autosomal dominant];									7.3390							loss/acceptor/161140278-161140279/Medium/4.873991			0	2						PPOX (inh=AD oe_syn=1.05 oe_mis=0.83 oe_lof=0.30)
chr1	161184059	161184059	-	TG	wt	het	wt		QUAL=1559;DP=204,210,158;AF=0.02,0.30,0.35;MQM=59	NDUFS2	3'UTR	NDUFS2:ENST00000367993:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000392179:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359dup::		602985 [GENE=NDUFS2 PHENOS=Mitochondrial complex I deficiency,nuclear type 6,618228,Autosomal recessive];	293284 [uncertain significance DISEASE=Mitochondrial complex I deficiency];		(TG)n (Simple_repeat)	rs10629771		0.2818	1160,.						14.78						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34)
chr1	161184059	161184059	-	TGTG	wt	wt	het		QUAL=1559;DP=204,210,158;AF=0.02,0.30,0.35;MQM=60	NDUFS2	3'UTR	NDUFS2:ENST00000367993:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000392179:3_prime_UTR_variant:MODIFIER:exon13/13:c.*356_*359dup::		602985 [GENE=NDUFS2 PHENOS=Mitochondrial complex I deficiency,nuclear type 6,618228,Autosomal recessive];			(TG)n (Simple_repeat)	rs10629771		0.1273	218,.						14.74						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34)
chr1	161184097	161184097	A	G	wt	het	wt		QUAL=2163;DP=360,251,186;AF=0.00,0.39,0.00;MQM=59	NDUFS2	3'UTR	NDUFS2:ENST00000367993:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000392179:3_prime_UTR_variant:MODIFIER:exon13/13:c.*366A>G::		602985 [GENE=NDUFS2 PHENOS=Mitochondrial complex I deficiency,nuclear type 6,618228,Autosomal recessive];	293289 [likely benign DISEASE=Mitochondrial complex I deficiency];			rs1136224	0.1821	0.1399	362,.		-0.2700			0.00,0.12	2.63						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34)
chr1	161274648	161274648	G	C	wt	het	het		QUAL=71;DP=35,33,28;AF=0.00,0.30,0.29;MQM=60	MPZ	3'UTR	MPZ:ENST00000360451:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1018C>G::,MPZ:ENST00000491222:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1018C>G::,MPZ:ENST00000533357:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1018C>G::	regulatory_region_variant:promoter,TF_binding_site_variant	159440 [GENE=MPZ PHENOS=Charcot-Marie-Tooth disease,dominant intermediate D,607791,Autosomal dominant/Charcot-Marie-Tooth disease,type 1B,118200,Autosomal dominant/Charcot-Marie-Tooth disease,type 2I,607677,Autosomal dominant/Charcot-Marie-Tooth disease,type 2J,607736,Autosomal dominant/Dejerine-Sottas disease,145900,Autosomal recessive,Autosomal dominant/Hypomyelinating neuropathy,congenital,2,618184,Autosomal dominant/Roussy-Levy syndrome,180800,Autosomal dominant];				rs185093979		0.2991	0,.		-0.6030			0.01,0.16	0.43						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPZ (inh=AR+AD oe_syn=0.82 oe_mis=0.77 oe_lof=0.25)
chr1	161274905	161274905	T	C	wt	wt	het		QUAL=172;DP=68,18,29;AF=0.00,0.00,0.38;MQM=60	MPZ	3'UTR	MPZ:ENST00000360451:3_prime_UTR_variant:MODIFIER:exon6/6:c.*761A>G::,MPZ:ENST00000491222:3_prime_UTR_variant:MODIFIER:exon5/5:c.*761A>G::,MPZ:ENST00000533357:3_prime_UTR_variant:MODIFIER:exon6/6:c.*761A>G::	regulatory_region_variant:promoter,TF_binding_site_variant	159440 [GENE=MPZ PHENOS=Charcot-Marie-Tooth disease,dominant intermediate D,607791,Autosomal dominant/Charcot-Marie-Tooth disease,type 1B,118200,Autosomal dominant/Charcot-Marie-Tooth disease,type 2I,607677,Autosomal dominant/Charcot-Marie-Tooth disease,type 2J,607736,Autosomal dominant/Dejerine-Sottas disease,145900,Autosomal recessive,Autosomal dominant/Hypomyelinating neuropathy,congenital,2,618184,Autosomal dominant/Roussy-Levy syndrome,180800,Autosomal dominant];	293304 [benign DISEASE=Roussy-Levy syndrome,Congenital hypomyelinating neuropathy 1, autosomal recessive,Charcot-Marie-Tooth disease, type I,Charcot-Marie-Tooth, Intermediate];			rs16832786	0.1364	0.1287	314,.		-1.1460			0.02,0.13	1.77			gain/acceptor/161274904-161274905/Medium/2.003992			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPZ (inh=AR+AD oe_syn=0.82 oe_mis=0.77 oe_lof=0.25)
chr1	167399868	167399868	-	AG	hom	hom	hom		QUAL=15338;DP=188,177,147;AF=0.99,0.99,0.99;MQM=60	CD247,POU2F1	downstream_gene	CD247:ENST00000362089:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000367862:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000367866:downstream_gene_variant:MODIFIER::::,CD247:ENST00000392122:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region	186780 [GENE=CD247 PHENOS=Immunodeficiency 25,610163,Autosomal recessive];				rs5778549	0.9870	0.9883	15342,.						1.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39), POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18)
chr1	167399962	167399962	T	C	hom	hom	hom		QUAL=39469;DP=381,464,380;AF=1.00,1.00,1.00;MQM=60	CD247	3'UTR	CD247:ENST00000362089:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::,CD247:ENST00000392122:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::	regulatory_region_variant:promoter_flanking_region	186780 [GENE=CD247 PHENOS=Immunodeficiency 25,610163,Autosomal recessive];				rs947480		0.9884	15346,.		-1.3530			0.00,0.12	7.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167400074	167400074	T	A	hom	hom	hom		QUAL=45520;DP=400,593,433;AF=1.00,1.00,1.00;MQM=60	CD247	3'UTR	CD247:ENST00000362089:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::,CD247:ENST00000392122:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::	regulatory_region_variant:promoter_flanking_region	186780 [GENE=CD247 PHENOS=Immunodeficiency 25,610163,Autosomal recessive];				rs1052231	0.8111	0.8147	10458,.		-0.1760			0.02,0.15	0.89						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167408670	167408670	C	T	het	hom	het	off-target	QUAL=11514;DP=75,288,218;AF=0.52,0.99,0.49;MQM=60	CD247	intron	CD247:ENST00000362089:intron_variant:MODIFIER:exon2/7:c.163-33G>A::,CD247:ENST00000392122:intron_variant:MODIFIER:exon2/7:c.163-33G>A::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	186780 [GENE=CD247 PHENOS=Immunodeficiency 25,610163,Autosomal recessive];				rs840016	0.1907	0.3109	1410,.	0.0805,0.2358,0.1048,0.3992,0.2976	0.5230			0.06,0.20	10.07						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167487586	167487586	C	G	het	wt	het	off-target	QUAL=1434;DP=49,87,67;AF=0.53,0.00,0.55;MQM=60	CD247	intron	CD247:ENST00000362089:intron_variant:MODIFIER:exon1/7:c.58+59G>C::,CD247:ENST00000392122:intron_variant:MODIFIER:exon1/7:c.58+59G>C::	regulatory_region_variant:promoter	186780 [GENE=CD247 PHENOS=Immunodeficiency 25,610163,Autosomal recessive];			(CCACTC)n (Simple_repeat)	rs35864197	0.1108	0.1398	351,.		0.7990			0.15,0.20	3.40						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	173795804	173795804	T	-	het	het	het	off-target	QUAL=427;DP=69,41,17;AF=0.25,0.22,0.29;MQM=60	DARS2	intron	DARS2:ENST00000239457:intron_variant:MODIFIER:exon1/15:c.-1127-5del::,DARS2:ENST00000361951:intron_variant:MODIFIER:exon1/16:c.128-5del::	regulatory_region_variant:promoter	610956 [GENE=DARS2 PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation,611105,Autosomal recessive];	559192 [benign DISEASE=not provided];		(T)n (Simple_repeat)	rs772280960		0.4237	1,.	0.3542,0.4108,0.4051,0.4329,0.4481	0.8260				1.59						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	173819422	173819422	A	-	het	het	het	off-target	QUAL=418;DP=66,30,20;AF=0.24,0.23,0.25;MQM=60	DARS2	intron	DARS2:ENST00000239457:intron_variant:MODIFIER:exon12/15:c.-63-29del::,DARS2:ENST00000361951:intron_variant:MODIFIER:exon12/16:c.1192-29del::		610956 [GENE=DARS2 PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation,611105,Autosomal recessive];				rs199872112		0.1305	0,.	0.0973,0.1303,0.0955,0.1534,0.1207	-2.2520				0.48						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	179519638	179519641	TTTC	-	wt	het	wt	off-target	QUAL=707;DP=124,61,52;AF=0.00,0.52,0.00;MQM=60	AXDND1	intron	AXDND1:ENST00000367618:intron_variant:MODIFIER:exon25/25:c.3032-4006_3032-4003del::						rs147171656	0.1324	0.2086	845,.		0.8270				9.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78)
chr1	179519880	179519880	T	C	hom	hom	hom		QUAL=27854;DP=267,327,272;AF=1.00,1.00,1.00;MQM=60	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615:3_prime_UTR_variant:MODIFIER:exon8/8:c.*428A>G::,NPHS2:ENST00000367616:3_prime_UTR_variant:MODIFIER:exon7/7:c.*428A>G::,AXDND1:ENST00000367618:intron_variant:MODIFIER:exon25/25:c.3032-3767T>C::	regulatory_region_variant:promoter_flanking_region	604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];	224486 [benign DISEASE=Steroid-resistant nephrotic syndrome,Nephrotic syndrome, idiopathic, steroid-resistant];			rs1060775		0.9098	13021,.		0.2720			0.03,0.16	0.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78)
chr1	179520050	179520050	T	C	het	wt	hom		QUAL=8006;DP=329,177,121;AF=0.46,0.00,1.00;MQM=60	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615:3_prime_UTR_variant:MODIFIER:exon8/8:c.*258A>G::,NPHS2:ENST00000367616:3_prime_UTR_variant:MODIFIER:exon7/7:c.*258A>G::,AXDND1:ENST00000367618:intron_variant:MODIFIER:exon25/25:c.3032-3597T>C::	regulatory_region_variant:promoter_flanking_region	604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];	224485 [likely benign DISEASE=Steroid-resistant nephrotic syndrome,Nephrotic syndrome, idiopathic, steroid-resistant];			rs2274622	0.2831	0.2334	920,.		0.2690			0.13,0.36	8.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78)
chr1	179520151	179520151	C	T	hom	hom	hom		QUAL=24152;DP=285,263,194;AF=1.00,0.99,1.00;MQM=60	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615:3_prime_UTR_variant:MODIFIER:exon8/8:c.*157G>A::,NPHS2:ENST00000367616:3_prime_UTR_variant:MODIFIER:exon7/7:c.*157G>A::,AXDND1:ENST00000367618:intron_variant:MODIFIER:exon25/25:c.3032-3496C>T::	regulatory_region_variant:promoter_flanking_region	604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];	224483 [benign DISEASE=Steroid-resistant nephrotic syndrome,Nephrotic syndrome, idiopathic, steroid-resistant];			rs1410590	0.9052	0.9126	13107,.		-1.2820			0.00,0.14	0.64						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78)
chr1	179520254	179520254	C	G	hom	hom	hom		QUAL=22112;DP=389,174,131;AF=0.99,0.99,0.99;MQM=60	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615:3_prime_UTR_variant:MODIFIER:exon8/8:c.*54G>C::,NPHS2:ENST00000367616:3_prime_UTR_variant:MODIFIER:exon7/7:c.*54G>C::,AXDND1:ENST00000367618:intron_variant:MODIFIER:exon25/25:c.3032-3393C>G::	regulatory_region_variant:promoter_flanking_region	604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];	293845 [likely benign DISEASE=Steroid-resistant nephrotic syndrome];			rs1410591	0.5879	0.6139	5932,.		0.9020			0.00,0.13	3.81						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78)
chr1	179520506	179520506	G	A	hom	hom	hom		QUAL=20705;DP=343,184,128;AF=0.99,1.00,0.99;MQM=60	NPHS2,AXDND1	synonymous,intron	NPHS2:ENST00000367615:synonymous_variant:LOW:exon8/8:c.954C>T:p.Ala318=:,NPHS2:ENST00000367616:synonymous_variant:LOW:exon7/7:c.750C>T:p.Ala250=:,AXDND1:ENST00000367618:intron_variant:MODIFIER:exon25/25:c.3032-3141G>A::	regulatory_region_variant:promoter_flanking_region	604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];	260432 [benign/likely benign DISEASE=Steroid-resistant nephrotic syndrome,Nephrotic syndrome, idiopathic, steroid-resistant,not specified,not provided];			rs1410592		0.6190	5903,.	0.6004,0.6654,0.4727,0.6310,0.6037	-0.5630			0.03,0.33	6.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78)
chr1	179521684	179521684	T	C	het	het	wt	off-target	QUAL=3066;DP=146,124,83;AF=0.45,0.47,0.00;MQM=60	NPHS2,AXDND1	intron	NPHS2:ENST00000367615:intron_variant:MODIFIER:exon7/7:c.873+54A>G::,NPHS2:ENST00000367616:intron_variant:MODIFIER:exon6/6:c.669+54A>G::,AXDND1:ENST00000367618:intron_variant:MODIFIER:exon25/25:c.3032-1963T>C::		604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];				rs11808359	0.0214	0.0518	49,.		0.1240			0.01,0.16	8.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78)
chr1	179521731	179521731	T	C	wt	wt	het		QUAL=1100;DP=136,196,113;AF=0.01,0.00,0.44;MQM=60	NPHS2,AXDND1	splice_region&intron,intron	NPHS2:ENST00000367615:splice_region_variant&intron_variant:LOW:exon7/7:c.873+7A>G::,NPHS2:ENST00000367616:splice_region_variant&intron_variant:LOW:exon6/6:c.669+7A>G::,AXDND1:ENST00000367618:intron_variant:MODIFIER:exon25/25:c.3032-1916T>C::		604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];	260430 [benign DISEASE=not specified];			rs115778946	0.0160	0.0305	18,.	0.0082,0.0236,0.0000,0.0488,0.0103	-1.5420			0.07,0.27	13.08				0.000/0.064		23	723						NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), AXDND1 (inh=n/a oe_syn=0.99 oe_mis=1.04 oe_lof=0.78)
chr1	179528917	179528917	G	A	wt	het	wt	off-target	QUAL=2053;DP=166,157,134;AF=0.00,0.53,0.00;MQM=60	NPHS2	intron	NPHS2:ENST00000367615:intron_variant:MODIFIER:exon3/7:c.452-21C>T::,NPHS2:ENST00000367616:intron_variant:MODIFIER:exon3/6:c.452-21C>T::		604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];				rs12401708	0.1334	0.2376	879,.	0.0633,0.2414,0.0433,0.2751,0.2021	0.0010			0.04,0.14	0.69						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179528942	179528942	G	A	wt	het	wt	off-target	QUAL=1838;DP=144,138,114;AF=0.00,0.54,0.00;MQM=60	NPHS2	intron	NPHS2:ENST00000367615:intron_variant:MODIFIER:exon3/7:c.452-46C>T::,NPHS2:ENST00000367616:intron_variant:MODIFIER:exon3/6:c.452-46C>T::		604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];				rs12401711	0.1334	0.2370	881,.	0.0631,0.2396,0.0434,0.2736,0.2011	-0.2810			0.03,0.18	6.58						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179544898	179544898	T	C	n/a	hom	hom		QUAL=441;DP=1,13,3;AF=1.00,1.00,1.00;MQM=60	NPHS2	synonymous	NPHS2:ENST00000367615:synonymous_variant:LOW:exon1/8:c.102A>G:p.Gly34=:,NPHS2:ENST00000367616:synonymous_variant:LOW:exon1/7:c.102A>G:p.Gly34=:	regulatory_region_variant:promoter	604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];	260424 [benign DISEASE=Steroid-resistant nephrotic syndrome,Nephrotic syndrome, idiopathic, steroid-resistant,not specified];			rs1079292	0.9309	0.9774	14172,.	0.8073,0.9855,0.9753,0.9928,0.9446	-0.4500			0.01,0.06	0.59						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179545050	179545050	C	A	n/a	het	wt		QUAL=195;DP=1,18,9;AF=0.00,0.61,0.00;MQM=60	NPHS2	5'UTR	NPHS2:ENST00000367615:5_prime_UTR_variant:MODIFIER:exon1/8:c.-51G>T::,NPHS2:ENST00000367616:5_prime_UTR_variant:MODIFIER:exon1/7:c.-51G>T::	regulatory_region_variant:promoter	604766 [GENE=NPHS2 PHENOS=Nephrotic syndrome,type 2,600995,Autosomal recessive];	225144 [likely benign DISEASE=Steroid-resistant nephrotic syndrome,Nephrotic syndrome, idiopathic, steroid-resistant]; 225143 [pathogenic DISEASE=Nephrotic syndrome, idiopathic, steroid-resistant];	CR068160 [CLASS=FP MUT=ALT PHEN="Reduced expression" GENE=NPHS2];		rs12406197	0.1833	0.2545	972,.	0.1427,0.3448,0.0981,0.2766,0.1991	-1.1450			0.01,0.20	9.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179545115	179545115	G	A	n/a	wt	hom	off-target	QUAL=61;DP=1,7,4;AF=1.00,0.00,1.00;MQM=60	NPHS2,RNU5F-2P	upstream_gene	NPHS2:ENST00000367615:upstream_gene_variant:MODIFIER::::,NPHS2:ENST00000367616:upstream_gene_variant:MODIFIER::::,RNU5F-2P:ENST00000516066:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter			CR068161 [CLASS=FP MUT=ALT PHEN="Reduced expression" GENE=NPHS2];		rs1079291	0.2746	0.2234	878,.		-3.7360			0.01,0.14	8.25						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), RNU5F-2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	180199384	180199384	-	AG	het	wt	hom	off-target	QUAL=240;DP=32,9,9;AF=0.38,0.00,1.00;MQM=60	LHX4	upstream_gene	LHX4:ENST00000263726:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter				G-rich (Low_complexity)	rs138033992	0.3672	0.4080	2632,.						20.20						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35)
chr1	180235728	180235728	C	T	het	het	wt		QUAL=1869;DP=75,107,91;AF=0.52,0.42,0.00;MQM=60	LHX4	splice_region&synonymous	LHX4:ENST00000263726:splice_region_variant&synonymous_variant:LOW:exon3/6:c.450C>T:p.Asn150=:		602146 [GENE=LHX4 PHENOS=Pituitary hormone deficiency,combined,4,262700,Autosomal dominant];	262223 [benign/likely benign DISEASE=not specified,Combined Pituitary Hormone Deficiency, Dominant];			rs16855642	0.0427	0.0366	45,.	0.1045,0.0092,0.0111,0.0105,0.0175	-0.7970			0.16,0.87	15.55		9.89>9.26		0.000/0.054		7	225						LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35)
chr1	180240510	180240510	T	C	het	wt	het		QUAL=1636;DP=67,115,77;AF=0.52,0.00,0.47;MQM=60	LHX4,RP5-1180C10.2	splice_region&intron,non_coding_transcript_exon	LHX4:ENST00000263726:splice_region_variant&intron_variant:LOW:exon3/5:c.452-5T>C::,RP5-1180C10.2:ENST00000415414:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.945A>G::	regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	602146 [GENE=LHX4 PHENOS=Pituitary hormone deficiency,combined,4,262700,Autosomal dominant];	293866 [likely benign DISEASE=Combined Pituitary Hormone Deficiency, Dominant];			rs2764449	0.0413	0.0658	92,.	0.0140,0.0291,0.0113,0.0780,0.0791	1.9980			0.33,0.91	15.71		10.03>9.20				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), RP5-1180C10.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	180243524	180243524	A	G	het	het	het		QUAL=7700;DP=209,203,155;AF=0.48,0.57,0.48;MQM=60	LHX4,RP5-1180C10.2	missense,intron&non_coding_transcript	LHX4:ENST00000263726:missense_variant:MODERATE:exon6/6:c.983A>G:p.Asn328Ser:,RP5-1180C10.2:ENST00000415414:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/4:n.31+262T>C::,RP5-1180C10.2:ENST00000440959:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/2:n.1574+262T>C::		602146 [GENE=LHX4 PHENOS=Pituitary hormone deficiency,combined,4,262700,Autosomal dominant];	262225 [benign DISEASE=Pituitary hormone deficiency, combined 4,not specified,Combined Pituitary Hormone Deficiency, Dominant];			rs7536561	0.4263	0.4824	3265,.	0.1826,0.2569,0.5889,0.5227,0.6011	2.5300	T(1.00), , 	B(0.00), , 	0.92,0.98	19.13	0.26		gain/acceptor/180243523-180243524/Medium/3.185493			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), RP5-1180C10.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	180257692	180257692	A	C	hom	hom	hom	off-target	QUAL=19085;DP=249,202,155;AF=1.00,1.00,1.00;MQM=60	ACBD6	intron	ACBD6:ENST00000367595:intron_variant:MODIFIER:exon7/7:c.695-40T>G::	regulatory_region_variant:promoter_flanking_region					rs2254465		0.9569	14376,.	0.9632,0.9680,0.9876,0.9423,0.9138	-3.3430			0.01,0.15	0.33						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	183155228	183155228	C	A	wt	wt	het		QUAL=2642;DP=171,306,249;AF=0.00,0.01,0.49;MQM=60	LAMC2	upstream_gene	LAMC2:ENST00000264144:upstream_gene_variant:MODIFIER::::,LAMC2:ENST00000493293:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant		293975 [benign DISEASE=Epidermolysis bullosa, junctional];			rs2276544	0.1603	0.1393	374,.		0.2470			0.35,0.21	7.30						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183155305	183155305	G	A	het	hom	wt		QUAL=19361;DP=265,500,354;AF=0.54,1.00,0.00;MQM=60	LAMC2	upstream_gene	LAMC2:ENST00000264144:upstream_gene_variant:MODIFIER::::,LAMC2:ENST00000493293:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant		293977 [benign DISEASE=Epidermolysis bullosa, junctional];			rs2276543	0.2989	0.2739	1252,.		2.8840			0.70,0.90	22.30			loss/acceptor/183155304-183155305/Medium/5.652343			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183155399	183155399	A	G	wt	wt	het		QUAL=3318;DP=353,397,283;AF=0.00,0.00,0.48;MQM=60	LAMC2	5'UTR	LAMC2:ENST00000493293:5_prime_UTR_variant:MODIFIER:exon1/22:c.-89A>G::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	293979 [benign DISEASE=Epidermolysis bullosa, junctional];			rs2276542	0.2091	0.1803	549,.		2.8120			0.62,0.75	14.85						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183155482	183155482	C	A	wt	het	wt		QUAL=790;DP=25,90,68;AF=0.00,0.47,0.00;MQM=60	LAMC2	5'UTR	LAMC2:ENST00000264144:5_prime_UTR_variant:MODIFIER:exon1/23:c.-6C>A::,LAMC2:ENST00000493293:5_prime_UTR_variant:MODIFIER:exon1/22:c.-6C>A::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	293983 [benign DISEASE=Epidermolysis bullosa, junctional];			rs684527	0.2748	0.3122	1290,.	0.0999,0.3338,0.4192,0.2979,0.3598	1.3870			0.39,0.33	16.02						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183176970	183176970	-	T	het	het	het	off-target	QUAL=1134;DP=75,46,53;AF=0.20,0.28,0.40;MQM=60	LAMC2	intron	LAMC2:ENST00000264144:intron_variant:MODIFIER:exon1/22:c.80-31dup::,LAMC2:ENST00000493293:intron_variant:MODIFIER:exon1/21:c.80-31dup::		150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];				rs11480551		0.2688	441,.	0.2697,0.2585,0.3149,0.2623,0.2771					4.28						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183176970	183176970	-	TT	wt	het	wt	off-target	QUAL=1134;DP=75,46,53;AF=0.09,0.39,0.06;MQM=59	LAMC2	intron	LAMC2:ENST00000264144:intron_variant:MODIFIER:exon1/22:c.80-32_80-31dup::,LAMC2:ENST00000493293:intron_variant:MODIFIER:exon1/21:c.80-32_80-31dup::		150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];				rs11480551		0.3214	1281,.	0.2093,0.2541,0.2462,0.1999,0.1521					4.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183177218	183177218	A	G	het	hom	wt	off-target	QUAL=9001;DP=133,242,212;AF=0.47,1.00,0.00;MQM=60	LAMC2	intron	LAMC2:ENST00000264144:intron_variant:MODIFIER:exon2/22:c.268+14A>G::,LAMC2:ENST00000493293:intron_variant:MODIFIER:exon2/21:c.268+14A>G::		150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	259785 [benign DISEASE=Epidermolysis bullosa, junctional,not specified];		GA-rich (Low_complexity)	rs647347	0.4962	0.4732	3229,.	0.4660,0.5096,0.5629,0.4381,0.5155	-1.4960			0.00,0.05	0.81						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183184616	183184616	C	T	wt	wt	het		QUAL=2920;DP=271,345,244;AF=0.00,0.01,0.48;MQM=60	LAMC2	synonymous	LAMC2:ENST00000264144:synonymous_variant:LOW:exon3/23:c.297C>T:p.Ser99=:PF00053,LAMC2:ENST00000493293:synonymous_variant:LOW:exon3/22:c.297C>T:p.Ser99=:PF00053	regulatory_region_variant:open_chromatin_region	150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	259787 [benign DISEASE=Epidermolysis bullosa, junctional,not specified];			rs2274980	0.3137	0.2508	1153,.	0.3883,0.3782,0.3433,0.1766,0.3155	0.0150			0.02,0.16	8.07						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183187494	183187494	T	C	wt	wt	het	off-target	QUAL=3529;DP=340,464,294;AF=0.00,0.00,0.48;MQM=60	LAMC2	intron	LAMC2:ENST00000264144:intron_variant:MODIFIER:exon3/22:c.405-31T>C::,LAMC2:ENST00000493293:intron_variant:MODIFIER:exon3/21:c.405-31T>C::		150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];				rs10911285	0.3139	0.2509	1155,.	0.3884,0.3788,0.3433,0.1766,0.3153	-0.8980			0.00,0.09	0.37						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183187603	183187603	C	T	wt	wt	het		QUAL=3068;DP=194,323,249;AF=0.00,0.00,0.50;MQM=60	LAMC2	synonymous	LAMC2:ENST00000264144:synonymous_variant:LOW:exon4/23:c.483C>T:p.Val161=:PF00053,LAMC2:ENST00000493293:synonymous_variant:LOW:exon4/22:c.483C>T:p.Val161=:PF00053		150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	259789 [benign DISEASE=Epidermolysis bullosa, junctional,not specified];			rs1129723	0.3139	0.2507	1157,.	0.3875,0.3784,0.3423,0.1762,0.3155	0.7130			0.54,0.97	12.37						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183192304	183192304	T	G	wt	wt	het		QUAL=2777;DP=225,280,207;AF=0.00,0.00,0.53;MQM=60	LAMC2	synonymous	LAMC2:ENST00000264144:synonymous_variant:LOW:exon7/23:c.798T>G:p.Gly266=:PF00052,LAMC2:ENST00000493293:synonymous_variant:LOW:exon7/22:c.798T>G:p.Gly266=:PF00052	regulatory_region_variant:CTCF_binding_site	150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	259790 [benign DISEASE=Epidermolysis bullosa, junctional,not specified];			rs1047980	0.3550	0.2862	1645,.	0.5145,0.3869,0.3442,0.1779,0.3165	-0.4130			0.12,0.91	12.71						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183192496	183192496	A	G	wt	wt	het	off-target	QUAL=2028;DP=214,172,137;AF=0.00,0.00,0.59;MQM=60	LAMC2	intron	LAMC2:ENST00000264144:intron_variant:MODIFIER:exon7/22:c.953+37A>G::,LAMC2:ENST00000493293:intron_variant:MODIFIER:exon7/21:c.953+37A>G::	regulatory_region_variant:CTCF_binding_site	150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];				rs3738824	0.1132	0.1334	290,.	0.1116,0.1648,0.1782,0.1267,0.0906	0.7180			0.18,0.19	4.55						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183201970	183201970	G	C	wt	wt	het		QUAL=907;DP=128,163,109;AF=0.00,0.00,0.39;MQM=60	LAMC2	missense	LAMC2:ENST00000264144:missense_variant:MODERATE:exon14/23:c.2198G>C:p.Ser733Thr:,LAMC2:ENST00000493293:missense_variant:MODERATE:exon14/22:c.2198G>C:p.Ser733Thr:		150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	259784 [benign/likely benign DISEASE=Epidermolysis bullosa, junctional,not specified];			rs2296303	0.1450	0.1674	495,.	0.2289,0.1701,0.1797,0.1272,0.0914	1.2080	D(0.05),D(0.05)	B(0.13),B(0.17)	0.35,0.50	11.92	0.07		loss/donor/183201970-183201971/Medium/2.810183			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183206573	183206573	G	A	wt	wt	het		QUAL=3682;DP=362,404,276;AF=0.00,0.00,0.51;MQM=60	LAMC2	synonymous	LAMC2:ENST00000264144:synonymous_variant:LOW:exon18/23:c.2688G>A:p.Gln896=:,LAMC2:ENST00000493293:synonymous_variant:LOW:exon18/22:c.2688G>A:p.Gln896=:		150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	259786 [benign DISEASE=Epidermolysis bullosa, junctional,not specified];			rs1047981	0.3524	0.2851	1629,.	0.5110,0.3851,0.3431,0.1779,0.3162	-0.3580			0.01,0.10	0.11						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183207603	183207603	T	C	wt	wt	het	off-target	QUAL=1090;DP=197,112,82;AF=0.00,0.00,0.56;MQM=60	LAMC2	intron	LAMC2:ENST00000264144:intron_variant:MODIFIER:exon19/22:c.2869+47T>C::,LAMC2:ENST00000493293:intron_variant:MODIFIER:exon19/21:c.2869+47T>C::		150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];				rs1925043	0.3588	0.2911	1729,.	0.5345,0.3875,0.3445,0.1784,0.3163	-1.2960			0.00,0.09	6.45						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183212548	183212548	T	G	wt	wt	het		QUAL=2484;DP=213,247,174;AF=0.00,0.00,0.56;MQM=60	LAMC2	3'UTR	LAMC2:ENST00000264144:3_prime_UTR_variant:MODIFIER:exon23/23:c.*13T>G::		150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	294025 [benign DISEASE=Epidermolysis bullosa, junctional];			rs3768593	0.3109	0.2397	969,.	0.3628,0.3779,0.3678,0.1651,0.3129	0.2330			0.00,0.15	10.53						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183213410	183213410	G	T	wt	wt	het		QUAL=2295;DP=275,200,178;AF=0.00,0.01,0.49;MQM=60	LAMC2	3'UTR	LAMC2:ENST00000264144:3_prime_UTR_variant:MODIFIER:exon23/23:c.*875G>T::		150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	294036 [likely benign DISEASE=Epidermolysis bullosa, junctional];			rs10797863	0.0913	0.1025	206,.		-0.1180			0.09,0.17	0.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183213933	183213933	C	T	wt	het	wt		QUAL=4919;DP=467,395,284;AF=0.00,0.47,0.00;MQM=60	LAMC2	3'UTR	LAMC2:ENST00000264144:3_prime_UTR_variant:MODIFIER:exon23/23:c.*1398C>T::		150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	294053 [uncertain significance DISEASE=Epidermolysis bullosa, junctional];			rs564740740	0.0012	0.0031	0,.		0.4840			0.08,0.80	15.94						0	10						LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183524855	183524855	C	A	hom	hom	hom		QUAL=44398;DP=469,546,387;AF=1.00,0.99,0.99;MQM=59	NCF2	3'UTR	NCF2:ENST00000367536:3_prime_UTR_variant:MODIFIER:exon16/16:c.*398G>T::,NCF2:ENST00000413720:3_prime_UTR_variant:MODIFIER:exon14/14:c.*398G>T::,NCF2:ENST00000418089:3_prime_UTR_variant:MODIFIER:exon13/13:c.*398G>T::		608515 [GENE=NCF2 PHENOS=Chronic granulomatous disease due to deficiency of NCF-2,233710,Autosomal recessive];	294066 [benign DISEASE=Chronic granulomatous disease];			rs796860	0.9393	0.9052	12853,.		-2.0230			0.00,0.08	0.67						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183534935	183534935	C	T	hom	het	hom	off-target	QUAL=13706;DP=146,253,193;AF=1.00,0.51,1.00;MQM=60	NCF2	intron	NCF2:ENST00000367535:intron_variant:MODIFIER:exon9/14:c.925-21G>A::,NCF2:ENST00000367536:intron_variant:MODIFIER:exon10/15:c.925-21G>A::,NCF2:ENST00000413720:intron_variant:MODIFIER:exon8/13:c.790-21G>A::,NCF2:ENST00000418089:intron_variant:MODIFIER:exon7/12:c.682-21G>A::		608515 [GENE=NCF2 PHENOS=Chronic granulomatous disease due to deficiency of NCF-2,233710,Autosomal recessive];				rs2296164	0.4776	0.4930	3292,.	0.3535,0.6456,0.6096,0.4669,0.4657	-3.2360			0.01,0.09	0.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183542387	183542387	T	C	hom	het	hom		QUAL=18361;DP=256,266,192;AF=0.99,0.55,1.00;MQM=59	NCF2	missense,intron	NCF2:ENST00000367535:missense_variant:MODERATE:exon5/15:c.542A>G:p.Lys181Arg:,NCF2:ENST00000367536:missense_variant:MODERATE:exon6/16:c.542A>G:p.Lys181Arg:,NCF2:ENST00000413720:missense_variant:MODERATE:exon4/14:c.407A>G:p.Lys136Arg:,NCF2:ENST00000418089:intron_variant:MODIFIER:exon3/12:c.367-2413A>G::		608515 [GENE=NCF2 PHENOS=Chronic granulomatous disease due to deficiency of NCF-2,233710,Autosomal recessive];	256116 [benign DISEASE=Chronic granulomatous disease,not specified];			rs2274064	0.4916	0.4988	3288,.	0.3588,0.6448,0.6234,0.4659,0.5073	0.5830	T(0.81),T(0.81),T(0.88), 	B(0.00),B(0.00),B(0.00), 	0.46,0.95	16.95	0.08					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	196642072	196642072	C	T	wt	wt	het	off-target	QUAL=324;DP=121,74,48;AF=0.00,0.00,0.38;MQM=60	CFH	intron	CFH:ENST00000359637:intron_variant:MODIFIER:exon1/8:c.59-36C>T::,CFH:ENST00000367429:intron_variant:MODIFIER:exon1/21:c.59-36C>T::,CFH:ENST00000439155:intron_variant:MODIFIER:exon1/9:c.59-36C>T::		134370 [GENE=CFH PHENOS=Basal laminar drusen,126700,Autosomal dominant/Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Macular degeneration,age-related,4,610698];				rs551397	0.4681	0.3936	3073,.	0.7248,0.3721,0.4170,0.2314,0.3114	-0.1960			0.00,0.05	1.94						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196642233	196642233	G	A	wt	wt	het		QUAL=924;DP=231,138,83;AF=0.00,0.00,0.48;MQM=60	CFH	missense	CFH:ENST00000359637:missense_variant:MODERATE:exon2/9:c.184G>A:p.Val62Ile:PF00084,CFH:ENST00000367429:missense_variant:MODERATE:exon2/22:c.184G>A:p.Val62Ile:PF00084,CFH:ENST00000439155:missense_variant:MODERATE:exon2/10:c.184G>A:p.Val62Ile:PF00084		134370 [GENE=CFH PHENOS=Basal laminar drusen,126700,Autosomal dominant/Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Macular degeneration,age-related,4,610698];	16550 [benign DISEASE=Macular degeneration,Mesangiocapillary glomerulonephritis, type II,Basal laminar drusen,Age-related macular degeneration 4,Atypical hemolytic uremic syndrome,not provided];			rs800292	0.4681	0.3929	3060,.	0.7254,0.3751,0.4206,0.2350,0.3144	1.7350	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	0.00,0.09	7.18	0.14					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196642969	196642969	-	TT	wt	wt	het	off-target	QUAL=993;DP=98,131,112;AF=0.00,0.00,0.40;MQM=60	CFH	intron	CFH:ENST00000359637:intron_variant:MODIFIER:exon2/8:c.245-10_245-9dup::,CFH:ENST00000367429:intron_variant:MODIFIER:exon2/21:c.245-10_245-9dup::,CFH:ENST00000439155:intron_variant:MODIFIER:exon2/9:c.245-10_245-9dup::		134370 [GENE=CFH PHENOS=Basal laminar drusen,126700,Autosomal dominant/Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Macular degeneration,age-related,4,610698];		CI063658 [CLASS=DM MUT=ALT PHEN="Membranoproliferative glomerulonephritis" GENE=CFH];		rs552281857		0.2354	811,.						0.64						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196654324	196654324	A	C	het	het	het		QUAL=9409;DP=284,266,209;AF=0.49,0.48,0.48;MQM=60	CFH	synonymous	CFH:ENST00000359637:synonymous_variant:LOW:exon6/9:c.729A>C:p.Ala243=:PF00084,CFH:ENST00000367429:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:PF00084,CFH:ENST00000439155:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:PF00084		134370 [GENE=CFH PHENOS=Basal laminar drusen,126700,Autosomal dominant/Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Macular degeneration,age-related,4,610698];	294488 [benign DISEASE=Macular degeneration,Mesangiocapillary glomerulonephritis, type II,Basal laminar drusen,Atypical hemolytic uremic syndrome];			rs1061147	0.7131	0.6762	6137,.	0.5734,0.8312,0.9540,0.6166,0.6976	-0.0870			0.02,0.15	3.53						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196658497	196658497	G	T	het	het	het	off-target	QUAL=1472;DP=93,17,15;AF=0.54,0.18,0.53;MQM=60	CFH	intron	CFH:ENST00000359637:intron_variant:MODIFIER:exon6/8:c.773-53G>T::,CFH:ENST00000367429:intron_variant:MODIFIER:exon7/21:c.965-53G>T::,CFH:ENST00000439155:intron_variant:MODIFIER:exon7/9:c.965-53G>T::		134370 [GENE=CFH PHENOS=Basal laminar drusen,126700,Autosomal dominant/Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Macular degeneration,age-related,4,610698];				rs482934	0.7816	0.6784	7369,.		-0.0470			0.00,0.13	1.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196659237	196659237	C	T	het	het	het		QUAL=5479;DP=191,108,104;AF=0.57,0.49,0.41;MQM=56	CFH	missense	CFH:ENST00000359637:missense_variant:MODERATE:exon8/9:c.1012C>T:p.His338Tyr:PF00084,CFH:ENST00000367429:missense_variant:MODERATE:exon9/22:c.1204C>T:p.His402Tyr:PF00084,CFH:ENST00000439155:missense_variant:MODERATE:exon9/10:c.1204C>T:p.His402Tyr:PF00084		134370 [GENE=CFH PHENOS=Basal laminar drusen,126700,Autosomal dominant/Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Macular degeneration,age-related,4,610698];	294490 [benign DISEASE=Macular degeneration,Mesangiocapillary glomerulonephritis, type II,Basal laminar drusen,Atypical hemolytic uremic syndrome];			rs1061170	0.7334	0.6797	6399,.	0.6270,0.8335,0.9541,0.6159,0.6976	-6.7160	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	0.00,0.04	0.01	0.09					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196682947	196682947	G	A	het	het	het		QUAL=8619;DP=262,257,192;AF=0.42,0.48,0.49;MQM=60	CFH	synonymous	CFH:ENST00000367429:synonymous_variant:LOW:exon10/22:c.1419G>A:p.Ala473=:PF00084		134370 [GENE=CFH PHENOS=Basal laminar drusen,126700,Autosomal dominant/Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Macular degeneration,age-related,4,610698];	294491 [benign DISEASE=Macular degeneration,Mesangiocapillary glomerulonephritis, type II,Basal laminar drusen,Atypical hemolytic uremic syndrome];	CM062504 [CLASS=DP MUT=ALT PHEN="Membranoproliferative glomerulonephritis association" GENE=CFH];		rs2274700	0.4790	0.4435	2835,.	0.4618,0.4590,0.4312,0.4121,0.5459	0.4760			0.00,0.09	0.14						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196705926	196705926	C	A	het	het	het	off-target	QUAL=138;DP=16,13,4;AF=0.25,0.38,0.50;MQM=60	CFH	intron	CFH:ENST00000367429:intron_variant:MODIFIER:exon15/21:c.2414-28C>A::		134370 [GENE=CFH PHENOS=Basal laminar drusen,126700,Autosomal dominant/Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Macular degeneration,age-related,4,610698];			(TTAATT)n (Simple_repeat)	rs375046	0.7748	0.6624	6673,.	0.7404,0.7100,0.9333,0.5543,0.6854	-0.3700			0.00,0.11	0.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196709816	196709816	G	T	het	het	wt		QUAL=6951;DP=283,216,187;AF=0.53,0.51,0.00;MQM=60	CFH	missense	CFH:ENST00000367429:missense_variant:MODERATE:exon18/22:c.2850G>T:p.Gln950His:PF00084		134370 [GENE=CFH PHENOS=Basal laminar drusen,126700,Autosomal dominant/Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Macular degeneration,age-related,4,610698];	294510 [likely benign DISEASE=Macular degeneration,Mesangiocapillary glomerulonephritis, type II,Basal laminar drusen,Atypical hemolytic uremic syndrome,not specified];	CM034428 [CLASS=DM? MUT=ALT PHEN="Haemolytic uraemic syndrome" GENE=CFH];		rs149474608	0.0016	0.0039	0,.	0.0008,0.0019,0.0000,0.0060,0.0001	-0.2730	D(0.04)	D(0.99)	0.02,0.17	14.41	0.32					0	77		2	[2] Ute Grasshoff 30.01.2015 [n/a] comment imported from detected variant: conflicting evidence			CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196712577	196712577	T	C	wt	wt	het		QUAL=305;DP=179,120,132;AF=0.00,0.00,0.23;MQM=45	CFH	splice_region&intron	CFH:ENST00000367429:splice_region_variant&intron_variant:LOW:exon19/21:c.3134-5T>C::	regulatory_region_variant:CTCF_binding_site	134370 [GENE=CFH PHENOS=Basal laminar drusen,126700,Autosomal dominant/Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Macular degeneration,age-related,4,610698];				rs513699		0.0468	0,.	0.0370,0.0684,0.1172,0.0401,0.0177	2.9620			0.62,0.39	7.95		9.26>8.55		0.000/0.028		0	2236						CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196712586	196712586	C	T	wt	wt	het		QUAL=512;DP=191,135,149;AF=0.00,0.00,0.26;MQM=46	CFH	synonymous	CFH:ENST00000367429:synonymous_variant:LOW:exon20/22:c.3138C>T:p.Thr1046=:	regulatory_region_variant:CTCF_binding_site	134370 [GENE=CFH PHENOS=Basal laminar drusen,126700,Autosomal dominant/Complement factor H deficiency,609814,Autosomal recessive,Autosomal dominant/Hemolytic uremic syndrome,atypical,susceptibility to,1,235400,Autosomal recessive,Autosomal dominant/Macular degeneration,age-related,4,610698];	294519 [benign DISEASE=Macular degeneration,Mesangiocapillary glomerulonephritis, type II,Basal laminar drusen,Atypical hemolytic uremic syndrome];			rs61822181		0.1278	0,.	0.1049,0.1903,0.2414,0.1127,0.0746	-0.0290			0.00,0.17	7.62						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	197053373	197053373	G	A	hom	hom	hom		QUAL=18998;DP=240,197,138;AF=1.00,1.00,1.00;MQM=60	ASPM	3'UTR	ASPM:ENST00000294732:3_prime_UTR_variant:MODIFIER:exon27/27:c.*81C>T::,ASPM:ENST00000367408:3_prime_UTR_variant:MODIFIER:exon23/23:c.*81C>T::,ASPM:ENST00000367409:3_prime_UTR_variant:MODIFIER:exon28/28:c.*81C>T::		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	294591 [benign DISEASE=Primary Microcephaly, Recessive];			rs12677	0.7823	0.7918	10517,.		1.4990			0.00,0.17	2.83						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197053562	197053562	A	-	het	het	het		QUAL=326;DP=97,41,26;AF=0.18,0.29,0.12;MQM=59	ASPM	splice_region&intron	ASPM:ENST00000294732:splice_region_variant&intron_variant:LOW:exon26/26:c.5577-6del::,ASPM:ENST00000367408:splice_region_variant&intron_variant:LOW:exon22/22:c.3327-6del::,ASPM:ENST00000367409:splice_region_variant&intron_variant:LOW:exon27/27:c.10332-6del::		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];				rs369160994		0.2071	0,.	0.2939,0.2902,0.2922,0.1565,0.2351	-1.2230				0.05					COSM5445356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197055925	197055925	T	C	hom	hom	hom		QUAL=13630;DP=168,137,108;AF=1.00,1.00,1.00;MQM=60	ASPM	splice_region&intron	ASPM:ENST00000294732:splice_region_variant&intron_variant:LOW:exon26/26:c.5576+8A>G::,ASPM:ENST00000367408:splice_region_variant&intron_variant:LOW:exon22/22:c.3326+8A>G::,ASPM:ENST00000367409:splice_region_variant&intron_variant:LOW:exon27/27:c.10331+8A>G::		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	157775 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,Primary Microcephaly, Recessive,not provided];			rs10754213	0.7827	0.8877	10520,.	0.4435,0.9346,0.9998,0.9062,0.8985	-0.2090			0.00,0.34	8.07				0.000/0.000		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197059928	197059928	A	G	hom	hom	hom	off-target	QUAL=8867;DP=104,101,80;AF=1.00,1.00,1.00;MQM=60	ASPM	intron	ASPM:ENST00000294732:intron_variant:MODIFIER:exon22/26:c.4881+52T>C::,ASPM:ENST00000367408:intron_variant:MODIFIER:exon18/22:c.2631+52T>C::,ASPM:ENST00000367409:intron_variant:MODIFIER:exon23/27:c.9636+52T>C::		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];				rs4915316	0.7564	0.7695	10207,.		0.0220			0.03,0.22	6.53						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197070521	197070521	C	G	wt	wt	het		QUAL=1188;DP=299,129,97;AF=0.00,0.00,0.49;MQM=60	ASPM	intron,missense	ASPM:ENST00000294732:intron_variant:MODIFIER:exon17/26:c.4066-5227G>C::,ASPM:ENST00000367408:intron_variant:MODIFIER:exon13/22:c.1816-5227G>C::,ASPM:ENST00000367409:missense_variant:MODERATE:exon18/28:c.7860G>C:p.Gln2620His:	regulatory_region_variant:promoter_flanking_region	605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	21609 [benign/likely benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,Primary Microcephaly, Recessive,not provided];			rs12138336	0.0288	0.0507	34,.	0.0130,0.0317,0.0001,0.0715,0.0310	-1.0950	 , ,T(0.10)	 , ,B(0.03)	0.08,0.16	0.08	0.08					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197070776	197070776	C	T	het	het	het		QUAL=8712;DP=227,246,189;AF=0.55,0.49,0.46;MQM=60	ASPM	intron,synonymous	ASPM:ENST00000294732:intron_variant:MODIFIER:exon17/26:c.4066-5482G>A::,ASPM:ENST00000367408:intron_variant:MODIFIER:exon13/22:c.1816-5482G>A::,ASPM:ENST00000367409:synonymous_variant:LOW:exon18/28:c.7605G>A:p.Val2535=:PF00612	regulatory_region_variant:promoter_flanking_region	605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	21603 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,Primary Microcephaly, Recessive];			rs10922162	0.2949	0.2570	802,.	0.0395,0.4648,0.7055,0.1568,0.2767	0.1820			0.14,0.43	3.91						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197070815	197070815	T	C	hom	hom	hom		QUAL=19696;DP=238,197,155;AF=1.00,1.00,1.00;MQM=60	ASPM	intron,synonymous	ASPM:ENST00000294732:intron_variant:MODIFIER:exon17/26:c.4066-5521A>G::,ASPM:ENST00000367408:intron_variant:MODIFIER:exon13/22:c.1816-5521A>G::,ASPM:ENST00000367409:synonymous_variant:LOW:exon18/28:c.7566A>G:p.Leu2522=:	regulatory_region_variant:promoter_flanking_region	605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	21602 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,Primary Microcephaly, Recessive];			rs1412640		0.8954	10934,.	0.5426,0.9393,0.9997,0.9064,0.8990	-0.1270			0.06,0.15	2.87						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197070901	197070901	A	G	hom	hom	hom		QUAL=23170;DP=318,205,167;AF=1.00,1.00,1.00;MQM=60	ASPM	intron,missense	ASPM:ENST00000294732:intron_variant:MODIFIER:exon17/26:c.4066-5607T>C::,ASPM:ENST00000367408:intron_variant:MODIFIER:exon13/22:c.1816-5607T>C::,ASPM:ENST00000367409:missense_variant:MODERATE:exon18/28:c.7480T>C:p.Tyr2494His:	regulatory_region_variant:promoter_flanking_region	605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	21599 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,Primary Microcephaly, Recessive];			rs964201	0.9974	0.9963	15559,.	0.9990,0.9992,1.0000,0.9936,0.9974	3.0000	 , ,T(1.00)	 , ,B(0.00)	0.09,0.87	17.26	0.19					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197091537	197091537	A	T	hom	hom	hom		QUAL=24392;DP=311,250,201;AF=1.00,1.00,1.00;MQM=59	ASPM	synonymous	ASPM:ENST00000294732:synonymous_variant:LOW:exon14/27:c.3579T>A:p.Ser1193=:,ASPM:ENST00000367408:synonymous_variant:LOW:exon10/23:c.1329T>A:p.Ser443=:,ASPM:ENST00000367409:synonymous_variant:LOW:exon14/28:c.3579T>A:p.Ser1193=:		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	21578 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,Primary Microcephaly, Recessive];			rs4915337	0.7825	0.8873	10513,.	0.4432,0.9345,0.9998,0.9060,0.8986	-0.3320			0.05,0.27	6.88						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197094030	197094030	C	T	het	het	het		QUAL=9364;DP=391,183,152;AF=0.50,0.48,0.48;MQM=60	ASPM	synonymous	ASPM:ENST00000294732:synonymous_variant:LOW:exon12/27:c.3138G>A:p.Arg1046=:,ASPM:ENST00000367408:synonymous_variant:LOW:exon8/23:c.888G>A:p.Arg296=:,ASPM:ENST00000367409:synonymous_variant:LOW:exon12/28:c.3138G>A:p.Arg1046=:		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	21573 [benign/likely benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,Primary Microcephaly, Recessive];			rs6676084	0.2167	0.2794	1047,.	0.1541,0.2515,0.1110,0.3145,0.3089	-1.1000			0.03,0.20	7.29					COSM3677510	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197102745	197102745	A	G	het	het	het	off-target	QUAL=3189;DP=141,73,70;AF=0.48,0.45,0.40;MQM=60	ASPM	intron	ASPM:ENST00000294732:intron_variant:MODIFIER:exon5/26:c.2174-20T>C::,ASPM:ENST00000367408:intron_variant:MODIFIER:exon1/22:c.-77-20T>C::,ASPM:ENST00000367409:intron_variant:MODIFIER:exon5/27:c.2174-20T>C::		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	95887 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified];			rs4915344	0.2997	0.2574	806,.	0.0421,0.4639,0.7053,0.1566,0.2815	1.0580			0.04,0.21	10.35		6.91>6.50				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197108946	197108946	A	G	het	wt	het		QUAL=4087;DP=256,143,109;AF=0.41,0.00,0.44;MQM=60	ASPM	synonymous	ASPM:ENST00000294732:synonymous_variant:LOW:exon4/27:c.1977T>C:p.Ile659=:,ASPM:ENST00000367409:synonymous_variant:LOW:exon4/28:c.1977T>C:p.Ile659=:		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	21561 [benign/likely benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,Primary Microcephaly, Recessive];			rs17550662	0.0192	0.0450	36,.	0.0080,0.0217,0.0001,0.0655,0.0106	1.6300			0.85,0.95	13.94						26	808						ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197109042	197109042	C	T	hom	hom	hom	off-target	QUAL=12541;DP=234,88,65;AF=1.00,1.00,1.00;MQM=60	ASPM	intron	ASPM:ENST00000294732:intron_variant:MODIFIER:exon3/26:c.1922-41G>A::,ASPM:ENST00000367409:intron_variant:MODIFIER:exon3/27:c.1922-41G>A::		605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	157788 [likely benign DISEASE=not specified];			rs1332663	0.7825	0.8877	10528,.	0.4400,0.9344,0.9998,0.9052,0.8984	-0.7260			0.00,0.06	4.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197112533	197112533	G	A	hom	hom	hom		QUAL=7440;DP=111,52,61;AF=1.00,1.00,0.98;MQM=60	ASPM	synonymous	ASPM:ENST00000294732:synonymous_variant:LOW:exon3/27:c.849C>T:p.Ser283=:,ASPM:ENST00000367409:synonymous_variant:LOW:exon3/28:c.849C>T:p.Ser283=:	regulatory_region_variant:promoter	605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	95890 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,Primary Microcephaly, Recessive,not provided];			rs6677082	0.7556	0.8802	10211,.	0.3650,0.9303,0.9816,0.9055,0.8983	-0.0770			0.01,0.14	1.80						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197113073	197113073	G	A	hom	hom	hom	off-target	QUAL=4415;DP=107,21,14;AF=1.00,1.00,1.00;MQM=60	ASPM	intron	ASPM:ENST00000294732:intron_variant:MODIFIER:exon2/26:c.441+14C>T::,ASPM:ENST00000367409:intron_variant:MODIFIER:exon2/27:c.441+14C>T::	regulatory_region_variant:promoter	605481 [GENE=ASPM PHENOS=Microcephaly 5,primary,autosomal recessive,608716,Autosomal recessive];	95888 [benign/likely benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,Primary Microcephaly, Recessive];			rs1571964	0.7556	0.8798	10202,.	0.3621,0.9305,0.9817,0.9049,0.8982	-0.6110			0.05,0.43	9.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	198661668	198661668	G	A	het	wt	het		QUAL=807;DP=56,5,7;AF=0.46,0.00,0.86;MQM=60	PTPRC	intron,3'UTR	PTPRC:ENST00000348564:intron_variant:MODIFIER:exon3/29:c.100+166G>A::,PTPRC:ENST00000352140:intron_variant:MODIFIER:exon3/31:c.94+166G>A::,PTPRC:ENST00000367364:3_prime_UTR_variant:MODIFIER:exon3/3:c.*155G>A::,PTPRC:ENST00000367376:intron_variant:MODIFIER:exon3/32:c.94+166G>A::,PTPRC:ENST00000413409:intron_variant:MODIFIER:exon3/3:c.100+166G>A::,PTPRC:ENST00000442510:intron_variant:MODIFIER:exon3/32:c.100+166G>A::,PTPRC:ENST00000594404:intron_variant:MODIFIER:exon3/29:c.94+166G>A::,PTPRC:ENST00000598951:3_prime_UTR_variant:MODIFIER:exon3/3:c.*155G>A::		151460 [GENE=PTPRC PHENOS=Hepatitis C virus,susceptibility to,609532/Severe combined immunodeficiency,T cell-negative,B-cell/natural killer-cell positive,608971,Autosomal recessive];				rs115067628	0.0040	0.0118	2,.		-0.7770			0.01,0.10	0.30						0	21						PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198665917	198665917	C	G	wt	wt	het		QUAL=3192;DP=448,293,205;AF=0.00,0.00,0.58;MQM=60	PTPRC	intron,synonymous	PTPRC:ENST00000348564:intron_variant:MODIFIER:exon3/29:c.100+4415C>G::,PTPRC:ENST00000352140:synonymous_variant:LOW:exon4/32:c.171C>G:p.Pro57=:PF12453,PTPRC:ENST00000367376:synonymous_variant:LOW:exon4/33:c.171C>G:p.Pro57=:PF12453,PTPRC:ENST00000442510:synonymous_variant:LOW:exon4/33:c.177C>G:p.Pro59=:PF12453,PTPRC:ENST00000594404:intron_variant:MODIFIER:exon3/29:c.94+4415C>G::	regulatory_region_variant:promoter_flanking_region	151460 [GENE=PTPRC PHENOS=Hepatitis C virus,susceptibility to,609532/Severe combined immunodeficiency,T cell-negative,B-cell/natural killer-cell positive,608971,Autosomal recessive];	378444 [benign/likely benign DISEASE=Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive,not specified];	CS952043 [CLASS=DFP MUT=ALT PHEN="Defective splicing" GENE=PTPRC];		rs17612648	0.0044	0.0088	2,.	0.0022,0.0038,0.0001,0.0134,0.0117	0.5020			0.10,0.31	6.44						1	187						PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198677420	198677420	T	A	wt	het	wt	off-target	QUAL=520;DP=105,45,37;AF=0.00,0.51,0.00;MQM=60	PTPRC	intron	PTPRC:ENST00000348564:intron_variant:MODIFIER:exon7/29:c.550+30T>A::,PTPRC:ENST00000352140:intron_variant:MODIFIER:exon9/31:c.883+30T>A::,PTPRC:ENST00000367376:intron_variant:MODIFIER:exon10/32:c.1027+30T>A::,PTPRC:ENST00000442510:intron_variant:MODIFIER:exon10/32:c.1033+30T>A::,PTPRC:ENST00000594404:intron_variant:MODIFIER:exon7/29:c.544+30T>A::		151460 [GENE=PTPRC PHENOS=Hepatitis C virus,susceptibility to,609532/Severe combined immunodeficiency,T cell-negative,B-cell/natural killer-cell positive,608971,Autosomal recessive];				rs2274368	0.0845	0.0597	51,.	0.0735,0.1212,0.1401,0.0311,0.0774	-0.3210			0.03,0.14	0.44						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198717218	198717218	-	T	wt	het	het	off-target	QUAL=1733;DP=55,35,18;AF=0.29,0.23,0.50;MQM=59	PTPRC	intron	PTPRC:ENST00000348564:intron_variant:MODIFIER:exon23/29:c.2365-4dup::,PTPRC:ENST00000352140:intron_variant:MODIFIER:exon25/31:c.2698-4dup::,PTPRC:ENST00000367376:intron_variant:MODIFIER:exon26/32:c.2842-4dup::,PTPRC:ENST00000442510:intron_variant:MODIFIER:exon26/32:c.2848-4dup::,PTPRC:ENST00000594404:intron_variant:MODIFIER:exon23/29:c.2359-4dup::		151460 [GENE=PTPRC PHENOS=Hepatitis C virus,susceptibility to,609532/Severe combined immunodeficiency,T cell-negative,B-cell/natural killer-cell positive,608971,Autosomal recessive];			(T)n (Simple_repeat)	rs371692042		0.2602	795,.	0.1448,0.2047,0.2027,0.2855,0.2463					0.82						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198717218	198717218	G	T	hom	wt	het	off-target	QUAL=1733;DP=55,35,18;AF=0.13,0.00,0.17;MQM=60	PTPRC	intron	PTPRC:ENST00000348564:intron_variant:MODIFIER:exon23/29:c.2365-20G>T::,PTPRC:ENST00000352140:intron_variant:MODIFIER:exon25/31:c.2698-20G>T::,PTPRC:ENST00000367376:intron_variant:MODIFIER:exon26/32:c.2842-20G>T::,PTPRC:ENST00000442510:intron_variant:MODIFIER:exon26/32:c.2848-20G>T::,PTPRC:ENST00000594404:intron_variant:MODIFIER:exon23/29:c.2359-20G>T::		151460 [GENE=PTPRC PHENOS=Hepatitis C virus,susceptibility to,609532/Severe combined immunodeficiency,T cell-negative,B-cell/natural killer-cell positive,608971,Autosomal recessive];			(T)n (Simple_repeat)	rs369232264					-0.7850			0.00,0.10	0.09		11.01>11.78				9	50						PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198718732	198718732	A	G	het	het	wt	off-target	QUAL=3757;DP=213,108,80;AF=0.46,0.50,0.00;MQM=60	PTPRC	intron	PTPRC:ENST00000348564:intron_variant:MODIFIER:exon25/29:c.2589+54A>G::,PTPRC:ENST00000352140:intron_variant:MODIFIER:exon27/31:c.2922+54A>G::,PTPRC:ENST00000367376:intron_variant:MODIFIER:exon28/32:c.3066+54A>G::,PTPRC:ENST00000442510:intron_variant:MODIFIER:exon28/32:c.3072+54A>G::,PTPRC:ENST00000594404:intron_variant:MODIFIER:exon25/29:c.2583+54A>G::		151460 [GENE=PTPRC PHENOS=Hepatitis C virus,susceptibility to,609532/Severe combined immunodeficiency,T cell-negative,B-cell/natural killer-cell positive,608971,Autosomal recessive];				rs549239314	0.0004	0.0009	0,.		-0.9030			0.02,0.23	12.05						0	17						PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	201008582	201008582	-	G	hom	het	het	off-target	QUAL=1980;DP=41,55,30;AF=0.98,0.53,0.53;MQM=60	RP11-168O16.2	intron&non_coding_transcript	RP11-168O16.2:ENST00000415359:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.211-2397dup::						rs35360610		0.5490	5089,.						0.52						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RP11-168O16.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	201009556	201009556	A	G	hom	het	het	off-target	QUAL=5821;DP=127,83,63;AF=0.99,0.48,0.52;MQM=60	CACNA1S,RP11-168O16.2	intron,intron&non_coding_transcript	CACNA1S:ENST00000362061:intron_variant:MODIFIER:exon42/43:c.5227-54T>C::,CACNA1S:ENST00000367338:intron_variant:MODIFIER:exon41/42:c.5170-54T>C::,RP11-168O16.2:ENST00000415359:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.211-1427A>G::		114208 [GENE=CACNA1S PHENOS=Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant/Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant];				rs1546416	0.3325	0.3573	2068,.		-0.3490			0.03,0.12	3.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39), RP11-168O16.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	201009897	201009897	T	C	hom	hom	hom	off-target	QUAL=3763;DP=51,46,30;AF=1.00,1.00,1.00;MQM=60	CACNA1S,RP11-168O16.2	intron,intron&non_coding_transcript	CACNA1S:ENST00000362061:intron_variant:MODIFIER:exon41/43:c.5135-56A>G::,CACNA1S:ENST00000367338:intron_variant:MODIFIER:exon40/42:c.5078-56A>G::,RP11-168O16.2:ENST00000415359:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/3:n.211-1086T>C::		114208 [GENE=CACNA1S PHENOS=Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant/Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant];				rs6427875	0.9970	0.9947	15525,.		-5.3380			0.00,0.06	0.31						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39), RP11-168O16.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	201012597	201012597	G	A	hom	hom	wt		QUAL=366;DP=10,4,3;AF=1.00,1.00,0.00;MQM=60	CACNA1S	synonymous	CACNA1S:ENST00000362061:synonymous_variant:LOW:exon40/44:c.4860C>T:p.Pro1620=:,CACNA1S:ENST00000367338:synonymous_variant:LOW:exon39/43:c.4803C>T:p.Pro1601=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	114208 [GENE=CACNA1S PHENOS=Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant/Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant];	254841 [benign DISEASE=Malignant hyperthermia susceptibility,Hypokalemic periodic paralysis,not specified];			rs41267497	0.0461	0.1051	202,.	0.0262,0.0673,0.0004,0.1612,0.0264	-1.1950			0.08,0.13	0.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201016296	201016296	G	A	wt	het	wt		QUAL=3274;DP=344,245,183;AF=0.00,0.52,0.00;MQM=60	CACNA1S	missense	CACNA1S:ENST00000362061:missense_variant:MODERATE:exon38/44:c.4615C>T:p.Arg1539Cys:PF08763,CACNA1S:ENST00000367338:missense_variant:MODERATE:exon37/43:c.4558C>T:p.Arg1520Cys:PF08763		114208 [GENE=CACNA1S PHENOS=Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant/Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant];	197021 [benign DISEASE=Malignant hyperthermia susceptibility,Hypokalemic periodic paralysis,not specified,not provided];			rs3850625	0.0841	0.1157	181,.	0.0206,0.0958,0.0333,0.1184,0.2102	6.1960	D(0.01),D(0.01)	B(0.30),B(0.30)	0.96,0.98	25.80	0.28					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201020105	201020105	A	G	wt	het	het		QUAL=6113;DP=131,276,211;AF=0.01,0.49,0.53;MQM=60	CACNA1S	splice_region&intron	CACNA1S:ENST00000362061:splice_region_variant&intron_variant:LOW:exon33/43:c.4113+7T>C::,CACNA1S:ENST00000367338:splice_region_variant&intron_variant:LOW:exon32/42:c.4056+7T>C::	regulatory_region_variant:promoter_flanking_region	114208 [GENE=CACNA1S PHENOS=Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant/Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant];	199680 [benign DISEASE=Malignant hyperthermia susceptibility,Hypokalemic periodic paralysis,not specified,not provided];			rs6702590	0.8804	0.7833	9824,.	0.9371,0.8682,0.9959,0.6687,0.8663	-0.1250			0.01,0.16	0.47				0.000/0.000		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201038687	201038687	A	G	het	het	wt		QUAL=8114;DP=218,426,341;AF=0.47,0.51,0.00;MQM=60	CACNA1S	synonymous	CACNA1S:ENST00000362061:synonymous_variant:LOW:exon18/44:c.2403T>C:p.Phe801=:,CACNA1S:ENST00000367338:synonymous_variant:LOW:exon18/43:c.2403T>C:p.Phe801=:	regulatory_region_variant:enhancer	114208 [GENE=CACNA1S PHENOS=Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant/Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant];	254814 [benign DISEASE=Malignant hyperthermia susceptibility,Hypokalemic periodic paralysis,not specified,not provided];			rs7415038	0.2941	0.4108	2882,.	0.5285,0.2185,0.0030,0.4491,0.1847	5.5810			0.07,0.95	12.69						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201042618	201042618	G	A	het	hom	wt	off-target	QUAL=4970;DP=79,140,101;AF=0.49,1.00,0.00;MQM=60	CACNA1S	intron	CACNA1S:ENST00000362061:intron_variant:MODIFIER:exon15/43:c.2157+59C>T::,CACNA1S:ENST00000367338:intron_variant:MODIFIER:exon15/42:c.2157+59C>T::		114208 [GENE=CACNA1S PHENOS=Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant/Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant];				rs9333652		0.4497	3452,.		0.2760			0.04,0.17	3.53						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201044748	201044748	A	G	het	hom	wt		QUAL=10500;DP=149,278,258;AF=0.52,1.00,0.00;MQM=59	CACNA1S	splice_region&intron	CACNA1S:ENST00000362061:splice_region_variant&intron_variant:LOW:exon12/43:c.1828-5T>C::,CACNA1S:ENST00000367338:splice_region_variant&intron_variant:LOW:exon12/42:c.1828-5T>C::		114208 [GENE=CACNA1S PHENOS=Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant/Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant];	254804 [benign DISEASE=Malignant hyperthermia susceptibility,Hypokalemic periodic paralysis,not specified,not provided];			rs1998721	0.7596	0.7819	8354,.	0.5463,0.7202,0.9604,0.7765,0.8902	-1.1900			0.00,0.12	0.41		11.27>10.69		0.000/0.002		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201046025	201046025	G	T	het	het	wt	off-target	QUAL=4258;DP=79,331,275;AF=0.48,0.52,0.01;MQM=60	CACNA1S	intron	CACNA1S:ENST00000362061:intron_variant:MODIFIER:exon12/43:c.1827+23C>A::,CACNA1S:ENST00000367338:intron_variant:MODIFIER:exon12/42:c.1827+23C>A::		114208 [GENE=CACNA1S PHENOS=Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant/Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant];			L2c (LINE/L2)	rs7549030	0.0457	0.0696	78,.	0.0773,0.0392,0.0001,0.0739,0.0251	0.0950			0.07,0.22	2.87						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201047062	201047062	G	A	hom	het	hom		QUAL=15009;DP=139,266,260;AF=0.99,0.48,1.00;MQM=60	CACNA1S	synonymous	CACNA1S:ENST00000362061:synonymous_variant:LOW:exon11/44:c.1564C>T:p.Leu522=:PF00520,CACNA1S:ENST00000367338:synonymous_variant:LOW:exon11/43:c.1564C>T:p.Leu522=:PF00520		114208 [GENE=CACNA1S PHENOS=Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant/Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant];	254801 [benign DISEASE=Malignant hyperthermia susceptibility,Hypokalemic periodic paralysis,not specified];	CM023570 [CLASS=DP MUT=ALT PHEN="Hypokalaemic periodic paralysis association with" GENE=CACNA1S];		rs4915476	0.1909	0.2220	801,.	0.2594,0.2751,0.0403,0.2290,0.1119	3.9470			0.93,0.98	9.52						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201047075	201047075	A	G	hom	het	hom		QUAL=17399;DP=185,286,267;AF=0.99,0.50,1.00;MQM=60	CACNA1S	synonymous	CACNA1S:ENST00000362061:synonymous_variant:LOW:exon11/44:c.1551T>C:p.Gly517=:PF00520,CACNA1S:ENST00000367338:synonymous_variant:LOW:exon11/43:c.1551T>C:p.Gly517=:PF00520		114208 [GENE=CACNA1S PHENOS=Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant/Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant];	254800 [benign DISEASE=Malignant hyperthermia susceptibility,Hypokalemic periodic paralysis,Malignant hyperthermia susceptibility type 5,Hypokalemic periodic paralysis 1,not specified,not provided];			rs4915477	0.5711	0.6663	7402,.	0.8959,0.5864,0.2246,0.6543,0.3215	-1.5080			0.02,0.47	9.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201054197	201054197	G	T	wt	wt	het	off-target	QUAL=922;DP=82,113,88;AF=0.00,0.00,0.50;MQM=60	CACNA1S	intron	CACNA1S:ENST00000362061:intron_variant:MODIFIER:exon8/43:c.1151-38C>A::,CACNA1S:ENST00000367338:intron_variant:MODIFIER:exon8/42:c.1151-38C>A::	regulatory_region_variant:promoter_flanking_region	114208 [GENE=CACNA1S PHENOS=Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant/Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant];				rs41267505	0.1286	0.1585	359,.	0.1434,0.2471,0.0363,0.1667,0.0878	-0.2930			0.07,0.23	5.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201060865	201060865	G	A	wt	het	wt		QUAL=2467;DP=166,185,158;AF=0.01,0.54,0.00;MQM=60	CACNA1S	synonymous	CACNA1S:ENST00000362061:synonymous_variant:LOW:exon5/44:c.597C>T:p.Ile199=:PF00520,CACNA1S:ENST00000367338:synonymous_variant:LOW:exon5/43:c.597C>T:p.Ile199=:PF00520		114208 [GENE=CACNA1S PHENOS=Hypokalemic periodic paralysis,type 1,170400,Autosomal dominant/Malignant hyperthermia susceptibility 5,601887,Autosomal dominant/Thyrotoxic periodic paralysis,susceptibility to,1,188580,Autosomal dominant];	254852 [benign DISEASE=Malignant hyperthermia susceptibility,Hypokalemic periodic paralysis,not specified,not provided];			rs2296383	0.3051	0.3897	1979,.	0.1009,0.3501,0.3592,0.4292,0.4506	-0.7520			0.15,0.96	10.23						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AR+AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	209788213	209788213	T	C	hom	het	het		QUAL=5650;DP=152,72,41;AF=0.99,0.46,0.59;MQM=60	CAMK1G,LAMB3	downstream_gene	CAMK1G:ENST00000009105:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000356082:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000361322:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000367030:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000391911:downstream_gene_variant:MODIFIER::::		150310 [GENE=LAMB3 PHENOS=Amelogenesis imperfecta,type IA,104530,Autosomal dominant/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	368859 [benign DISEASE=Epidermolysis bullosa, junctional];			rs926387	0.7748	0.7541	9116,.		-1.1700			0.00,0.11	0.73						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209788514	209788514	G	A	het	het	wt		QUAL=5430;DP=185,262,240;AF=0.52,0.46,0.00;MQM=60	LAMB3	3'UTR	LAMB3:ENST00000356082:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::,LAMB3:ENST00000367030:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::,LAMB3:ENST00000391911:3_prime_UTR_variant:MODIFIER:exon22/22:c.*102C>T::		150310 [GENE=LAMB3 PHENOS=Amelogenesis imperfecta,type IA,104530,Autosomal dominant/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	295059 [benign DISEASE=Epidermolysis bullosa, junctional];	CR1010233 [CLASS=DP MUT=ALT PHEN="Cervical cancer increased risk association with" GENE=LAMB3];		rs2566	0.2951	0.2762	1192,.		1.1010			0.10,0.19	5.68						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209792015	209792015	-	C	hom	hom	hom	off-target	QUAL=13081;DP=156,184,127;AF=0.97,0.99,0.98;MQM=60	LAMB3	intron	LAMB3:ENST00000356082:intron_variant:MODIFIER:exon18/22:c.2702-12dup::,LAMB3:ENST00000367030:intron_variant:MODIFIER:exon18/22:c.2702-12dup::,LAMB3:ENST00000391911:intron_variant:MODIFIER:exon17/21:c.2702-12dup::		150310 [GENE=LAMB3 PHENOS=Amelogenesis imperfecta,type IA,104530,Autosomal dominant/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	255590 [benign DISEASE=Epidermolysis bullosa, junctional,not specified,not provided];			rs1418651256		0.9574	14335,.	0.9896,0.9832,0.9998,0.9314,0.9883					10.36						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209799253	209799253	A	G	het	het	hom		QUAL=21363;DP=297,547,382;AF=0.40,0.50,1.00;MQM=59	LAMB3	synonymous	LAMB3:ENST00000356082:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:PF00053,LAMB3:ENST00000367030:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:PF00053,LAMB3:ENST00000391911:synonymous_variant:LOW:exon13/22:c.1716T>C:p.Cys572=:PF00053		150310 [GENE=LAMB3 PHENOS=Amelogenesis imperfecta,type IA,104530,Autosomal dominant/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	255587 [benign DISEASE=Epidermolysis bullosa, junctional,not specified];			rs2179402	0.7650	0.7542	8634,.	0.7692,0.7728,0.8231,0.7368,0.7431	-0.8090			0.06,0.75	12.66						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209804095	209804095	G	A	hom	hom	hom	off-target	QUAL=12047;DP=111,157,124;AF=1.00,1.00,1.00;MQM=60	LAMB3	intron	LAMB3:ENST00000356082:intron_variant:MODIFIER:exon8/22:c.823-15C>T::,LAMB3:ENST00000367030:intron_variant:MODIFIER:exon8/22:c.823-15C>T::,LAMB3:ENST00000391911:intron_variant:MODIFIER:exon7/21:c.823-15C>T::	TF_binding_site_variant	150310 [GENE=LAMB3 PHENOS=Amelogenesis imperfecta,type IA,104530,Autosomal dominant/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	255598 [benign DISEASE=Epidermolysis bullosa, junctional,not specified];			rs4844863	0.8233	0.8455	11143,.	0.8295,0.8277,0.8233,0.8546,0.8121	-2.2320			0.01,0.10	0.10		8.37>7.66				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209807972	209807972	G	A	hom	hom	hom		QUAL=5395;DP=34,91,58;AF=1.00,1.00,1.00;MQM=60	LAMB3	synonymous	LAMB3:ENST00000356082:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:PF00055,LAMB3:ENST00000367030:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:PF00055,LAMB3:ENST00000391911:synonymous_variant:LOW:exon5/22:c.384C>T:p.Pro128=:PF00055		150310 [GENE=LAMB3 PHENOS=Amelogenesis imperfecta,type IA,104530,Autosomal dominant/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	255596 [benign DISEASE=Epidermolysis bullosa, junctional,not specified];			rs1130667	0.2454	0.3424	1719,.	0.1309,0.2131,0.2290,0.4051,0.3404	-4.0330			0.08,0.78	3.99						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209811886	209811886	T	G	hom	hom	hom		QUAL=18913;DP=251,210,137;AF=1.00,1.00,1.00;MQM=59	LAMB3	synonymous	LAMB3:ENST00000356082:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:PF00055,LAMB3:ENST00000367030:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:PF00055,LAMB3:ENST00000391911:synonymous_variant:LOW:exon3/22:c.291A>C:p.Ser97=:PF00055		150310 [GENE=LAMB3 PHENOS=Amelogenesis imperfecta,type IA,104530,Autosomal dominant/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];	255592 [benign DISEASE=Epidermolysis bullosa, junctional,not specified];			rs2076356	0.4325	0.5708	5421,.	0.4101,0.4441,0.2859,0.6558,0.4959	-0.9220			0.06,0.45	5.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209824707	209824707	A	T	hom	hom	hom	off-target	QUAL=9166;DP=163,84,80;AF=0.99,1.00,1.00;MQM=59	LAMB3	intron	LAMB3:ENST00000356082:intron_variant:MODIFIER:exon1/22:c.-37-381T>A::,LAMB3:ENST00000367030:intron_variant:MODIFIER:exon1/22:c.-37-381T>A::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	150310 [GENE=LAMB3 PHENOS=Amelogenesis imperfecta,type IA,104530,Autosomal dominant/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive/Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive];				rs10779510	0.8966	0.8758	12093,.		-0.2920			0.00,0.06	8.85			gain/acceptor/209824707-209824708/Medium/2.164679			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209959614	209959614	G	T	het	het	wt		QUAL=6901;DP=337,185,125;AF=0.53,0.50,0.00;MQM=57	IRF6	3'UTR	IRF6:ENST00000367021:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2151C>A::		607199 [GENE=IRF6 PHENOS=Orofacial cleft 6,608864,Autosomal dominant/Popliteal pterygium syndrome 1,119500,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295175 [benign DISEASE=Popliteal pterygium syndrome,Van der Woude syndrome,Cleft Lip +/- Cleft Palate, Autosomal Dominant];			rs1044516	0.3099	0.2164	874,.		-0.3100			0.02,0.11	0.72						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209959872	209959872	G	A	hom	hom	hom		QUAL=19022;DP=311,150,125;AF=1.00,0.99,0.99;MQM=56	IRF6	3'UTR	IRF6:ENST00000367021:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1893C>T::		607199 [GENE=IRF6 PHENOS=Orofacial cleft 6,608864,Autosomal dominant/Popliteal pterygium syndrome 1,119500,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295178 [benign DISEASE=Popliteal pterygium syndrome,Van der Woude syndrome,Cleft Lip +/- Cleft Palate, Autosomal Dominant];			rs680331	0.8081	0.8037	10114,.		-0.0130			0.00,0.06	5.40						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209960087	209960087	A	-	wt	het	wt		QUAL=1538;DP=243,113,128;AF=0.00,0.53,0.00;MQM=59	IRF6	3'UTR	IRF6:ENST00000367021:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1678del::		607199 [GENE=IRF6 PHENOS=Orofacial cleft 6,608864,Autosomal dominant/Popliteal pterygium syndrome 1,119500,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295181 [benign DISEASE=Popliteal pterygium syndrome,Van der Woude syndrome,Cleft Lip +/- Cleft Palate, Autosomal Dominant];			rs141112353	0.1673	0.2010	586,.		0.4150				2.35						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209960152	209960152	T	A	wt	het	wt		QUAL=1216;DP=264,104,101;AF=0.00,0.48,0.00;MQM=59	IRF6	3'UTR	IRF6:ENST00000367021:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1613A>T::		607199 [GENE=IRF6 PHENOS=Orofacial cleft 6,608864,Autosomal dominant/Popliteal pterygium syndrome 1,119500,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];				rs1195550606					-0.6290			0.05,0.13	2.36						0	1						IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209960436	209960436	G	A	het	het	wt		QUAL=6339;DP=255,249,200;AF=0.46,0.51,0.00;MQM=59	IRF6,RP3-434O14.8	3'UTR,non_coding_transcript_exon	IRF6:ENST00000367021:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1329C>T::,RP3-434O14.8:ENST00000430751:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.479C>T::		607199 [GENE=IRF6 PHENOS=Orofacial cleft 6,608864,Autosomal dominant/Popliteal pterygium syndrome 1,119500,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295184 [benign DISEASE=Popliteal pterygium syndrome,Van der Woude syndrome,Cleft Lip +/- Cleft Palate, Autosomal Dominant];		AluJo (SINE/Alu)	rs2235372	0.2991	0.2097	786,.		-1.0970			0.00,0.09	2.94						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00), RP3-434O14.8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209960922	209960922	A	C	het	wt	hom		QUAL=2847;DP=123,124,44;AF=0.48,0.00,1.00;MQM=60	IRF6,RP3-434O14.8	3'UTR,splice_donor&non_coding_transcript	IRF6:ENST00000367021:3_prime_UTR_variant:MODIFIER:exon9/9:c.*843T>G::,RP3-434O14.8:ENST00000430751:splice_donor_variant&non_coding_transcript_variant:HIGH:exon1/1:n.115+2T>G::		607199 [GENE=IRF6 PHENOS=Orofacial cleft 6,608864,Autosomal dominant/Popliteal pterygium syndrome 1,119500,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295189 [benign DISEASE=Popliteal pterygium syndrome,Van der Woude syndrome,Cleft Lip +/- Cleft Palate, Autosomal Dominant];			rs599021	0.3043	0.3677	2220,.		0.2650			0.09,0.22	15.47		0.67>-6.98				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00), RP3-434O14.8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209960925	209960925	T	C	het	het	wt		QUAL=3113;DP=128,123,43;AF=0.54,0.45,0.00;MQM=60	IRF6,RP3-434O14.8	3'UTR,splice_region&non_coding_transcript_exon	IRF6:ENST00000367021:3_prime_UTR_variant:MODIFIER:exon9/9:c.*840A>G::,RP3-434O14.8:ENST00000430751:splice_region_variant&non_coding_transcript_exon_variant:LOW:exon1/2:n.114A>G::		607199 [GENE=IRF6 PHENOS=Orofacial cleft 6,608864,Autosomal dominant/Popliteal pterygium syndrome 1,119500,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295190 [benign DISEASE=Popliteal pterygium syndrome,Van der Woude syndrome,Cleft Lip +/- Cleft Palate, Autosomal Dominant];			rs742214	0.2971	0.2092	788,.		-1.1730			0.04,0.15	2.52		0.67>-3.49				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00), RP3-434O14.8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209961023	209961023	T	A	het	het	wt		QUAL=2213;DP=97,81,51;AF=0.51,0.49,0.02;MQM=60	IRF6,RP3-434O14.8	3'UTR,non_coding_transcript_exon	IRF6:ENST00000367021:3_prime_UTR_variant:MODIFIER:exon9/9:c.*742A>T::,RP3-434O14.8:ENST00000430751:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.16A>T::		607199 [GENE=IRF6 PHENOS=Orofacial cleft 6,608864,Autosomal dominant/Popliteal pterygium syndrome 1,119500,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295193 [benign DISEASE=Popliteal pterygium syndrome,Van der Woude syndrome,Cleft Lip +/- Cleft Palate, Autosomal Dominant];			rs742215	0.3037	0.2151	837,.		0.9660			0.09,0.28	10.39						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00), RP3-434O14.8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209961314	209961314	T	C	het	het	wt		QUAL=6579;DP=266,239,188;AF=0.51,0.47,0.01;MQM=60	IRF6	3'UTR	IRF6:ENST00000367021:3_prime_UTR_variant:MODIFIER:exon9/9:c.*451A>G::		607199 [GENE=IRF6 PHENOS=Orofacial cleft 6,608864,Autosomal dominant/Popliteal pterygium syndrome 1,119500,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295199 [benign DISEASE=Popliteal pterygium syndrome,Van der Woude syndrome,Cleft Lip +/- Cleft Palate, Autosomal Dominant];			rs17317411	0.0875	0.1004	211,.		0.3060			0.26,0.20	14.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209961354	209961354	G	A	wt	het	wt		QUAL=2559;DP=331,207,163;AF=0.00,0.47,0.00;MQM=60	IRF6	3'UTR	IRF6:ENST00000367021:3_prime_UTR_variant:MODIFIER:exon9/9:c.*411C>T::		607199 [GENE=IRF6 PHENOS=Orofacial cleft 6,608864,Autosomal dominant/Popliteal pterygium syndrome 1,119500,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295200 [likely benign DISEASE=Popliteal pterygium syndrome,Van der Woude syndrome,Cleft Lip +/- Cleft Palate, Autosomal Dominant];		MIR3 (SINE/MIR)	rs187379424	0.0008	0.0068	2,.		1.8560			0.20,0.22	7.51						0	7						IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209963803	209963803	G	A	het	het	wt	off-target	QUAL=3807;DP=194,127,88;AF=0.51,0.52,0.00;MQM=60	IRF6	intron	IRF6:ENST00000367021:intron_variant:MODIFIER:exon7/8:c.1060+37C>T::,IRF6:ENST00000542854:intron_variant:MODIFIER:exon5/6:c.775+37C>T::		607199 [GENE=IRF6 PHENOS=Orofacial cleft 6,608864,Autosomal dominant/Popliteal pterygium syndrome 1,119500,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];				rs2235373	0.2883	0.2356	711,.	0.2316,0.3481,0.4833,0.1761,0.2970	-0.5940			0.04,0.14	1.72						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209965587	209965587	G	C	het	hom	wt	off-target	QUAL=10463;DP=195,261,213;AF=0.46,1.00,0.00;MQM=60	IRF6	intron	IRF6:ENST00000367021:intron_variant:MODIFIER:exon6/8:c.667+27C>G::,IRF6:ENST00000542854:intron_variant:MODIFIER:exon4/6:c.382+27C>G::		607199 [GENE=IRF6 PHENOS=Orofacial cleft 6,608864,Autosomal dominant/Popliteal pterygium syndrome 1,119500,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	259926 [benign DISEASE=not specified];			rs2235375	0.4052	0.4101	2126,.	0.2825,0.5576,0.5725,0.3734,0.4171	0.0930			0.00,0.11	2.81						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209968684	209968684	C	A	het	hom	wt		QUAL=18494;DP=338,458,325;AF=0.45,1.00,0.00;MQM=60	IRF6	synonymous	IRF6:ENST00000367021:synonymous_variant:LOW:exon5/9:c.459G>T:p.Ser153=:,IRF6:ENST00000542854:synonymous_variant:LOW:exon3/7:c.174G>T:p.Ser58=:	regulatory_region_variant:promoter_flanking_region	607199 [GENE=IRF6 PHENOS=Orofacial cleft 6,608864,Autosomal dominant/Popliteal pterygium syndrome 1,119500,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	259925 [benign DISEASE=Popliteal pterygium syndrome,Van der Woude syndrome,not specified,Cleft Lip +/- Cleft Palate, Autosomal Dominant];			rs2013162	0.4038	0.4098	2095,.	0.2750,0.5605,0.5730,0.3733,0.4156	-1.6140			0.07,0.83	14.56						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209969902	209969902	G	C	het	hom	wt		QUAL=4765;DP=209,86,51;AF=0.47,0.99,0.02;MQM=60	IRF6	splice_region&intron	IRF6:ENST00000367021:splice_region_variant&intron_variant:LOW:exon3/8:c.175-5C>G::,IRF6:ENST00000542854:splice_region_variant&intron_variant:LOW:exon1/6:c.-111-5C>G::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	607199 [GENE=IRF6 PHENOS=Orofacial cleft 6,608864,Autosomal dominant/Popliteal pterygium syndrome 1,119500,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	259923 [benign DISEASE=Van der Woude syndrome,not specified];			rs7552506	0.2710	0.3223	1659,.	0.2672,0.2976,0.1538,0.3585,0.3323	1.2850			0.47,0.29	9.52		9.65>6.86		0.002/0.074		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209975386	209975386	A	G	het	wt	hom		QUAL=11940;DP=283,350,263;AF=0.49,0.00,1.00;MQM=60	IRF6	splice_region&5'UTR,intron	IRF6:ENST00000367021:splice_region_variant&5_prime_UTR_variant:LOW:exon2/9:c.-73T>C::,IRF6:ENST00000542854:intron_variant:MODIFIER:exon1/6:c.-112+3906T>C::	regulatory_region_variant:promoter	607199 [GENE=IRF6 PHENOS=Orofacial cleft 6,608864,Autosomal dominant/Popliteal pterygium syndrome 1,119500,Autosomal dominant/van der Woude syndrome,119300,Autosomal dominant];	295214 [benign DISEASE=Popliteal pterygium syndrome,Van der Woude syndrome,Cleft Lip +/- Cleft Palate, Autosomal Dominant];			rs861019	0.3864	0.4358	3044,.		-0.2130			0.04,0.15	2.62		10.77>11.03				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209979518	209979518	T	A	wt	het	wt		QUAL=1264;DP=34,126,92;AF=0.00,0.54,0.00;MQM=60	IRF6	upstream_gene	IRF6:ENST00000367021:upstream_gene_variant:MODIFIER::::,IRF6:ENST00000542854:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site		295219 [benign DISEASE=Popliteal pterygium syndrome,Van der Woude syndrome,Cleft Lip +/- Cleft Palate, Autosomal Dominant];			rs12403006	0.1180	0.1687	530,.		-0.0120			0.01,0.19	9.30						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209979529	209979529	A	T	wt	het	wt		QUAL=1206;DP=25,117,82;AF=0.00,0.53,0.00;MQM=60	IRF6	upstream_gene	IRF6:ENST00000367021:upstream_gene_variant:MODIFIER::::,IRF6:ENST00000542854:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site		368864 [benign DISEASE=Popliteal pterygium syndrome,Van der Woude syndrome,Cleft Lip +/- Cleft Palate, Autosomal Dominant];	CR173661 [CLASS=R MUT=ALT PHEN="Orofacial clefting" GENE=IRF6];		rs34743335	0.1182	0.1689	531,.		0.0230			0.39,0.86	17.37						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	215796196	215796196	-	TTATT	het	wt	het	off-target	QUAL=541;DP=83,34,19;AF=0.34,0.00,0.26;MQM=60	KCTD3,USH2A	downstream_gene	KCTD3:ENST00000259154:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000307340:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000366943:downstream_gene_variant:MODIFIER::::						rs142497108		0.2235	847,.						0.87						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=n/a oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215796350	215796350	T	G	het	hom	wt		QUAL=13517;DP=353,266,178;AF=0.52,1.00,0.00;MQM=60	USH2A	3'UTR	USH2A:ENST00000307340:3_prime_UTR_variant:MODIFIER:exon72/72:c.*2773A>C::,USH2A:ENST00000366943:3_prime_UTR_variant:MODIFIER:exon73/73:c.*2773A>C::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];				rs6667509	0.1030	0.0990	164,.		2.2250			0.13,0.19	6.85						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215798014	215798014	G	A	hom	hom	hom		QUAL=33442;DP=445,327,226;AF=1.00,1.00,1.00;MQM=60	USH2A	3'UTR	USH2A:ENST00000307340:3_prime_UTR_variant:MODIFIER:exon72/72:c.*1109C>T::,USH2A:ENST00000366943:3_prime_UTR_variant:MODIFIER:exon73/73:c.*1109C>T::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];				rs2797255	0.9912	0.9899	15391,.		-0.3140			0.02,0.10	0.33						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215808007	215808007	G	A	het	wt	het		QUAL=3674;DP=174,193,136;AF=0.48,0.00,0.50;MQM=60	USH2A	missense	USH2A:ENST00000307340:missense_variant:MODERATE:exon70/72:c.15091C>T:p.Arg5031Trp:,USH2A:ENST00000366943:missense_variant:MODERATE:exon70/73:c.15091C>T:p.Arg5031Trp:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48455 [benign/likely benign DISEASE=Usher syndrome, type 2A,Retinitis pigmentosa 39,not specified,not provided];	CM165975 [CLASS=DM? MUT=ALT PHEN="Retinitis pigmentosa" GENE=USH2A];		rs56038610	0.0060	0.0161	5,.	0.0031,0.0030,0.0000,0.0192,0.0102	3.0680	D(0.02),D(0.02)	B(0.15),B(0.30)	0.24,0.45	17.14	0.09					1	242		1	[3] auto-classification 14.09.2017 [1] harmuth 08.05.2018			USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215848062	215848062	C	T	het	wt	het		QUAL=8131;DP=373,314,246;AF=0.51,0.01,0.50;MQM=60	USH2A	synonymous	USH2A:ENST00000307340:synonymous_variant:LOW:exon63/72:c.13191G>A:p.Glu4397=:PF00041,USH2A:ENST00000366943:synonymous_variant:LOW:exon63/73:c.13191G>A:p.Glu4397=:PF00041		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48413 [benign DISEASE=not specified];			rs2009923	0.2035	0.2029	445,.	0.0531,0.1748,0.3522,0.1842,0.2862	0.2840			0.16,0.61	0.39						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215848587	215848587	T	C	wt	wt	het		QUAL=3267;DP=276,319,245;AF=0.00,0.00,0.51;MQM=60	USH2A	synonymous	USH2A:ENST00000307340:synonymous_variant:LOW:exon63/72:c.12666A>G:p.Thr4222=:PF00041,USH2A:ENST00000366943:synonymous_variant:LOW:exon63/73:c.12666A>G:p.Thr4222=:PF00041		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48403 [benign DISEASE=not specified,not provided];			rs2797234	0.3031	0.3698	2039,.	0.2132,0.4699,0.3257,0.3857,0.3019	-0.3630			0.13,0.41	0.80						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215848641	215848641	T	C	het	hom	het		QUAL=20760;DP=383,374,280;AF=0.48,0.99,0.50;MQM=60	USH2A	synonymous	USH2A:ENST00000307340:synonymous_variant:LOW:exon63/72:c.12612A>G:p.Thr4204=:PF00041,USH2A:ENST00000366943:synonymous_variant:LOW:exon63/73:c.12612A>G:p.Thr4204=:PF00041		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	177993 [benign DISEASE=not specified];			rs2797235	0.6897	0.7669	8791,.	0.6285,0.8089,0.6474,0.8124,0.6953	0.0940			0.10,0.32	0.59						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215853749	215853749	T	-	het	het	het	off-target	QUAL=3422;DP=147,66,53;AF=0.50,0.86,0.64;MQM=60	USH2A	intron	USH2A:ENST00000307340:intron_variant:MODIFIER:exon61/71:c.12067-31del::,USH2A:ENST00000366943:intron_variant:MODIFIER:exon61/72:c.12067-31del::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];				rs5780842		0.8782	10393,.	0.6261,0.6573,0.7264,0.7176,0.6117	0.0640				0.50						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215901492	215901492	C	T	hom	hom	het		QUAL=39483;DP=410,641,542;AF=0.99,0.99,0.42;MQM=60	USH2A	synonymous	USH2A:ENST00000307340:synonymous_variant:LOW:exon61/72:c.11946G>A:p.Leu3982=:PF00041,USH2A:ENST00000366943:synonymous_variant:LOW:exon61/73:c.11946G>A:p.Leu3982=:PF00041		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48387 [benign DISEASE=not specified];			rs2820718	0.1188	0.1772	511,.	0.1669,0.0795,0.0013,0.1845,0.1444	1.0060			0.87,0.94	6.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215914751	215914751	G	T	het	wt	het		QUAL=5379;DP=207,253,192;AF=0.53,0.00,0.52;MQM=60	USH2A	missense	USH2A:ENST00000307340:missense_variant:MODERATE:exon60/72:c.11677C>A:p.Pro3893Thr:,USH2A:ENST00000366943:missense_variant:MODERATE:exon60/73:c.11677C>A:p.Pro3893Thr:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48380 [benign DISEASE=not specified];	CM165987 [CLASS=DM? MUT=ALT PHEN="Usher syndrome 2" GENE=USH2A];		rs41303285	0.0062	0.0158	5,.	0.0033,0.0035,0.0000,0.0225,0.0137	5.6550	D(0.03),D(0.03)	D(0.98),D(1.00)	0.96,0.99	25.00	0.34					4	258		3	[3] auto-classification 14.09.2017  			USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215931928	215931928	T	A	wt	het	wt		QUAL=2192;DP=223,196,176;AF=0.00,0.46,0.00;MQM=60	USH2A	intron	USH2A:ENST00000307340:intron_variant:MODIFIER:exon58/71:c.11389+9A>T::,USH2A:ENST00000366943:intron_variant:MODIFIER:exon58/72:c.11389+9A>T::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48372 [benign DISEASE=not specified];			rs12095085	0.0749	0.1257	272,.	0.1320,0.0683,0.0003,0.1292,0.0526	-0.0740			0.04,0.21	1.66						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215932957	215932957	G	A	wt	wt	het	off-target	QUAL=1056;DP=203,122,82;AF=0.00,0.00,0.55;MQM=60	USH2A	intron	USH2A:ENST00000307340:intron_variant:MODIFIER:exon57/71:c.11231+45C>T::,USH2A:ENST00000366943:intron_variant:MODIFIER:exon57/72:c.11231+45C>T::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];				rs17025373	0.1322	0.1066	163,.	0.0135,0.2038,0.3716,0.0655,0.0847	-1.3270			0.05,0.17	0.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215956304	215956304	A	G	hom	hom	hom	off-target	QUAL=3924;DP=79,27,22;AF=0.99,1.00,1.00;MQM=60	USH2A	intron	USH2A:ENST00000307340:intron_variant:MODIFIER:exon52/71:c.10388-27T>C::,USH2A:ENST00000366943:intron_variant:MODIFIER:exon52/72:c.10388-27T>C::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];				rs7518466	0.6016	0.5887	5551,.	0.7315,0.5765,0.6322,0.5268,0.4964	-1.5270			0.01,0.13	0.43						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215960167	215960167	T	G	hom	hom	hom		QUAL=26812;DP=217,366,286;AF=1.00,1.00,1.00;MQM=60	USH2A	missense	USH2A:ENST00000307340:missense_variant:MODERATE:exon52/72:c.10232A>C:p.Glu3411Ala:,USH2A:ENST00000366943:missense_variant:MODERATE:exon52/73:c.10232A>C:p.Glu3411Ala:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48344 [benign DISEASE=not specified,not provided];			rs10864198	0.5887	0.5788	5329,.	0.6867,0.5749,0.6342,0.5215,0.4946	2.5990	T(1.00),T(1.00)	B(0.00),B(0.00)	0.02,0.80	14.37	0.09					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215963374	215963374	G	A	wt	het	wt	off-target	QUAL=1532;DP=129,128,110;AF=0.00,0.50,0.00;MQM=60	USH2A	intron	USH2A:ENST00000307340:intron_variant:MODIFIER:exon51/71:c.10182+27C>T::,USH2A:ENST00000366943:intron_variant:MODIFIER:exon51/72:c.10182+27C>T::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];				rs11120629	0.0805	0.1297	289,.	0.1483,0.0687,0.0004,0.1292,0.0529	-0.0130			0.10,0.24	10.45						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215987222	215987222	T	C	wt	het	wt		QUAL=3233;DP=271,280,169;AF=0.00,0.46,0.00;MQM=60	USH2A	missense	USH2A:ENST00000307340:missense_variant:MODERATE:exon49/72:c.9595A>G:p.Asn3199Asp:,USH2A:ENST00000366943:missense_variant:MODERATE:exon49/73:c.9595A>G:p.Asn3199Asp:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48631 [benign DISEASE=not specified];			rs4129843	0.0871	0.0549	69,.	0.0814,0.0613,0.1694,0.0373,0.0812	0.1850	T(1.00),T(1.00)	B(0.00),B(0.00)	0.01,0.19	0.70	0.04					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216011361	216011361	T	C	wt	het	wt		QUAL=3249;DP=340,263,238;AF=0.00,0.49,0.00;MQM=60	USH2A	missense	USH2A:ENST00000307340:missense_variant:MODERATE:exon47/72:c.9343A>G:p.Thr3115Ala:,USH2A:ENST00000366943:missense_variant:MODERATE:exon47/73:c.9343A>G:p.Thr3115Ala:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48623 [benign DISEASE=not specified,not provided];			rs56032526	0.0647	0.0497	39,.	0.0089,0.0581,0.1691,0.0373,0.0814	0.1260	T(1.00),T(1.00)	B(0.00),B(0.00)	0.08,0.28	0.03	0.14					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216019427	216019427	A	-	wt	het	wt	off-target	QUAL=372;DP=123,44,42;AF=0.02,0.48,0.00;MQM=60	USH2A	intron	USH2A:ENST00000307340:intron_variant:MODIFIER:exon44/71:c.8846-52del::,USH2A:ENST00000366943:intron_variant:MODIFIER:exon44/72:c.8846-52del::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];				rs146638027		0.0657	41,.	0.0131,0.0781,0.2087,0.0500,0.1034	0.0630				0.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216051125	216051125	G	A	wt	het	wt		QUAL=2903;DP=195,215,198;AF=0.00,0.52,0.00;MQM=60	USH2A	missense	USH2A:ENST00000307340:missense_variant:MODERATE:exon43/72:c.8656C>T:p.Leu2886Phe:PF00041,USH2A:ENST00000366943:missense_variant:MODERATE:exon43/73:c.8656C>T:p.Leu2886Phe:PF00041		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48607 [benign DISEASE=not specified,not provided];	CM1413302 [CLASS=R MUT=ALT PHEN="Hearing loss" GENE=USH2A];		rs41277200	0.0777	0.0523	43,.	0.0607,0.0625,0.1561,0.0365,0.0799	6.9270	T(1.00),T(1.00)	B(0.00),B(0.00)	0.20,0.97	20.60	0.14					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216166454	216166454	T	G	het	wt	het		QUAL=2801;DP=125,98,94;AF=0.48,0.00,0.57;MQM=60	USH2A	missense	USH2A:ENST00000307340:missense_variant:MODERATE:exon35/72:c.6713A>C:p.Glu2238Ala:,USH2A:ENST00000366943:missense_variant:MODERATE:exon35/73:c.6713A>C:p.Glu2238Ala:	regulatory_region_variant:CTCF_binding_site	608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48568 [benign DISEASE=not specified,not provided];	CM140482 [CLASS=DM? MUT=ALT PHEN="Retinitis pigmentosa autosomal recessive" GENE=USH2A];		rs41277212	0.0076	0.0222	6,.	0.0052,0.0173,0.0001,0.0284,0.0151	4.8830	D(0.00),D(0.00)	P(0.91),D(0.99)	0.92,0.95	24.70	0.27					9	354		3	[3] auto-classification 14.09.2017  			USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216172380	216172380	A	G	hom	hom	hom		QUAL=18996;DP=180,228,188;AF=0.99,1.00,1.00;MQM=60	USH2A	missense	USH2A:ENST00000307340:missense_variant:MODERATE:exon34/72:c.6506T>C:p.Ile2169Thr:,USH2A:ENST00000366943:missense_variant:MODERATE:exon34/73:c.6506T>C:p.Ile2169Thr:	regulatory_region_variant:CTCF_binding_site	608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48562 [benign DISEASE=not specified,not provided];			rs10864219		0.5628	4207,.	0.4335,0.6697,0.8405,0.5004,0.5979	2.3960	T(0.12),T(0.12)	B(0.02),B(0.08)	0.92,0.96	19.38	0.11					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216219781	216219781	A	G	het	hom	het		QUAL=8817;DP=201,147,124;AF=0.49,1.00,0.51;MQM=60	USH2A	missense	USH2A:ENST00000307340:missense_variant:MODERATE:exon32/72:c.6317T>C:p.Ile2106Thr:,USH2A:ENST00000366943:missense_variant:MODERATE:exon32/73:c.6317T>C:p.Ile2106Thr:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	167815 [benign DISEASE=not specified];			rs6657250	0.5956	0.6760	7257,.	0.7709,0.3526,0.4408,0.6711,0.5082	0.9870	T(1.00),T(1.00)	B(0.00),B(0.00)	0.04,0.66	15.15	0.13					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216246676	216246676	G	-	het	het	het	off-target	QUAL=5153;DP=176,132,99;AF=0.52,0.55,0.54;MQM=60	USH2A,RP11-22M7.2	intron,intron&non_coding_transcript	USH2A:ENST00000307340:intron_variant:MODIFIER:exon27/71:c.5573-34del::,USH2A:ENST00000366943:intron_variant:MODIFIER:exon27/72:c.5573-34del::,RP11-22M7.2:ENST00000430890:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/2:n.78+530del::,RP11-22M7.2:ENST00000445619:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.159+372del::,RP11-22M7.2:ENST00000446411:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/2:n.136+736del::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];				rs35944387	0.7873	0.7336	7945,.	0.7474,0.7849,0.9538,0.6880,0.7713	0.7670				14.23						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), RP11-22M7.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216258194	216258194	G	T	het	het	het		QUAL=5966;DP=155,176,133;AF=0.48,0.51,0.51;MQM=60	USH2A,RP11-22M7.2	synonymous,intron&non_coding_transcript	USH2A:ENST00000307340:synonymous_variant:LOW:exon25/72:c.5013C>A:p.Gly1671=:PF02210,USH2A:ENST00000366943:synonymous_variant:LOW:exon25/73:c.5013C>A:p.Gly1671=:PF02210,RP11-22M7.2:ENST00000430890:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/2:n.208-1870G>T::,RP11-22M7.2:ENST00000442606:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/2:n.207-1870G>T::,RP11-22M7.2:ENST00000445619:intron_variant&non_coding_transcript_variant:MODIFIER:exon1/1:n.160-1870G>T::,RP11-22M7.2:ENST00000446411:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/2:n.266-1870G>T::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48527 [benign DISEASE=not specified];			rs56110889	0.1058	0.1602	436,.	0.1935,0.0944,0.0001,0.1752,0.0772	0.1420			0.68,0.96	16.93						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), RP11-22M7.2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216347452	216347452	C	A	het	wt	het		QUAL=3549;DP=217,121,108;AF=0.41,0.00,0.45;MQM=60	USH2A	intron,3'UTR	USH2A:ENST00000307340:intron_variant:MODIFIER:exon21/71:c.4627+1142G>T::,USH2A:ENST00000366942:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1128G>T::,USH2A:ENST00000366943:intron_variant:MODIFIER:exon21/72:c.4627+1142G>T::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	295405 [likely benign DISEASE=Retinitis pigmentosa-deafness syndrome,Retinitis Pigmentosa, Recessive];			rs401269	0.1945	0.1996	669,.		-0.1910			0.04,0.19	1.85						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216347556	216347556	A	G	het	wt	het		QUAL=3709;DP=224,55,56;AF=0.48,0.00,0.54;MQM=60	USH2A	intron,3'UTR	USH2A:ENST00000307340:intron_variant:MODIFIER:exon21/71:c.4627+1038T>C::,USH2A:ENST00000366942:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1024T>C::,USH2A:ENST00000366943:intron_variant:MODIFIER:exon21/72:c.4627+1038T>C::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	295407 [likely benign DISEASE=Retinitis pigmentosa-deafness syndrome,Retinitis Pigmentosa, Recessive];			rs439940	0.1953	0.2006	677,.		0.7440			0.08,0.22	6.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216348764	216348764	C	T	het	hom	het		QUAL=29556;DP=478,509,455;AF=0.53,1.00,0.49;MQM=60	USH2A	missense	USH2A:ENST00000307340:missense_variant:MODERATE:exon21/72:c.4457G>A:p.Arg1486Lys:,USH2A:ENST00000366942:missense_variant:MODERATE:exon21/21:c.4457G>A:p.Arg1486Lys:,USH2A:ENST00000366943:missense_variant:MODERATE:exon21/73:c.4457G>A:p.Arg1486Lys:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	177992 [benign DISEASE=not specified];			rs1805049	0.6623	0.6605	6437,.	0.5814,0.7160,0.7813,0.6225,0.6986	-1.6250	T(0.56),T(0.30),T(0.57)	B(0.03),B(0.03),B(0.05)	0.03,0.16	9.87	0.02					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216370108	216370108	C	T	het	wt	het	off-target	QUAL=3474;DP=188,127,93;AF=0.51,0.00,0.51;MQM=60	USH2A,RP5-1099E6.3	intron,intron&non_coding_transcript	USH2A:ENST00000307340:intron_variant:MODIFIER:exon18/71:c.4082-44G>A::,USH2A:ENST00000366942:intron_variant:MODIFIER:exon18/20:c.4082-44G>A::,USH2A:ENST00000366943:intron_variant:MODIFIER:exon18/72:c.4082-44G>A::,RP5-1099E6.3:ENST00000420867:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/2:n.362+841C>T::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];				rs447102	0.1645	0.2094	575,.	0.0693,0.1891,0.2103,0.2388,0.2321	-0.7920			0.00,0.10	0.33						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), RP5-1099E6.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216371934	216371934	A	C	het	wt	het		QUAL=4091;DP=223,90,82;AF=0.54,0.00,0.55;MQM=59	USH2A,RP5-1099E6.3	splice_region&intron,intron&non_coding_transcript	USH2A:ENST00000307340:splice_region_variant&intron_variant:LOW:exon17/71:c.3812-8T>G::,USH2A:ENST00000366942:splice_region_variant&intron_variant:LOW:exon17/20:c.3812-8T>G::,USH2A:ENST00000366943:splice_region_variant&intron_variant:LOW:exon17/72:c.3812-8T>G::,RP5-1099E6.3:ENST00000420867:intron_variant&non_coding_transcript_variant:MODIFIER:exon2/2:n.362+2667A>C::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48508 [benign/likely benign DISEASE=Retinitis pigmentosa-deafness syndrome,not specified,Retinitis Pigmentosa, Recessive];			rs646094	0.1977	0.2133	676,.	0.1641,0.1892,0.2059,0.2339,0.2298	1.0410			0.41,0.79	13.66		9.73>8.94		0.003/0.164		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), RP5-1099E6.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216390694	216390694	C	T	het	hom	het	off-target	QUAL=7339;DP=177,125,110;AF=0.48,1.00,0.52;MQM=60	USH2A	intron	USH2A:ENST00000307340:intron_variant:MODIFIER:exon15/71:c.3157+35G>A::,USH2A:ENST00000366942:intron_variant:MODIFIER:exon15/20:c.3157+35G>A::,USH2A:ENST00000366943:intron_variant:MODIFIER:exon15/72:c.3157+35G>A::		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];			L3b (LINE/CR1)	rs1324330	0.5875	0.6376	5412,.	0.3347,0.7025,0.7786,0.6182,0.6829	0.0420			0.01,0.15	3.29						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216592003	216592003	T	C	hom	hom	hom		QUAL=18954;DP=160,255,189;AF=1.00,1.00,0.99;MQM=60	USH2A	synonymous	USH2A:ENST00000307340:synonymous_variant:LOW:exon3/72:c.504A>G:p.Thr168=:PF13385,USH2A:ENST00000366942:synonymous_variant:LOW:exon3/21:c.504A>G:p.Thr168=:PF13385,USH2A:ENST00000366943:synonymous_variant:LOW:exon3/73:c.504A>G:p.Thr168=:PF13385		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48528 [benign DISEASE=Retinitis pigmentosa-deafness syndrome,not specified,Retinitis Pigmentosa, Recessive,not provided];			rs4253963	0.6328	0.6527	6209,.	0.4930,0.6943,0.8390,0.6474,0.6011	-0.6980			0.02,0.14	0.58						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216595306	216595306	C	T	hom	hom	hom		QUAL=32977;DP=293,442,279;AF=1.00,1.00,1.00;MQM=60	USH2A	missense	USH2A:ENST00000307340:missense_variant:MODERATE:exon2/72:c.373G>A:p.Ala125Thr:,USH2A:ENST00000366942:missense_variant:MODERATE:exon2/21:c.373G>A:p.Ala125Thr:,USH2A:ENST00000366943:missense_variant:MODERATE:exon2/73:c.373G>A:p.Ala125Thr:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48507 [benign DISEASE=Retinitis pigmentosa-deafness syndrome,not specified,Retinitis Pigmentosa, Recessive,not provided];			rs10779261	0.7612	0.7390	8544,.	0.7567,0.7303,0.8364,0.7049,0.7321	0.3550	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	0.01,0.12	5.53	0.08					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	220323449	220323449	T	-	het	het	het		QUAL=1274;DP=140,48,38;AF=0.28,0.25,0.37;MQM=59	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951:3_prime_UTR_variant:MODIFIER:exon35/35:c.*1144del::		609275 [GENE=RAB3GAP2 PHENOS=Martsolf syndrome,212720,Autosomal recessive/Warburg micro syndrome 2,614225,Autosomal recessive];	295627 [uncertain significance DISEASE=Martsolf syndrome,Warburg micro syndrome];		FLAM_C (SINE/Alu)	rs11316594		0.4720	2426,.		-2.8180				1.32						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220323794	220323794	T	-	het	het	het		QUAL=525;DP=49,21,14;AF=0.29,0.29,0.43;MQM=60	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951:3_prime_UTR_variant:MODIFIER:exon35/35:c.*799del::		609275 [GENE=RAB3GAP2 PHENOS=Martsolf syndrome,212720,Autosomal recessive/Warburg micro syndrome 2,614225,Autosomal recessive];			(T)n (Simple_repeat)	rs577626438	0.3638	0.1809	399,.		0.1390				8.49						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220324189	220324189	A	G	het	het	wt		QUAL=9733;DP=413,267,217;AF=0.54,0.53,0.00;MQM=60	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951:3_prime_UTR_variant:MODIFIER:exon35/35:c.*404T>C::		609275 [GENE=RAB3GAP2 PHENOS=Martsolf syndrome,212720,Autosomal recessive/Warburg micro syndrome 2,614225,Autosomal recessive];	295635 [likely benign DISEASE=Martsolf syndrome,Warburg micro syndrome];			rs1059140	0.0627	0.0692	94,.		0.4840			0.01,0.20	10.99						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220330672	220330672	C	T	het	het	wt		QUAL=9359;DP=412,288,209;AF=0.55,0.48,0.00;MQM=60	RAB3GAP2	synonymous	RAB3GAP2:ENST00000358951:synonymous_variant:LOW:exon31/35:c.3495G>A:p.Leu1165=:PF14656		609275 [GENE=RAB3GAP2 PHENOS=Martsolf syndrome,212720,Autosomal recessive/Warburg micro syndrome 2,614225,Autosomal recessive];	130080 [benign/likely benign DISEASE=Martsolf syndrome,Warburg micro syndrome,not specified];			rs11547779	0.0605	0.0866	96,.	0.0150,0.0479,0.0566,0.0976,0.1336	-0.6200			0.14,0.31	6.62						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220331205	220331205	C	G	het	het	wt		QUAL=6506;DP=291,248,182;AF=0.45,0.46,0.00;MQM=60	RAB3GAP2	missense	RAB3GAP2:ENST00000358951:missense_variant:MODERATE:exon30/35:c.3275G>C:p.Ser1092Thr:PF14656		609275 [GENE=RAB3GAP2 PHENOS=Martsolf syndrome,212720,Autosomal recessive/Warburg micro syndrome 2,614225,Autosomal recessive];	130079 [benign/likely benign DISEASE=Martsolf syndrome,Warburg micro syndrome,not specified];			rs2289189	0.0603	0.0859	95,.	0.0150,0.0456,0.0565,0.0969,0.1333	7.4320	D(0.05)	P(0.86)	0.99,0.99	28.00	0.18					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220369746	220369746	A	-	wt	wt	het		QUAL=827;DP=101,94,89;AF=0.06,0.01,0.49;MQM=60	RAB3GAP2	splice_region&intron	RAB3GAP2:ENST00000358951:splice_region_variant&intron_variant:LOW:exon9/34:c.812-6del::		609275 [GENE=RAB3GAP2 PHENOS=Martsolf syndrome,212720,Autosomal recessive/Warburg micro syndrome 2,614225,Autosomal recessive];	295665 [benign DISEASE=Martsolf syndrome,Warburg micro syndrome];			rs35396665	0.3041	0.3794	1016,.	0.3400,0.4778,0.4509,0.3419,0.3871	0.3690				0.98						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	223101939	223101939	A	C	het	het	het	off-target	QUAL=5386;DP=179,156,136;AF=0.42,0.50,0.47;MQM=60	DISP1	intron	DISP1:ENST00000284476:intron_variant:MODIFIER:exon1/7:c.-18+27A>C::,DISP1:ENST00000360254:intron_variant:MODIFIER:exon2/3:c.-18+27A>C::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site					rs35491159	0.2486	0.3307	1795,.		-0.1080			0.03,0.23	5.66						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223116109	223116109	C	T	het	het	het	off-target	QUAL=3241;DP=101,104,91;AF=0.48,0.48,0.51;MQM=60	DISP1	intron	DISP1:ENST00000284476:intron_variant:MODIFIER:exon1/7:c.-17-40C>T::,DISP1:ENST00000360254:intron_variant:MODIFIER:exon2/3:c.-17-40C>T::						rs75109669	0.1220	0.1799	559,.		-0.3380			0.02,0.26	6.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223156382	223156382	C	T	hom	hom	hom	off-target	QUAL=17367;DP=271,157,113;AF=1.00,1.00,1.00;MQM=60	DISP1	intron	DISP1:ENST00000284476:intron_variant:MODIFIER:exon2/7:c.510-40C>T::						rs2926159	0.9998	0.9999	15228,.	0.9992,1.0000,1.0000,1.0000,1.0000	0.6990			0.00,0.11	7.04						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223168213	223168213	T	C	wt	het	wt	off-target	QUAL=1099;DP=181,93,56;AF=0.00,0.48,0.00;MQM=60	DISP1	intron	DISP1:ENST00000284476:intron_variant:MODIFIER:exon6/7:c.890-14T>C::	regulatory_region_variant:promoter_flanking_region		262132 [benign DISEASE=not specified];			rs2609359	0.3796	0.3440	1927,.	0.4328,0.3755,0.3002,0.3011,0.4574	1.5460			0.18,0.46	12.08		10.87>9.80				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223177574	223177574	A	G	wt	het	wt		QUAL=5303;DP=502,406,262;AF=0.00,0.50,0.00;MQM=60	DISP1	synonymous	DISP1:ENST00000284476:synonymous_variant:LOW:exon8/8:c.2835A>G:p.Lys945=:			262128 [benign DISEASE=not specified,not provided];			rs2609355	0.2414	0.2896	1134,.	0.1816,0.2986,0.2129,0.3013,0.3117	-0.6020			0.04,0.19	5.31						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223178561	223178561	A	C	hom	het	hom		QUAL=20421;DP=189,371,288;AF=1.00,0.53,1.00;MQM=60	DISP1	synonymous	DISP1:ENST00000284476:synonymous_variant:LOW:exon8/8:c.3822A>C:p.Pro1274=:			262131 [benign DISEASE=not specified];			rs9441941	0.4980	0.5467	4731,.	0.4474,0.5375,0.5131,0.5771,0.4763	-1.2410			0.04,0.15	0.81						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	225589473	225589473	C	T	het	het	wt		QUAL=8367;DP=322,352,266;AF=0.50,0.44,0.00;MQM=60	LBR	3'UTR	LBR:ENST00000272163:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::,LBR:ENST00000338179:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::		600024 [GENE=LBR PHENOS=Greenberg skeletal dysplasia,215140,Autosomal recessive/Pelger-Huet anomaly,169400,Autosomal dominant/Pelger-Huet anomaly with mild skeletal anomalies,618019/Reynolds syndrome,613471,Autosomal dominant];	295917 [benign DISEASE=Greenberg dysplasia];			rs7406	0.2726	0.2485	1414,.		0.7820			0.16,0.37	14.14						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225590750	225590750	G	C	het	het	wt		QUAL=4478;DP=310,55,46;AF=0.47,0.51,0.00;MQM=60	LBR	3'UTR	LBR:ENST00000272163:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::,LBR:ENST00000338179:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::		600024 [GENE=LBR PHENOS=Greenberg skeletal dysplasia,215140,Autosomal recessive/Pelger-Huet anomaly,169400,Autosomal dominant/Pelger-Huet anomaly with mild skeletal anomalies,618019/Reynolds syndrome,613471,Autosomal dominant];	295928 [benign DISEASE=Greenberg dysplasia];			rs11551874	0.1020	0.0913	132,.		0.4490			0.18,0.22	5.93						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225607144	225607144	C	T	het	het	hom		QUAL=1838;DP=75,47,20;AF=0.40,0.45,1.00;MQM=60	LBR	missense	LBR:ENST00000272163:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:,LBR:ENST00000338179:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:		600024 [GENE=LBR PHENOS=Greenberg skeletal dysplasia,215140,Autosomal recessive/Pelger-Huet anomaly,169400,Autosomal dominant/Pelger-Huet anomaly with mild skeletal anomalies,618019/Reynolds syndrome,613471,Autosomal dominant];	258619 [benign DISEASE=Greenberg dysplasia,not specified,not provided];			rs2230419		0.8115	9045,.	0.4185,0.8721,0.9579,0.8381,0.6987	-0.1880	T(0.41),T(0.41)	B(0.01),B(0.01)	0.01,0.10	0.01	0.17					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225609884	225609884	A	G	het	het	hom		QUAL=2341;DP=123,17,15;AF=0.57,0.59,1.00;MQM=60	LBR	synonymous	LBR:ENST00000272163:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:,LBR:ENST00000338179:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:		600024 [GENE=LBR PHENOS=Greenberg skeletal dysplasia,215140,Autosomal recessive/Pelger-Huet anomaly,169400,Autosomal dominant/Pelger-Huet anomaly with mild skeletal anomalies,618019/Reynolds syndrome,613471,Autosomal dominant];	258617 [benign DISEASE=Greenberg dysplasia,not specified,not provided];			rs1056608		0.7631	7849,.	0.3854,0.8478,0.8973,0.7866,0.6557	-0.4330			0.28,0.95	14.64						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225611661	225611661	C	T	het	hom	het		QUAL=17130;DP=364,283,210;AF=0.53,1.00,0.49;MQM=60	LBR	synonymous	LBR:ENST00000272163:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:PF09465,LBR:ENST00000338179:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:PF09465		600024 [GENE=LBR PHENOS=Greenberg skeletal dysplasia,215140,Autosomal recessive/Pelger-Huet anomaly,169400,Autosomal dominant/Pelger-Huet anomaly with mild skeletal anomalies,618019/Reynolds syndrome,613471,Autosomal dominant];	258616 [benign DISEASE=Greenberg dysplasia,not specified,not provided];			rs1056607		0.7259	8324,.	0.6399,0.7860,0.7681,0.7349,0.5212	-2.9810			0.04,0.70	7.90						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225611845	225611845	C	T	wt	het	het	off-target	QUAL=2276;DP=183,110,83;AF=0.00,0.52,0.43;MQM=60	LBR	intron	LBR:ENST00000272163:intron_variant:MODIFIER:exon1/13:c.-14-54G>A::,LBR:ENST00000338179:intron_variant:MODIFIER:exon1/13:c.-14-54G>A::		600024 [GENE=LBR PHENOS=Greenberg skeletal dysplasia,215140,Autosomal recessive/Pelger-Huet anomaly,169400,Autosomal dominant/Pelger-Huet anomaly with mild skeletal anomalies,618019/Reynolds syndrome,613471,Autosomal dominant];				rs1340867	0.6018	0.6251	6178,.		-0.4700			0.01,0.08	2.48						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225616378	225616378	G	C	het	wt	het	off-target	QUAL=4073;DP=192,249,179;AF=0.55,0.00,0.50;MQM=60	LBR	intron	LBR:ENST00000338179:intron_variant:MODIFIER:exon1/13:c.-15+30C>G::	regulatory_region_variant:promoter,TF_binding_site_variant	600024 [GENE=LBR PHENOS=Greenberg skeletal dysplasia,215140,Autosomal recessive/Pelger-Huet anomaly,169400,Autosomal dominant/Pelger-Huet anomaly with mild skeletal anomalies,618019/Reynolds syndrome,613471,Autosomal dominant];				rs75691342	0.0996	0.0732	88,.		-0.4440			0.05,0.33	6.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	226548554	226548554	A	G	wt	wt	het		QUAL=859;DP=168,97,77;AF=0.01,0.00,0.49;MQM=60	PARP1	3'UTR	PARP1:ENST00000366794:3_prime_UTR_variant:MODIFIER:exon23/23:c.*607T>C::				CR122378 [CLASS=DP MUT=ALT PHEN="Bladder cancer increased risk association with" GENE=PARP1];		rs8679	0.1428	0.1525	446,.		-0.4050			0.01,0.20	3.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226555302	226555302	A	G	het	het	wt		QUAL=5799;DP=195,300,218;AF=0.48,0.47,0.00;MQM=60	PARP1	missense	PARP1:ENST00000366794:missense_variant:MODERATE:exon17/23:c.2285T>C:p.Val762Ala:PF02877				CM042761 [CLASS=DFP MUT=ALT PHEN="Prostate cancer susceptibility association with" GENE=PARP1];		rs1136410	0.1969	0.2131	552,.	0.0487,0.4231,0.4477,0.1664,0.1026	8.9590	D(0.02)	P(0.68)	0.98,0.98	28.10	0.18					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226555348	226555348	G	A	wt	wt	het	off-target	QUAL=2128;DP=205,243,175;AF=0.00,0.00,0.49;MQM=60	PARP1	intron	PARP1:ENST00000366794:intron_variant:MODIFIER:exon16/22:c.2278-39C>T::						rs3219123	0.0266	0.0445	28,.	0.0086,0.0237,0.0004,0.0601,0.0452	0.9070			0.07,0.19	1.03						36	936						PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226570840	226570840	T	C	het	het	hom		QUAL=4873;DP=92,92,72;AF=0.58,0.51,1.00;MQM=59	PARP1	synonymous	PARP1:ENST00000366794:synonymous_variant:LOW:exon8/23:c.1056A>G:p.Lys352=:						rs1805415	0.7893	0.8241	10763,.	0.9002,0.5748,0.5531,0.8337,0.8974	-0.1150			0.12,0.95	10.25						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226573364	226573364	A	G	het	het	wt		QUAL=4695;DP=152,247,208;AF=0.55,0.45,0.00;MQM=60	PARP1	synonymous	PARP1:ENST00000366794:synonymous_variant:LOW:exon7/23:c.852T>C:p.Ala284=:PF08063				CM071915 [CLASS=DP MUT=ALT PHEN="Colorectal adenoma association with" GENE=PARP1];		rs1805414	0.5166	0.4276	3103,.	0.5525,0.5538,0.8133,0.3377,0.3647	-2.5850			0.12,0.46	5.84						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226578099	226578099	T	C	hom	hom	het	off-target	QUAL=9065;DP=92,162,121;AF=1.00,0.99,0.55;MQM=60	PARP1	intron	PARP1:ENST00000366794:intron_variant:MODIFIER:exon4/22:c.617+12A>G::						rs1805403	0.8576	0.8468	11314,.	0.9411,0.8703,0.9388,0.7678,0.7385	-5.6250			0.01,0.16	0.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226589958	226589958	G	A	het	het	wt		QUAL=9295;DP=294,468,299;AF=0.47,0.49,0.00;MQM=59	PARP1	synonymous	PARP1:ENST00000366790:synonymous_variant:LOW:exon2/2:c.243C>T:p.Asp81=:PF00645,PARP1:ENST00000366791:synonymous_variant:LOW:exon2/3:c.243C>T:p.Asp81=:PF00645,PARP1:ENST00000366792:synonymous_variant:LOW:exon2/4:c.243C>T:p.Asp81=:PF00645,PARP1:ENST00000366794:synonymous_variant:LOW:exon2/23:c.243C>T:p.Asp81=:PF00645						rs1805404	0.2183	0.2184	629,.	0.1230,0.4261,0.4479,0.1663,0.1030	3.3120			0.86,0.92	11.65						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226595647	226595647	C	G	het	het	wt		QUAL=2217;DP=40,146,138;AF=0.55,0.50,0.00;MQM=59	PARP1	5'UTR	PARP1:ENST00000366790:5_prime_UTR_variant:MODIFIER:exon1/2:c.-17G>C::,PARP1:ENST00000366791:5_prime_UTR_variant:MODIFIER:exon1/3:c.-17G>C::,PARP1:ENST00000366792:5_prime_UTR_variant:MODIFIER:exon1/4:c.-17G>C::,PARP1:ENST00000366794:5_prime_UTR_variant:MODIFIER:exon1/23:c.-17G>C::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant					rs907187	0.1991	0.2135	582,.	0.0465,0.4177,0.4433,0.1652,0.1020	1.1800			0.12,0.67	12.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	227149203	227149203	G	A	wt	wt	het		QUAL=294;DP=71,35,31;AF=0.00,0.00,0.48;MQM=60	COQ8A	synonymous,splice_region&intron,intron	COQ8A:ENST00000366777:synonymous_variant:LOW:exon2/15:c.117G>A:p.Ala39=:,COQ8A:ENST00000366778:splice_region_variant&intron_variant:LOW:exon1/14:c.-34-6G>A::,COQ8A:ENST00000366779:synonymous_variant:LOW:exon7/20:c.117G>A:p.Ala39=:,COQ8A:ENST00000458507:intron_variant:MODIFIER:exon1/11:c.-182-15947G>A::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	128273 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,not specified,Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type,not provided];			rs11549708	0.0807	0.1645	503,.	0.0465,0.0978,0.0005,0.2379,0.0769	-3.4260			0.01,0.13	0.23		-0.47>-4.84				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227152662	227152662	C	T	wt	wt	het	off-target	QUAL=930;DP=83,85,67;AF=0.01,0.00,0.63;MQM=60	COQ8A	intron	COQ8A:ENST00000366777:intron_variant:MODIFIER:exon2/14:c.178-39C>T::,COQ8A:ENST00000366778:intron_variant:MODIFIER:exon2/14:c.22-39C>T::,COQ8A:ENST00000366779:intron_variant:MODIFIER:exon7/19:c.178-39C>T::,COQ8A:ENST00000458507:intron_variant:MODIFIER:exon1/11:c.-182-12488C>T::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];				rs759581953		0.0001		0.0000,0.0000,0.0001,0.0001,0.0001	-1.6860			0.01,0.11	0.15						0	2						COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227165235	227165235	C	T	het	het	wt	off-target	QUAL=432;DP=18,24,31;AF=0.50,0.50,0.00;MQM=60	COQ8A	intron	COQ8A:ENST00000366777:intron_variant:MODIFIER:exon5/14:c.730+11C>T::,COQ8A:ENST00000366778:intron_variant:MODIFIER:exon5/14:c.574+11C>T::,COQ8A:ENST00000366779:intron_variant:MODIFIER:exon10/19:c.730+11C>T::,COQ8A:ENST00000433743:intron_variant:MODIFIER:exon2/10:c.-108+11C>T::,COQ8A:ENST00000458507:intron_variant:MODIFIER:exon2/11:c.-108+11C>T::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];				rs759489004		0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	1.0160			0.08,0.16	4.69						0	3						COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227170543	227170543	C	G	het	wt	het	off-target	QUAL=3761;DP=113,294,177;AF=0.61,0.01,0.47;MQM=60	COQ8A	intron	COQ8A:ENST00000366777:intron_variant:MODIFIER:exon7/14:c.940-52C>G::,COQ8A:ENST00000366778:intron_variant:MODIFIER:exon7/14:c.784-52C>G::,COQ8A:ENST00000366779:intron_variant:MODIFIER:exon12/19:c.940-52C>G::,COQ8A:ENST00000433743:intron_variant:MODIFIER:exon4/10:c.102+79C>G::,COQ8A:ENST00000458507:intron_variant:MODIFIER:exon4/11:c.103-52C>G::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];				rs2297413	0.1983	0.1993	675,.		0.6440			0.00,0.09	1.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227171210	227171210	G	A	het	hom	wt	off-target	QUAL=5903;DP=83,175,143;AF=0.51,0.99,0.00;MQM=59	COQ8A	intron	COQ8A:ENST00000366777:intron_variant:MODIFIER:exon8/14:c.1081-43G>A::,COQ8A:ENST00000366778:intron_variant:MODIFIER:exon8/14:c.925-43G>A::,COQ8A:ENST00000366779:intron_variant:MODIFIER:exon13/19:c.1081-43G>A::,COQ8A:ENST00000433743:intron_variant:MODIFIER:exon4/10:c.103-43G>A::,COQ8A:ENST00000458507:intron_variant:MODIFIER:exon5/11:c.244-43G>A::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];				rs12739480	0.0871	0.1248	284,.	0.0331,0.0460,0.0446,0.1408,0.2082	-0.2170			0.10,0.16	0.60						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227171585	227171585	T	-	het	wt	hom	off-target	QUAL=1970;DP=104,77,42;AF=0.42,0.00,1.00;MQM=60	COQ8A	intron	COQ8A:ENST00000366777:intron_variant:MODIFIER:exon10/14:c.1256+32del::,COQ8A:ENST00000366778:intron_variant:MODIFIER:exon10/14:c.1100+32del::,COQ8A:ENST00000366779:intron_variant:MODIFIER:exon15/19:c.1256+32del::,COQ8A:ENST00000433743:intron_variant:MODIFIER:exon6/10:c.278+32del::,COQ8A:ENST00000458507:intron_variant:MODIFIER:exon7/11:c.419+32del::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];				rs3215919	0.2622	0.3635	2172,.	0.2910,0.2790,0.1388,0.4449,0.2053	-0.6290				0.40						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227171737	227171737	G	T	het	wt	hom	off-target	QUAL=1870;DP=52,39,55;AF=0.75,0.00,0.96;MQM=60	COQ8A	intron	COQ8A:ENST00000366777:intron_variant:MODIFIER:exon10/14:c.1257-58G>T::,COQ8A:ENST00000366778:intron_variant:MODIFIER:exon10/14:c.1101-58G>T::,COQ8A:ENST00000366779:intron_variant:MODIFIER:exon15/19:c.1257-58G>T::,COQ8A:ENST00000433743:intron_variant:MODIFIER:exon6/10:c.279-58G>T::,COQ8A:ENST00000458507:intron_variant:MODIFIER:exon7/11:c.420-58G>T::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];				rs1574184	0.2812	0.2902	767,.		2.3640			0.53,0.16	1.55						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227171738	227171738	-	T	wt	wt	het	off-target	QUAL=1870;DP=52,39,55;AF=0.75,0.00,0.96;MQM=60	COQ8A	intron	COQ8A:ENST00000366777:intron_variant:MODIFIER:exon10/14:c.1257-57_1257-56insT::,COQ8A:ENST00000366778:intron_variant:MODIFIER:exon10/14:c.1101-57_1101-56insT::,COQ8A:ENST00000366779:intron_variant:MODIFIER:exon15/19:c.1257-57_1257-56insT::,COQ8A:ENST00000433743:intron_variant:MODIFIER:exon6/10:c.279-57_279-56insT::,COQ8A:ENST00000458507:intron_variant:MODIFIER:exon7/11:c.420-57_420-56insT::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];				rs201300405									1.76						4	21		2	[2] auto-classification 20.10.2017  			COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227171739	227171739	G	T	het	wt	het	off-target	QUAL=1870;DP=52,39,55;AF=0.75,0.00,0.96;MQM=59	COQ8A	intron	COQ8A:ENST00000366777:intron_variant:MODIFIER:exon10/14:c.1257-56G>T::,COQ8A:ENST00000366778:intron_variant:MODIFIER:exon10/14:c.1101-56G>T::,COQ8A:ENST00000366779:intron_variant:MODIFIER:exon15/19:c.1257-56G>T::,COQ8A:ENST00000433743:intron_variant:MODIFIER:exon6/10:c.279-56G>T::,COQ8A:ENST00000458507:intron_variant:MODIFIER:exon7/11:c.420-56G>T::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];				rs1574185	0.2802	0.2305	705,.		-0.0790			0.17,0.13	0.27						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227171958	227171958	G	C	wt	wt	het	off-target	QUAL=1013;DP=114,107,75;AF=0.00,0.00,0.53;MQM=60	COQ8A	intron	COQ8A:ENST00000366777:intron_variant:MODIFIER:exon11/14:c.1398+22G>C::,COQ8A:ENST00000366778:intron_variant:MODIFIER:exon11/14:c.1242+22G>C::,COQ8A:ENST00000366779:intron_variant:MODIFIER:exon16/19:c.1398+22G>C::,COQ8A:ENST00000433743:intron_variant:MODIFIER:exon7/10:c.420+22G>C::,COQ8A:ENST00000458507:intron_variant:MODIFIER:exon8/11:c.561+22G>C::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];				rs7530213	0.1683	0.2495	1051,.	0.1551,0.2011,0.0930,0.3134,0.1314	0.8940			0.11,0.31	6.79						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227172290	227172290	C	T	het	wt	hom		QUAL=15706;DP=329,506,380;AF=0.47,0.00,0.98;MQM=60	COQ8A	synonymous	COQ8A:ENST00000366777:synonymous_variant:LOW:exon12/15:c.1440C>T:p.Phe480=:,COQ8A:ENST00000366778:synonymous_variant:LOW:exon12/15:c.1284C>T:p.Phe428=:,COQ8A:ENST00000366779:synonymous_variant:LOW:exon17/20:c.1440C>T:p.Phe480=:,COQ8A:ENST00000433743:synonymous_variant:LOW:exon8/11:c.462C>T:p.Phe154=:,COQ8A:ENST00000458507:synonymous_variant:LOW:exon9/12:c.603C>T:p.Phe201=:		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	128274 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,not specified,Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type,not provided];			rs12593	0.2386	0.3534	2080,.	0.1976,0.2696,0.1758,0.4533,0.2031	-0.0650			0.20,0.87	10.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227172903	227172903	G	A	het	wt	hom	off-target	QUAL=8107;DP=101,303,230;AF=0.59,0.00,0.98;MQM=60	COQ8A	intron	COQ8A:ENST00000366777:intron_variant:MODIFIER:exon13/14:c.1573-52G>A::,COQ8A:ENST00000366778:intron_variant:MODIFIER:exon13/14:c.1417-52G>A::,COQ8A:ENST00000366779:intron_variant:MODIFIER:exon18/19:c.1573-52G>A::,COQ8A:ENST00000433743:intron_variant:MODIFIER:exon9/10:c.595-52G>A::,COQ8A:ENST00000458507:intron_variant:MODIFIER:exon10/11:c.736-52G>A::	regulatory_region_variant:open_chromatin_region	606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];				rs2297415	0.2696	0.3733	2299,.		-0.7670			0.01,0.14	2.72						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227172935	227172935	C	G	het	wt	hom	off-target	QUAL=9640;DP=113,339,265;AF=0.62,0.00,1.00;MQM=60	COQ8A	intron	COQ8A:ENST00000366777:intron_variant:MODIFIER:exon13/14:c.1573-20C>G::,COQ8A:ENST00000366778:intron_variant:MODIFIER:exon13/14:c.1417-20C>G::,COQ8A:ENST00000366779:intron_variant:MODIFIER:exon18/19:c.1573-20C>G::,COQ8A:ENST00000433743:intron_variant:MODIFIER:exon9/10:c.595-20C>G::,COQ8A:ENST00000458507:intron_variant:MODIFIER:exon10/11:c.736-20C>G::	regulatory_region_variant:open_chromatin_region	606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	518313 [likely benign DISEASE=Coenzyme Q10 deficiency, primary, 4];			rs2297416	0.2652	0.3685	2261,.	0.2678,0.2816,0.1674,0.4597,0.2070	-1.1720			0.10,0.22	2.88		12.28>10.93				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227174122	227174122	C	G	wt	wt	het	off-target	QUAL=939;DP=87,139,73;AF=0.00,0.00,0.56;MQM=60	COQ8A	intron	COQ8A:ENST00000366777:intron_variant:MODIFIER:exon14/14:c.1660-32C>G::,COQ8A:ENST00000366778:intron_variant:MODIFIER:exon14/14:c.1504-32C>G::,COQ8A:ENST00000366779:intron_variant:MODIFIER:exon19/19:c.1660-32C>G::,COQ8A:ENST00000433743:intron_variant:MODIFIER:exon10/10:c.682-32C>G::,COQ8A:ENST00000458507:intron_variant:MODIFIER:exon11/11:c.823-32C>G::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];				rs41303131	0.1136	0.1980	701,.	0.0873,0.1155,0.0030,0.2805,0.1235	-0.8240			0.03,0.13	0.28						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227174145	227174145	T	C	het	wt	hom		QUAL=4110;DP=103,168,90;AF=0.54,0.00,1.00;MQM=60	COQ8A	intron	COQ8A:ENST00000366777:intron_variant:MODIFIER:exon14/14:c.1660-9T>C::,COQ8A:ENST00000366778:intron_variant:MODIFIER:exon14/14:c.1504-9T>C::,COQ8A:ENST00000366779:intron_variant:MODIFIER:exon19/19:c.1660-9T>C::,COQ8A:ENST00000433743:intron_variant:MODIFIER:exon10/10:c.682-9T>C::,COQ8A:ENST00000458507:intron_variant:MODIFIER:exon11/11:c.823-9T>C::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	296024 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type,not provided];			rs7552783	0.3516	0.4392	3049,.	0.4148,0.3047,0.2207,0.5014,0.2758	-0.4800			0.04,0.18	9.86		11.51>10.71		0.001/0.006	COSM3997298,COSM3997299	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227174210	227174210	T	C	het	wt	hom		QUAL=5285;DP=158,185,118;AF=0.45,0.00,1.00;MQM=60	COQ8A	synonymous	COQ8A:ENST00000366777:synonymous_variant:LOW:exon15/15:c.1716T>C:p.Ser572=:,COQ8A:ENST00000366778:synonymous_variant:LOW:exon15/15:c.1560T>C:p.Ser520=:,COQ8A:ENST00000366779:synonymous_variant:LOW:exon20/20:c.1716T>C:p.Ser572=:,COQ8A:ENST00000433743:synonymous_variant:LOW:exon11/11:c.738T>C:p.Ser246=:,COQ8A:ENST00000458507:synonymous_variant:LOW:exon12/12:c.879T>C:p.Ser293=:		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	128275 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,not specified,Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type,not provided];			rs3738725	0.3139	0.4095	2712,.	0.3106,0.2982,0.2240,0.5020,0.2756	-5.9700			0.07,0.08	0.02						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227174823	227174823	-	T	het	wt	hom		QUAL=13665;DP=238,471,369;AF=0.47,0.00,1.00;MQM=60	COQ8A	3'UTR	COQ8A:ENST00000366777:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,COQ8A:ENST00000366778:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,COQ8A:ENST00000366779:3_prime_UTR_variant:MODIFIER:exon20/20:c.*389dup::,COQ8A:ENST00000458507:3_prime_UTR_variant:MODIFIER:exon12/12:c.*389dup::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	296038 [benign DISEASE=Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type];			rs11420839	0.2927	0.3993	2638,.						7.82						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227175245	227175245	-	T	het	wt	hom		QUAL=8083;DP=155,319,215;AF=0.45,0.00,0.99;MQM=60	COQ8A	3'UTR	COQ8A:ENST00000366779:3_prime_UTR_variant:MODIFIER:exon20/20:c.*807_*808insT::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	296050 [benign DISEASE=Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type];			rs3215920	0.2548	0.3678	2367,.						0.59						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	227175253	227175253	C	T	het	wt	hom		QUAL=8793;DP=165,324,218;AF=0.48,0.00,1.00;MQM=60	CDC42BPA,COQ8A,RP5-1087E8.3	downstream_gene,upstream_gene	CDC42BPA:ENST00000334218:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366764:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366766:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366767:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366769:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000366777:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000366778:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000366779:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000433743:downstream_gene_variant:MODIFIER::::,RP5-1087E8.3:ENST00000433837:upstream_gene_variant:MODIFIER::::,COQ8A:ENST00000458507:downstream_gene_variant:MODIFIER::::		606980 [GENE=COQ8A PHENOS=Coenzyme Q10 deficiency,primary,4,612016,Autosomal recessive];	368867 [benign DISEASE=Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type];			rs10495274	0.4191	0.5227	4474,.		-0.6030			0.03,0.10	0.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19), COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), RP5-1087E8.3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	228346936	228346936	G	A	het	het	wt		QUAL=2230;DP=41,130,92;AF=0.59,0.54,0.00;MQM=59	GJC2	3'UTR	GJC2:ENST00000366714:3_prime_UTR_variant:MODIFIER:exon2/2:c.*157G>A::		608803 [GENE=GJC2 PHENOS=Leukodystrophy,hypomyelinating,2,608804,Autosomal recessive/Lymphatic malformation 3,613480,Autosomal dominant/Spastic paraplegia 44,autosomal recessive,613206,Autosomal recessive];				rs45491398	0.0234	0.0601	77,.		-1.0290			0.01,0.14	1.97						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJC2 (inh=AR+AD oe_syn=0.94 oe_mis=0.67 oe_lof=0.54)
chr1	228347352	228347352	A	G	hom	hom	hom		QUAL=1499;DP=30,13,8;AF=1.00,1.00,1.00;MQM=60	GJC2	3'UTR	GJC2:ENST00000366714:3_prime_UTR_variant:MODIFIER:exon2/2:c.*573A>G::		608803 [GENE=GJC2 PHENOS=Leukodystrophy,hypomyelinating,2,608804,Autosomal recessive/Lymphatic malformation 3,613480,Autosomal dominant/Spastic paraplegia 44,autosomal recessive,613206,Autosomal recessive];				rs6668719	0.8043	0.8421	11358,.		-0.0280			0.01,0.11	2.12						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJC2 (inh=AR+AD oe_syn=0.94 oe_mis=0.67 oe_lof=0.54)
chr1	228612838	228612838	G	T	het	hom	het		QUAL=18462;DP=276,384,284;AF=0.51,1.00,0.46;MQM=60	HIST3H3	synonymous	HIST3H3:ENST00000366696:synonymous_variant:LOW:exon1/1:c.189C>A:p.Ile63=:PF00125						rs2230656		0.8318	8932,.	0.3976,0.9254,0.6604,0.8863,0.8559	2.3090			0.89,0.92	4.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HIST3H3 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	228612892	228612892	G	A	wt	het	wt		QUAL=2234;DP=173,259,209;AF=0.00,0.47,0.00;MQM=60	HIST3H3	synonymous	HIST3H3:ENST00000366696:synonymous_variant:LOW:exon1/1:c.135C>T:p.Gly45=:						rs56336130	0.0433	0.0708	79,.	0.0128,0.0359,0.0198,0.0923,0.0907	-0.0050			0.72,0.96	1.46			gain/donor/228612891-228612892/Medium/8.005367			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HIST3H3 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	228613052	228613052	T	C	het	hom	het	off-target	QUAL=1559;DP=56,30,34;AF=0.38,1.00,0.41;MQM=60	HIST3H3	upstream_gene	HIST3H3:ENST00000366696:upstream_gene_variant:MODIFIER::::						rs1188474		0.8781	12123,.	0.9285,0.9608,0.6693,0.8916,0.8646	-2.7120			0.01,0.16	0.23						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HIST3H3 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	229568231	229568231	T	G	hom	hom	hom	off-target	QUAL=2167;DP=8,46,34;AF=1.00,1.00,1.00;MQM=60	ACTA1	intron	ACTA1:ENST00000366683:intron_variant:MODIFIER:exon3/5:c.352+174A>C::,ACTA1:ENST00000366684:intron_variant:MODIFIER:exon3/6:c.455-53A>C::	regulatory_region_variant:promoter	102610 [GENE=ACTA1 PHENOS=Myopathy,actin,congenital,with cores,161800,Autosomal recessive,Autosomal dominant/Myopathy,actin,congenital,with excess of thin myofilaments,161800,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion 1,255310,Autosomal recessive,Autosomal dominant/Myopathy,scapulohumeroperoneal,616852,Autosomal dominant/Nemaline myopathy 3,autosomal dominant or recessive,161800,Autosomal recessive,Autosomal dominant];				rs527621	0.9990	0.9992	14550,.		-1.1130			0.02,0.12	6.73						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	229569803	229569803	A	G	het	het	het		QUAL=3189;DP=63,110,74;AF=0.57,0.55,0.49;MQM=60	ACTA1	5'UTR	ACTA1:ENST00000366683:5_prime_UTR_variant:MODIFIER:exon1/6:c.-65T>C::,ACTA1:ENST00000366684:5_prime_UTR_variant:MODIFIER:exon1/7:c.-65T>C::	regulatory_region_variant:promoter	102610 [GENE=ACTA1 PHENOS=Myopathy,actin,congenital,with cores,161800,Autosomal recessive,Autosomal dominant/Myopathy,actin,congenital,with excess of thin myofilaments,161800,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion 1,255310,Autosomal recessive,Autosomal dominant/Myopathy,scapulohumeroperoneal,616852,Autosomal dominant/Nemaline myopathy 3,autosomal dominant or recessive,161800,Autosomal recessive,Autosomal dominant];	296060 [likely benign DISEASE=Nemaline myopathy,Familial restrictive cardiomyopathy,Congenital fiber-type disproportion];			rs605430,rs879788591	0.6302	0.6045	5836,.		0.4410			0.01,0.32	15.75						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	229569804	229569804	G	A	het	het	het		QUAL=3189;DP=63,110,74;AF=0.57,0.55,0.49;MQM=60	ACTA1	5'UTR	ACTA1:ENST00000366683:5_prime_UTR_variant:MODIFIER:exon1/6:c.-66C>T::,ACTA1:ENST00000366684:5_prime_UTR_variant:MODIFIER:exon1/7:c.-66C>T::	regulatory_region_variant:promoter	102610 [GENE=ACTA1 PHENOS=Myopathy,actin,congenital,with cores,161800,Autosomal recessive,Autosomal dominant/Myopathy,actin,congenital,with excess of thin myofilaments,161800,Autosomal recessive,Autosomal dominant/Myopathy,congenital,with fiber-type disproportion 1,255310,Autosomal recessive,Autosomal dominant/Myopathy,scapulohumeroperoneal,616852,Autosomal dominant/Nemaline myopathy 3,autosomal dominant or recessive,161800,Autosomal recessive,Autosomal dominant];	296062 [likely benign DISEASE=Nemaline myopathy,Familial restrictive cardiomyopathy,Congenital fiber-type disproportion];			rs605428	0.6436	0.6041	5836,.		-0.0810			0.02,0.41	15.11						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	231377081	231377081	C	T	hom	het	hom		QUAL=18954;DP=292,316,250;AF=0.98,0.55,0.99;MQM=60	GNPAT	5'UTR	GNPAT:ENST00000366646:5_prime_UTR_variant:MODIFIER:exon1/15:c.-44C>T::,GNPAT:ENST00000366647:5_prime_UTR_variant:MODIFIER:exon1/16:c.-44C>T::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	602744 [GENE=GNPAT PHENOS=Rhizomelic chondrodysplasia punctata,type 2,222765,Autosomal recessive];	296108 [benign DISEASE=Rhizomelic chondrodysplasia punctata,not specified];			rs518686	0.5819	0.5542	4406,.	0.5701,0.6072,0.5936,0.5291,0.6243	0.1150			0.03,0.50	11.89						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231401204	231401204	T	C	hom	het	het	off-target	QUAL=12307;DP=212,232,178;AF=1.00,0.51,0.48;MQM=60	GNPAT	intron	GNPAT:ENST00000366646:intron_variant:MODIFIER:exon4/14:c.513+38T>C::,GNPAT:ENST00000366647:intron_variant:MODIFIER:exon5/15:c.696+38T>C::		602744 [GENE=GNPAT PHENOS=Rhizomelic chondrodysplasia punctata,type 2,222765,Autosomal recessive];				rs6702011	0.2678	0.2745	1061,.	0.2822,0.3909,0.2137,0.2542,0.2725	-0.6740			0.09,0.20	9.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231401902	231401902	G	A	hom	het	het		QUAL=17592;DP=348,257,202;AF=1.00,0.50,0.49;MQM=60	GNPAT	synonymous	GNPAT:ENST00000366646:synonymous_variant:LOW:exon6/15:c.732G>A:p.Glu244=:,GNPAT:ENST00000366647:synonymous_variant:LOW:exon7/16:c.915G>A:p.Glu305=:		602744 [GENE=GNPAT PHENOS=Rhizomelic chondrodysplasia punctata,type 2,222765,Autosomal recessive];	260363 [benign DISEASE=Rhizomelic chondrodysplasia punctata,not specified,not provided];			rs574553	0.6286	0.5698	5223,.	0.6931,0.6150,0.5972,0.5398,0.6247	1.6170			0.61,0.96	8.66						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231500353	231500353	-	T	hom	hom	het		QUAL=17414;DP=339,183,161;AF=0.97,0.97,0.45;MQM=60	EGLN1	3'UTR	EGLN1:ENST00000366641:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1803dup::		606425 [GENE=EGLN1 PHENOS=Erythrocytosis,familial,3,609820,Autosomal dominant/Hemoglobin,high altitude adaptation,609070,Autosomal dominant];				rs541569859		0.5887	5677,.						5.52						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231502245	231502245	T	-	het	het	wt	off-target	QUAL=11721;DP=211,212,175;AF=0.89,0.91,0.38;MQM=59	EGLN1	intron	EGLN1:ENST00000366641:intron_variant:MODIFIER:exon4/4:c.1217-24del::		606425 [GENE=EGLN1 PHENOS=Erythrocytosis,familial,3,609820,Autosomal dominant/Hemoglobin,high altitude adaptation,609070,Autosomal dominant];				rs371204614	0.1103	0.1471	0,.	0.0682,0.1075,0.1613,0.1716,0.1280	-0.0460				0.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231502245	231502245	T	A	het	het	het	off-target	QUAL=11721;DP=211,212,175;AF=0.89,0.91,0.38;MQM=59	EGLN1	intron	EGLN1:ENST00000366641:intron_variant:MODIFIER:exon4/4:c.1217-24A>T::		606425 [GENE=EGLN1 PHENOS=Erythrocytosis,familial,3,609820,Autosomal dominant/Hemoglobin,high altitude adaptation,609070,Autosomal dominant];				rs1435167	0.4297	0.5696	4953,.	0.3345,0.3784,0.4142,0.4517,0.4127	-0.0460			0.00,0.08	0.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231557255	231557255	C	G	het	wt	hom		QUAL=206;DP=3,3,9;AF=0.67,0.00,1.00;MQM=60	EGLN1	missense	EGLN1:ENST00000366641:missense_variant:MODERATE:exon1/5:c.380G>C:p.Cys127Ser:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	606425 [GENE=EGLN1 PHENOS=Erythrocytosis,familial,3,609820,Autosomal dominant/Hemoglobin,high altitude adaptation,609070,Autosomal dominant];	242640 [benign DISEASE=Familial erythrocytosis]; 156155 [affects DISEASE=Hemoglobin, high altitude adaptation];	CM140742 [CLASS=DFP MUT=ALT PHEN="Reduced haemoglobin levels" GENE=EGLN1];	(GCC)n (Simple_repeat)	rs12097901	0.2604	0.1572	626,.	0.4444,0.2239,0.5097,0.0939,0.3281	-0.0300	T(0.74)	B(0.00)	0.00,0.09	10.79	0.21					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231559226	231559226	A	G	het	wt	hom		QUAL=5108;DP=197,82,71;AF=0.51,0.02,1.00;MQM=60	EGLN1	5'UTR	EGLN1:ENST00000366641:5_prime_UTR_variant:MODIFIER:exon1/5:c.-1592T>C::	regulatory_region_variant:promoter	606425 [GENE=EGLN1 PHENOS=Erythrocytosis,familial,3,609820,Autosomal dominant/Hemoglobin,high altitude adaptation,609070,Autosomal dominant];	296223 [benign DISEASE=Familial erythrocytosis];			rs12406290	0.2915	0.1902	664,.		3.1480			0.17,0.40	9.79						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231560220	231560220	A	G	het	wt	hom		QUAL=15505;DP=597,205,209;AF=0.54,0.00,1.00;MQM=60	EGLN1	5'UTR	EGLN1:ENST00000366641:5_prime_UTR_variant:MODIFIER:exon1/5:c.-2586T>C::		606425 [GENE=EGLN1 PHENOS=Erythrocytosis,familial,3,609820,Autosomal dominant/Hemoglobin,high altitude adaptation,609070,Autosomal dominant];	296240 [benign DISEASE=Familial erythrocytosis];			rs2153364	0.2939	0.1905	668,.		0.2300			0.03,0.19	3.45						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	235543477	235543480	TGTG	-	wt	het	wt	off-target	QUAL=2001;DP=51,29,90;AF=0.92,0.34,0.92;MQM=60	TBCE	intron	TBCE:ENST00000366601:intron_variant:MODIFIER:exon2/16:c.100+62_100+65del::,TBCE:ENST00000406207:intron_variant:MODIFIER:exon2/16:c.100+62_100+65del::,TBCE:ENST00000543662:intron_variant:MODIFIER:exon2/17:c.100+62_100+65del::		604934 [GENE=TBCE PHENOS=Encephalopathy,progressive,with amyotrophy and optic atrophy,617207,Autosomal recessive/Hypoparathyroidism-retardation-dysmorphism syndrome,241410,Autosomal recessive/Kenny-Caffey syndrome,type 1,244460,Autosomal recessive];			(TG)n (Simple_repeat)	rs1413776382		0.0673	135,.	0.0194,0.0288,0.0438,0.0234,0.0253	0.5310				6.65						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235543477	235543490	TGTGTGTGTGTGTG	-	het	wt	het	off-target	QUAL=2001;DP=51,29,90;AF=0.92,0.34,0.92;MQM=60	TBCE	intron	TBCE:ENST00000366601:intron_variant:MODIFIER:exon2/16:c.100+52_100+65del::,TBCE:ENST00000406207:intron_variant:MODIFIER:exon2/16:c.100+52_100+65del::,TBCE:ENST00000543662:intron_variant:MODIFIER:exon2/17:c.100+52_100+65del::		604934 [GENE=TBCE PHENOS=Encephalopathy,progressive,with amyotrophy and optic atrophy,617207,Autosomal recessive/Hypoparathyroidism-retardation-dysmorphism syndrome,241410,Autosomal recessive/Kenny-Caffey syndrome,type 1,244460,Autosomal recessive];			(TG)n (Simple_repeat)	rs750237565		0.3333	1474,.	0.1041,0.1006,0.0754,0.2091,0.0685	0.8290				6.25						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235543477	235543492	TGTGTGTGTGTGTGTG	-	het	wt	wt	off-target	QUAL=2001;DP=51,29,90;AF=0.92,0.34,0.92;MQM=59	TBCE	intron	TBCE:ENST00000366601:intron_variant:MODIFIER:exon2/16:c.100+50_100+65del::,TBCE:ENST00000406207:intron_variant:MODIFIER:exon2/16:c.100+50_100+65del::,TBCE:ENST00000543662:intron_variant:MODIFIER:exon2/17:c.100+50_100+65del::		604934 [GENE=TBCE PHENOS=Encephalopathy,progressive,with amyotrophy and optic atrophy,617207,Autosomal recessive/Hypoparathyroidism-retardation-dysmorphism syndrome,241410,Autosomal recessive/Kenny-Caffey syndrome,type 1,244460,Autosomal recessive];			(TG)n (Simple_repeat)	rs145735844		0.0770	135,.	0.0784,0.0478,0.0847,0.0917,0.0437	0.8290				6.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235543477	235543494	TGTGTGTGTGTGTGTGTG	-	wt	wt	het	off-target	QUAL=2001;DP=51,29,90;AF=0.92,0.34,0.92;MQM=60	TBCE	intron	TBCE:ENST00000366601:intron_variant:MODIFIER:exon2/16:c.100+48_100+65del::,TBCE:ENST00000406207:intron_variant:MODIFIER:exon2/16:c.100+48_100+65del::,TBCE:ENST00000543662:intron_variant:MODIFIER:exon2/17:c.100+48_100+65del::		604934 [GENE=TBCE PHENOS=Encephalopathy,progressive,with amyotrophy and optic atrophy,617207,Autosomal recessive/Hypoparathyroidism-retardation-dysmorphism syndrome,241410,Autosomal recessive/Kenny-Caffey syndrome,type 1,244460,Autosomal recessive];			(TG)n (Simple_repeat)	rs200922223		0.1700	591,.	0.1339,0.2137,0.3190,0.0680,0.1604	0.8290				6.02						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235612320	235612320	C	T	het	wt	hom	off-target	QUAL=4418;DP=134,91,84;AF=0.54,0.00,0.99;MQM=60	B3GALNT2,TBCE	downstream_gene	B3GALNT2:ENST00000366600:downstream_gene_variant:MODIFIER::::,TBCE:ENST00000366601:downstream_gene_variant:MODIFIER::::,TBCE:ENST00000406207:downstream_gene_variant:MODIFIER::::,TBCE:ENST00000543662:downstream_gene_variant:MODIFIER::::						rs704705	0.7446	0.7405	8797,.		0.7840			0.00,0.12	9.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					B3GALNT2 (inh=AR oe_syn=0.91 oe_mis=0.84 oe_lof=0.55), TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235825643	235825643	G	A	het	wt	het		QUAL=2736;DP=205,66,30;AF=0.46,0.00,0.33;MQM=60	LYST	3'UTR	LYST:ENST00000389793:3_prime_UTR_variant:MODIFIER:exon53/53:c.*597C>T::,LYST:ENST00000389794:3_prime_UTR_variant:MODIFIER:exon53/53:c.*597C>T::	regulatory_region_variant:enhancer	606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];				rs1400168809		0.0001	0,.		1.0370			0.03,0.22	2.73						0	2						LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235826383	235826383	A	-	hom	hom	het		QUAL=14476;DP=219,270,185;AF=0.90,0.89,0.51;MQM=59	LYST	splice_region&intron	LYST:ENST00000389793:splice_region_variant&intron_variant:LOW:exon52/52:c.11268-5del::,LYST:ENST00000389794:splice_region_variant&intron_variant:LOW:exon52/52:c.11268-5del::	regulatory_region_variant:enhancer	606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	403065 [benign/likely benign DISEASE=Chediak-Higashi syndrome,not specified];	CD181021 [CLASS=DM? MUT=ALT PHEN="Haemophagocytic lymphohistiocytosis" GENE=LYST];		rs36014994		0.5819	5019,.	0.6809,0.4483,0.2392,0.5340,0.4148	0.0090				6.59					COSM5491310	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235860340	235860340	C	T	hom	hom	het	off-target	QUAL=3178;DP=67,23,29;AF=1.00,1.00,0.59;MQM=60	LYST	intron	LYST:ENST00000389793:intron_variant:MODIFIER:exon46/52:c.10564+43G>A::,LYST:ENST00000389794:intron_variant:MODIFIER:exon46/52:c.10564+43G>A::		606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	254908 [benign DISEASE=not specified];			rs7541057	0.4000	0.5467	5044,.	0.7306,0.2734,0.0498,0.5150,0.1857	-1.5040			0.00,0.07	1.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235872665	235872665	T	C	hom	hom	het	off-target	QUAL=7712;DP=179,56,47;AF=0.99,1.00,0.51;MQM=60	LYST	intron	LYST:ENST00000389793:intron_variant:MODIFIER:exon43/52:c.9926-57A>G::,LYST:ENST00000389794:intron_variant:MODIFIER:exon43/52:c.9926-57A>G::	regulatory_region_variant:promoter_flanking_region	606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];				rs2275856	0.4137	0.5119	4807,.		-0.8160			0.00,0.08	1.82						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235887276	235887276	G	T	hom	hom	het	off-target	QUAL=9189;DP=133,116,99;AF=0.99,1.00,0.52;MQM=60	LYST	intron	LYST:ENST00000389793:intron_variant:MODIFIER:exon39/52:c.9315+52C>A::,LYST:ENST00000389794:intron_variant:MODIFIER:exon39/52:c.9315+52C>A::		606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];				rs6667717	0.4117	0.5099	4791,.		-2.8510			0.00,0.07	0.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235922228	235922228	T	C	het	het	wt	off-target	QUAL=2271;DP=141,43,28;AF=0.56,0.44,0.04;MQM=60	LYST	intron	LYST:ENST00000389793:intron_variant:MODIFIER:exon23/52:c.6881+44A>G::,LYST:ENST00000389794:intron_variant:MODIFIER:exon23/52:c.6881+44A>G::		606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	254935 [benign DISEASE=not specified];			rs3738519	0.2300	0.3160	1706,.	0.4262,0.1913,0.0094,0.2694,0.1679	-4.9410			0.02,0.16	0.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235940450	235940450	C	T	hom	hom	het		QUAL=17711;DP=241,237,202;AF=1.00,1.00,0.43;MQM=60	LYST	synonymous,3'UTR	LYST:ENST00000389793:synonymous_variant:LOW:exon17/53:c.5373G>A:p.Lys1791=:,LYST:ENST00000389794:synonymous_variant:LOW:exon17/53:c.5373G>A:p.Lys1791=:,LYST:ENST00000536965:3_prime_UTR_variant:MODIFIER:exon16/22:c.*797G>A::		606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	254927 [benign DISEASE=Chediak-Higashi syndrome,not specified];			rs2273584	0.3009	0.4197	2915,.	0.5010,0.2776,0.0588,0.4050,0.2022	0.6140			0.09,0.31	5.45						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235945186	235945186	G	A	het	het	het	off-target	QUAL=4499;DP=135,151,92;AF=0.44,0.50,0.53;MQM=59	LYST	intron	LYST:ENST00000389793:intron_variant:MODIFIER:exon15/52:c.5023+41C>T::,LYST:ENST00000389794:intron_variant:MODIFIER:exon15/52:c.5023+41C>T::,LYST:ENST00000536965:intron_variant:MODIFIER:exon14/21:c.*447+41C>T::		606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	254924 [benign DISEASE=not specified];		AluJo (SINE/Alu)	rs72763416	0.0707	0.1043	196,.	0.0709,0.0880,0.0493,0.1372,0.0408	-1.1670			0.00,0.14	0.37						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235945294	235945294	T	C	hom	hom	het		QUAL=15470;DP=184,232,150;AF=0.99,1.00,0.51;MQM=60	LYST	synonymous,3'UTR	LYST:ENST00000389793:synonymous_variant:LOW:exon15/53:c.4956A>G:p.Leu1652=:,LYST:ENST00000389794:synonymous_variant:LOW:exon15/53:c.4956A>G:p.Leu1652=:,LYST:ENST00000536965:3_prime_UTR_variant:MODIFIER:exon14/22:c.*380A>G::		606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	254923 [benign DISEASE=Chediak-Higashi syndrome,not specified];			rs6696123	0.3035	0.4206	2931,.	0.5020,0.2780,0.0588,0.4053,0.2079	-0.4200			0.05,0.21	5.62						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235955150	235955150	G	A	wt	het	wt		QUAL=6495;DP=579,522,414;AF=0.00,0.48,0.00;MQM=60	LYST	synonymous,intron	LYST:ENST00000389793:synonymous_variant:LOW:exon12/53:c.4392C>T:p.Asn1464=:,LYST:ENST00000389794:synonymous_variant:LOW:exon12/53:c.4392C>T:p.Asn1464=:,LYST:ENST00000536965:intron_variant:MODIFIER:exon11/21:c.4116+1653C>T::		606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	254921 [benign/likely benign DISEASE=Chediak-Higashi syndrome,not specified];			rs11583387	0.0643	0.0882	147,.	0.0660,0.0778,0.0491,0.1125,0.0381	3.0230			0.93,0.98	9.95						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235971763	235971763	A	G	het	het	het		QUAL=8462;DP=203,267,197;AF=0.53,0.51,0.51;MQM=60	LYST	synonymous	LYST:ENST00000389793:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:,LYST:ENST00000389794:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:,LYST:ENST00000536965:synonymous_variant:LOW:exon5/22:c.2355T>C:p.Leu785=:		606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	254915 [benign/likely benign DISEASE=Chediak-Higashi syndrome,not specified];			rs3768066	0.0707	0.1048	197,.	0.0716,0.0882,0.0494,0.1374,0.0413	-0.0400			0.44,0.49	9.83						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235972435	235972435	T	C	hom	hom	het		QUAL=27832;DP=481,286,195;AF=0.99,1.00,0.52;MQM=60	LYST	synonymous	LYST:ENST00000389793:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:,LYST:ENST00000389794:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:,LYST:ENST00000536965:synonymous_variant:LOW:exon5/22:c.1683A>G:p.Leu561=:	regulatory_region_variant:enhancer	606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	254912 [benign DISEASE=Chediak-Higashi syndrome,not specified];			rs3820553	0.3027	0.4205	2934,.	0.5025,0.2785,0.0589,0.4057,0.2077	-0.4530			0.04,0.73	4.72						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235972867	235972867	T	C	hom	hom	het		QUAL=27833;DP=454,307,190;AF=1.00,0.99,0.56;MQM=60	LYST	synonymous	LYST:ENST00000389793:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:,LYST:ENST00000389794:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:,LYST:ENST00000536965:synonymous_variant:LOW:exon5/22:c.1251A>G:p.Gln417=:	regulatory_region_variant:enhancer	606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];	254910 [benign DISEASE=Chediak-Higashi syndrome,not specified];			rs1063128	0.3033	0.4204	2924,.	0.5029,0.2784,0.0588,0.4057,0.2078	-0.0600			0.52,0.97	8.59			gain/acceptor/235972866-235972867/Medium/1.608005			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	236030277	236030277	C	G	n/a	het	n/a	off-target	QUAL=25;DP=0,6,1;AF=,0.50,0.00;MQM=60	LYST	intron	LYST:ENST00000536965:intron_variant:MODIFIER:exon1/21:c.-98+16210G>C::	regulatory_region_variant:promoter	606897 [GENE=LYST PHENOS=Chediak-Higashi syndrome,214500,Autosomal recessive];				rs3820556	0.0561	0.0837	156,.		0.8250			0.34,0.83	21.30						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	236557771	236557771	G	A	hom	hom	hom		QUAL=24508;DP=250,289,225;AF=1.00,1.00,1.00;MQM=60	EDARADD	missense	EDARADD:ENST00000334232:missense_variant:MODERATE:exon1/6:c.27G>A:p.Met9Ile:	regulatory_region_variant:promoter	606603 [GENE=EDARADD PHENOS=Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940,Autosomal dominant/Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941,Autosomal recessive];	262600 [benign DISEASE=not specified,Hypohidrotic Ectodermal Dysplasia, Recessive,not provided];			rs966365		0.8410	9203,.	0.5373,0.9067,0.9186,0.8370,0.9121	-0.0830	T(0.45)	B(0.00)	0.04,0.21	5.96	0.13					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236572475	236572475	A	G	het	het	hom	off-target	QUAL=10232;DP=180,161,171;AF=0.49,0.55,1.00;MQM=60	EDARADD	intron	EDARADD:ENST00000334232:intron_variant:MODIFIER:exon1/5:c.62-41A>G::,EDARADD:ENST00000359362:intron_variant:MODIFIER:exon1/5:c.32-41A>G::		606603 [GENE=EDARADD PHENOS=Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940,Autosomal dominant/Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941,Autosomal recessive];				rs669710	0.4619	0.5436	4755,.	0.4768,0.4369,0.2597,0.5943,0.4913	0.2900			0.09,0.17	3.89						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236590659	236590659	G	C	het	het	hom	off-target	QUAL=6441;DP=151,153,89;AF=0.50,0.51,0.99;MQM=60	EDARADD	intron	EDARADD:ENST00000334232:intron_variant:MODIFIER:exon3/5:c.161-33G>C::,EDARADD:ENST00000359362:intron_variant:MODIFIER:exon3/5:c.131-33G>C::		606603 [GENE=EDARADD PHENOS=Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940,Autosomal dominant/Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941,Autosomal recessive];			(T)n (Simple_repeat)	rs636048	0.3582	0.4936	3732,.	0.1851,0.4187,0.2266,0.5866,0.4570	0.8840			0.04,0.14	1.74						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236645670	236645670	C	T	wt	het	wt		QUAL=5235;DP=208,478,356;AF=0.00,0.44,0.01;MQM=60	EDARADD	synonymous	EDARADD:ENST00000334232:synonymous_variant:LOW:exon6/6:c.369C>T:p.Asp123=:,EDARADD:ENST00000359362:synonymous_variant:LOW:exon6/6:c.339C>T:p.Asp113=:		606603 [GENE=EDARADD PHENOS=Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940,Autosomal dominant/Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941,Autosomal recessive];	262602 [benign/likely benign DISEASE=not specified,Hypohidrotic Ectodermal Dysplasia, Recessive,not provided];			rs604070	0.1332	0.1998	694,.	0.0709,0.1097,0.0906,0.2558,0.1497	0.1880			0.19,0.44	11.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236647511	236647511	T	C	het	hom	het		QUAL=12981;DP=271,225,142;AF=0.54,1.00,0.49;MQM=60	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000359362:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::,ENO1P1:ENST00000366587:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1047T>C::		606603 [GENE=EDARADD PHENOS=Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940,Autosomal dominant/Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941,Autosomal recessive];	296476 [likely benign DISEASE=Hypohidrotic Ectodermal Dysplasia, Recessive];			rs7513402	0.2540	0.3104	1623,.		-2.0580			0.01,0.58	6.32						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236647550	236647550	C	G	het	hom	het		QUAL=13830;DP=327,225,127;AF=0.54,1.00,0.53;MQM=60	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000359362:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::,ENO1P1:ENST00000366587:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1086C>G::		606603 [GENE=EDARADD PHENOS=Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940,Autosomal dominant/Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941,Autosomal recessive];	296479 [likely benign DISEASE=Hypohidrotic Ectodermal Dysplasia, Recessive];			rs3916983	0.2033	0.2234	846,.		-0.0890			0.15,0.87	6.98						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236647736	236647736	C	T	het	hom	het		QUAL=7158;DP=153,129,73;AF=0.54,0.99,0.53;MQM=59	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000359362:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::,ENO1P1:ENST00000366587:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1272C>T::		606603 [GENE=EDARADD PHENOS=Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940,Autosomal dominant/Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941,Autosomal recessive];	296481 [likely benign DISEASE=Hypohidrotic Ectodermal Dysplasia, Recessive];			rs6428955	0.1378	0.1741	584,.		0.1490			0.03,0.80	7.70						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236648008	236648008	G	A	hom	hom	wt		QUAL=168;DP=12,20,7;AF=0.50,0.05,0.00;MQM=60	EDARADD	3'UTR	EDARADD:ENST00000359362:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059G>A::		606603 [GENE=EDARADD PHENOS=Ectodermal dysplasia 11A,hypohidrotic/hair/tooth type,autosomal dominant,614940,Autosomal dominant/Ectodermal dysplasia 11B,hypohidrotic/hair/tooth type,autosomal recessive,614941,Autosomal recessive];			AluSc (SINE/Alu)	rs200288312		0.0048	2,.		-4.5420			0.00,0.05	0.07						3	8						EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236958532	236958532	G	T	het	hom	het	off-target	QUAL=1127;DP=14,29,23;AF=0.50,1.00,0.48;MQM=60	MTR	upstream_gene	MTR:ENST00000366577:upstream_gene_variant:MODIFIER::::,MTR:ENST00000418145:upstream_gene_variant:MODIFIER::::,MTR:ENST00000535889:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site					rs28372871	0.4673	0.4682	3460,.		-0.7480			0.01,0.21	6.32						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236978992	236978992	-	TCTG	het	hom	het	off-target	QUAL=8851;DP=161,175,111;AF=0.55,0.98,0.55;MQM=60	MTR	intron	MTR:ENST00000366577:intron_variant:MODIFIER:exon7/32:c.669+32_669+33insGTCT::,MTR:ENST00000418145:intron_variant:MODIFIER:exon7/7:c.*204+32_*204+33insGTCT::,MTR:ENST00000535889:intron_variant:MODIFIER:exon7/31:c.669+32_669+33insGTCT::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];				rs5781924		0.7265	8488,.	0.9264,0.6865,0.8106,0.6222,0.7313					2.27						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236988593	236988593	-	T	het	hom	het	off-target	QUAL=4019;DP=137,50,38;AF=0.56,1.00,0.68;MQM=60	MTR	intron	MTR:ENST00000366577:intron_variant:MODIFIER:exon9/32:c.866-40dup::,MTR:ENST00000535889:intron_variant:MODIFIER:exon9/31:c.866-40dup::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];				rs5781926	0.3155	0.3832	2048,.	0.2055,0.4468,0.4037,0.4058,0.3105					3.17						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236990141	236990141	G	A	wt	wt	het		QUAL=1793;DP=294,221,153;AF=0.00,0.00,0.47;MQM=60	MTR	missense	MTR:ENST00000366577:missense_variant:MODERATE:exon11/33:c.940G>A:p.Asp314Asn:PF02574,MTR:ENST00000535889:missense_variant:MODERATE:exon11/32:c.940G>A:p.Asp314Asn:PF02574		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	296556 [benign/likely benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not specified,not provided];			rs2229274	0.0084	0.0186	3,.	0.0080,0.0152,0.0001,0.0255,0.0049	4.0180	T(0.26),T(0.26)	B(0.19),B(0.19)	0.97,0.98	22.20	0.12					9	376						MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237001926	237001926	A	G	het	hom	het	off-target	QUAL=12905;DP=177,256,180;AF=0.51,1.00,0.51;MQM=60	MTR	intron	MTR:ENST00000366577:intron_variant:MODIFIER:exon15/32:c.1515+27A>G::,MTR:ENST00000535889:intron_variant:MODIFIER:exon15/31:c.1515+27A>G::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];				rs3820568	0.3277	0.3931	2250,.	0.2101,0.4522,0.4331,0.4117,0.3140	-1.0070			0.03,0.18	0.45						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237024414	237024414	G	T	het	wt	wt	off-target	QUAL=50;DP=40,25,17;AF=0.38,0.08,0.12;MQM=48	MTR	intron	MTR:ENST00000366577:intron_variant:MODIFIER:exon19/32:c.2044-11G>T::,MTR:ENST00000535889:intron_variant:MODIFIER:exon19/31:c.2044-1122G>T::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	516909 [benign DISEASE=not specified];		(T)n (Simple_repeat)	rs570088952	0.3079	0.4608	0,.	0.4112,0.4861,0.4212,0.4562,0.4908	0.8970			0.01,0.13	0.55		14.66>14.39		0.000/0.000		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237024416	237024416	C	T	het	wt	wt		QUAL=50;DP=40,25,17;AF=0.38,0.08,0.12;MQM=48	MTR	intron	MTR:ENST00000366577:intron_variant:MODIFIER:exon19/32:c.2044-9C>T::,MTR:ENST00000535889:intron_variant:MODIFIER:exon19/31:c.2044-1120C>T::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	506702 [benign DISEASE=not specified];		(T)n (Simple_repeat)	rs531027742	0.3099	0.4387	0,.	0.3917,0.4825,0.4045,0.4230,0.4851	0.1440			0.00,0.12	1.71		14.66>13.33		0.000/0.000		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237037999	237037999	T	-	het	hom	het	off-target	QUAL=1964;DP=102,61,34;AF=0.20,0.74,0.53;MQM=59	MTR	intron	MTR:ENST00000366577:intron_variant:MODIFIER:exon23/32:c.2474-18del::,MTR:ENST00000535889:intron_variant:MODIFIER:exon22/31:c.2321-18del::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];				rs150727404		0.6380	5381,.	0.5590,0.4889,0.5359,0.4505,0.4878	0.1560				2.32						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237038008	237038008	T	A	het	hom	het	off-target	QUAL=1964;DP=102,61,34;AF=0.20,0.74,0.53;MQM=59	MTR	intron	MTR:ENST00000366577:intron_variant:MODIFIER:exon23/32:c.2474-18T>A::,MTR:ENST00000535889:intron_variant:MODIFIER:exon22/31:c.2321-18T>A::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	378884 [benign DISEASE=not specified];			rs10925256	0.3832	0.4344	2308,.	0.4750,0.4576,0.4459,0.4159,0.3773	-0.2600			0.08,0.37	2.98		-1.58>-1.77				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237038161	237038161	T	C	het	wt	het	off-target	QUAL=2566;DP=81,168,126;AF=0.47,0.00,0.52;MQM=60	MTR	intron	MTR:ENST00000366577:intron_variant:MODIFIER:exon24/32:c.2594+15T>C::,MTR:ENST00000535889:intron_variant:MODIFIER:exon23/31:c.2441+15T>C::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	138288 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not specified];			rs1770449	0.2322	0.3220	1391,.	0.0701,0.3134,0.1923,0.3749,0.2791	-0.0530			0.05,0.22	2.43						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237048562	237048562	G	A	het	hom	het	off-target	QUAL=11044;DP=332,149,113;AF=0.55,1.00,0.50;MQM=60	MTR	intron	MTR:ENST00000366577:intron_variant:MODIFIER:exon26/32:c.2775+43G>A::,MTR:ENST00000535889:intron_variant:MODIFIER:exon25/31:c.2622+43G>A::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];				rs2275566		0.7231	8411,.	0.9063,0.6827,0.8081,0.6227,0.7187	-0.8130			0.03,0.11	0.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237054569	237054569	A	G	het	hom	het		QUAL=7203;DP=98,144,101;AF=0.55,1.00,0.50;MQM=60	MTR	synonymous	MTR:ENST00000366577:synonymous_variant:LOW:exon29/33:c.3144A>G:p.Ala1048=:PF02965,MTR:ENST00000535889:synonymous_variant:LOW:exon28/32:c.2991A>G:p.Ala997=:PF02965	regulatory_region_variant:promoter_flanking_region	156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	138290 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not specified];			rs2229276	0.3233	0.3896	2189,.	0.1936,0.4474,0.4430,0.4047,0.3210	-1.1260			0.10,0.16	0.23						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237057608	237057608	G	A	het	hom	het	off-target	QUAL=8014;DP=97,175,140;AF=0.51,1.00,0.50;MQM=60	MTR	intron	MTR:ENST00000366577:intron_variant:MODIFIER:exon29/32:c.3205-49G>A::,MTR:ENST00000535889:intron_variant:MODIFIER:exon28/31:c.3052-49G>A::	regulatory_region_variant:promoter_flanking_region	156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];				rs2297965		0.5905	5181,.	0.4581,0.6321,0.5411,0.5949,0.6252	-0.5190			0.03,0.14	2.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237058744	237058744	C	A	het	hom	het		QUAL=14682;DP=212,309,222;AF=0.52,1.00,0.45;MQM=60	MTR	synonymous	MTR:ENST00000366577:synonymous_variant:LOW:exon31/33:c.3492C>A:p.Arg1164=:PF02965,MTR:ENST00000535889:synonymous_variant:LOW:exon30/32:c.3339C>A:p.Arg1113=:PF02965		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	138283 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not specified];			rs12070777	0.3215	0.3869	2179,.	0.1981,0.4453,0.4322,0.4014,0.3121	0.0720			0.58,0.23	5.59						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237058828	237058828	C	T	wt	het	het		QUAL=4192;DP=135,182,168;AF=0.00,0.53,0.43;MQM=60	MTR	synonymous	MTR:ENST00000366577:synonymous_variant:LOW:exon31/33:c.3576C>T:p.Leu1192=:PF02965,MTR:ENST00000535889:synonymous_variant:LOW:exon30/32:c.3423C>T:p.Leu1141=:PF02965		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	138284 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not specified];			rs1131449		0.5762	4962,.	0.4608,0.6146,0.5430,0.5720,0.6205	-3.4610			0.02,0.09	0.11						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237060433	237060433	G	T	het	hom	het	off-target	QUAL=12413;DP=204,245,200;AF=0.42,0.99,0.50;MQM=60	MTR	intron	MTR:ENST00000366577:intron_variant:MODIFIER:exon32/32:c.3711+15G>T::,MTR:ENST00000535889:intron_variant:MODIFIER:exon31/31:c.3558+15G>T::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	138285 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not specified];			rs3820571	0.7524	0.7166	8242,.	0.8870,0.6808,0.8080,0.6181,0.7188	-0.2760			0.00,0.13	2.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237061056	237061056	A	C	het	hom	het		QUAL=10729;DP=307,154,80;AF=0.54,1.00,0.53;MQM=60	MTR	3'UTR	MTR:ENST00000366577:3_prime_UTR_variant:MODIFIER:exon33/33:c.*112A>C::,MTR:ENST00000535889:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	296587 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs2853522		0.5728	5214,.		-1.1210			0.00,0.05	5.31						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237061705	237061705	T	-	het	hom	het		QUAL=2038;DP=94,37,26;AF=0.51,0.84,0.58;MQM=58	MTR	3'UTR	MTR:ENST00000366577:3_prime_UTR_variant:MODIFIER:exon33/33:c.*773del::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	296595 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluY (SINE/Alu)	rs1234008757		0.6811	5595,.		0.1060				6.82						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237061849	237061849	G	A	het	wt	het		QUAL=1236;DP=80,65,34;AF=0.43,0.00,0.59;MQM=51	MTR	3'UTR	MTR:ENST00000366577:3_prime_UTR_variant:MODIFIER:exon33/33:c.*905G>A::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	296598 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluY (SINE/Alu)	rs1131450	0.2460	0.2755	1337,.		0.1700			0.00,0.07	2.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237062198	237062198	A	C	het	hom	het		QUAL=16911;DP=264,297,243;AF=0.55,1.00,0.47;MQM=60	MTR	3'UTR	MTR:ENST00000366577:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1254A>C::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	296610 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs2853523	0.7646	0.7272	8540,.		-0.2270			0.00,0.06	7.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237062305	237062305	A	G	het	hom	het		QUAL=21931;DP=412,370,294;AF=0.52,0.99,0.52;MQM=60	MTR	3'UTR	MTR:ENST00000366577:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1361A>G::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	296611 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs1050993		0.7272	8539,.		-0.4580			0.00,0.06	3.14						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237063335	237063335	G	C	het	hom	het		QUAL=12869;DP=227,221,207;AF=0.49,1.00,0.53;MQM=60	MTR	3'UTR	MTR:ENST00000366577:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2391G>C::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	296631 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs1050996	0.7328	0.6980	7755,.		-0.1640			0.00,0.07	3.60						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237063504	237063504	A	G	het	hom	het		QUAL=11943;DP=379,147,108;AF=0.50,1.00,0.55;MQM=60	MTR	3'UTR	MTR:ENST00000366577:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2560A>G::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	296633 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs9779	0.3219	0.3704	2128,.	0.1885,0.4325,0.4310,0.3913,0.2992	-1.1440			0.01,0.12	3.66						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237063709	237063709	-	A	het	hom	het		QUAL=12646;DP=171,172,132;AF=0.92,0.94,0.94;MQM=59	MTR	3'UTR	MTR:ENST00000366577:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2774dup::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	296635 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs1304650915		0.7250	6621,.						4.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237063718	237063719	AG	-	het	wt	het		QUAL=12646;DP=171,172,132;AF=0.92,0.94,0.94;MQM=60	MTR	3'UTR	MTR:ENST00000366577:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2775_*2776del::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	296637 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs34686098,rs1491037196	0.2332	0.2694	1367,.		0.5860				3.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237064626	237064626	T	G	het	hom	het		QUAL=33695;DP=416,670,512;AF=0.49,0.99,0.48;MQM=60	MTR	3'UTR	MTR:ENST00000366577:3_prime_UTR_variant:MODIFIER:exon33/33:c.*3682T>G::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	296655 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs6676866		0.5736	5223,.		1.5630			0.10,0.14	2.26						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237065326	237065326	C	T	het	hom	het		QUAL=8100;DP=170,156,112;AF=0.55,1.00,0.47;MQM=60	MTR	3'UTR	MTR:ENST00000366577:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4382C>T::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	296668 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs4659746	0.5447	0.5793	5338,.		-0.6210			0.00,0.10	1.07						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237065583	237065583	G	T	het	hom	het		QUAL=13263;DP=219,256,175;AF=0.52,1.00,0.57;MQM=60	MTR	3'UTR	MTR:ENST00000366577:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4639G>T::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	296673 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs10925264	0.7646	0.7270	8512,.		-0.3240			0.00,0.07	0.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237065810	237065810	T	G	het	het	wt		QUAL=4846;DP=177,171,178;AF=0.53,0.55,0.00;MQM=60	MTR	3'UTR	MTR:ENST00000366577:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4866T>G::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	296677 [uncertain significance DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L2c (LINE/L2)	rs45563435	0.0076	0.0136	3,.		-0.3090			0.02,0.12	1.20						0	34						MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	237066114	237066114	A	G	het	wt	het		QUAL=3122;DP=156,113,84;AF=0.49,0.00,0.58;MQM=60	MTR	3'UTR	MTR:ENST00000366577:3_prime_UTR_variant:MODIFIER:exon33/33:c.*5170A>G::		156570 [GENE=MTR PHENOS=Homocystinuria-megaloblastic anemia,cblG complementation type,250940,Autosomal recessive/Neural tube defects,folate-sensitive,susceptibility to,601634,Autosomal recessive];	296679 [likely benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs6680753	0.0104	0.0204	8,.		0.5380			0.05,0.20	6.93						0	11						MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	240939104	240939104	G	A	het	wt	hom		QUAL=9092;DP=345,165,146;AF=0.48,0.00,0.99;MQM=60	RGS7	intron,3'UTR	RGS7:ENST00000331110:intron_variant:MODIFIER:exon17/17:c.*7-7526C>T::,RGS7:ENST00000348120:3_prime_UTR_variant:MODIFIER:exon15/15:c.*416C>T::,RGS7:ENST00000366563:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:ENST00000366564:3_prime_UTR_variant:MODIFIER:exon17/17:c.*359C>T::,RGS7:ENST00000366565:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:ENST00000446183:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::						rs35557904	0.1727	0.1719	600,.		0.5550			0.22,0.93	13.99						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240939152	240939152	A	G	het	wt	hom		QUAL=9443;DP=317,209,181;AF=0.44,0.00,0.99;MQM=60	RGS7	intron,3'UTR	RGS7:ENST00000331110:intron_variant:MODIFIER:exon17/17:c.*7-7574T>C::,RGS7:ENST00000348120:3_prime_UTR_variant:MODIFIER:exon15/15:c.*368T>C::,RGS7:ENST00000366563:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:ENST00000366564:3_prime_UTR_variant:MODIFIER:exon17/17:c.*311T>C::,RGS7:ENST00000366565:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:ENST00000446183:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::						rs16840577	0.1727	0.1711	600,.		2.3800			0.05,0.93	15.78						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240939391	240939391	C	T	het	wt	het		QUAL=12760;DP=503,687,550;AF=0.46,0.00,0.47;MQM=60	RGS7	intron,3'UTR	RGS7:ENST00000331110:intron_variant:MODIFIER:exon17/17:c.*7-7813G>A::,RGS7:ENST00000348120:3_prime_UTR_variant:MODIFIER:exon15/15:c.*129G>A::,RGS7:ENST00000366563:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:ENST00000366564:3_prime_UTR_variant:MODIFIER:exon17/17:c.*72G>A::,RGS7:ENST00000366565:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:ENST00000446183:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::						rs12757054	0.0497	0.0599	68,.		1.8120			0.71,0.97	15.80						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240975213	240975213	T	C	het	hom	wt		QUAL=11073;DP=254,237,201;AF=0.55,1.00,0.00;MQM=60	RGS7	splice_region&intron	RGS7:ENST00000331110:splice_region_variant&intron_variant:LOW:exon14/17:c.1004+5A>G::,RGS7:ENST00000348120:splice_region_variant&intron_variant:LOW:exon11/14:c.923+5A>G::,RGS7:ENST00000366562:splice_region_variant&intron_variant:LOW:exon13/15:c.1082+5A>G::,RGS7:ENST00000366563:splice_region_variant&intron_variant:LOW:exon14/17:c.1082+5A>G::,RGS7:ENST00000366564:splice_region_variant&intron_variant:LOW:exon14/16:c.1082+5A>G::,RGS7:ENST00000366565:splice_region_variant&intron_variant:LOW:exon14/17:c.1082+5A>G::,RGS7:ENST00000401882:splice_region_variant&intron_variant:LOW:exon11/13:c.923+5A>G::,RGS7:ENST00000407727:splice_region_variant&intron_variant:LOW:exon13/16:c.1082+5A>G::,RGS7:ENST00000446183:splice_region_variant&intron_variant:LOW:exon14/17:c.830+5A>G::						rs2275742	0.4046	0.5076	4239,.	0.2546,0.4101,0.4598,0.5768,0.4338	0.4500			0.04,0.89	13.31		8.38>10.57		0.000/0.002		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240977964	240977964	G	T	hom	hom	het	off-target	QUAL=9590;DP=169,108,64;AF=0.99,1.00,0.44;MQM=60	RGS7	intron	RGS7:ENST00000331110:intron_variant:MODIFIER:exon12/17:c.767+52C>A::,RGS7:ENST00000348120:intron_variant:MODIFIER:exon9/14:c.686+52C>A::,RGS7:ENST00000366562:intron_variant:MODIFIER:exon11/15:c.845+52C>A::,RGS7:ENST00000366563:intron_variant:MODIFIER:exon12/17:c.845+52C>A::,RGS7:ENST00000366564:intron_variant:MODIFIER:exon12/16:c.845+52C>A::,RGS7:ENST00000366565:intron_variant:MODIFIER:exon12/17:c.845+52C>A::,RGS7:ENST00000401882:intron_variant:MODIFIER:exon9/13:c.686+52C>A::,RGS7:ENST00000407727:intron_variant:MODIFIER:exon11/16:c.845+52C>A::,RGS7:ENST00000446183:intron_variant:MODIFIER:exon12/17:c.593+52C>A::						rs12744536	0.5292	0.6313	6601,.		-1.2830			0.00,0.08	4.20						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241146322	241146322	A	G	het	het	wt	off-target	QUAL=4121;DP=215,82,57;AF=0.53,0.54,0.00;MQM=60	RGS7	intron	RGS7:ENST00000331110:intron_variant:MODIFIER:exon4/17:c.148+57T>C::,RGS7:ENST00000348120:intron_variant:MODIFIER:exon3/14:c.226+57T>C::,RGS7:ENST00000366562:intron_variant:MODIFIER:exon3/15:c.226+57T>C::,RGS7:ENST00000366563:intron_variant:MODIFIER:exon4/17:c.226+57T>C::,RGS7:ENST00000366564:intron_variant:MODIFIER:exon4/16:c.226+57T>C::,RGS7:ENST00000366565:intron_variant:MODIFIER:exon4/17:c.226+57T>C::,RGS7:ENST00000401882:intron_variant:MODIFIER:exon3/13:c.226+57T>C::,RGS7:ENST00000407727:intron_variant:MODIFIER:exon3/16:c.226+57T>C::,RGS7:ENST00000446183:intron_variant:MODIFIER:exon4/17:c.-27+57T>C::						rs7520707	0.3560	0.3630	2125,.		0.6750			0.03,0.13	2.36						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241519098	241519098	T	A	hom	hom	hom		QUAL=35121;DP=432,418,285;AF=1.00,1.00,1.00;MQM=60	RGS7	5'UTR	RGS7:ENST00000366563:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:ENST00000366564:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:ENST00000366565:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::	regulatory_region_variant:promoter					rs4659599	0.9483	0.9795	14388,.	0.8691,0.9883,0.9973,0.9877,0.9871	1.2450			0.34,0.42	10.70						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241520188	241520188	T	C	n/a	hom	hom	off-target	QUAL=979;DP=0,16,17;AF=,1.00,1.00;MQM=60	RGS7	intron	RGS7:ENST00000366563:intron_variant:MODIFIER:exon1/17:c.-51+11A>G::,RGS7:ENST00000366564:intron_variant:MODIFIER:exon1/16:c.-51+11A>G::,RGS7:ENST00000366565:intron_variant:MODIFIER:exon1/17:c.-51+11A>G::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site					rs1891130	0.9485	0.9565	14020,.		0.5930			0.00,0.25	15.37						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241663902	241663902	-	GAGA	wt	het	het	off-target	QUAL=1278;DP=9,118,76;AF=0.00,0.58,0.42;MQM=60	FH	intron	FH:ENST00000366560:intron_variant:MODIFIER:exon8/9:c.1237-16_1237-13dup::		136850 [GENE=FH PHENOS=Fumarase deficiency,606812,Autosomal recessive/Leiomyomatosis and renal cell cancer,150800,Autosomal dominant];	296866 [uncertain significance DISEASE=Multiple cutaneous leiomyomas,Fumarase deficiency,not specified,Multiple Cutaneous and Uterine Leiomyomas];		(GA)n (Simple_repeat)	rs144131869		0.2511	802,.						1.89						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241663902	241663902	-	GAGAGA	wt	wt	het	off-target	QUAL=1278;DP=9,118,76;AF=0.00,0.58,0.42;MQM=60	FH	intron	FH:ENST00000366560:intron_variant:MODIFIER:exon8/9:c.1237-18_1237-13dup::		136850 [GENE=FH PHENOS=Fumarase deficiency,606812,Autosomal recessive/Leiomyomatosis and renal cell cancer,150800,Autosomal dominant];	296867 [uncertain significance DISEASE=Multiple cutaneous leiomyomas,Fumarase deficiency,Multiple Cutaneous and Uterine Leiomyomas];		(GA)n (Simple_repeat)	rs144131869		0.2089	574,.						1.80						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241663902	241663902	-	GAGAGAGAGA	wt	het	wt	off-target	QUAL=1278;DP=9,118,76;AF=0.00,0.58,0.42;MQM=59	FH	intron	FH:ENST00000366560:intron_variant:MODIFIER:exon8/9:c.1237-22_1237-13dup::		136850 [GENE=FH PHENOS=Fumarase deficiency,606812,Autosomal recessive/Leiomyomatosis and renal cell cancer,150800,Autosomal dominant];	296869 [uncertain significance DISEASE=Multiple cutaneous leiomyomas,Fumarase deficiency,Multiple Cutaneous and Uterine Leiomyomas];		(GA)n (Simple_repeat)	rs144131869		0.0424	52,.						1.63						49	28						FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	247581560	247581560	A	T	het	het	wt		QUAL=12561;DP=494,452,340;AF=0.51,0.53,0.00;MQM=60	NLRP3	5'UTR	NLRP3:ENST00000336119:5_prime_UTR_variant:MODIFIER:exon1/9:c.-537A>T::,NLRP3:ENST00000348069:5_prime_UTR_variant:MODIFIER:exon1/7:c.-537A>T::,NLRP3:ENST00000366496:5_prime_UTR_variant:MODIFIER:exon1/8:c.-537A>T::,NLRP3:ENST00000366497:5_prime_UTR_variant:MODIFIER:exon2/9:c.-537A>T::,NLRP3:ENST00000391828:5_prime_UTR_variant:MODIFIER:exon2/11:c.-71A>T::		606416 [GENE=NLRP3 PHENOS=CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant];	296927 [likely benign DISEASE=Familial amyloid nephropathy with urticaria AND deafness,Familial cold autoinflammatory syndrome,Chronic infantile neurological, cutaneous and articular syndrome];			rs116502550	0.0030	0.0112	5,.		0.2450			0.03,0.10	1.02						0	23						NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247581692	247581692	T	C	hom	hom	hom		QUAL=17664;DP=263,168,161;AF=1.00,1.00,1.00;MQM=58	NLRP3	5'UTR,intron	NLRP3:ENST00000336119:5_prime_UTR_variant:MODIFIER:exon1/9:c.-405T>C::,NLRP3:ENST00000348069:5_prime_UTR_variant:MODIFIER:exon1/7:c.-405T>C::,NLRP3:ENST00000366496:5_prime_UTR_variant:MODIFIER:exon1/8:c.-405T>C::,NLRP3:ENST00000366497:5_prime_UTR_variant:MODIFIER:exon2/9:c.-405T>C::,NLRP3:ENST00000391828:intron_variant:MODIFIER:exon2/10:c.-39+100T>C::		606416 [GENE=NLRP3 PHENOS=CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant];	296931 [benign DISEASE=Familial amyloid nephropathy with urticaria AND deafness,Familial cold autoinflammatory syndrome,Chronic infantile neurological, cutaneous and articular syndrome];		AluSx1 (SINE/Alu)	rs7523422	0.9978	0.9976	15575,.		-2.9100			0.00,0.02	0.40						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247581872	247581872	G	A	het	het	het		QUAL=5055;DP=217,85,68;AF=0.54,0.44,0.56;MQM=58	NLRP3	5'UTR,intron	NLRP3:ENST00000336119:5_prime_UTR_variant:MODIFIER:exon1/9:c.-225G>A::,NLRP3:ENST00000348069:5_prime_UTR_variant:MODIFIER:exon1/7:c.-225G>A::,NLRP3:ENST00000366496:5_prime_UTR_variant:MODIFIER:exon1/8:c.-225G>A::,NLRP3:ENST00000366497:5_prime_UTR_variant:MODIFIER:exon2/9:c.-225G>A::,NLRP3:ENST00000391828:intron_variant:MODIFIER:exon2/10:c.-38-187G>A::		606416 [GENE=NLRP3 PHENOS=CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant];	296932 [likely benign DISEASE=Familial amyloid nephropathy with urticaria AND deafness,Familial cold autoinflammatory syndrome,Chronic infantile neurological, cutaneous and articular syndrome];		AluSx1 (SINE/Alu)	rs138900557	0.0158	0.0452	52,.		0.3960			0.00,0.07	1.88						1	27						NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247582063	247582063	G	T	het	het	het		QUAL=9884;DP=330,285,231;AF=0.48,0.50,0.41;MQM=60	NLRP3	5'UTR	NLRP3:ENST00000336119:5_prime_UTR_variant:MODIFIER:exon1/9:c.-34G>T::,NLRP3:ENST00000348069:5_prime_UTR_variant:MODIFIER:exon1/7:c.-34G>T::,NLRP3:ENST00000366496:5_prime_UTR_variant:MODIFIER:exon1/8:c.-34G>T::,NLRP3:ENST00000366497:5_prime_UTR_variant:MODIFIER:exon2/9:c.-34G>T::,NLRP3:ENST00000391828:5_prime_UTR_variant:MODIFIER:exon3/11:c.-34G>T::		606416 [GENE=NLRP3 PHENOS=CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant];	296937 [benign DISEASE=Familial amyloid nephropathy with urticaria AND deafness,Familial cold autoinflammatory syndrome,Chronic infantile neurological, cutaneous and articular syndrome,not provided];			rs73136263	0.0270	0.0550	60,.	0.0360,0.0125,0.0009,0.0471,0.0219	0.0630			0.07,0.17	1.99						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247587477	247587477	G	A	het	het	het		QUAL=6208;DP=160,190,152;AF=0.48,0.57,0.41;MQM=60	NLRP3	synonymous	NLRP3:ENST00000336119:synonymous_variant:LOW:exon3/9:c.732G>A:p.Ala244=:PF05729,NLRP3:ENST00000348069:synonymous_variant:LOW:exon3/7:c.732G>A:p.Ala244=:PF05729,NLRP3:ENST00000366496:synonymous_variant:LOW:exon3/8:c.732G>A:p.Ala244=:PF05729,NLRP3:ENST00000366497:synonymous_variant:LOW:exon4/9:c.732G>A:p.Ala244=:PF05729,NLRP3:ENST00000391827:synonymous_variant:LOW:exon3/8:c.732G>A:p.Ala244=:PF05729,NLRP3:ENST00000391828:synonymous_variant:LOW:exon5/11:c.732G>A:p.Ala244=:PF05729		606416 [GENE=NLRP3 PHENOS=CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant];	138528 [benign DISEASE=Familial amyloid nephropathy with urticaria AND deafness,Familial cold autoinflammatory syndrome,Chronic infantile neurological, cutaneous and articular syndrome,not specified,not provided];			rs3806268	0.3874	0.5025	3599,.	0.1030,0.4077,0.5315,0.5585,0.5436	-2.1770			0.01,0.10	0.25						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247587531	247587531	A	G	hom	hom	hom		QUAL=14017;DP=154,161,117;AF=1.00,1.00,1.00;MQM=60	NLRP3	synonymous	NLRP3:ENST00000336119:synonymous_variant:LOW:exon3/9:c.786A>G:p.Arg262=:PF05729,NLRP3:ENST00000348069:synonymous_variant:LOW:exon3/7:c.786A>G:p.Arg262=:PF05729,NLRP3:ENST00000366496:synonymous_variant:LOW:exon3/8:c.786A>G:p.Arg262=:PF05729,NLRP3:ENST00000366497:synonymous_variant:LOW:exon4/9:c.786A>G:p.Arg262=:PF05729,NLRP3:ENST00000391827:synonymous_variant:LOW:exon3/8:c.786A>G:p.Arg262=:PF05729,NLRP3:ENST00000391828:synonymous_variant:LOW:exon5/11:c.786A>G:p.Arg262=:PF05729		606416 [GENE=NLRP3 PHENOS=CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant];	403243 [benign DISEASE=not specified];			rs4925543		0.9463	13681,.	0.8482,0.9714,0.9988,0.9579,0.8828	-0.1580			0.30,0.95	6.63						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247597349	247597349	G	A	het	het	het	off-target	QUAL=2343;DP=148,30,16;AF=0.63,0.20,0.19;MQM=57	NLRP3	intron	NLRP3:ENST00000336119:intron_variant:MODIFIER:exon4/8:c.2328-56G>A::,NLRP3:ENST00000348069:intron_variant:MODIFIER:exon3/6:c.2157-56G>A::,NLRP3:ENST00000366496:intron_variant:MODIFIER:exon4/7:c.2328-56G>A::,NLRP3:ENST00000366497:intron_variant:MODIFIER:exon5/8:c.2328-56G>A::,NLRP3:ENST00000391827:intron_variant:MODIFIER:exon3/7:c.2157-56G>A::,NLRP3:ENST00000391828:intron_variant:MODIFIER:exon6/10:c.2328-56G>A::		606416 [GENE=NLRP3 PHENOS=CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant];				rs75241539		0.0110	3,.		-0.1560			0.00,0.09	0.12			gain/acceptor/247597349-247597350/Medium/6.515386			82	201		2	[2] auto-classification 20.10.2017  			NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247597365	247597365	G	A	hom	het	het	off-target	QUAL=4544;DP=103,40,32;AF=0.98,0.58,0.75;MQM=56	NLRP3	intron	NLRP3:ENST00000336119:intron_variant:MODIFIER:exon4/8:c.2328-40G>A::,NLRP3:ENST00000348069:intron_variant:MODIFIER:exon3/6:c.2157-40G>A::,NLRP3:ENST00000366496:intron_variant:MODIFIER:exon4/7:c.2328-40G>A::,NLRP3:ENST00000366497:intron_variant:MODIFIER:exon5/8:c.2328-40G>A::,NLRP3:ENST00000391827:intron_variant:MODIFIER:exon3/7:c.2157-40G>A::,NLRP3:ENST00000391828:intron_variant:MODIFIER:exon6/10:c.2328-40G>A::		606416 [GENE=NLRP3 PHENOS=CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant];				rs10925022		0.3126	2196,.		-2.1850			0.00,0.06	0.20			loss/donor/247597365-247597366/Medium/1.683999			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247597365	247597365	G	ATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAGA	wt	het	het	off-target	QUAL=4544;DP=103,40,32;AF=0.00,0.40,0.25;MQM=59	NLRP3	intron	NLRP3:ENST00000336119:intron_variant:MODIFIER:exon4/8:c.2328-40delinsATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAGA::,NLRP3:ENST00000348069:intron_variant:MODIFIER:exon3/6:c.2157-40delinsATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAGA::,NLRP3:ENST00000366496:intron_variant:MODIFIER:exon4/7:c.2328-40delinsATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAGA::,NLRP3:ENST00000366497:intron_variant:MODIFIER:exon5/8:c.2328-40delinsATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAGA::,NLRP3:ENST00000391827:intron_variant:MODIFIER:exon3/7:c.2157-40delinsATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAGA::,NLRP3:ENST00000391828:intron_variant:MODIFIER:exon6/10:c.2328-40delinsATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAGA::		606416 [GENE=NLRP3 PHENOS=CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant];									-2.1850				0.11			loss/donor/247597365-247597366/Medium/1.683999			3	2						NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247599232	247599232	G	A	het	het	het	off-target	QUAL=1373;DP=46,62,38;AF=0.50,0.50,0.39;MQM=60	NLRP3	intron	NLRP3:ENST00000336119:intron_variant:MODIFIER:exon5/8:c.2499-40G>A::,NLRP3:ENST00000348069:intron_variant:MODIFIER:exon4/6:c.2327+1657G>A::,NLRP3:ENST00000366496:intron_variant:MODIFIER:exon5/7:c.2498+1657G>A::,NLRP3:ENST00000366497:intron_variant:MODIFIER:exon6/8:c.2498+1657G>A::,NLRP3:ENST00000391827:intron_variant:MODIFIER:exon4/7:c.2328-40G>A::,NLRP3:ENST00000391828:intron_variant:MODIFIER:exon7/10:c.2499-40G>A::		606416 [GENE=NLRP3 PHENOS=CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant];				rs10754557	0.4840	0.5915	4901,.	0.2406,0.4940,0.6688,0.6219,0.6035	-0.8120			0.04,0.17	2.52						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247611660	247611661	AG	-	het	wt	het	off-target	QUAL=2195;DP=185,76,39;AF=0.45,0.00,0.54;MQM=60	NLRP3	intron	NLRP3:ENST00000336119:intron_variant:MODIFIER:exon8/8:c.3012-45_3012-44del::,NLRP3:ENST00000348069:intron_variant:MODIFIER:exon6/6:c.2670-45_2670-44del::,NLRP3:ENST00000366496:intron_variant:MODIFIER:exon7/7:c.2841-45_2841-44del::,NLRP3:ENST00000366497:intron_variant:MODIFIER:exon8/8:c.2841-45_2841-44del::,NLRP3:ENST00000391827:intron_variant:MODIFIER:exon7/7:c.2841-45_2841-44del::,NLRP3:ENST00000391828:intron_variant:MODIFIER:exon10/10:c.3012-45_3012-44del::	regulatory_region_variant:CTCF_binding_site	606416 [GENE=NLRP3 PHENOS=CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant];				rs201053423	0.0485	0.0494	33,.	0.0102,0.0263,0.0341,0.0561,0.0969	-0.3230				2.78						16	730						NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247612036	247612036	G	C	hom	hom	hom		QUAL=49934;DP=691,501,384;AF=1.00,1.00,1.00;MQM=60	NLRP3	3'UTR	NLRP3:ENST00000336119:3_prime_UTR_variant:MODIFIER:exon9/9:c.*230G>C::,NLRP3:ENST00000348069:3_prime_UTR_variant:MODIFIER:exon7/7:c.*230G>C::,NLRP3:ENST00000366496:3_prime_UTR_variant:MODIFIER:exon8/8:c.*230G>C::,NLRP3:ENST00000366497:3_prime_UTR_variant:MODIFIER:exon9/9:c.*230G>C::,NLRP3:ENST00000391828:3_prime_UTR_variant:MODIFIER:exon11/11:c.*230G>C::	regulatory_region_variant:CTCF_binding_site	606416 [GENE=NLRP3 PHENOS=CINCA syndrome,607115,Autosomal dominant/Deafness,autosomal dominant 34,with or without inflammation,617772,Autosomal dominant/Familial cold inflammatory syndrome 1,120100,Autosomal dominant/Keratoendothelitis fugax hereditaria,148200,Autosomal dominant/Muckle-Wells syndrome,191900,Autosomal dominant];	296956 [benign DISEASE=Familial amyloid nephropathy with urticaria AND deafness,Familial cold autoinflammatory syndrome,Chronic infantile neurological, cutaneous and articular syndrome];			rs10754558		0.6325	6369,.		0.1530			0.00,0.09	5.43						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247612435	247612435	A	T	hom	n/a	hom	off-target	QUAL=1322;DP=38,1,3;AF=1.00,1.00,1.00;MQM=60	OR2B11,NLRP3	downstream_gene	OR2B11:ENST00000318749:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000336119:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000348069:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000366496:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000366497:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000391827:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000391828:downstream_gene_variant:MODIFIER::::						rs4925547	0.4157	0.3578	2111,.		2.0950			0.82,0.94	13.14						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OR2B11 (inh=n/a oe_syn=1.03 oe_mis=0.94 oe_lof=0.83), NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chrMT	72	72	T	C	hom	wt	hom		QUAL=255729;DP=4345,4566,4374;AF=0.99,0.00,0.99;MQM=54	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680:upstream_gene_variant:MODIFIER::::						rs879158303															208	16						MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	73	73	A	G	wt	hom	wt		QUAL=123473;DP=4282,4662,4415;AF=0.01,1.00,0.00;MQM=50	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680:upstream_gene_variant:MODIFIER::::						rs869183622															4029	111						MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	150	150	C	T	wt	hom	wt		QUAL=131572;DP=4145,3999,3294;AF=0.00,0.99,0.00;MQM=59	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680:upstream_gene_variant:MODIFIER::::						rs62581312															621	52						MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	152	152	T	C	wt	hom	wt		QUAL=131572;DP=4145,3999,3294;AF=0.00,0.99,0.00;MQM=59	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680:upstream_gene_variant:MODIFIER::::						rs117135796															1480	110						MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	195	195	T	C	wt	hom	wt		QUAL=107895;DP=3712,3375,2436;AF=0.00,1.00,0.00;MQM=59	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680:upstream_gene_variant:MODIFIER::::						rs2857291															1279	106						MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	215	215	A	G	wt	hom	wt		QUAL=100106;DP=3337,3146,2042;AF=0.00,0.99,0.00;MQM=59	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680:upstream_gene_variant:MODIFIER::::						rs879219259															88	11						MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	263	263	A	G	hom	hom	hom		QUAL=194497;DP=2654,2347,1157;AF=1.00,1.00,1.00;MQM=59	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680:upstream_gene_variant:MODIFIER::::			441147 [not provided DISEASE=not provided];			rs2853515															6866	10						MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	295	295	C	T	wt	hom	wt		QUAL=56602;DP=2162,1905,774;AF=0.00,0.99,0.00;MQM=59	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680:upstream_gene_variant:MODIFIER::::						rs41528348															601	24						MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	302	302	-	CC	hom	wt	hom		QUAL=44182;DP=718,1253,300;AF=0.08,0.97,0.15;MQM=59	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680:upstream_gene_variant:MODIFIER::::																					287	402						MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	310	310	-	C	hom	wt	hom		QUAL=44182;DP=718,1253,300;AF=0.88,0.98,0.96;MQM=59	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680:upstream_gene_variant:MODIFIER::::						rs369786048															3638	1981						MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	310	310	-	TC	wt	hom	wt		QUAL=44182;DP=718,1253,300;AF=0.90,0.98,0.97;MQM=59	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680:upstream_gene_variant:MODIFIER::::																					62	8						MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	319	319	T	C	wt	hom	wt		QUAL=44182;DP=718,1253,300;AF=0.92,0.98,0.98;MQM=59	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680:upstream_gene_variant:MODIFIER::::						rs879055956															84	3						MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	430	430	T	C	wt	hom	wt		QUAL=54717;DP=2887,1853,1252;AF=0.00,0.99,0.00;MQM=59	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680:upstream_gene_variant:MODIFIER::::																					2	1						MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	489	489	T	C	wt	hom	wt		QUAL=66125;DP=3024,2265,1845;AF=0.00,0.99,0.00;MQM=60	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680:upstream_gene_variant:MODIFIER::::						rs28625645															825	45						MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	513	513	G	A	wt	hom	wt		QUAL=66297;DP=3150,2283,1832;AF=0.00,0.99,0.00;MQM=59	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-TW,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377:upstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680:upstream_gene_variant:MODIFIER::::						rs879162984												loss/acceptor/512-513/Medium/3.788898			104	6						MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	750	750	A	G	hom	hom	hom		QUAL=291152;DP=3337,3123,2664;AF=1.00,1.00,1.00;MQM=59	MT-RNR1	non_coding_transcript_exon	MT-RNR1:ENST00000389680:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.103A>G::			441148 [not provided DISEASE=not provided];			rs2853518															6934	7						MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	1438	1438	A	G	hom	hom	hom		QUAL=708396;DP=8492,7277,6305;AF=1.00,1.00,1.00;MQM=55	MT-RNR1	non_coding_transcript_exon	MT-RNR1:ENST00000389680:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.791A>G::			42220 [benign DISEASE=not specified,not provided];			rs2001030															6715	10						MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	1850	1850	T	C	wt	hom	wt		QUAL=121409;DP=5778,3822,3333;AF=0.00,0.99,0.00;MQM=59	MT-RNR2	non_coding_transcript_exon	MT-RNR2:ENST00000387347:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.180T>C::						rs878878913															63	12						MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	2706	2706	A	G	hom	hom	hom		QUAL=181193;DP=3096,1452,1272;AF=1.00,1.00,1.00;MQM=59	MT-RNR2	non_coding_transcript_exon	MT-RNR2:ENST00000387347:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1036A>G::						rs2854128															4128	179						MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	3107	3107	N	C	het	het	het		QUAL=11714;DP=152,41,44;AF=0.41,0.41,0.57;MQM=60	MT-RNR2	non_coding_transcript_exon	MT-RNR2:ENST00000387347:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1437N>C::																					39	134						MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	3107	3107	N	T	het	het	het		QUAL=11714;DP=152,41,44;AF=0.58,0.59,0.41;MQM=60	MT-RNR2	non_coding_transcript_exon	MT-RNR2:ENST00000387347:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1437N>T::																					169	158						MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	3109	3109	T	C	het	het	het		QUAL=11714;DP=152,41,44;AF=0.99,1.00,0.98;MQM=60	MT-RNR2	non_coding_transcript_exon	MT-RNR2:ENST00000387347:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1439T>C::																					13	14						MT-RNR2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4216	4216	T	C	wt	hom	wt		QUAL=105335;DP=3774,3516,3102;AF=0.00,0.99,0.00;MQM=44	MT-ND1	missense	MT-ND1:ENST00000361390:missense_variant:MODERATE:exon1/1:c.910T>C:p.Tyr304His:PF00146			9724 [likely pathogenic(replaced by megSAP based on classifications:1x3,1x5) DISEASE=Leber's optic atrophy,not provided];			rs1599988						T(1.00)	B(0.01)							COSM1138370,COSM1138371	1091	48						MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4580	4580	G	A	hom	wt	hom		QUAL=102526;DP=2454,1944,1672;AF=0.99,0.00,0.99;MQM=31	MT-ND2	synonymous	MT-ND2:ENST00000361453:synonymous_variant:LOW:exon1/1:c.111G>A:p.Met37=:PF00361						rs28357975															127	5						MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4769	4769	A	G	hom	hom	hom		QUAL=170382;DP=2338,2312,2035;AF=1.00,1.00,1.00;MQM=32	MT-ND2	synonymous	MT-ND2:ENST00000361453:synonymous_variant:LOW:exon1/1:c.300A>G:p.Met100=:PF00361			441150 [not provided DISEASE=not provided];			rs3021086															5366	14						MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7028	7028	C	T	hom	hom	hom		QUAL=308981;DP=3117,3998,3478;AF=0.99,1.00,1.00;MQM=42	MT-CO1	synonymous	MT-CO1:ENST00000361624:synonymous_variant:LOW:exon1/1:c.1125C>T:p.Ala375=:PF00115						rs2015062															3968	140						MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7476	7476	C	T	wt	hom	wt		QUAL=44924;DP=4053,1599,1392;AF=0.00,0.99,0.00;MQM=42	MT-TS1	non_coding_transcript_exon	MT-TS1:ENST00000387416:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.39G>A::			42228 [likely benign DISEASE=not specified];			rs201950015															109	10						MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7789	7789	G	A	wt	hom	wt		QUAL=141895;DP=7810,4960,5635;AF=0.00,0.99,0.00;MQM=57	MT-CO2	synonymous	MT-CO2:ENST00000361739:synonymous_variant:LOW:exon1/1:c.204G>A:p.Leu68=:PF02790			376897 [benign DISEASE=not provided];			rs386829014															114	8						MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	8860	8860	A	G	hom	hom	hom		QUAL=172415;DP=1890,2330,2140;AF=1.00,1.00,1.00;MQM=33	MT-ATP6	missense	MT-ATP6:ENST00000361899:missense_variant:MODERATE:exon1/1:c.334A>G:p.Thr112Ala:PF00119						rs2001031						T(0.10)	B(0.00)								5403	20						MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	10398	10398	A	G	wt	hom	wt		QUAL=119820;DP=4702,3733,3105;AF=0.00,0.99,0.00;MQM=59	MT-ND3	missense	MT-ND3:ENST00000361227:missense_variant:MODERATE:exon1/1:c.340A>G:p.Thr114Ala:			9713 [protective DISEASE=Parkinson disease, resistance to];			rs2853826						T(1.00)	B(0.00)								1314	64						MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	10499	10499	A	G	wt	hom	wt		QUAL=122618;DP=4621,3751,3081;AF=0.00,0.99,0.00;MQM=59	MT-ND4L	synonymous	MT-ND4L:ENST00000361335:synonymous_variant:LOW:exon1/1:c.30A>G:p.Leu10=:PF00420			376866 [benign DISEASE=not provided];			rs1057520074															83	4						MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11251	11251	A	G	wt	hom	wt		QUAL=178194;DP=6484,5623,4780;AF=0.00,0.99,0.00;MQM=59	MT-ND4	synonymous	MT-ND4:ENST00000361381:synonymous_variant:LOW:exon1/1:c.492A>G:p.Leu164=:PF00361						rs869096886														COSM1138232	1299	69						MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11377	11377	G	A	wt	hom	wt		QUAL=145189;DP=6135,4559,4068;AF=0.00,0.99,0.00;MQM=59	MT-ND4	synonymous	MT-ND4:ENST00000361381:synonymous_variant:LOW:exon1/1:c.618G>A:p.Lys206=:PF00361						rs193302938															129	13						MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11719	11719	G	A	wt	hom	wt		QUAL=165746;DP=6929,5317,4181;AF=0.00,1.00,0.01;MQM=57	MT-ND4	synonymous	MT-ND4:ENST00000361381:synonymous_variant:LOW:exon1/1:c.960G>A:p.Gly320=:PF00361						rs2853495															3753	127						MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	12612	12612	A	G	wt	hom	wt		QUAL=164296;DP=7620,5136,4364;AF=0.00,0.99,0.00;MQM=59	MT-ND5	synonymous	MT-ND5:ENST00000361567:synonymous_variant:LOW:exon1/1:c.276A>G:p.Val92=:PF00662						rs28359172															552	70						MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	13708	13708	G	A	wt	hom	wt		QUAL=51206;DP=4548,1714,1554;AF=0.00,0.99,0.00;MQM=59	MT-ND5	missense	MT-ND5:ENST00000361567:missense_variant:MODERATE:exon1/1:c.1372G>A:p.Ala458Thr:PF06455			9696 [likely pathogenic(replaced by megSAP based on classifications:1x3,1x5) DISEASE=Leber's optic atrophy];			rs28359178						T(0.19)	B(0.00)								717	34						MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	13722	13722	A	G	wt	hom	wt		QUAL=53849;DP=4635,1805,1669;AF=0.00,0.99,0.00;MQM=60	MT-ND5	synonymous	MT-ND5:ENST00000361567:synonymous_variant:LOW:exon1/1:c.1386A>G:p.Leu462=:PF06455			377244 [benign DISEASE=not provided];			rs386829190															86	5						MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14133	14133	A	G	wt	hom	wt		QUAL=97052;DP=3880,3080,2747;AF=0.00,1.00,0.00;MQM=59	MT-ND5	synonymous	MT-ND5:ENST00000361567:synonymous_variant:LOW:exon1/1:c.1797A>G:p.Leu599=:PF06455			377029 [benign DISEASE=not provided];			rs879100848															86	7						MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14370	14370	A	G	hom	wt	hom		QUAL=191347;DP=3931,2351,2175;AF=0.99,0.00,0.99;MQM=59	MT-ND6	synonymous	MT-ND6:ENST00000361681:synonymous_variant:LOW:exon1/1:c.304T>C:p.Leu102=:PF00499																					3	0						MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14766	14766	C	T	wt	hom	wt		QUAL=71223;DP=3282,2284,2100;AF=0.00,1.00,0.01;MQM=59	MT-CYB	missense	MT-CYB:ENST00000361789:missense_variant:MODERATE:exon1/1:c.20C>T:p.Thr7Ile:			140587 [likely pathogenic DISEASE=Familial cancer of breast];			rs193302980,rs527236041						D(0.04)	B(0.00)								3738	119						MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15257	15257	G	A	wt	hom	wt		QUAL=122431;DP=4492,3827,3613;AF=0.00,0.99,0.00;MQM=60	MT-CYB	missense	MT-CYB:ENST00000361789:missense_variant:MODERATE:exon1/1:c.511G>A:p.Asp171Asn:PF13631			9674 [likely pathogenic(replaced by megSAP based on classifications:1x3,1x5) DISEASE=Leber's optic atrophy];			rs41518645						D(0.01)	B(0.01)							COSM1138306,COSM1138307	126	14						MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15326	15326	A	G	hom	hom	hom		QUAL=369220;DP=4425,3647,3479;AF=1.00,1.00,1.00;MQM=59	MT-CYB	missense	MT-CYB:ENST00000361789:missense_variant:MODERATE:exon1/1:c.580A>G:p.Thr194Ala:PF13631			140592 [likely pathogenic DISEASE=Familial cancer of breast];			rs2853508						T(0.28)	B(0.01)								6900	28		1	[1] harmuth 09.04.2018		most likely WT variant; in 98,6% of all full length sequences (MitoMap); FH 09.04.2018	MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15452	15452	C	A	wt	hom	wt		QUAL=107082;DP=6642,3390,3237;AF=0.00,0.99,0.00;MQM=59	MT-CYB	missense	MT-CYB:ENST00000361789:missense_variant:MODERATE:exon1/1:c.706C>A:p.Leu236Ile:PF13631			143925 [likely pathogenic DISEASE=Neoplasm of ovary];			rs193302994,rs527236209						T(0.51)	B(0.24)								1261	99						MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15904	15904	C	T	hom	wt	hom		QUAL=300923;DP=5963,3771,3321;AF=0.99,0.00,0.99;MQM=59	MT-TT	non_coding_transcript_exon	MT-TT:ENST00000387460:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.17C>T::						rs35788393															144	14						MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16069	16069	C	T	wt	hom	wt		QUAL=118988;DP=5759,3738,3605;AF=0.00,0.99,0.00;MQM=60	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461:upstream_gene_variant:MODIFIER::::						rs147903261															569	43						MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16126	16126	T	C	wt	hom	wt		QUAL=123539;DP=5704,3904,4012;AF=0.00,0.99,0.00;MQM=60	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461:upstream_gene_variant:MODIFIER::::						rs147029798															1268	203						MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16145	16145	G	A	wt	hom	wt		QUAL=123948;DP=5649,3930,4045;AF=0.00,0.99,0.00;MQM=60	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461:upstream_gene_variant:MODIFIER::::						rs41419246															225	58						MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16231	16231	T	C	wt	hom	wt		QUAL=148528;DP=6558,4763,4459;AF=0.00,0.99,0.00;MQM=59	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461:upstream_gene_variant:MODIFIER::::						rs386829286															77	19						MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16261	16261	C	T	wt	hom	wt		QUAL=148285;DP=7100,4737,4283;AF=0.00,0.99,0.00;MQM=60	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461:upstream_gene_variant:MODIFIER::::						rs138126107															263	65						MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16298	16298	T	C	hom	wt	hom		QUAL=331938;DP=6101,4784,4217;AF=0.99,0.00,0.99;MQM=59	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461:upstream_gene_variant:MODIFIER::::						rs148377232															276	58						MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16519	16519	T	C	hom	wt	hom		QUAL=371239;DP=6983,4912,4512;AF=1.00,0.01,1.00;MQM=58	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461:upstream_gene_variant:MODIFIER::::						rs3937033															4421	145						MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
